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2Abstract
Huntington’s disease (HD) is a late onset, neurodegenerative disorder that typically progresses for 
10-20 years, resulting in premature death. Symptoms include choreic movement disorder, cognitive 
deficits and psychiatric disturbances. The neurodegeneration associated with HD occurs most 
prominently in the striatum with the additional involvement of the cortex and other brain regions in 
later stages. Initial neuropathology within the striatum demonstrates the selective vulnerability of 
medium spiny neurons. HD is inherited in an autosomal dominant fashion and is caused by the 
expansion o f a polymorphic trinucleotide (CAG) repeat within exon 1 o f the ubiquitously 
expressed HD  gene. The expansion mutation results in an elongated poly glutamine stretch within 
the protein product, called huntingtin. An inverse correlation between the repeat number and age at 
onset/extent of pathology has been observed with the longest repeats causing severe juvenile HD.
A  knock-in HD mouse model has been created by homologous recombination, inserting a perfect 
CAG repeat tract (72-80 repeats) into exon 1 o f the mouse Hdh gene (Shelboume et a l ,  1999), the 
mouse orthologue of the human HD  gene. This HD knock-in mouse model provides an opportunity 
to explore the consequences of the HD mutation in its appropriate genomic and protein context.
Previous studies o f the HD knock-in mice have demonstrated several alterations reminiscent of 
human HD, including behavioural changes (Shelboume et a l ,  1999) and synaptic dysfunction 
(Usdin et a l ,  1999). Protein aggregates, a cellular hallmark of the HD disease process, have been 
detected within the nucleus and neuropil of neurons selectively vulnerable to HD (Li et a l ,  2000). 
The presence o f neuropil aggregates has also been associated with axonal degeneration (Li et a l ,  
2001). The alterations observed in HD knock-in mice occur in the absence of obvious cell loss, 
suggesting that this system maybe modelling the events involved in early HD pathogenesis.
Movement disorder is a prominent symptom associated with human HD. Behavioural studies using 
sensitive, quantitative methods to assess motor function have been carried out in the HD knock-in 
mice. Gait abnormalities, at 9 months o f age, in the form o f altered weight distribution were 
observed and appeared to be influenced by the sex o f the mouse since significant alterations were 
restricted to male HD knock-in mice.
In an attempt to assess cognitive deficits that may result from hippocampal synaptic dysfunction 
previously observed in HD knock-in mice, spatial learning and memory was also investigated. 
Experimental design problems prevented the acquisition of robust data from these experiments and 
the cognitive abilities of the HD knock-in mice remain unknown.
3To investigate the neuronal integrity in the HD knock-in mice, neurotransmitter receptor densities 
were determined by quantitative ligand binding autoradiography. By examining receptor density in 
the striatum and cortex o f 18 month old HD knock-in mice a significant reduction in striatal 
dopamine D2 receptors was detected, along with significant increases in striatal and cortical 
benzodiazepine receptor binding. Conversely, no changes were observed in dopamine Di and 
opioid receptor densities although a strong trend towards increased opioid receptor density was 
observed within the striatum. A  comparison o f neurotransmitter receptor densities in different 
congenic HD mouse lines demonstrated an influence o f genetic background on neurotransmitter 
receptor levels in wild-type and HD knock-in mice, suggesting the presence o f possible genetic 
modifiers of the disease process.
To investigate possible molecular mechanisms responsible for the selective pattern o f HD 
neuropathology, mutation profiles in the somatic tissues of HD knock-in mice were investigated 
using a small pool PCR approach. Age-dependent, tissue-specific somatic repeat instability was 
observed, with the striatum, the brain region most affected by HD neuropathology, displaying the 
greatest level and magnitude o f repeat size changes. Studies also suggested that the mechanism  
underlying brain repeat instability might not be replication-based. Finally, the tissue-specific 
mutation profiles observed appeared to be influenced by the presence or absence of amino acid 
residues downstream of the polyglutamine stretch within the huntingtin protein.
Investigations of human juvenile HD tissue confirm the presence of extensive brain region-specific 
repeat instability. The largest repeat size changes were observed in the cortex with lower levels of 
repeat instability in the striatum, perhaps reflecting the pattern of extensive cell loss noted at 
autopsy.
The work presented in this thesis contributes to the further phenotypic characterisation o f the 
knock-in HD mouse model and identifies early molecular and cellular mechanisms underlying HD 
pathogenesis. These studies will inform future discussions o f potential therapeutic targets and the 
utility of biomarkers to evaluate therapeutic efficacy.
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H DV Knock-in HD mouse, homozygous for full-length mutant huntingtin
HIP Hippocampus
HIP-1 Huntingtin-interacting protein 1
Hprt Hypoxanthine phosphoribosyltransferase
HNPCC Hereditary non-polyposis colorectal cancer
Hz Hertz
IAgp Intermediate allele, general population
IAnm Intermediate allele, new mutation
00 Infinite
K Kidney
kb Kilo base pair
kDa Kilodaltons
Kg Kilogram
LTP Long term potentiation
M Male
Pg Microgram (10'6)
mg Milligram (10'3)
m j MilliJules
MJD Machado-Joseph Disease
mGluR Metabotropic glutamate receptor
min Minutes
Microlitres (10‘6)
ml Millilitres (10'3)
\iM Micromolar (1C)'6)
mM Millimolar (10'3)
MM R Mismatch repair
mRNA messenger RNA
MSN Medium spiny neurons
N/A Not applicable
NADPH Nicotinamide adenine dinucleotide phosphate
N-CoR Nuclear receptor co-repressor
neo neomycin resistance cassette
NER Nucleotide excision repair
ng Nanogram (10'9)
NGF Nerve growth factor
N il Neuronal intranuclear inclusions
NLS Nuclear localisation sequence
NM DA receptor N-methyl-D-aspartate glutamate receptor
NO Nitric oxide
NOS Nitric oxide synthase
3NP 3-nitropropionic acid
N/R Not reported
OD Optical density
OLB Oligonucleotide labelling buffer
PCR Polymerase Chain Reaction
PET Positron emission tomography
Pg Picogram (1 0 12)
PH degrees of acidity or alkalinity of solutions
PSD-95 Postsynaptic density-95
PTP Post-tetanic potentiation
PPF Paired pulse facilitation
RNA Ribonucleic acid
Rpm Rotations per minute
RT Room temperature
SBMA Spinobulbar muscular atrophy
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SCA Spinocerebellar ataxia
S.D. Standard deviation
SDS Sodium dodecyl sulfate
SDSA Synthesis-dependent strand annealing
S.E. Standard error
sec Seconds
SP Substance P
SPET Single-photon emission tomography
SP-PCR Small Pool Polymerase Chain Reaction
St Striatum
s v z Subventricular zone
T Thymine
TAFs TBP-associated factors
TBP TATA-binding protein
TE Tissue Equivalent
TRS Trinucleotide repeat sequence
U Units
UV Ultraviolet
V Volts
vs versus
v/v volume-to-volume ratio
W Watts
Wks Weeks
WT Wild-type
X-ray Electromagnetic ray
YAC Yeast artificial chromosome
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1 Introduction
1.1 Huntington’s disease
Huntington’s disease (HD) is an autosomal dominantly inherited neurological disorder affecting ~1 
in 10000 individuals ((HDCRG), 1993). HD displays an adult-onset, typically during the 3rd-4th 
decade of life, and slowly progresses over a 10-20 year period to premature death (Harper, 1991). 
Approximately 7 % of HD patients suffer from the more severe juvenile form of the disease, which 
displays a faster decline in health (Foroud et al., 1999; Harper, 1992) and variation in symptoms 
compared to typical adult-onset HD (Kirkwood et al., 2001; Naarding et al., 2001; Nance and 
Myers, 2001).
1.1.1 Clinical HD
HD is characterised by movement disorder, changes in behaviour and personality, and cognitive 
impairment (Harper, 1991; Hayden, 1981). The relationship between the symptoms is complex and 
significant variation between individuals in disease course and expression has been observed 
(Martin and Gusella, 1986).
1.1.1.1 Movement disorder in HD
The most common form of movement disorder associated with HD is chorea. Chorea, the Greek 
word for dance, refers to irregular, random, involuntary movements that occur in a rapid and 
flowing manner (Higgins, 2001). Initially writhing distal chorea can be mistaken for restlessness. 
However, disease progression leads to ballism, a term that describes severe proximal involuntary 
movements (Higgins, 2001). As HD progresses other movement disorders such as dystonia, 
athetosis and additional impairment o f voluntary movement occur (Kirkwood et al., 1999). 
Sensitive motor assessments have detected a subtle movement disorder in HD mutation carriers 
previously considered to be presymptomatic, suggesting that movement deficits manifest early in 
the disease course (de Boo et al., 1997; Kirkwood et al., 1999). In contrast, juvenile HD is 
commonly characterised by abnormalities in voluntary movement including bradykinesia, which 
progresses to Parkinsonian-like rigidity (Kirkwood et al., 2001; Nance and Myers, 2001).
1.1.1.2 Cognitive deficits in HD
A  variety o f impairments in cognitive functioning have been reported in HD patients, including 
deficits in memory, executive functions, visuospatial abilities, cognitive speed, sensorimotor 
function and olfactory recognition (Brown and Marsden, 1988; Butters et al., 1978; Caine et al., 
1978; Lawrence et al., 1996; Moberg et al., 1987). Brown and Marsden (1988) simplified the
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description of HD-associated cognitive impairment by highlighting processing speed as a central 
component in many impaired functions, suggesting that a general reduction in ‘mental tempo’ that 
progresses to global sub-cortical dementia (Caine et al., 1978).
A  number of studies have attempted to dissect the complex nature of cognitive decline in HD and 
have suggested a differential onset for various types o f cognitive deficits. Deficits in executive 
system functioning, short-term memory and visuospatial functioning present early in the disease 
process while language-based functions appear to remain intact (Kirkwood et al., 2001; Lawrence 
et al., 1996). Despite several studies claiming an absence o f cognitive deficits prior to clinical onset 
(Campodonico et al., 1996; de Boo et al., 1997; Giordani et al., 1995; Gomez-Tortosa et al., 1996), 
evidence for subtle cognitive impairment in HD gene carriers before clinical onset is mounting 
(Foroud et al., 1995; Hahn-Barma et al., 1998; Jason et al., 1997; Kirkwood et al., 1999; Lawrence 
et al., 1998a). The reasons for these discrepant findings may stem from the different population 
sizes, mean age, test sensitivity and clinical criteria used in various cognitive studies.
Juvenile HD cognitive ability is thought to differ from adult-onset HD, particularly in the severity 
of the visual and prefrontal deficits (Gomez-Tortosa et al., 1998). In initial stages of juvenile HD 
cognitive ability is good (superior to that of adult-onset patients in initial stages) with this form of 
the disease predominantly characterised by psychiatric and movement symptoms (Gomez-Tortosa 
et al., 1998; Kirkwood et a l ,  2001).
1.1.1.3 Psychiatric disturbances in HD
Several studies have illustrated a high incidence (50-98 %) o f psychiatric symptoms in HD 
(Anderson and Marder, 2001; Marder et a l ,  2000; Paulsen et a l ,  2001). Although the psychology 
of HD is complex, symptoms such as dysphoria, agitation, irritability, apathy and anxiety are all 
apparent in more than 50 % o f HD patients (Paulsen et al., 2001). Obsessive/compulsive disorders 
have also been observed, with 52 % o f HD patients suffering from at least one obsessive disorder 
(Anderson and Marder, 2001). Despite the varied psychiatric phenotype displayed, the occurrence 
of serious psychoses in HD patients has rarely been observed (Bolt, 1970; Folstein et al., 1983). It 
has been suggested that in most cases of HD psychiatric symptoms precede chorea and intellectual 
decline and in juvenile HD, psychiatric symptoms and dis-inhibition predominate (Paulsen et al., 
2001).
1.1.2 Neuropathology of HD
The neuropathology observed in HD is characterised by the selective neurodegeneration o f the 
striatum (caudate nucleus and putamen) (Vonsattel et al., 1985), with the additional loss of cortical 
layers (Rosas et a l ,  2002; Vonsattel and DiFiglia, 1998). Although the striatum is most affected, a
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general atrophy of the brain also occurs (Hedreen and DeLong, 1991; Vonsattel et al., 1985). 
Initially neuropathology occurs in a cell-type specific manner affecting the medium spiny 
projection neurons (MSN) within the striatum selectively (Goto et al., 1989; Graveland et al., 
1985).
1.1.2.1 Basal ganglia
The basal ganglia, comprised o f the corpus striatum, subthalamic nucleus and substantia nigra, is 
thought to be involved in the integration of the cortico-striato-thalamic circuits concerned with the 
production o f movement (Parent, 1990). The extensive connections o f the basal ganglia with the 
temporal and anterior frontal cortex also indicate additional involvement in memory, emotion, and 
other cognitive functions (Brown et al., 1997).
The major output structure o f the basal ganglia is the inhibitory medial globus pallidus (named 
entopeduncular nucleus in rodents), part of the corpus striatum (Figure 1.1). Excitatory input to the 
medial globus pallidus comes from the subthalamic nucleus and inhibitory input is provided by the 
striatum. The major output tract from the medial globus pallidus innervates nuclei within the 
thalamus. The thalamic nuclei project to and excite the premotor, supplementary motor, prefrontal 
and temporal areas o f the cerebral cortex. This creates a loop as cortical neurons project to the 
striatum, which can therefore modulate the activation of the thalamus (Mitchell et al., 1999).
1.1.2.2 Functional anatomy of the striatum
The structures within the basal ganglia involved in HD pathology are the caudate nucleus and the 
putamen (striatum) within the corpus striatum (Vonsattel et al., 1985). The corpus striatum is made 
up of the striatum (the caudate nucleus and the putamen are structurally distinct in primates but one 
integrated structure in rodents (M itchell et al., 1999)) and the pallidum (lateral and medial globus 
pallidus).
The major afferents to all areas within the striatum arise from the cerebral cortex (Goldman-Rakic 
and Selemon, 1990; Nauta, 1979). The fibres are topographically organised with each area 
preferentially receiving input from specific regions of the cerebral cortex (Goldman-Rakic and 
Selemon, 1990; McGeorge and Faull, 1989). The corticostriatal connections are excitatory 
glutamatergic fibres, which make direct synaptic contact with the medium spiny neurons (MSN), 
the main cell-type within the striatum (Bouyer et al., 1984). The dopaminergic neurons o f the 
midbrain (substantia nigra pars compacta) and the glutamatergic fibres from the thalamus also 
innervate all areas of the striatum (Parent, 1990; Pollack, 2001).
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The striatum has an intergral role in controlling the activity o f  the cortico-striato-thalamic 
circuit. The GABAergic MSN in the striatum are split into two groups by their neuropeptide 
content and route o f  projection to the medial globus pallidus (the output structure o f  the 
basal ganglia). The indirect pathway is made up o f  MSN expressing GABA and ENK, which
project to the S T N (  ). The inhibitory effect o f  this pathway causes the STN to excite
the medial globus pallidus and so inhibit the thalmus and therefore the cortex. The direct 
pathway consists o f  MSN expressing GABA and SP and/or DN, which project to the medial
globus pallidus ( ............. ). Their inhibitory effect releases the thalamus and therefore the cortex
from the inhibitory effects o f  the medial globus pallidus. The output o f  the basal ganglia 
m odula tes  the ac tiv i ty  o f  the cortex  and tha lam us and is determ ined  by the balance 
between the indirect and direct pathways. The activity o f  the pathways are controlled by 
differential responses to Ach and DA. The indirect pathway MSN express the inhibitory DA 
receptors  D2 and the d irec t pa thw ay  MSN express  the exc ita tory  DA recep to rs  D j .  
Ach has a excitatory effect o f  the indirect MSN and an inhibitory effect o f  the direct MSN. 
The striatum is split neurochemically  into two compartments,  the patch and matrix. MSN 
w ith in  both c o m p a r tm e n ts  rec e iv e  ex c i ta to ry  g lu ta m in e rg ic  input from  the  cortex . 
M S N  w i th in  th e  m a t r ix  a l s o  r e c e i v e  e x c i t a t o r y  i n p u t  f rom  th e  th a l a m u s .  
T he  M SN  w i th in  th e  m a t r ix  a re  th o s e  in v o lv e d  in th e  i n d i r e c t  a n d  d i r e c t  
pa thw ays  ( red),  those  in the patch  p ro jec t to the SN pC (blue) .  The H D -assoc ia ted  
neurodegeneration is initially selective to the striatum. The MSN in the indirect pathway and 
all the patch MSN are more vulnerable to neurodegeneration than the direct pathway MSN. 
MSN = medium spiny neurons, STN =  subthalamic nucleus, SNpR = substantia nigra pars 
reticulata, SNpC = substantia nigra pars compacta, P = patch, M = matrix, DA = dopamine, 
GABA = aminobutyric acid, Ach = Acetylcholine, SP = substance P, ENK = Enkephalin, 
DN = dynorphin, - = inhibitory projections, + = excitatory projections.
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y-aminobutyric acid (GABAergic) expressing medium spiny projection neurons (M SN) are the 
main cell-type within the striatum and constitute the output pathways of the structure. Although 
MSN show low levels o f spontaneous discharge, they phasically respond to excitatory inputs from 
the cortex. In addition to the inhibitory neurotransmitter, GABA, MSN co-localise neuropeptides 
such as enkephalin (ENK) in those that project to the lateral globus pallidus (named globus pallidus 
in rodents) and substance P (SP) and/or dynorphin (DN) in neurons projecting to the medial globus 
pallidus and the substantia nigra pars reticulata (Figure 1.1) (Gerfen and Young, 1988; Parent et al., 
1984). Significant numbers of efferents from both groups o f MSN synapse with the dopaminergic 
neurons o f the substantia nigra pars compata (Figure 1.1) (Gerfen, 1992; Somogyi and Smith, 
1979). Although both kinds o f MSN are distributed throughout the striatum, cells with common 
projections tend to be grouped in small clusters (Kawaguchi, 1997).
The MSN co-localising SP/DN make up the ‘direct pathway’, as they directly inhibit the output 
structure o f the basal ganglia, the medial globus pallidus (Penney and Young, 1986). The ENK- 
containing MSN constitute the ‘indirect pathway’ as they indirectly stimulate the medial globus 
pallidus via inhibitory projections to the lateral globus pallidus and the subthalamic nucleus 
(Penney and Young, 1986). The direct pathway neurons principally express dopamine Di 
neurotransmitter receptors whereas indirect neurons express dopamine D2 receptors (Albin, 1995; 
Hedreen and Folstein, 1995). The direct and indirect MSN also respond differently to cholinergic 
agonists, which stimulate indirect neurons but inhibit direct neurons (Harrison et al., 1996). 
Indirect neurons also express the A2a adenosine receptor subtype, which are absent on the direct 
pathway neurons (Ferre et al., 1993). The differential characteristics o f the MSN populations 
provide the ability to control the output of the direct and indirect pathways, thereby, balancing the 
pattern and level o f thalamic and cortical stimulation.
The neuronal population within the striatum is made up o f ~95 % MSN and ~5 % intemeurons 
(Kawaguchi, 1997). The main group o f intemeurons within the striatum are the cholinergic 
interneurons that possess large soma and widespread dendritic trees. They receive direct 
dopaminergic inputs from the midbrain and form synapses on MSN. Other intemeurons present 
within the striatum stain positive for nicotinamide adenine dinucleotide phosphate (NADPH) 
diaphorase (a marker for nitric oxide synthase (NOS)), somatostatin, neuropeptide Y and the 
calcium binding protein, calbindin (Ferrante et al., 1997) and a distinct population of medium-sized 
intemeurons localise parvalbumin (Kawaguchi, 1997).
Different neurochemical compartments within the striatum have been observed, referred to as the 
patch (striosome) and matrix (Gerfen, 1992; Graybiel, 1990). Calbindin is expressed in MSN lying 
in the matrix whereas p opiate receptors are found on neurons within the patch (Kawaguchi, 1997). 
Slightly different afferent connections to the compartments are observed, with innervation from
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differing regions o f the cortex. Efferent projections also vary, with patch MSN projecting to the 
dopaminergic cells o f the substantia nigra pars compacta and matrix MSN directly to the lateral and 
medial globus pallidus and the substantia nigra pars reticulata (Gerfen, 1985). The dendrites o f 
MSN tend to stay within their own compartment (Kawaguchi, 1997; Penny et al., 1988) but 
intemeurons are able to interact with all MSN as their dendritic trees extent into both compartments 
(Kubota and Kawaguchi, 1993).
1.1.2.3 Pattern of neurodegeneration in HD
Post-mortem investigation o f HD brains has revealed that the caudate nucleus and putamen 
(striatum) are the brain regions predominantly involved in the neurodegeneration associated with 
HD (Vonsattel et al., 1985). The additional loss of the large pyramidal neurons in layers III, V and 
VI of the cerebral cortex is also been seen in late stages o f the disease process (Vonsattel and 
DiFiglia, 1998). The neurodegenerative changes within the striatum can be graded on macroscopic 
and light microscopic examination (Vonsattel et al., 1985). Grade 0 indicates a patient with a 
clinical diagnosis of HD but no gross or microscopic abnormalities whereas grade 4 describes brain 
tissue with severe shrinking of the striatum and -9 5  % neuronal loss. Subsequent quantitative 
analysis has revealed a reduced neuronal population in grade 0 HD brains compared to controls, in 
the absence o f reactive gliosis, suggesting reduced numbers o f cells due to abnormal brain 
development (Myers et al., 1991). The striatum is generally thought to be involved in the control of 
movement. However, circuits connecting this region to other structures, such as the cortex and 
those involved in the limbic system also suggest involvement in functions including control of 
attention, executive function and motivated behaviours (McGeorge and Faull, 1989; Mogenson et 
al., 1980; Saint-Cyr et al., 1995). Therefore, the neuropathological findings from HD post-mortem 
brain tissue correlate with the clinical manifestations of the disease.
Whilst, neurodegeneration within the striatum is seen first in the caudate nucleus, it spreads to the 
putamen. The wave o f degeneration spreads ventrally such that the nucleus accumbens (ventral 
striatum) is only affected in the late stages of the disease. A  gradient of neuropathological change is 
seen in the striatum with the process beginning in a posterior, medial and dorsal location and 
moving along the antero-posterior, latero-medial and ventro-dorsal axes. This gradient is seen in 
grade 1 to 3 HD brains but severe degeneration is observed throughout the entire striatum in grade 
4 brains (Vonsattel et al., 1985).
Differential sensitivity of the MSN within the direct and indirect efferent pathways o f the striatum 
has been observed, with the ENK/dopamine D2 receptor-expressing MSN involved in the indirect 
pathway preferentially targeted by HD pathogenesis (Albin, 1995; Hedreen and Folstein, 1995; 
R i c h f i e l d  et al., 1995). This sensitivity is illustrated by the early decrease in ENK  
immunoreactivity in the lateral globus pallidus but no alteration in SP immunoreactivity in the
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m edial globus pallidus in asymptomatic cases o f HD (Albin, 1995). A  reduction in 
preproenkephalin mRNA in the striatum early in HD is also observed but changes in 
preprotachykinin mRNA only become apparent in late stages of the disease (Richfield et al., 1995). 
The circuitry within the cortico-striato-thalamic loop (Figure 1.1) would suggest that preferential 
degeneration or hypoactivity o f the indirect pathway MSN causes an imbalance in the control of 
the cerebral cortex that leads to cortical excitation and involuntary movement. This suggestion is 
supported by the previous association of the indirect pathway with choreiform movements, the 
major movement disorder associated with HD (Crossman et a l ,  1987).
The concentration o f neuropeptides co-localising in NADPH diaphorase-positive interneurons 
increases in the striatum of HD patients, suggesting that these cells are retained as the MSN  
succumb to the disease process (Ellison et al., 1987). Ferrente et al. (1987) similarly observed that 
large cholinergic intemeurons remain relatively untouched in HD brains, illustrating the striking 
cell-selective vulnerability of MSN to the disease process.
In addition to the MSN-type specific neuropathology in HD, a compartment-specific pattern has 
also been reported. Neurodegeneration appears to affect MSN within the patch first before 
spreading to the matrix, since pathology in early stage HD correlates with calbindin-poor regions of 
the striatum (Hedreen and Folstein, 1995) and there is a preferential reduction in neuropeptide 
markers (ENK and SP mRNA) within the patch neurons (Augood et al., 1996). Although it is 
unknown why cells within the patch are more vulnerable to HD pathology, the higher concentration 
of the calcium regulator, calbindin, in the matrix (Gerfen, 1985) may help prevent potential 
problems in calcium homeostasis that contribute to neurodegeneration (Gerlach et al., 1996). The 
initial neurodegeneration in HD observed throughout the striatum within the patch compartment 
(Hedreen and Folstein, 1995) gradually spreads to the matrix progressing in a gradient fashion. 
MSN within the patch project mainly to the substantia nigra pars compacta where they synapse 
with dopaminergic neurons (Gerfen, 1985). Therefore, loss of patch MSN early in HD could lead to 
loss of GABAergic inhibition of dopaminergic cells and increased striatal dopamine levels. There 
is increasing evidence from studies that demonstrate intraparenchymal injections o f dopamine 
produce dose-dependent striatal lesions (Hastings et al., 1996) and toxicity in striatal cell culture, 
that this neurotransmitter can be neurotoxic (Cheng et al., 1996). At this time, however, there is no 
evidence of increased dopamine levels in the striatum of HD brains (Pearson et al., 1990) and no 
sign o f cell loss in the substantia nigra pars compacta in HD brains (Albin, 1995; Ferrante et al., 
1997).
1.1.2.4 Neurodegeneration versus neuronal dysfunction in HD
Investigations into the relationship between anatomical and functional changes in HD brains have 
raised the possibility that functional deficits may be present prior to obvious anatomical alteration.
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The first illustration of anatomical changes in clinical HD patients by brain imaging demonstrated a 
significant enlargement o f the bi-caudate diameter, reflecting a reduction in caudate volume and 
dilation o f the ventricles (Barr et a l , 1978). Further studies found a significant reduction o f basal 
ganglia volume in asymptomatic HD gene carriers, indicating that anatomical changes may be 
present early in the disease process, before obvious symptoms (Aylward et a l ,  1996). However, 
reports o f  HD patients suffering from overt symptoms in the absence o f any obvious 
neuropathology (Vonsattel grade 0) have suggested that the development of gross anatomical 
changes within the striatum may lag behind clinical manifestations (Vonsattel et a l ,  1985). The 
absence o f a correlation between the rate o f change in caudate size and reduced glucose 
metabolism in asymptomatic, at risk, subjects (Grafton et a l ,  1992) suggests that metabolic decline 
and caudal atrophy can develop independently. In addition, significant hypometabolism with no 
evidence of caudate atrophy has been observed in at risk, HD gene carriers (Mazziotta et a l ,  1987). 
No significant change in the bi-caudate ratio, despite significant caudate nucleus hypometabolism  
and a reduction in dopamine receptor binding, has also been demonstrated in asymptomatic HD 
gene carriers (Antonini et a l ,  1996). These studies suggest that, at least in presymptomatic phases 
of HD, striatal dysfunctioning can occur without obvious striatal atrophy. A  number o f studies have 
now detected subtle phenotypic changes in HD gene carriers previously considered to be 
asymptomatic (de Boo et a l ,  1997; Kirkwood et a l ,  1999; Lawrence et a l ,  1998a), suggesting that 
reduced striatal glucose metabolism and receptor binding alterations may contribute to early 
symptoms in HD without the requirement for overt cell loss. If a period of symptom-inducing 
neuronal dysfunction precedes neurodegeneration in HD, the effectiveness of treatment strategies 
purely aimed at preventing cell death is somewhat questionable, as they may not necessarily 
eliminate the entire HD phenotype.
1.2 Molecular basis of HD
Lengthening (expansion) o f a repeated DNA sequence, most commonly a trinucleotide repeat, is 
the mutation associated with a growing number o f human hereditary diseases. HD is caused by the 
expansion o f the trinucleotide (CAG) repeat residing in exon 1 o f the HD (IT-15) gene, which 
spans 210 kb of chromosome 4 ((HDCRG), 1993). The CAG repeat within the HD  gene displays a 
non-pathogenic, polymorphic repeat range o f between 10-41 repeats within the general population 
(Andrew et a l ,  1993; Duyao et a l ,  1993; (HDCRG), 1993; Snell et a l ,  1993). The occurrence of 
HD has been noted in patients possessing between 36 and approximately 250 CAG repeats 
(Andrew et a l ,  1993; Duyao et a l ,  1993; (HDCRG), 1993; Nance et a l ,  1999; Snell et a l ,  1993). 
As long CAG repeat tracts tend to be unstable in the germline, pathogenic mutations may result 
from small, successive increases in repeats within the non-pathogenic range, eventually resulting in 
the inheritance o f a disease-causing mutation (Leeflang et a l ,  1999; Leeflang et a l ,  1995). The 
alleles carrying the repeats that eventually give rise to HD mutations are designated intermediate
Laura Kennedy, 2002 Chapter 1, 26
alleles (29-35 repeats) (Chong et al., 1997; Goldberg et al., 1993; Goldberg et al., 1995). The 
normal and pathogenic repeat ranges overlap and HD patients possessing 36 to 41 repeats have 
been described expressing typical disease onset and course, while other individuals carrying repeats 
within this range have failed to display symptoms within a normal life-span (Brinkman et al., 
1997). These findings suggest that disease mutations may initially display reduced penetrance (36- 
41 repeats) (Brinkman et al., 1997; McNeil et al., 1997; Myers et al., 1993; Rubinsztein et a l ,  
1996).
Repeat length also has an influence on the clinical manifestation o f the disease. The length o f the 
inherited repeat expansion displays an inverse correlation with age at onset (Figure 1.2A), disease 
severity and degree o f pathology at death, suggesting increased toxicity of longer repeats (Andrew 
et al., 1993; Duyao et al., 1993; (HDCRG), 1993; Penney et al., 1997; Snell et al., 1993). A  
significant correlation has been observed between longer repeat lengths and a faster rate o f clinical 
deterioration (Brandt et a l ,  1996; Jason et a l ,  1997). Several reports have established that the 
severity o f cognitive deficits observed inversely correlates with the CAG repeat length (Foroud et 
a l ,  1995; Lawrence et a l ,  1998b; Snell ef al., 1993). The heterogeneity o f neuropsychological 
symptoms observed within groups of HD mutation carriers is also related to the CAG repeat length 
(Hahn-Barma et al., 1998). Analysis of subtle symptoms observed in preclinical HD gene carriers 
has shown that those who carry longer CAG repeats have greater cognitive impairment (Foroud et 
al., 1995; Jason et a l ,  1997) and motor deficits (Siemers et a l ,  1996). However, no such 
correlation has been found with the psychiatric symptoms seen in preclinical HD gene carriers 
(Berrios et a l ,  2001). The correlation between repeat length and cognitive deficits seen in 
preclinical HD patients appears to be lost when investigating cognitive deficits in clinically 
affected individuals (Jason et a l ,  1997). Studies have suggested that cognitive functioning declines 
sharply prior to clinical onset and then levels out to a slow progressive decline. This sharp decline 
may be worse in patients with longer repeats, perhaps contributing to their earlier onset and 
explaining why there is a correlation with repeat length at this stage in the disease process (Jason et 
al., 1997). The relationship between symptoms and repeat length is clearly complicated by the 
suggestion that only specific cognitive symptoms (language, memory, intelligence) have a 
significant correlation with repeat length when others may not (executive and spatial functioning) 
(Jason et a l ,  1997).
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F igu re 1.2 The correlation between CAG repeat length and age o f onset in HD
A. A regression curve demonstrating the correlation between repeat length and age at onset of HD.
B. The confidence intervals for the predicted age at onset for a given repeat length. These data 
illustrate the large range of onset ages for the repeats within the 40-50 repeat range suggesting 
that other factors also influence age at onset. The graphs were generated with transformed data 
of the repeat length and age of onset from 360 HD sufferers.
Figure modified from Andrew et al, 1993.
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The link between repeat length and disease manifestation is supported by the observation that HD 
patients carrying over 50 CAG repeats most commonly suffer from the severe juvenile form of HD 
(Nance and Myers, 2001). Whilst, the early age at onset observed in juvenile HD patients 
contributes significantly to the correlation between the age at onset and repeat length detected in 
HD (Figure 1.2A), the absolute repeat size for adult-onset HD is a relatively poor index for 
predicting the age at onset of symptoms (Figure 1.2B) (Andrew et al., 1993; Barron et al., 1993; 
Kremer et al., 1995). Indeed, repeat length is thought to account for about 50 % o f the variation in 
the age at onset for many adult-onset HD patients (Andrew et al., 1993). The onset age of the 
parent, sex o f affected parent and repeat size o f the offspring are together thought to be responsible 
for -6 9  % o f the variance in age at onset for adult-onset HD cases (Ranen et al., 1995), clearly 
indicating that other genetic or environmental factors can influence age at onset and severity of 
HD. Polymorphisms close to the CAG repeat tract have already been associated with a decreased 
age at onset when comparing alleles carrying the same repeat length (Vuillaume et al., 1998), 
suggesting possible ds-acting genetic factors which may influence the course o f HD pathogenesis.
1.2.1 Germline repeat instability in HD
By examining the inheritance of repeat sizes within HD families and identifying mutation sizes of 
individual germ cells, information can be obtained about the behaviour o f the HD-associated CAG 
repeat tract within the germline. Inheritance studies have demonstrated that a high percentage of 
meioses (-70-85  %) result in a change of repeat size on the mutant HD chromosome (Duyao et al., 
1993; Kremer et al., 1995; Leeflang et al., 1995). This is in stark contrast to the -1  % of meioses 
that produce a change in repeat size on normal chromosomes (Duyao et al., 1993; Kremer et al., 
1995; Leeflang et al., 1995). Repeat size spectra obtained from sperm cells show the mutation 
frequency and mean changes in allele size increase with higher somatic repeat number (Leeflang et 
al., 1999). A s longer repeats are more prone to expansion, repeats that have expanded on 
transmission are more likely to expand again, providing the genetic basis for the phenomenon of 
anticipation (Myers et al., 1993; Telenius et al., 1994; Zuhlke et al., 1993). Anticipation is a term 
that describes a decrease of onset age in successive generations observed in HD families.
Evidence for a sex-of-origin effect influencing transmitted repeat sizes was provided by the 
observation that although small fluctuations are present in both maternal and paternal 
transmissions, there are overall differences in the behaviour of repeats within male and female 
germlines. It is more likely that small contractions or no change in repeat size is transmitted 
through the maternal line (Kremer et al., 1995) and dramatic increases in repeat number are most 
commonly observed on paternal transmission (Duyao et al., 1993). Due to the correlation between 
repeat length and age at disease onset (Andrew et al., 1993; Brinkman et al., 1997; Ranen et al., 
1995) there is a preponderance (-8 0  %) for juvenile patients to inherit the HD mutation from their 
father (Brinkman et al., 1997; Goldberg et al., 1993; Kremer et al., 1995; Ranen et al., 1995).
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Furthermore, inheritance studies indicate that -14 .5  % o f affected fathers produce juvenile HD 
offspring but only 4.5 % o f affected mothers (Duyao et a l ,  1993). Offspring o f affected mothers 
have similar onset ages to their mother whereas offspring o f affected fathers have onset ages of -8  
years earlier than their father (= anticipation) (Kremer et a l ,  1995). The differences in repeat 
instability observed in the male and female germlines remain unexplained. As DNA replication is a 
possible candidate for the underlying mechanism responsible for repeat instability, the high 
replication rate (-4 0 0  cell divisions per 30 year generation in humans (Drost and Lee, 1995)) of 
mature sperm cells compared to oocytes (-3 0  cell divisions per 30 year generation in humans), may 
in part explain the sex-of-origin effect observed in HD inheritance.
Studies have been carried out to investigate genomic factors that play a role in the germline repeat 
instability observed in HD patients. A  comparison o f single sperm containing intermediate alleles 
(29-35 repeats), which expanded into new mutations (IAnm) and those that continued in the 
general population without change (LAgp), demonstrated that when LAgp and IAnm have the same 
repeat length, IAnm are significantly more unstable (Chong et a l ,  1997). This study suggested that 
there are c/s-acting factors involved in the propensity for repeat expansion. One common 
characteristic of the H D  gene CAG tract is an interruption consisting o f a penultimate CAA codon. 
Alleles with mutations in this codon, deleting the interruption and producing a perfect CAG repeat, 
have demonstrated significant increases in the spectrum of sperm repeat instability observed 
(Goldberg et a l ,  1995; McNeil et a l ,  1997). This illustrates the higher propensity o f longer repeats 
to display instability and the stability conferred on a repeat sequence by interruptions in a perfect 
repeat tract. Indeed, investigations reporting the mutation responsible for SCA17 as a CAG repeat 
expansion within the TATA binding protein, demonstrated its complete germline stability and 
speculated that this was caused by the numerous CAA repeat interruptions present (Fujigasaki et 
a l ,  2001). Investigations have also demonstrated that the CAG repeat size on the normal 
chromosome of either the affected parent or the affected offspring has no influence on the mutant 
CAG repeat instability (Kremer et a l ,  1995).
Within the male germline, a 1:1 ratio o f mutant to normal sperm suggests a lack of segregation 
distortion in male HD patients, with -9 6  % of mutant sperm possessing a repeat length that differed 
from the somatic repeat length (Leeflang et a l ,  1999). The variability o f repeat length changes 
within the male germline was greater than previously estimated from inheritance studies and may 
reflect selection against sperm carrying longer CAG repeat tracts. This putative selection could 
reflect lower survival rates or an inability to carry out fertilisation o f oocytes. However, if  this 
negative selection is operating, it does not appear to reduce fertility in HD patients (Leeflang et a l ,  
1999). The mutation spectrum within the maternal germline has not been directly analysed due to 
the difficulty in obtaining oocytes. Although large expansions have rarely been transmitted through
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the maternal line, it is thought that the low frequency of these transmissions may also be due to 
negative selection of oocytes containing larger repeats (Laccone and Christian, 2000).
1.2.2 Som atic repeat instability in HD
Although germline repeat instability is responsible for such interesting phenomenon as anticipation 
and sex-of-origin effects in HD, the behaviour of repeat sequences within somatic tissues could 
have important implications regarding the selective vulnerability o f tissues to the disease process. 
Although the HD  gene is widely expressed in all somatic tissues (Landwehrmeyer et al., 1995a; Li 
et al., 1993; Strong et al., 1993), the pathology expressed is limited to specific brain regions. CAG 
repeat length in HD correlates with age of onset and clinical severity (Andrew et al., 1993; Duyao 
et al., 1993) and therefore, repeat length variation between somatic cells may present an 
explanation for why some tissues are less affected than others.
Radioactive PCR followed by separation o f the products through polyacrylamide gels and 
densitometric analysis o f the autoradiographic images has been used to investigate somatic repeat 
instability in HD. However, a number o f studies have provided inconsistent results. MacDonald et 
al. (1993) investigated somatic repeat instability by PCR amplification, comparing the allele repeat 
size in blood and lymphoblastoid cell lines from HD patients at two time points. Additional bands 
detected did not alter with different samples or the progression o f the disease and so were proposed 
to be due to PCR stutter, suggesting that there is no somatic instability o f the mutation throughout 
the course o f HD. Additional in depth studies o f skeletal and heart muscle, liver, kidney, 
lymphocytes, cortex, thalamus, hippocampus, and the caudate nucleus were carried out and no 
significant somatic repeat instability was observed (Zuhlke et al., 1993). The selection of tissues 
included at least one organ from all three regions o f the embryo (endoderm, ectoderm and 
mesoderm) suggesting that the repeat is also stable throughout development.
Telenius et al. (1994) investigated DNA obtained from several somatic organs and central nervous 
system regions and found that the predominant mutant allele was invariably the same size in each 
tissue. However, the brain samples consistently showed extra bands above the major progenitor 
allele band. These additional bands previously dismissed as PCR artefacts by other investigators 
(MacDonald et al., 1993; Zuhlke et al., 1993), were interpreted as somatic repeat instability in this 
study. This stance was justified by the observation that no additional bands were detected when 
amplifying normal alleles or cloned mutant alleles. A  densitometric index representing the ratio of 
intensity o f the major band compared to the first band immediately above this was used as a 
measure of mosaicism when comparing individual tissues with the same major allele size from one 
patient. These studies produced a consistent tissue-specific pattern o f CAG mosaicism. It was 
found that the mosaicism was always highest in the brain, specifically the cortex and striatum, 
intermediate in the blood and low in the liver and cerebellum. It was also reported that juvenile
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cases of HD had higher degrees of instability than late-onset cases. Further analysis carried out on 
brain tissue from juvenile HD patients, demonstrated that the cerebellar cortex expressed a 
significantly lower repeat size (8-13 CAG repeats) compared to other brain regions. These findings 
were supported by the comparison o f repeat size in severely affected, mildly and unaffected brain 
regions to other tissues (De Rooij et a l ,  1995). Severely affected regions did not give rise to larger 
PCR products compared to mildly affected regions. However, alleles from all affected brain 
regions showed larger repeat lengths compared to cerebellum and blood.
1.2.3 Hom ologues of the HD gene
The human HD  gene spans -2 1 0  kb of genomic DNA and consists o f 67 exons ((HDCRG), 1993). 
The protein sequence o f human huntingtin has no significant similarity to any other known 
proteins. Nor have any proven functional domains or motifs been identified over any stretch o f the 
large protein. One way of identifying potentially important functional domains within the protein is 
to isolate orthologues from other organisms. In the case o f the HD protein, vertebrate homologues 
from mouse (Bames et a l ,  1994; Lin et a l ,  1994), rat (Schmitt et a l ,  1995), pufferfish (Baxendale 
et a l ,  1995) and zebrafish (Karlovich et a l ,  1998) have all been identified.
All vertebrate H D  gene homologues identified have displayed high identity with the human H D  
gene sequence. The murine cD NA has 91 % peptide sequence identity with the human gene 
(Bames et a l ,  1994). DNA sequence analysis o f the pufferfish and zebrafish HD  genes have 
revealed 90 % and 70 % identity, respectively, at the amino acid level with the human sequence 
(Baxendale et a l ,  1995; Karlovich et a l ,  1998). When the human, mouse, pufferfish, and zebrafish 
huntingtin proteins are aligned, the overall amino acid identity is 64 %, and the homology spans the 
entire length o f the protein. Despite the high level o f conservation at the amino acid level, 
suggesting an important functional role, the HD protein family continues to exhibit no strong 
similarity to any known proteins or motifs currently held in the databases.
The polymorphic poly glutamine stretch within the human protein sequence has an average o f 18 
glutamines ((HDCRG), 1993). The rat H D  gene sequence contains eight glutamines (Schmitt et a l ,
1995) and the mouse has seven, with the third glutamine encoded by CAA rather than CAG 
(Bames et a l ,  1994; Lin et a l ,  1994). The fish sequence displays four glutamines, encoded by 
(CAG)3(CAA) in the pufferfish (Baxendale et a l ,  1995) and (CAG)2(CAA )2  zebrafish (Karlovich 
et a l ,  1998). The CAA interruption in the glutamine stretch in all vertebrates, other than humans, 
may account for the CAG repeat stability and why naturally occurring animal models o f HD are 
unknown.
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The high degree o f amino acid sequence similarity between these vertebrate proteins has made it 
difficult to determine potential functional domains. Sequence comparison with more distantly 
related species, in particular that of an invertebrate, could be more informative.
Identification o f the Drosophila HD  gene homologue has shown three large, contiguous regions at 
the N-terminus, middle and C-terminus o f the protein, in which there is an overall identity of 24 % 
with the human sequence (Li et al., 1999b). Within this sequence, five relatively discrete regions 
are highly conserved with areas of the huntingtin protein family suggesting possible functional 
importance. However, at this time databases have failed to identify any known domains or motifs 
for these regions. The N-terminus was found to be the most highly conserved region between 
Drosophila and human although no polyglutamine is observed (Li et al., 1999b).
1.2.4 Huntingtin
The H D  gene encodes a ubiquitously expressed protein o f unknown function, called huntingtin 
((HDCRG), 1993). The huntingtin protein has a predicted size of -3 5 0  kDa, and antibody studies 
have demonstrated that the CAG repeat tract within exon of 1 of the H D  gene is translated into a 
polyglutamine stretch within the protein product (Jou and Myers, 1995). Huntingtin has been 
detected in the CNS and peripheral tissues (Gutekunst et a l ,  1995; Li et al., 1993; Strong et a l ,
1993), with the highest expression levels observed within the brain and testis (Li et al., 1993; Sharp 
et al., 1995; Strong et al., 1993). Expression throughout the brain is observed in all neurons and 
displays no sign of enrichment within the basal ganglia (Li et al., 1993; Strong et a l ,  1993).
The function of huntingtin is unknown and it displays no homology to other known genes 
((HDCRG), 1993; Hoogeveen et al., 1993; Lin et al., 1993; Strong et al., 1993). Expression is 
typically as a cytosolic protein associated with microtubules, vesicles and synaptic components, 
concentrated at the nerve endings, suggesting a role in cellular transport and neurotransmission 
(DiFiglia et al., 1995; Gourfinkel-An et al., 1997; (HDCRG), 1993; Li et al., 2000; Li et a l ,  1993; 
Sharp et al., 1995; Strong et al., 1993; Trottier et al., 1995; Tukamoto et al., 1997). Mice with 
reduced levels o f wild-type huntingtin display aberrant brain development and pre-natal lethality 
(White et al., 1997) or neuronal degeneration in the basal ganglia during adulthood (O ’kusky et a l
1999). In vitro studies have also suggested an anti-apoptotic property of wild-type huntingtin, as 
the expression of wild-type huntingtin has been shown to protect neurons from various apoptotic 
stimuli (Rigamonti et al., 2000). The embryonic lethality, on day 8.5 o f development (E8.5), o f  
huntingtin knock-out mice demonstrated an essential role in embryonic development (Bhide et a l ,  
1996; Duyao et al., 1995; Nasir et al., 1995; Zeitlin et al., 1995). Studies using transgenic HD mice 
have also illustrated that the expression o f wild-type huntingtin reduces the toxicity o f mutant 
huntingtin (Leavitt et al., 2001). The production o f a conditional knock-out mouse model has 
provided further evidence that normal huntingtin function is necessary to maintain viable and
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properly functioning neurons in the adult brain (Dragatsis et al., 2000) indicating, along with 
information derived from the other mouse models, that the role o f normal huntingtin is essential for 
both embryogenesis and neuronal survival in the adult brain.
The mechanism of disease pathogenesis exerted by the extended polyglutamine stretch is largely 
unknown. However, several lines o f evidence including the autosomal dominant inheritance 
pattern, a comparable phenotype in homozygous and heterozygous HD mutation carriers (Wexler 
et al., 1987) and H D  gene knockout mice lacking the appropriate disease phenotypes, suggest that 
the repeat expansion mutation exerts its toxicity through a gain-of-function mechanism. However, 
studies have also suggested that a loss of function effect due to the expansion mutation could also 
play a part in HD neuropathogenesis (O ’kusky et al., 1999; White et a l ,  1997).
1.2.5 Huntingtin expression  and selective vulnerability of neurons
Uncertainty remains concerning a possible correlation between the expression of huntingtin protein 
and the cell-selective vulnerability (section 1.1.2.3) observed in HD. It has been established that 
striatal neurons are not uniquely enriched in huntingtin compared with other parts o f the brain (Li 
et al., 1993; Strong et al., 1993). Studies on post-mortem HD tissue have also showed that the 
regional and cellular expression levels o f huntingtin or its mRNA are not significantly altered by 
the mutation or the disease process (Aronin et al., 1995; Bhide et a l ,  1996; Gourfinkel-An et al., 
1997; Landwehrmeyer et al., 1995a; Sapp et al., 1997; Schilling et al., 1995; Sharp et a l ,  1995; 
Trottier et al., 1995). However, it remains unclear whether the initial cell-type specific pathology 
within the striatum is connected to differential expression levels in the mutant protein. 
Investigations have been carried out in an to attempt to relate the distinct sensitivity observed in the 
patch and matrix compartments within the striatum to the expression of huntingtin but these have 
produced conflicting results. High levels o f huntingtin within the matrix and lower levels within the 
patch have been reported (Ferrante et al., 1997; Sapp et a l ,  1997). However other studies have 
found the highest expression levels in the patch and the lowest in matrix (Kosinski et al., 1997). In 
addition, differential expression in the striatal compartments has been questioned in several other 
studies, which failed to find any difference in expression levels (Bhide et al., 1996; Fusco et al., 
1999; Landwehrmeyer et al., 1995a).
Cholinergic intemeurons that are resistant to pathology in HD, appear richer in huntingtin than the 
MSN, suggesting an inverse relationship between huntingtin expression levels and vulnerability 
(Kowall et al., 1987). This theory is substantiated by the ENK, indirect, MSN, the most vulnerable 
cells in HD, expressing lower huntingtin mRNA levels than the less vulnerable SP, direct, MSN  
(Fusco et al., 1999). The striatonigral projection neurons (ENK+ and SP+), which are as vulnerable 
as the ENK, indirect MSN also express low HD mRNA levels. The cortical pyramidal, pallidal, and 
basal forebrain cholinergic neurons are all relatively resistant to HD and all rich in huntingtin
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(Sharp and Ross, 1996). In contrast, the aspiny NADPH-diaphorase, somatostatin striatal 
intemeurons, which survive well in HD, are largely devoid o f huntingtin (Ferrante et al., 1997) and 
parvalbumin-positive striatal intemeurons, which are as vulnerable as the projection neurons are 
often rich in huntingtin (Ferrer et al., 1994). The cortical layer III and V neurons are uniformly rich 
in huntingtin and project to the striatum. However, they tend to be affected in later stages of the 
disease process.
In summary, at present there is no clear evidence to confirm that cells expressing higher levels of 
mutant huntingtin are more vulnerable, or indeed that cells with low levels are at increased risk of 
HD pathology. These findings do however suggest that factors other than huntingtin expression 
levels are probably involved in the cell-selective vulnerability observed in HD.
1.2.6 Protein aggregation and HD pathogenesis
The presence o f neuronal intranuclear inclusions (N il) was reported in brain tissue o f a HD 
transgenic mouse model, the R6/2 mice (Davies et al., 1997). Further in vitro experiments 
confirmed that the mutant N-terminal huntingtin protein expressed from the human HD  gene exon 
1 construct present in R6/2 mice aggregates in ubiquitinated insoluble N il and that these structures 
have a fibrillar morphology (Scherzinger et al., 1997). These findings suggest that mutant 
huntingtin protein is marked by the ubiquitination machinery but appears to be resistant to 
degradation. A  pathogenic role for N il was suggested, as the inclusions were visible shortly before 
the animals developed behavioural abnormalities. These findings have since been supported with 
the observation o f N il within brain regions involved in HD pathology in other HD mouse models 
(Li et al., 1999a; Li et al., 2000; Reddy et al., 1998; Schilling et al., 1999).
N il consisting o f aggregated polyglutamine-containing protein were also detected in brain tissue of 
patients suffering from HD (Becher et al., 1998; DiFiglia et al., 1997; Gutekunst et a l ,  1999) and 
other disorders caused by proteins expressing elongated stretches o f polyglutamine, including, 
SCA1 (Skinner et al., 1997), SCA3 (Paulson et al., 1997), SCA7 (Holmberg et al., 1998), SBMA  
(Li et al., 1998b) and DRPLA (Becher et al., 1998; Igarashi et al., 1998).
Several forms of interactions have been proposed for proteins containing polyglutamine stretches. 
It has been noted that mutant huntingtin can self-polymerase in vitro in the absence of any enzymes 
(Scherzinger et a l ,  1997). The formation of polar-zipper structures between proteins containing 
polyglutamine stretches, has been postulated (Perutz et al., 1994). Transglutamination, with 
polyglutamine serving as a substrate for the enzyme transglutaminase (Green, 1993; Kahlem et al.,
1998) has also been discussed as a possible mechanism involved in aggregate formation.
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1.2.6.1 Nuclear localisation of huntingtin
Studies of post-mortem human HD brain tissue have demonstrated the occurrence of N il within the 
neurons (striatal and cortical) specifically involved in HD pathogenesis. N il were not observed in 
control or presymptomatic HD brains, only in symptomatic brain tissue, suggesting a connection 
between aggregate formation and onset o f symptoms (DiFiglia et al., 1997). Aggregate formation 
occurs in a repeat length-dependent manner as juvenile HD brains display N il in 38-52 % of their 
cortical neurons whereas only 3-6 % o f cortical neurons within adult onset HD brains contain N il 
(DiFiglia et al., 1997). Immunohistochemistry analysis using an antibody raised to the first 17 N- 
terminal amino acids o f huntingtin showed intense labelling o f N il in the cortex and striatum but 
not within the globus pallidus or cerebellum. Studies using an antibody raised against an internal 
site downstream of the polyglutamine stretch labelled the cytoplasm in control and HD brains but 
showed no staining o f the nuclei or NIL These results suggest that the N il are made up from N- 
terminal fragments of huntingtin. To substantiate these findings western blot analysis o f control and 
juvenile HD brain protein extracts was carried (DiFiglia et al., 1997). Total protein extracts from 
control cortical samples displayed huntingtin protein migrating at its expected 350 kDa, however, 
this band was absent in nuclear extracts. Juvenile HD brain samples displayed an additional band 
migrating at 40 kD suggesting the presence o f huntingtin fragments (DiFiglia et al., 1997). These 
findings support the toxic fragment hypothesis, which proposes the cleavage o f full-length mutant 
huntingtin localised within the cytoplasm followed by nuclear translocation o f the resultant 
truncated huntingtin fragment. Once in the nucleus it may disrupt cellular functioning by 
interacting with other polyglutamine rich proteins or sequester proteins during the formation of 
aggregates.
Ubiquitin appears to co-localise with huntingtin within N il in humans (DiFiglia et al., 1997) and 
mice (Davies et a l ,  1997), suggesting that huntingtin fragments may be targets for ubiquitin- 
dependent proteolysis. This may play a role in producing the toxic huntingtin fragments as 
huntingtin can be cleaved, in a repeat-dependent manner, at its N-terminus by apopain, a cysteine 
protease involved in ubiquitin-dependent proteolytic cleavage (Goldberg et al., 1996). Full-length 
huntingtin could also undergo proteolytic cleavage by caspases before diffusing across the nuclear 
membrane (Kim et al., 1999; Wellington et al., 1998).
The toxic fragment hypothesis suggests that tissue-specific differences in protein proteolysis and 
ubiquitination could play a role in the selective vulnerability o f HD pathology. Studies o f 
huntingtin fragments in HD and control brains have demonstrated that the striatum of HD brains 
appears to contain more N-terminal fragments o f huntingtin than controls (Mende-Mueller et al.,
2001), suggesting an enhanced production or inhibited degradation o f the huntingtin fragments 
within the striatum in HD. In addition, different sized fragments o f huntingtin and variation in
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levels o f ubiquitination were observed within different regions o f HD brains also suggesting a role 
for differential huntingtin proteolysis in selective HD pathogenesis.
The processes leading to nuclear translocation of truncated huntingtin are still unclear but it has 
been demonstrated that the presence o f a polyglutamine stretch is essential. Insertion o f a 
polyglutamine coding sequence into the hypoxanthine phosphoribosyltransferase (Hprt) gene 
causes translocation o f the normally cytoplasmic protein into the nucleus (Ordway et al., 1997). 
Polyglutamine length also plays a role in translocation as many experimental systems have 
illustrated that longer polyglutamine stretches produce greater nuclear localisation within cells 
(Cooper et al., 1998; Hackam et a l ,  1998; Hackam et al., 1999b; Li and Li, 1998; Martindale et al., 
1998; W heeler et al., 2000). Another factor that influences translocation is the length o f the 
huntingtin molecule. Studies have indicated that translocation is more efficient for shorter 
huntingtin fragments with longer fragments tending to remain in the cytoplasm (Lunkes and 
Mandel, 1998; Martindale et al., 1998). Transgenic mouse models expressing truncated forms of 
mutant huntingtin (Mangiarini et al., 1996; Schilling et al., 1999), display more N il formation and 
greater phenotypic alterations than mice expressing full-length mutant huntingtin (Hodgson et al., 
1999; Li et a l ,  2000; Reddy et al., 1998; Shelboume et al., 1999; Wheeler et a l ,  2000). Similar 
results have been obtained in cell culture-based (Davies et a l ,  1999; Li and Li, 1998; Scherzinger 
et a l ,  1997) and Drosophila  models (Marsh et al., 2000) o f HD. These findings suggest that the 
expression of a truncated form of the mutant huntingtin protein may bypass a rate limiting cleavage 
step and allow faster accumulation of toxic truncated fragments within the nucleus.
However, protein truncation may not be the only mechanism involved as nuclear extracts from 
juvenile HD patients contain detectable levels o f apparently full-length huntingtin (DiFiglia et al.,
1997). This suggests that a conformational change due to the elongated poly glutamine may unmask 
a nuclear localisation sequence (NLS) or a protein association domain that allows huntingtin to be 
transported to the nucleus, perhaps by binding other proteins (e.g. chaperones) destined for the 
nucleus.
Studies have shown that nuclear localisation o f mutant huntingtin increases cellular toxicity (Kim 
et al., 1999; Peters et al., 1999; Saudou et al., 1998). However, further in vitro experiments have 
suggested that nuclear localisation of mutant huntingtin is crucial for toxicity, whereas aggregate 
formation is not (Klement et al., 1998; Saudou et al., 1998).
To investigate whether nuclear localisation o f the polyglutamine stretches is required for 
cytotoxicity in mice carrying mutant ataxin-1, a mutant NLS was used to prevent nuclear 
localisation (Klement et al., 1998). The resulting mice displaced no ataxia, N il or obvious 
histopathological alterations in their Purkinje cells, the usual site o f pathology. In contrast, animals
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expressing the same mutant ataxin-1 protein with an intact NLS displayed cellular alterations, N il 
and ataxia (Klement et al., 1998), suggesting that nuclear localisation is a necessary step in the 
pathogenic process. When mutant ataxin-1 with a disrupted self-association domain was transiently 
expressed in transfected cells, it appeared to enter the nucleus but did not form aggregates. Mice 
expressing this protein developed Purkinje cell pathology that was similar to that o f mice 
expressing intact mutant ataxin-1, capable of association (Klement et al., 1998). Thus, it appears 
that the formation of nuclear aggregates is not required for the initiation of mutant ataxin-1- 
mediated pathogenesis in transgenic mice (Klement et al., 1998).
Saudou et al. (1998) utilised cultured striatal neurons transfected with cDNAs encoding wild-type 
or mutant versions o f huntingtin and scored cell survival. Expression of a truncated huntingtin 
peptide containing an expanded polyglutamine stretch led to the accumulation of large nuclear 
aggregates and ultimately cell death. Co-expression o f a mutant huntingtin fragment and a 
dominant negative mutant o f the ubiquitin conjugating enzyme (Kalchman et al., 1996) caused a 
significant decrease in the number o f N il and markedly increased the rate of cell death compared to 
cultures expressing mutant huntingtin fragments alone. These findings suggest that the formation of 
N il might be a cellular strategy to inactivate toxic nuclear forms o f mutant huntingtin. In support of 
this idea, aggregates have been shown to increase in size in advanced pathological grades, 
suggesting that they may persist in neurons that are more likely to survive (Gutekunst et al., 1999). 
It is also noteworthy that in adult-onset HD the striatum only displays N il in ~ 4 % of neurons, in 
all grades of HD pathology (DiFiglia et al., 1997; Gutekunst et al., 1999).
The protective role of N il has been questioned by the findings of aggregates in peripheral tissues. 
For example, they have been observed in the pancreatic islets o f R6/2 mice, which often suffer 
from diabetes (Hurlbert et al., 1999). However, no association with cell death was observed when 
investigating N il found in the peripheral tissues in SBMA patients (Li et al., 1998a).
In addition to N il, electron microscopy studies o f human post-mortem tissue have detected  
numerous neuropil aggregates (DiFiglia et al., 1997; Gutekunst et al., 1999; Maat-Schieman et al.,
1999). Neuropil aggregates were frequently observed in the brain o f asymptomatic HD patients 
suggesting that they play a role in early neuronal dysfunction (DiFiglia et al., 1997; Gutekunst et 
al., 1999). Aggregates are also present in the neuronal processes o f HD mouse models (Li et al., 
1999a; Li et al., 2001). The formation o f neuropil aggregates is highly correlated with the 
development of symptoms in HD mice expressing exon 1 of a mutant human HD  gene. Neuropil 
aggregates are more common in the cortex than in the striatum, perhaps acting to impair axonal 
transport or associate with synaptic vesicles, thereby affecting corticostriatal transmission 
(Gutekunst et al., 1999). Neuropil aggregates occur more frequently within the dendrites and 
dendritic spines and could play a role in the known dendritic pathology that occurs in HD
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(Gutekunst et a l ,  1999; Li et a l ,  2001; Petersen et a l ,  2001). These cytoplasmic aggregates differ 
from nuclear aggregates in that they are usually smaller and are not ubiquitinated.
The phenomenon of aggregation could be involved in HD pathogenesis in many ways. Aggregate 
formation may cause the sequestration of other polyglutamine proteins within the nucleus or 
neuropil, thereby, disrupting neuronal gene and protein expression. The neuropil aggregates may 
also disrupt axonal trafficking and neuronal signalling, perhaps by altering the machinery involved 
in neurotransmission.
1.2.7 Protein-protein interactions of huntingtin
By studying huntingtin’s protein partners, insights into the cellular pathways which huntingtin 
contributes may be provided. These findings will help determine huntingtin’s wild-type function 
and suggest pathways involved in HD pathogenesis. Elongation o f the polyglutamine stretch within 
huntingtin may alter binding to customary protein partners or cause novel protein interactions. 
These aberrant interactions may disrupt cellular function by altering the function o f the protein 
partners and/or huntingtin. As HD pathology occurs in a cell-selective manner but huntingtin is a 
ubiquitously expressed protein, the expression pattern of protein partners may be a factor involved  
in determining selective HD pathology. In addition to soluble huntingtin protein interactions, 
huntingtin protein partners could also be sequestered due to the formation of aggregates, reducing 
the amount of protein available within the cell.
1.2.7.1 Huntingtin protein partners
Huntingtin has been found to interact with a novel protein called huntingtin-associated protein 1 
(HAP-1) (Li et a l ,  1995). HAP-1 binds to huntingtin in a repeat-dependent manner, with longer 
polyglutamine stretches enhancing interaction. The expression pattern o f HAP-1 shows that it is 
specifically expressed in neurons, and is absent from glia cells and the periphery. However, HAP-1 
is not enriched within the striatum and cortex, the brain regions specifically involved in HD 
pathogenesis. The function of HAP-1 is unknown, however, cellular localisation studies have 
illustrated a pattern of distribution similar to that of huntingtin. Both proteins have been associated 
with synaptic vesicles within axon terminals and postsynaptic dendritic spines. An association with 
microtubule and dynactin P150Glued, an accessory protein for the microtubule motor, dynein, 
suggests a role in microtubule-dependent retrograde transport o f membrane organelles (Li et a l ,  
1998c). The increased binding between mutant huntingtin and HAP-1 could therefore disrupt 
vesicle transport within neurons and cause cellular dysfunction through signalling deficits. On the 
other hand, it has been shown that HAP-1 does not bind to the huntingtin exon 1 fragment 
expressed in a transgenic mouse of HD, suggesting that cellular dysfunction reminiscent o f HD can 
be produced in the absence o f huntingtin and HAP-1 interactions (Bertaux et a l ,  1998). HAP-1
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knock-out mice have demonstrated a vital role for HAP-1 in postnatal feeding behaviour with 
homozygous mutant mice dying at day P2 (Chan et al., 2002). No alterations in huntingtin or 
dynactin P150Glued expression were detected and abnormalities in vesicle transport were not 
reported. Abnormal brain morphology in these animals is probably due to the significant 
malnutrition suffered because o f the abnormal feeding behaviour. There is no significant 
connection between this phenotype and that o f HD, suggesting that inhibition of HAP-1 by 
enhanced huntingtin binding may not play a significant role in HD pathogenesis.
Immunofluorescence microscopy and subcellular fractionation studies have demonstrated that 
huntingtin co-localises with the membranes o f the trans-Golgi-network and with clathrin-coated 
vesicles in the cytoplasm (Velier et al., 1998). Huntingtin-interacting protein 1 (HIP-1) is also 
enriched in the membrane-containing fractions suggesting that this protein also plays a functional 
role in vesicle transport in vivo. HIP-1, a clathrin and a-adaptin-binding protein involved in 
receptor-mediated endocytosis, binds to huntingtin in a repeat length-dependent manner (Wanker et 
al., 1997). Abnormal binding between HIP-1 and huntingtin may impair the formation and/or the 
transport o f clathrin-coated vesicles in vivo. HIP-1 and HAP-1 also bind to each other suggesting 
that a general dysfunction in vesicle transport may result from mutant huntingtin disrupting several 
proteins involved in this pathway (Waelter et al., 2001). Although HAP-1 and HIP-1 may be 
involved in HD pathogenesis, both are expressed in many neuronal cells type and can not be 
entirely responsible for the selective pathology observed in HD.
Huntingtin also binds to the ubiquitously expressed, key glycolytic enzyme, glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH) in a repeat dependent-manner (Burke et al., 1996). The 
enhanced binding of mutant huntingtin to GAPDH could lead to its sequestration or inhibition and 
subsequent depletion of cellular energy stores. These events could contribute to the impairment o f  
energy metabolism that has been demonstrated in HD brains (section 1.3.1.4) and suggest a 
possible mechanism responsible for HD pathogenesis.
SH3GL3 is a novel SH3-containing protein, which binds the exon 1 fragment o f huntingtin in a 
repeat length-dependent manner (Sittler et al., 1998). The enhanced binding o f mutant huntingtin 
was found to promote the formation o f insoluble aggregates in vivo. Furthermore, mutant 
huntingtin and SH3GL3 can be co-immunoprecipitated from human HD brain tissue (Sittler et al.,
1998). The selective expression pattern o f SH3GL3 mirrors that o f huntingtin with the highest 
levels found in the brain and testis (Sittler et al., 1998).
PSD-95 is a scaffold protein that binds to the NMDA receptor NR2 subunit and kainate receptor 
GluR6 subunit (Garcia et al., 1998; Kim et al., 1996). The binding of PSD-95 to NMDA or kainate 
receptors causes the clustering o f the receptors in the postsynaptic membrane and regulates
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processes such as long term potentiation (LTP) (Garcia et al., 1998). PSD-95 knock-out mice have 
severely impaired spatial learning due to alterations in NMDA-dependent long-term potentiation 
and depression (Migaud et al., 1998). PSD-95 mediates these processes by also binding to 
cytoplasmic signalling proteins, linking the receptors to cellular signalling cascades (Tezuka et al.,
1999). Reduced PSD-95 expression inhibits NM DA receptor-mediated activation of NOS and 
excitotoxicity (Sattler et al., 1999). Normal huntingtin binds to PSD-95 and is therefore associated 
with NM DA and kainite receptors (Sun et al., 2001). The expanded polyglutamine within mutant 
huntingtin interferes with its ability to interact with PSD-95 and the expression o f mutant 
huntingtin has been shown to cause sensitisation o f NM DA receptors and promote glutamate- 
induced neuronal apoptosis (Sun et al., 2001). These findings suggest that normal huntingtin binds 
to PSD-95, sequestering the scaffold protein in order to inhibit NM DA receptor activity and/or 
clustering. Over-expression o f normal N-terminal huntingtin significantly attenuates neuronal 
toxicity by both NM DA receptors and the mutated huntingtin and over-expression o f PSD-95 
reverses this neuroprotection (Sun et al., 2001). PSD-95 has been shown to mediate the neuronal 
toxicity induced by NM DA receptors and mutant huntingtin has been shown to disrupt this ability. 
Evidence to support these findings has been provided by protein lysates from human HD brains 
demonstrating that the expression of mutant huntingtin impairs the ability o f normal huntingtin to 
bind PSD-95 (Sun et al., 2001). This aberrant binding of mutant huntingtin to PSD-95 could be the 
underlying mechanism responsible for the suggested NMDA-mediated excitotoxicity associated 
with HD (section 1.3.1.1).
1.2.7.2 Transcriptional dysregulation and HD pathogenesis
It has been postulated that mutant huntingtin could cause neuronal dysfunction by disrupting 
transcription (Cha et al., 1999). Many transcription factors contain polyglutamine stretches and so 
could be prone to interacting with mutant huntingtin. Aberrant protein binding functions o f mutant 
huntingtin could disrupt the pattern or level of transcription in HD brains in several ways. Firstly, 
the elongated polyglutamine stretch could provide mutant huntingtin with the ability to directly 
bind to DNA. It could cause aberrant binding and inactivation of specific transcription factor 
proteins, thereby repressing transcription. Alternatively it could form complexes with co-repressor 
proteins and therefore de-repress transcription o f normally silent genes. Finally it could sequester 
transcription factors, depleting the levels o f required factors within the cells. It is still unknown 
whether pathological protein interactions occur in the cytoplasm or nucleus, or whether they occur 
during the formation of aggregates or are mediated by soluble mutant huntingtin.
An important study using a HD mouse model (R6/2) investigated alterations in gene expression, by 
DNA microarray, at different stages o f the disease (Luthi-Carter et al., 2000). Numerous changes 
were apparent at early stages (6 weeks) when mice showed minimal motor anomalies. The affected 
genes appear to be limited to several key molecular systems including neurotransmitter receptors,
Laura Kennedy, 2002 Chapter 1, 41
intracellular signalling mechanisms, retinoic acid receptor machinery and calcium homeostasis 
systems. Overall, only 1.2 % of the genes examined were altered. Gene expression changes that 
occurred at the presymptomatic time-point were still affected at later symptomatic stages. This 
finding suggests that detectable alterations in gene expression occur prior to cell loss, supporting 
the idea that neuronal dysfunction precedes cell loss in human HD patients (section 1.1.2.4). 
Interestingly there was no change in the expression levels o f cytoskeletal proteins, enzymes of 
intermediary metabolism, caspases or mitochondrial proteins, which might have been postulated 
from several theories of HD-associated pathogenesis. It is only at the latest time-point (12 weeks) 
tested, that alterations in genes relating to inflammation were noted, indicting that these changes 
are probably secondary to the events that initiate neuronal dysfunction. Thus, the selective pattern 
of pathology in HD might not be due to the level or pattern o f huntingtin expression, but the 
individual set of genes transcribed in a particular cell-type and the importance o f those that are 
altered by mutant huntingtin.
Recruitment of TATA-binding protein (TBP) and the transcriptional co-activator, CREB binding 
protein (CBP), into aggregates has been shown in vitro and in human HD post-mortem brains 
(Huang et al., 1998; Kazantsev et al., 1999; McCampbell and Fischbeck, 2001). CBP is also 
depleted from its normal nuclear location and CBP-activated gene transcription is altered within a 
cell culture HD model (Nucifora et al., 2001). Over-expression of CBP rescued the poly glutamine- 
induced cytotoxicity observed in this system. In support, recent studies have demonstrated that 
postnatal disruption o f CREB transcription factor expression, in a conditional knock-out mouse, 
leads to progressive neurodegeneration restricted to the dorsolateral striatum and the CA1 and 
dentate gyrus regions o f the hippocampus (Mantamadiotis et al., 2002). Mutant huntingtin could 
produce transcriptional dysregulation by sequestering proteasomal subunits, as the activation of 
NF-kB and p53 transcription factors is dependent upon proteasomal processing (Ciechanover,
1994).
Yeast-two hybrid experiments have also shown that mutant huntingtin binds to transcriptional 
repressors including nuclear receptor co-repressor (N-CoR) (B outell et al., 1999). N-CoR and 
mSin3A proteins link specific DNA-binding proteins to proteins with histone deacetylase activity 
and both have shown altered immunohistochemical staining patterns in the brains o f patients with 
HD (Boutell et al., 1999). In control human brains, neurons demonstrate N-CoR and mSin3A  
immunoreactivity in both the nucleus and the cytoplasm. However, HD brains demonstrate N-CoR  
and m Sin3A immunoreactivity solely in the cytoplasm, suggesting that binding o f mutant 
huntingtin may cause redistribution of transcriptional repressors. The lack of mSin3A within the 
nucleus may be related to the observation that a subset of N il in HD brains displays mSinA3 
immunoreactivity (Boutell et al., 1999). These interactions support the possibility that huntingtin
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might affect cellular functioning by disrupting gene expression through abnormal protein 
interactions, redistribution and/or sequestration.
S p l is a ubiquitous transcriptional activator whose major function is recruitment o f the general 
transcription factor TFIID to DNA. TFIID is a multi-subunit complex made up o f the TBP and 
multiple TBP associated factors (TAFs). Yeast two hybrid studies have shown that S p l and 
TAFII130 bind to full-length huntingtin (Dunah et al., 2002). Interactions between S p l and 
huntingtin are repeat length dependent and binding to the soluble form of N-terminal mutant 
huntingtin is tighter than to the aggregated form (Li et a l ,  2002). TAFII130 binds equally w ell to 
normal or mutant huntingtin in the soluble form. Recently S p l, TAFII130 and huntingtin have 
been shown to co-immunoprecipitate in extracts from human HD brain samples (Dunah et al.,
2002). Primary striatal neurons transfected with the dopamine D2 promoter gene constructs along 
with mutant or normal huntingtin displayed decreased Spl binding to the dopamine D2 receptor 
promoter in extracts expressing mutant huntingtin, compared to those expressing wild-type 
huntingtin. Sp l DNA binding is reduced by -2 0  % in the presence o f normal huntingtin and -7 0  % 
in the presence o f mutant huntingtin. Suppression o f transcriptional activity by mutant huntingtin 
and S p l interaction is not restricted to the dopamine D2 receptor promoter, as reduced transcription 
from the nerve growth factor (NGF) receptor promoter has also been demonstrated (Li et a l ,  2002). 
Over-expression o f S p l and TAFII130 in cultured striatal cells reverses the transcriptional 
inhibition o f the dopamine D2 receptor and NGF genes caused by mutant huntingtin and protects 
the neurons from huntingtin-induced cellular toxicity (Dunah et a l ,  2002; Li et a l ,  2002). 
Decreased DNA binding activity o f S p l has been reported in presymptomatic HD human brain 
samples (Dunah et a l ,  2002). The resulting transcriptional inhibition is not seen when other 
transcription factors (e.g. MEF2C) or other TAFs (TAFII105 and TAFII150), are co-expressed  
with mutant huntingtin suggesting that specific transcriptional changes are mediated by mutant 
huntingtin. Levels of Spl and TAFII130 proteins are increased selectively in the caudate nucleus of 
HD brains, perhaps illustrating a compensatory mechanism that attempts to maintain normal 
transcription levels. Since TAFII130 expression appears to be specific to different regions o f CNS 
(Metsis et a l ,  2001) and displays a role in transcribing a specific set o f genes (Albright and Tjian,
2000), the disruption o f TAFII130-regulated transcription may play a role in the selective  
pathology in HD. A  prominent feature o f the genes shown to have altered transcription in a 
transgenic mouse model of HD is that most contain S p l binding sites in their promoters (Dunah et 
a l ,  2002).
Brain-derived neurotrophic factor (BDNF) has an important role in the survival o f striatal neurons. 
It is produced by cortical and nigral neurons and released onto striatal neurons by anterograde 
transport (Altar et a l ,  1997). BDNF mRNA and protein are decreased in the cortex o f HD patients 
and HD transgenic mice expressing human mutant huntingtin (Zuccato et al., 2001). In transgenic
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HD mice, a decrease in cortical BDNF correlated with a decrease in striatal BDNF, suggesting that 
the integrity o f striatal cells may be compromised by a reduction in cortical BDNF. In an 
excitotoxic rat model o f HD, BDNF prevented the death of striatal neurons (Perez-Navarro et al.,
2000). A  reporter-gene assay has demonstrated that mutant huntingtin reduces transcription of the 
BDNF gene driven by 3 o f its 4 promoters (Zuccato et al., 2001). In addition, BDNF gene 
transcription is regulated by CBP (Shieh et al., 1998; Tao et al., 1998), which is sequestered into 
aggregates during HD. In cultured neurons and the brains of transgenic mice, BDNF depletion can 
be reversed by the over-expression o f wild-type human huntingtin since this stimulates expression 
o f BDNF mRNA (Zuccato et al., 2001). The mechanism by which wild-type huntingtin reverses 
the reduction o f BDNF transcription is not known, as wild-type huntingtin is predominantly a 
cytoplasmic protein. However, transcription factors can have a cytoplasmic distribution, as 
demonstrated by HYPB, which interacts with both wild-type and mutant huntingtin (Passani et al.,
2000). These findings suggest that a disruption of BDNF transcription by mutant huntingtin, 
perhaps through its aberrant binding to CBP or its interference with wild-type huntingtin function, 
causes a reduction in the levels o f the vital neurotrophic factor in the corticostriatal projection 
neurons. This leads to insufficient trophic support for the striatal neurons, perhaps rendering them 
more vulnerable to insults such as excitotoxicity. It remains unknown whether the reduction in 
BDNF transcription is due to loss o f wild-type huntingtin function, as this has not been reported in 
HD (Cattaneo et al., 2001). As wild-type huntingtin is required for efficient vesicle trafficking, it is 
also possible that mutant huntingtin causes disturbances in the anterograde transport o f cortical 
BDNF, contributing to BDNF depletion in the striatum.
1.2.8 Neurotransm itter receptor alterations in HD
One group of proteins that may be affected by transcriptional dysregulation or aberrant protein 
interactions with mutant huntingtin are the neurotransmitter receptors. Numerous studies have 
suggested that expression o f neurotransmitter receptors are altered in HD and that this may play an 
important role in phenotypic changes and mechanisms of pathogenesis in HD.
Efficient communication between neurons and therefore normal brain functioning, is reliant on the 
correct expression o f functional neurotransmitter receptors. Studies on human HD post-mortem  
tissue have indicated a progressive reduction in the levels of a number o f neurotransmitter receptors 
within the striatum including dopamine, acetylcholine, GABAA-benzodiazepine, glutamate, 
histamine, adenosine and cannabinoid receptors, suggesting that a disruption in neuronal circuitry 
and function occurs in HD (Dure et al., 1991; Faull et al., 1993; Glass et al., 2000; Goodchild et 
al., 1999; Penney and Young, 1982; Richfield et al., 1991). These post-mortem studies have been 
supported by brain imaging studies in HD patients investigating dopamine, opioid and GABAA- 
benzodiazepine receptor types (Andrews et al., 1999; Ginovart et al., 1997; Holthoff et al., 1993; 
Kunig et al., 2000; Pinborg et al., 2001; Tuijanski et al., 1995; Weeks et al., 1997). Severe loss of
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striatal dopamine Di and D2 receptor binding in HD has been demonstrated in vivo using positron 
emission tomography (PET) and single-photon emission tomography (SPET), which have revealed 
a 60 % reduction in dopamine receptor binding potentials in the striatum of clinically affected HD 
patients compared to controls (Tuijanski et al., 1995). Benzodiazepine receptor binding within the 
caudate nucleus is also reduced by 26-31 % in early HD (Holthoff et al., 1993; Pinborg et al.,
2001). Several o f these studies have also established that the extent o f receptor binding loss 
correlates with the duration of the disease (Ginovart et al., 1997; Pinborg et al., 2001). The levels 
o f reduction depends on receptor type, with striatal opioid receptor binding less severely  
compromised than dopamine receptor binding measurements at equivalent stages o f the disease 
(Weeks et al., 1997).
As substantial cell loss has generally occurred in HD post-mortem tissue the exact nature of 
neurotransmitter receptor changes is sometimes difficult to establish. However, support for early 
alterations in the expression o f neurotransmitter receptors in HD without obvious neuropathology, 
has been provided by autoradiographic studies carried out on grade 0 HD brains. Significant 
reductions in dopamine D2 (~60 %) and cannabinoid CBi receptors (-5 0  %) with no change in 
dopamine Di receptors, were observed within HD caudate putamen compared to control tissue 
(Glass et al., 2000). A  dramatic loss o f adenosine A2a receptors (-6 5  %) in the caudate putamen 
along with complete loss o f adenosine A2a receptors in the lateral globus pallidus was observed in 
grade 0 HD brains (Glass et al., 2000). This observation supports the suggestion that the adenosine 
A2a receptor-expressing MSN within the indirect pathway projecting specifically to the lateral 
globus pallidus, are preferentially vulnerable in HD (section 1.1.2.3). In situ hybridisation studies 
of HD brain tissue displaying no overt striatal pathology demonstrated significantly reduced levels 
of Di and D 2 dopamine receptor mRNAs and that the level continued to drop with increasing 
pathology (Augood et al., 1997). Two factors are thought to contribute to this reduction in 
dopamine receptors; a reduction in the number o f dopamine receptor expressing cells and/or 
reduced mRNA expression in the remaining cells. The abundance o f dopamine D2 mRNA in the 
remaining cells also reduced as the disease progressed. Although dopamine Di transcript levels in 
individual cells were also reduced with increasing pathology, at end stage HD the level o f  
dopamine Di receptor mRNA in the remaining cells appears to revert back to control levels, 
reflecting the selective pathology and the survival of dopamine Di receptor expressing intemeurons 
(Augood et al., 1997).
To establish the role of receptor change in early HD pathogenesis and minimise the confounding 
effects o f cell loss, studies utilising brain-imaging techniques on asymptomatic HD gene carriers 
have been carried out. Changes in dopamine receptor binding have been demonstrated in 
asymptomatic HD gene carriers (Andrews et al., 1999; Antonini et al., 1996; Lawrence et al., 
1998b; Weeks et al., 1996). PET has demonstrated -5 0  % of asymptomatic mutation carriers have
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reduced striatal dopamine Di and D2 receptor binding. These healthy, at risk subjects were found to 
have binding potentials that were 20-30 % below the population mean (Antonini et a l , 1996; 
W eeks et a l , 1996). Abnormalities were more commonly found in gene carriers nearer the typical 
age o f onset for HD, rather than in younger subjects. Subtle cognitive deficits were also detected 
and correlated with the extent o f receptor binding in asymptomatic gene carriers (Lawrence et a l ,  
1998b). These studies suggest that receptor alterations may cause changes to the functional 
integrity o f the MSN early in the disease process.
In vivo  studies have also illustrated that HD is not solely associated with dysfunction o f the 
striatum, but alterations in signalling may occur throughout the entire brain. For example, 
reductions in dopamine Di receptor binding have been reported in the cortical regions o f HD 
patients (Antonini et a l ,  1996; Ginovart et a l ,  1997). In addition, widespread reduction in opioid 
receptor binding within the caudate nucleus, putamen, globus pallidus, midbrain, cingulate and 
medial temporal cortex and increased binding in the thalamus and prefrontal areas in patients with 
early HD has also been demonstrated (Weeks et a l ,  1997).
Imaging studies have indicated that it is not only receptor loss that is associated with HD. For 
example, a reduction in dopamine D2 receptors in the caudate nucleus and putamen o f HD brains 
reflecting reduced glucose metabolism in both areas, suggest cell loss within these brain regions 
(Kunig et a l ,  2000). However, although a loss o f benzodiazepine receptors was also observed in 
the caudate nucleus there was no parallel change within the putamen (Holthoff et a l ,  1993; Kunig 
et a l ,  2000). Previous post-mortem studies of GABA binding have also observed an increase in 
GABAa binding in the globus pallidus, despite cell loss with increasing grades of neuropathology 
(Glass et a l ,  2000; Penney and Young, 1982). These findings suggest receptor activation may 
compensate for cell loss in the caudate nucleus as the globus pallidus loses its primary inhibitory 
input i.e. the MSN. These studies illustrate that not all receptor changes are reductions and there 
may be active modification by the cell to compensate for HD-induced dysfunction.
Many of these changes have been confirmed in transgenic mouse models of HD (Cha et a l ,  1998). 
In R6/2 transgenic mice, neurotransmitter receptors appear to be affected selectively and down- 
regulation of specific receptor types argues against a generalised problem with receptor production. 
Decreases in receptor binding reflect decreases in receptor mRNA levels, suggesting that affected 
receptors decrease in number, rather than changing their binding characteristics. Because receptor 
down-regulation occurs before the onset o f symptoms or observable cell loss in this mouse model, 
receptor decreases do not appear to be a result o f disease progression, supporting the notion that 
neuronal dysfunction as well as cell loss may contribute to the manifestation o f HD symptoms. The 
fact that a single mutant gene can affect the expression o f multiple neurotransmitter receptors,
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increases the likelihood that mutant huntingtin acts by affecting a crucial central mechanism. One 
such mechanism could be transcriptional regulation as discussed in section 1.2.12.
1.3 Mechanisms underlying HD pathogenesis
1.3.1 Excitotoxicity
1.3.1.1 Glutamate-mediated excitotoxicity
A  role for glutamate excitotoxicity has long been proposed to contribute to striatal cell death in HD 
(McGeer and McGeer, 1976; McGeer and McGeer, 1978). The striatum receives abundant 
glutamatergic excitatory input from the corticostriatal and thalmostriatal projections (Figure 1.1). 
Excitotoxic lesions o f the striatum have been produced in animals by infusion o f glutamate or 
ionotrophic glutamate receptor agonists (Beal et al., 1991; Beal et al., 1986). These lesions have 
been found to reproduce many of the neuropathological changes seen in HD. The NM DA receptor 
(an ionotrophic glutamate receptor) agonist, quinolinic acid, produces lesions which most closely 
replicate HD striatal pathology with selective loss o f MSN, relative sparing o f large NAPDH  
diaphorase, somatostatin, neuropeptide Y and cholinergic intemeurons and gliosis in rats (Beal, 
1992a; Beal et al., 1991; Beal et al., 1986; Dunnett et al., 1998; Figueredo-Cardenas et al., 1997; 
M alcon et al., 1997; Young et al., 1988) and primates (Ferrante e t  al., 1993). Medium spiny 
neurons in the striata o f quinolinic acid-lesioned rats also show changes in neurite morphology and 
calbindin immunoreactivity that resembles those seen in HD brains (Huang et al., 1995). These 
findings have lead to the suggestion that neurodegeneration in HD may result from an NMDA  
receptor-mediated excitotoxic process (Beal et al., 1991). Excess glutamate over-stimulation of 
NM DA receptors causes a toxic increase in intracellular calcium. The exact pathogenic targets for 
this calcium are unknown but biochemical pathways including the phospholipases, proteases, 
kinases and calmodulin-regulated enzymes such as NOS probably play a prominent role (Brouillet 
et al., 1999). The initial alteration could be an influx o f calcium into the mitochondrion resulting in 
a blockade o f the respiratory chain, thus disrupting cellular metabolism (Budd and Nicholls, 1996). 
An alteration in metabolic stress appears to increase the potential for glutamate excitotoxicity since 
prior decortication can attenuate, the mitochondrial inhibitor, 3-nitropropionic acid (3-NP)-induced 
lesions (Beal et al., 1993). Excitotoxic striatal lesions in rodents are also associated with 
behavioural deficits including hyperactivity but not chorea (Sanberg et al., 1989). The slow  
progression o f pathology in HD does not correspond to the complete neuronal depletion observed 
within hours o f experimental excitotoxic lesion studies. However, prolonged intra-striatal infusion 
of low levels o f glutamate (McBean and Roberts, 1984), or long term exposure o f cultured 
striatal/cortical cells to low concentrations o f quinolinic acid (Whetsell et al., 1989) still produces 
the same selective pattern of cell death. In contrast, the selective vulnerability o f quinolinic acid 
lesions is lost at higher concentrations o f excitotoxin (Davies and Roberts, 1987; Malcon et al.,
Laura Kennedy, 2002 Chapter 1, 47
1997) and even optimal concentrations can cause extra-striatal receptor changes and degeneration. 
To date, excitotoxic striatal lesions have also failed to reproduce the preferential degeneration of 
the striatal patch compartment and the pattern of selective degeneration of ENK MSN seen in early 
HD (section 1.1.2.3). Despite this, the suggestion that glutamate excitotoxicity plays a part in HD 
pathology has also been supported by brain imaging studies demonstrating disordered glutamate 
metabolism in HD patients (Taylor-Robinson et al., 1996).
1.3.1.2 Glutamate receptor expression pattern on different cell-types
Excitotoxicity relies on the activation of glutamate receptors and so selective vulnerability in HD 
could be determined by the glutamate receptor profiles expressed by different cell-types. The 
neurotransmitter glutamate activates three major families o f ionotrophic receptors (NM DA, 
AMP A, kainate) and one family o f metabotrophic glutamate receptors (mGluR). NM DA agonists 
appear to produce excitotoxic lesions that most closely reflect the pathology seen in HD (Beal, 
1992a; Beal e t a l ,  1991).
A  direct link between mutant huntingtin and sensitivity to NMDA agonists has been illustrated by 
the binding o f huntingtin to PSD-95, a scaffold protein that binds to the NMDA receptor NR2 and 
kainate receptor GluR6 subunits, inducing receptor clustering and mediating receptor signalling 
(section 1.2.7.1). Mutant huntingtin has been shown to disrupt this protein interaction, increasing 
receptor clustering and render cultured cells more sensitive to glutamate-induced apoptosis.
Native NM DA glutamate receptors exist mostly in heteromeric forms composed o f NR1 and NR2 
(A-D) subunits. The NR1 subunit is required for NM DA receptors to function but heteromeric 
expression with NR2s increase channel permeability and determine other channel properties, such 
as the extent of the voltage dependent Mg2+ block, glycine sensitivity and deactivation time (Sucher 
et al., 1996). At the single cell level, all striatal neurons possess functioning NMDA receptors, i.e. 
express NR1 subunits (Ghasemzadeh et al., 1996). However, there is a different pattern of NR2 
subunits expressed in MSN and interneurons. Most MSN express high levels o f NR2B but 
cholinergic intemeurons tend to express less NR2B/A mRNA and protein. NAPDH diaphorase, 
somatostatin intemeurons lack the NR2B/A protein altogether and generally express receptors with 
subunit combinations that have a lower agonist binding affinity compared to those expressed on 
MSN (Chen et al., 1999; Landwehrmeyer et al., 1995b). This differential expression o f NMDA  
receptor subunits may make intemeurons less sensitive to over-excitation by glutamate. Supporting 
this idea, it has been demonstrated that cultured cells co-expressing mutant huntingtin and NMDA  
receptors display increased ionic flow  through the NR1/NR2 NM DA receptor types, which 
predominate on MSN and are less abundant on intemeurons (Chen et al., 1999). These findings 
were replicated during NMDA-induced stimulation of MSN expressing mutant huntingtin (Zeron et 
al., 2002). In addition, it has been demonstrated that MSN and cholinergic intemeurons do show
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different responses to glutamate receptor activation (Calabresi et al., 1998). NR2B subtype-specific 
antagonists abolish the NMDA-induced cell death in neuronal cultures from a HD mouse model 
(Zeron et al., 2002). Further evidence that NMDA receptors may have an important role in HD 
pathogenesis is the observation that NM DA receptors are selectively reduced in the striata of 
presymptomatic HD brains and NM DA receptor-expressing cells are preferentially lost in HD 
brains (Albin et al., 1990; Arzberger et al., 1997).
Non-NM DA glutamate receptors could also contribute to cell-selective pathology as mutant 
huntingtin can disrupt the number and distribution o f AMPA receptors, the expression of GluR2 
subunits and render AM PA receptors impermeable to Ca2+ in cortical cell-types (Pellegrini- 
Giampietro et a l ,  1997; W eiss and Sensi, 2000). Studies using in situ hybridisation and 
immunocytochemical techniques have shown that various subtypes o f mGluRs and AM PA  
receptors, depending on their preferred activation substances and effects, are differentially 
expressed in striatal neuronal populations (Calabresi et a l ,  1999). The MSN and pyramidal cells of 
the striatum and cortex express high levels of GluR2/GluR3 subunits, which are absent or present 
at low  levels on interneurons (Bernard et al., 1997; Tallaksen-Greene and Albin, 1996). 
Differential receptor binding in the striatal compartments is also apparent with normal human 
striatum showing NM DA and AM PA receptor binding moderately enriched in the matrix 
compartment (by 17 % and 32 % respectively) but kainate binding 35 % higher in the patch (Dure 
etal.,  1992).
1.3.1.3 Dopamine-mediated toxicity
The mechanisms by which glutamate and glutamate analogues can induce excitotoxic lesions o f the 
striatum are complicated by the action of dopamine. Dopamine acts at proximal synapses on MSN  
dendritic spines and regulates the action o f glutamate at more distal synapses (Smith and Bolam, 
1990). In addition, the existence o f dopamine receptors on glutamatergic corticostriatal terminals 
has also been demonstrated (Calabresi et a l ,  1996). In contrast, glutamate acting at presynaptic 
glutamate receptors on dopaminergic nigrostriatal neurons can regulate the release o f striatal 
dopamine (Kulagina et a l ,  2001; Martinez-Fong et a l ,  1992). Dopamine levels in normal brain are 
higher in the dorsal striatum and become lower more ventrally, a gradient which corresponds to the 
pattern of the neuropathology seen in HD (Cass, 1997). Dopamine levels also appear to increase in 
the striatum after excitatory amino acid-induced striatal lesions (Buisson et a l ,  1991; Chapman et 
a l ,  1989). The potential for dopamine toxicity has been demonstrated in a study where excitotoxic 
striatal damage, induced by transient ischemia, was attenuated by lesioning the nigrostriatal 
pathway to reduce the striatal dopamine levels (Hashim oto et a l ,  1994). Cell culture systems 
derived from HD transgenic mouse models have demonstrated that transgenic cells are far more 
susceptible to cell death induced by a single exposure to toxic level of dopamine (Petersen e ta l.,
2001). This cell death involves production of oxyradicals and the induction of neuronal autophagy.
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It was also shown that translocation o f the huntingtin fragment to the nucleus only occurs after 
dopamine exposure. This toxicity was not attenuated through inhibiting dopamine receptors, 
suggesting the toxic action is mediated through the oxidation of dopamine and the production of 
free radicals, causing increased oxidative stress in the neurons. This potential has been further 
illustrated by the finding that dopamine metabolites themselves can be neurotoxic. In rodents, 
dopamine is metabolised via monoamine oxidase to 3,4-dihydroxy-phenylacetaldehyde and 
hydrogen peroxide (Spina and Cohen, 1989). Hydrogen peroxide can react with iron or other 
transition metals and generate highly toxic hydroxyl radicals. Dopamine can also undergo 
oxidation with molecular oxygen to form radical semi-ubiquinones and superoxide radicals 
(Graham et al., 1978). Indeed, administering antioxidants have provided neuroprotection against 
dopamine-induced cell death in striatal cell culture (McLaughlin et al., 1998). Depletion of striatal 
dopamine, with either the neurotoxin 6-hydroxydopamine or inhibition of monoamine oxidase, was 
neuroprotective against lesions induced by 3-NP (Maragos et al., 1998; Reynolds et al., 1998).
These findings raise the possibility that the dense striatal dopaminergic innervation, originating 
from the substantia nigra, and the distribution of the dopamine receptors within the striatum may 
play a role in the selective pathology in HD.
Dopamine receptors modulate the responsiveness o f neurons to excitatory neurotransmitters within 
the striatum. In the striatum, glutamate mediates fast excitatory synaptic transmission from cortical 
afferents through ion channels on MSN (Kita, 1996) (Kita 1996), whereas dopamine, from the 
substantia nigra, modulates intracellular cyclic-AM P levels by activating G-protein coupled 
receptors (Grandy and C ivelli, 1992). One pathway by which dopamine may modulate 
glutamatergic input from the cortex onto MSN is through activation o f the inhibitory presynaptic 
dopamine D2 receptors present on cortical glutamatergic terminals. This action may reduce the 
excitation of striatal MSN (H su et al., 1995). In support o f this idea, dopamine D 2 receptor 
activation appears to reduce both NM DA and kainate-induced neuronal swelling (Cepeda et al.,
1998). A  reduction of dopamine D2 receptors in HD may compromise this influence on glutamate 
stimulation of the MSN and may lead to excess glutamate release. Preferential loss of dopamine D2 
receptors early in HD has been observed (Augood et al., 1997; Glass et a i ,  2000). In contrast, 
dopamine Di receptor agonists potentiate MSN activation by enhancing postsynaptic glutamate 
receptor responsiveness (Cepeda et al., 1993) and could therefore enhance NM DA receptor 
mediated toxicity.
As membrane potential dictates the responsiveness of neurons, the modulatory effects o f dopamine 
receptor activation may vary in different activity states. Although tolerated under normal 
physiological conditions, it is conceivable that endogenous levels of dopamine might potentiate cell 
death in neurons with bioenergetic defects or subjected to glutamate excitotoxicity. In support of
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this suggestion, it has been reported that over a third o f asymptomatic relatives o f HD patients 
developed dyskinesias after being challenged with administration o f the dopamine anologue, L- 
DOPA (Klawans, 1970).
1.3.1.4 Metabolic stress
There have been several observations indicating metabolic stress may play a role in HD. HD 
patients often experience chronic weight loss despite an increased fat intake and several imaging 
studies have demonstrated reduced glucose metabolism within the striatum, prior to any cell loss 
(section 1.1.2.4). Evidence of anaerobic respiration has also been provided by the observation that 
the lactate concentration within the striatum o f HD patients is increased (Jenkins et al., 1993; 
Koroshetz et al., 1997). It is not only HD that may display selective striatal vulnerability as a result 
of metabolic stress. It has been demonstrated that damage to basal ganglia structures occurs in 
humans who attempt suicide by ingestion of cyanide or carbon monoxide inhalation, both o f which 
block complex IV of the mitochondrial respiratory chain (Klawans et al., 1982; Uitti et al., 1985). 
In addition, mitochondrial disorders such as Leigh’s disease, idiopathic dystonia and Leber’s 
hereditary optic neuropathy, also display striatal lesions (Beal et al., 1993).
The discovery that HD pathology can be mimicked in experimental animals by using mitochondrial 
inhibitors, has substantiated the role o f metabolic stress in HD and argued for its further 
investigation (Beal, 1992a). Mitochondrial inhibitors such as 3-NP, aminooxyacetic acid (AOAA) 
and malonate have been used, all o f which act to inhibit succinate dehydrogenase activity, a key 
component o f the mitochondrial respiratory chain. Administration of both 3-NP and AOAA has 
been reported to induce neuronal death, which is primarily confined to the striatum (Chang and 
Jang, 1995; Martinou et al., 1994). Systemic injection of 3-NP in rats produces selective loss of 
MSN in the striatum whilst sparing the dopaminergic fibres and NADPH diaphorase-positive 
intemeurons (Beal et al., 1993; Brouillet et al., 1993; Guyot et al., 1997; Ludolph et al., 1991). 
Other dosing regimes have induced preferential damage to dorsal aspects o f the striatum with 
relative sparing o f NADPH-diaphorase positive intemeurons (Palfi et al., 1996). Ingestion of 3-NP 
via contaminated food can also produce selective lesions of the basal ganglia in humans (Ludolph 
etal.,  1991).
Studies have been carried out to establish if  the striatal lesions induced by mitochondrial inhibitors 
produce deficits commonly observed in HD. Administration o f 3-NP in rats and primates can 
induce either a hyperactive or hypoactive syndrome depending on the dosing regime (Borlongan et 
al., 1995b; Guyot et al., 1997). Both of these states could resemble HD, as the movement disorder 
is initially hyperactive (chorea), but progresses into a hypoactive, dystonic state. Following 3-NP 
treatment animals also display cognitive deficits reminiscent of fronto-striatal problems shown in 
HD (Borlongan et al., 1995a; Palfi et al., 1996). The common hypoactive symptoms produced by
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3-NP are normally associated with the late stages or juvenile forms of HD and are probably the 
consequences o f significant degeneration o f MSN in both the direct and indirect pathways (Penney 
and Young, 1986). This suggests that the cellular toxicity of 3-NP lesions does not produce the 
cell-type and compartment-specific neuropathology required to model the early stages of HD.
In order to maintain normal functioning, neurons must sustain their transmembrane ion gradients 
by a high energy-dependent process mediated by Na+/K + ATPase. Any compromise in cellular 
energy metabolism, and therefore the activity o f this enzyme, will result in the collapse o f the 
transmembrane gradients (Lees, 1991). This causes elevation o f intracellular calcium, which is 
strongly implicated in the mechanisms involved in excitotoxic cell death, whether through loss of 
the transmembrane gradient or excessive receptor activation (Beal, 1992a; Beal, 1992b). The 
application of ouabain (an inhibitor o f the Na+/K + ATPase) on identified MSN results in an 
irreversible inward current with increased conductance, leading to cell deterioration (Calabresi et  
al., 1997a; Calabresi et al., 1995). A  lower dose of Na+/K+ ATPase inhibitor dramatically increases 
the membrane depolarisation and inward current produced by excitatory amino acids and increases 
the response to repetitive cortical activation of MSN. This suggests that impairment o f Na+/K+ 
ATPase will render MSN more sensitive to the action of glutamate and produce a lower threshold 
for excitotoxicity (Henneberry, 1989).
The ability to produce excitotoxic damage at normal concentrations o f excitatory amino acids is 
termed ‘weak excitotoxicity’ (Albin and Greenamyre, 1992; Beal, 1994). Cerebellar granule cells 
in culture are normally resistant to the excitotoxic effects of glutamate but if deprived of glucose, 
these neurons become sensitive to the excitotoxic effects of glutamate acting via NM DA receptors 
(Henneberry, 1989). Presumably, impaired cellular energy metabolism leads to failure o f the 
N a+/K + ATPase that normally maintains the membrane potential. The following membrane 
depolarisation leads to a reduction in the magnesium blockage and easy activation of NM DA  
receptors. In summary, the process o f cell death could be initiated by impairment of cellular 
metabolism or membrane potential but excitotoxicity would be the final common pathway leading 
to neuronal death.
It is possible that the differential distribution of various calcium-binding proteins could contribute 
to the selective vulnerability o f striatal neurons. Intracellular calcium levels are normally tightly 
regulated by a series o f calcium-binding proteins including calbindin, parvalbumin and calretinin. 
Calbindin is present at high concentrations within many striatal cells and comprises one of the 
criteria for distinguishing matrix from patch (section 1.1.2.3). The medium sized intemeurons 
spared in HD are calbindin positive and probably account for the increased levels observed in the 
matrix compartment o f the striatum in end-stage disease (Cicchetti and Parent, 1996). The profile 
of calcium-binding proteins cannot be the sole explanation for selective vulnerability since discrete
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populations of both calbindin-positive and parvalbumin-positive striatal intemeurons do degenerate 
in HD (Ferrer et al., 1994). However, stimulation of NM DA receptors can lead to neurotoxic 
effects through mechanisms that are not directly dependent upon calcium influx, such as the 
activation of nitric oxide synthase (NOS) (Sato et al., 1995).
Evidence has also been reported suggesting a role for the free radical nitric oxide (NO) in the 
striatal degeneration induced by inhibitors o f mitochondrial respiration. NO is known to 
irreversibly inhibit mitochondrial complexes II-III and IV and succinate dehydrogenase, which 
could lead to further toxic impairment o f metabolism and production of radical oxygen species 
(Bolanos et al., 1997; Connop et al., 1996). It has been reported that 3-NP-induced lesions in the 
rat striatum are accompanied by activation o f nitric oxide synthase (NOS) (Nishino et al., 1996). 
The potential toxic effects of NO production could also arise during excitotoxicity as NO formation 
can be induced by activation of NM DA receptors on NOS-containing neurons (Connop et al.,
1996). The resultant release o f NO within the striatum could lead to damage o f surrounding 
neurons, irrespective o f their calcium-binding protein content. Indeed, in culture, NM DA  
activation-induced toxicity appears to be mediated by NO (Dawson et al., 1993) and neurons from 
mice with deletions of the neuronal NOS gene appear to be resistant to excitotoxicity (Dawson,
1995). In addition, treatment with NOS inhibitors ameliorates several forms of excitotoxicity in 
animal models (Schulz et al., 1995).
The selective vulnerability of striatal cells after mitochondrial inhibition may be due to the different 
metabolic rates o f different cell-types. Cells with higher metabolic demands are probably more 
susceptible to toxicity (Bossi et al., 1993). This notion is supported by the observation that 
increased metabolic demands caused by glucose deprivation produces depolarisation o f MSN but 
hyperpolarisation of cholinergic intemeurons (Calabresi et al., 1997a).
Early reports o f a reduction in mitochondrial complex II and IV activities in the caudate of 
individuals with HD first provided the clue that defects in energy metabolism may be 
pathologically relevant in HD (Brennan et al., 1985). Mitochondrial complexes II-III and IV were 
later shown to have reduced activity within the striatum but not the cortex or cerebellum of HD 
patients (Bossi et al., 1993; Brown et al., 1997; Gu et al., 1996; Tabrizi et a l ,  1999). In addition, 
huntingtin has been shown to bind, in repeat length-dependent manner, to GAPDH, a key enzyme 
in energy metabolism (Guyot et al., 1997). This altered protein interaction could inhibit GAPDH 
activity and cause depleted energy stores, contributing to deficits in energy metabolism.
1.3.1.5 Oxidative stress
Compounds such as superoxide and hydroxyl radicals, are endogenously formed, highly reactive 
molecules that can oxidise lipids, proteins and DNA, thereby altering neuronal structure and
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function (Halliwell, 1992). The oxidative stress that results from excessive excitatory amino acid 
receptor stimulation or metabolic stress is a candidate for contributing to neuronal cell death in HD.
It has been demonstrated that following the administration o f 3-NP and glutamate agonists there is 
an increased production o f striatal reactive oxygen species in rats (Schulz et al., 1995; Schulz et al.,
1996). The pathology caused can be attenuated by antioxidants (Beal, 1995; Schulz et al., 1996), 
confirming the role of oxidative stress in mediating metabolic impairment-induced cell death.
Several pathways may be involved in the production o f increased levels of reactive oxygen species 
and their toxicity (Coyle and Puttfarcken, 1993). For example, NM DA receptor-mediated 
intracellular calcium increases can activate phospholipase A2, resulting in the release o f 
arachidonic acid (Miller et al., 1992). The subsequent metabolism of arachidonic acid can produce 
free radicals. Elevated calcium levels can also activate calcium-dependent proteases leading to the 
cleavage o f xanthine dehydrogenase, converting it to xanthine oxidase. The subsequent conversion 
of xanthine and hypoxanthine to uric acid produces superoxide radical and hydrogen peroxide 
(Greene and Paller, 1992; Sanhueza et al., 1992). Hydrogen peroxide, especially in the presence of 
Fe2+, decomposes to toxic hydroxyl radicals. Similarly, NM DA receptor activation can produce 
increased levels o f free radical NO (Dawson, 1995; Sato et al., 1995). Disruption o f mitochondrial 
electron transport and subsequent energy deficiency can also lead to the increased production o f 
toxic oxidants, including free radicals (Coyle and Puttfarcken, 1993; Schulz et al., 1995). 
Activation o f microglia in response to neurodegeneration could exacerbate the situation since they 
release a variety of toxins including glutamate, NO, hydrogen peroxide and superoxide (Bal-Price 
and Brown, 2001).
Several reports support the occurrence o f increased oxidative stress in HD patients. Levels o f  
oxidised glutathione (Sian et al., 1994) and 8-hydroxydeoxy-guanosine (Browne et al., 1997), 
which are markers o f oxidative stress, are significantly increased in the striatum in HD patients. 
The inactivation of mitochondrial aconitase is considered an indirect indicator o f reactive oxygen  
species production (Hausladen and Fridovich, 1994). Aconitase activity is decreased by more than 
90 % in the caudate and 70 % in the putamen of HD sufferers whereas normal levels are detected in 
cerebellar and fibroblast tissue (Tabrizi et al., 1999). It has also been suggested that the natural 
decline in oxidative brain metabolism and mitochondrial metabolism that occurs with increasing 
age could contribute to the onset age o f the HD phenotype (Bossi et al., 1993), supported by the 
observation that the severity o f mitochondrial inhibitor-induced lesions increases with age (Bossi et 
al., 1993).
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1.4 Trinucleotide repeat diseases
An increasing number o f human hereditary diseases are associated with the lengthening  
(expansion) o f repeated DNA sequences (Tables 1.1 and 1.2). The repeat sequences responsible are 
either trinucleotide, tetranucleotide or pentanucleotide repeat units and are typically polymorphic in 
length within the general population. However, expansion o f the repeat sequence to above a 
threshold number of repeat units initiates a pathogenic process.
To date, it is the trinucleotide repeat sequences that are most commonly associated with disease. 
This group can be divided into two general categories. Firstly, various untranslated trinucleotide 
repeat sequences responsible for diseases such as Fragile XA (CGG repeat), myotonic dystrophy 
type 1 (CTG), spinocerebellar ataxia 8 (CAG) and Friedreich’s ataxia (GAA). Secondly, translated 
CAG repeat sequences that manifest as elongated polyglutamine stretches within the gene product 
and cause the polyglutamine disorders.
There are currently nine different disorders that have been associated with elongated polyglutamine 
stretches: Huntington’s disease (HD), spinobulbar muscular atrophy (SBM A), dentatorubral 
pallidoluysian atrophy (DRPLA) and several spinocerebellar ataxias (SCA), 1, 2, 3, 6, 7 & 17 
(David et al., 1996; Fujigasaki et al., 2001; (HDCRG), 1993; Kawaguchi et al., 1994; La Spada et 
al., 1991; Nagafuchi et al., 1994; Orr et al., 1993; Sanpei et al., 1996; Zhuchenko et al., 1997). 
Polyglutamine disorders typically have a non-pathogenic repeat range of below 40 repeats and 
pathogenic expansions o f between 36 and -2 5 0  repeats. Most o f the expanded CAG repeat tracts 
responsible for polyglutamine disorders reside in genes, which encode proteins o f unknown 
function, with the exceptions o f SBM A (androgen receptor), SCA 6 (a  1a voltage-dependent Ca2+ 
channel) and SCA 17 (TATA-binding protein).
Although the mechanism of disease pathogenesis in the polyglutamine disorders is largely 
unknown, several lines of evidence suggest that the repeat expansion mutations exert their toxicity 
through a gain-of-function mechanism. These include autosomal dominant inheritance patterns 
(except in SBMA), similar phenotypes o f homozygous and heterozygous gene carriers and gene 
knockout mice lacking the appropriate disease phenotypes. The fact that the disorders share 
features such as late onset clinical picture, slow progression and specific patterns o f pathology 
induced by ubiquitous mutant proteins, intergenerational anticipation and a common disease 
threshold-expansion length (-3 6  CAG repeats) suggests the common mutation type may act 
through similar pathogenic mechanisms.
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A  common pathological feature observed in the polyglutamine disorders is the occurrence of N il in 
post-mortem brain tissue, reported in patients suffering from HD (Becher e t al., 1998; DiFiglia et 
al., 1997; Gutekunst et a l ,  1999), SCA1 (Skinner et al., 1997), SCA3 (Paulson et al., 1997), SCA7 
(Holmberg et al., 1998), SBMA (Li et al., 1998b) and DRPLA (Becher et al., 1998; Igarashi et al.,
1998), substantiating the suggestion of a common underlying mechanism of pathogenesis (Ross et 
al., 1999).
However, each polyglutamine disorder shows a specific, characteristically distinct pattern o f 
neurodegeneration (Ross et al., 1999), suggesting that the protein context o f the repeat and protein- 
specific interactions may also play a role in the pathology observed. Although the mutant genes 
responsible for the polyglutamine disorders are widely expressed in all somatic tissues (Banfi et al., 
1996; Doyu et al., 1994; Landwehrmeyer et al., 1995a; Li et al., 1993; Strong et al., 1993; Yazawa 
et al., 1995) each disorder displays selective neurodegeneration. As a significant correlation 
between pathology and somatic repeat length is well established in the tissue-specific pathology 
observed in other triplet repeat diseases such as DM1 (Joseph et al., 1997; Lavedan et al., 1993; 
Monckton et al., 1995), somatic mutation instability is a possible explanation for the tissue-specific 
pathology in polyglutamine disorders. Studies on post-mortem tissues from polyglutamine 
disorders have shown variable levels o f somatic repeat instability (Cancel et al., 1998; Chong et al., 
1995; Koefoed et al., 1998; MacDonald e t al., 1993; Spiegel et al., 1996; Takano et a l ,  1996; 
Tanaka et al., 1996; Telenius et al., 1994). However, several o f these studies have produced 
conflicting results, reporting the appearance or absence o f somatic repeat instability in the same 
polyglutamine disorders (MacDonald et al., 1993; Telenius et al., 1994). The general pattern o f  
somatic repeat instability reported (Cancel et al., 1998; Chong et al., 1995; Takano et al., 1996) is 
similar to that previously reported for HD (Telenius et al., 1995) but does not obviously correlate 
with the tissue-specific pattern of pathology. A  common observation is that shorter CAG repeats 
are present within the cerebellum compared to other CNS tissues. In HD the cerebellar cortex is 
rarely involved in neuropathology and displays low levels of CAG repeat instability (Telenius et 
al., 1995). However, the cerebellum is involved in the pathology associated with DRPLA, SCA1 
and SCA3 but also displays a shorter repeat length and less repeat length variability than other 
areas of the brain (Cancel et al., 1998; Chong et al., 1995; Takano et al., 1996). Moreover, regions 
showing the most obvious neuropathology, such as the dentate nucleus, red nucleus and cerebellar 
white matter in DRPLA and the spinal and bulbar motor neurons and dorsal root sensory ganglia in 
SBMA, do not show higher levels o f CAG instability (Takano et al., 1996). Although these 
findings do suggest similarities between the behaviour o f CAG repeats in somatic tissues, the 
corresponding patterns do not appear to support a role for somatic repeat instability in the tissue- 
specific pathology of the polyglutamine disorders.
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It has been suggested that genomic ds-acting factors may play a role in repeat instability observed 
in the germline (section 1.2.1). When comparing the magnitude o f paternal expansion of the CAG 
repeat units in different polyglutamine disorders, an average increase o f 9 repeat units is observed 
in HD (Duyao et al., 1993), 4.2 repeat units in DRPLA (Koide et al., 1994), 3.1 repeat units in 
SCA3 (Maruyama et al., 1995) and 1.4 repeat units in SBMA (La Spada et al., 1992; Shimada et 
al., 1995). These findings suggest that factors other than the absolute repeat length can affect repeat 
instability, perhaps including the surrounding genom ic sequence, which differs for each 
polyglutamine mutation. For example, the GC content o f the DNA flanking the expanded repeats 
has been implicated in influencing their tendency to expand (Brock et al., 1999). A s CAG repeat 
length correlates with age o f onset and clinical severity in several polyglutamine disorders, 
anticipation is observed (Andrew et al., 1993; Doyu et al., 1994; Duyao et al., 1993; La Spada et 
al., 1994). However, the differing extents of germline repeat instability means that variations in the 
clinical presentation are observed such as less apparent anticipation and fewer juvenile cases.
The polyglutamine disorders display similarities suggesting that the CAG repeat expansion and 
subsequent expression o f elongated polyglutamine initiates a common sequence o f pathogenic 
events resulting in the same cellular hallmarks o f pathology (N il) and causing similar disease 
characteristics, i.e. inheritance patterns, tissue-specific vulnerability, late-onset symptoms. It is 
clear that this common mechanism of pathogenesis must be modified in some way to generate the 
distinct behaviour o f the repeat in the germline and the unique pattern of disease-associated  
neurodegeneration. This modifying influence may be due to the differing genomic and protein 
context of each repeat sequence.
1.5 Tools for investigating HD
1.5.1 HD model system s
Investigations into HD using human post-mortem tissue are hampered by the limited availability of 
this tissue and the extensive neurodegeneration that occurs prior to death. To elucidate the events 
involved in HD pathogenesis it is essential to develop model systems to investigate the early 
pathological, cellular and molecular alterations caused by the HD mutation, which cannot be 
measured within HD patients in vivo. HD model systems may also provide high throughput 
systems to assess the efficacy of potential treatments. Generating HD models is simplified by the 
discovery that a single mutation is responsible for the disease ((HDCRG), 1993). The strategies 
undertaken to produce HD model systems generally entail either mutating the particular H D  gene 
orthologue within another species or expressing a mutant version o f the human H D  gene in a 
transgenic system.
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1.5.1.1 Mammalian cell culture
Mammalian cell culture allows investigations into the consequences of elongated polyglutamine 
stretches in a simple and flexible system. Many mammalian cell lines have been used to produce 
models of HD by stably transfecting cells with constructs expressing different sized fragments of 
mutant huntingtin, containing repeat tracts o f differing lengths. For example, cell culture systems 
have been commonly used to investigate the factors involved in the formation o f aggregates 
(Cooper et al., 1998; Hackam et a l ,  1999a; Li and Li, 1998; Ravikumar et al., 2002), the potential 
toxicity of aggregates in HD (Carmichael et a l ,  2000; Chun et a l ,  2002; Kim et a l ,  1999; Saudou 
et a l ,  1998) and the cellular alterations observed due to aggregate formation (Li et a l ,  1999a; 
Nucifora et a l ,  2001). However, the investigations carried out in cell culture can be broadened to 
include studies into the role o f receptor subunit expression in cell-selective vulnerability in HD 
(Zeron et a l ,  2002) and the pathways of cell death observed in HD (Kegel et a l ,  2000).
1.5.1.2 Bacteria
The bacterial species, Escherichia coli (E .coli) is commonly used to examine the behaviour of 
triplet repeat sequences and factors that influence repeat length changes. This system allows rapid 
investigation into the stability o f repeat sequences o f different lengths, different compositions and 
under different conditions (i.e. mutant strains of E .co li). Triplet repeat sequences appear to be 
unstable in E .co li (Kang et al., 1995), however, they exhibit preponderance for deletions, a 
behaviour not replicated in organisms such as mice and humans. This repeat behaviour has made 
the maintenance of long triplet repeat sequences within plasmids in bacterial systems difficult. 
Despite these problems studies have revealed factors involved in the generation of varying repeat 
lengths, which have been supported by studies in other systems. Studies in E.coli have suggested 
that mechanisms such as DNA replication (Bacolla et al., 1997; Bowater et a l ,  1997; Bowater et 
a l ,  1996; Kang et al., 1995; Kang et al., 1996; Schumacher et a l ,  1998), methyl-directed mismatch 
repair (Jaworski et a l ,  1995), transcription (Bowater et a l ,  1997; Schumacher et a l ,  2001) and 
nucleotide excision repair (Pamiewski et al., 1999) may contribute to triplet repeat instability.
1.5.1.3 Yeast
Yeast (mostly Saccharomyces cerevisiae) have also been used to analyse the behaviour o f repeat 
tracts under different conditions. Like E .coli, yeast cells have failed to exhibit the dramatic and 
frequent expansions observed in human disease (Freudenreich et a l ,  1997; Kang et al., 1995). 
Indeed, long triplet repeat sequences in yeast are predisposed to undergoing origin o f replication 
orientation-dependent expansions and frequent, large deletions (Freudenreich et al., 1997; Maurer 
et a l ,  1996; Miret et al., 1997). An advantage o f using a yeast model system is that mutant strains 
are widely available. Many strains affecting aspects o f DNA replication, repair and recombination
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have allowed investigations into their role in CAG tract stability (Freudenreich et al., 1997; 
Jankowski et al., 2000; Maurer et al., 1996; Richard et al., 1999; Schweitzer and Livingston,
1997).
Aberrant protein interactions that lead to transcriptional dysregulation and aggregate formation 
may represent an underlying mechanism for cellular disruption in HD (section 1.2.7). The yeast- 
two hybrid system has commonly been utilised to determine protein interactions with wild-type or 
mutant huntingtin. To date this use o f yeast cells has revealed many huntingtin-interacting protein 
partners (Boutell et al., 1999; Boutell et al., 1998; Holbert et al., 2001; Li et al., 1998c; Li et al., 
1995; Sittler et al., 1998).
1.5.1.4 Fly
The strategy of manipulating the genome to express a copy of the mutant human HD  gene has been 
carried out in Drosophila melanogaster. The first Drosophila  HD model expressed an N-terminal 
truncated mutant (75 or 150 glutamine residues) human huntingtin cDNA within the Drosophilia 
eye by using the eye-specific P element expression vector pGMR (Jackson et al., 1998). Cell loss 
within the Drosophila  photoreceptor neurons expressing truncated huntingtin occurred in a repeat 
length dependent, progressive manner. It was noted that nuclear accumulation o f the mutant 
huntingtin fragment preceded cell death; an event previously identified in cell culture models as a 
vital step in pathogenesis (section 1.2.6.1). In studies using other transgenic Drosophila  lines, 
widespread expression of elongated polyglutamine tracts induced degeneration in many cell-types. 
Reduced toxicity and specificity was conferred by the addition o f varying protein contexts (Marsh 
et a l ,  2000). Studies suppressing aggregation and polyglutamine binding within 2l Drosophila  HD 
model increased survival rates and decreased neuropathology (Kazantsev et al., 2002). Over­
expression o f the chaperone heat-shock proteins Hsp40 and Hsp70 also reduced pathology in
Drosophila  expressing polyglutamine peptides (Kazemi-Esfaijani and Benzer, 2000). Drosophila
studies have also illustrated that aberrant protein binding plays an essential role in initiating 
pathogenesis, suggesting that peptides designed to interfere with aberrant protein interactions may 
be o f therapeutic benefit (Kazantsev et a l ,  2002).
1.5.1.5 Nematode
A  transgenic Caenorhabditis elegans (C.elegans) model o f HD has been produced by expressing 
the N-terminal (171 amino acids) region o f human huntingtin with polyglutamine tracts o f 2, 23, 95 
and ~150 residues (Faber et al., 1999). To assess the effect o f the polyglutamine tracts, the 
structure and function o f sensory neurons were studied. Expression o f a huntingtin fragment 
containing 150 glutamine residues led to progressive neuronal dysfunction. However, the co­
expression of a sub-threshold level o f a second toxic protein (OSM-10::GFP) in the 95
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polyglutamine expressing line lead to neuronal dysfunction and in the 150 polyglutamine line 
resulted in progressive neuronal dysfunction leading to neurodegeneration. Under these 
circumstances, the huntingtin (150Q) protein forms cytoplasmic aggregates within the neurons and 
the number o f neurons containing aggregates increases with age. Similar results were obtained by 
expressing the 57 N-terminal amino acids o f human huntingtin with an expanded polyglutamine 
stretch (Q128) (Parker et al., 2001). Mechanosensory defects and the appearance o f cytoplasmic 
aggregates and morphological abnormalities in the neuronal processes indicates that cellular 
dysfunction in these animals does not correlate with the formation o f nuclear aggregates but with 
aggregation and morphological changes in the axons (Parker et al., 2001).
Polyglutamine stretches o f the length previously responsible for producing significant phenotypic 
alterations in humans and mice have been show to cause cellular dysfunction in C .elegans. 
However, cell death only occurs if challenged with additional cellular insults. Investigations of this 
cellular dysfunction may reveal insights into early HD pathogenesis but the short lifespan of this 
organism may restrict the modelling o f the entire course of the disease process.
1.5.1.6 Rodents
HD rodent models have been produced by the administration o f neurotoxins. It has been 
established that several chemicals produce selective patterns o f cell death reminiscent of HD and 
that these result in similar phenotypic alterations (section 1.3) (Beal et al., 1993; Beal et al., 1991; 
Coyle and Schwarcz, 1976). By investigating the mechanisms governing this cell-type selective 
neuropathology important factors influencing the production of the selective HD-associated  
neuropathology may be elucidated.
A  genetic HD rat model has been generated through lentiviral-mediated delivery o f mutant 
huntingtin into the striatum (de Almeida et al., 2002). Lentiviral vectors expressing the first 171, 
853, 1520 amino acids of huntingtin, with either 19, 44, 66 or 82 CAG glutamines, driven by either 
the phosphoglycerate kinase 1 or CMV promoters were injected into the rat striatum. When 
constructs expressing mutant (82Q) huntingtin infected cells, N il formation occurred within one 
week followed by cell death associated with astrogliosis at 6 months. The cell death occurs 
selectively in the MSN, leaving the infected, striatal intemeurons relatively untouched. Following 
N il formation but preceding cell death, DARPP-32, a regulator o f dopamine receptor signalling, 
was depleted in the MSN 4 weeks after injection, suggesting neuronal dysfunction. Earlier onset 
and more severe pathology is observed with shorter protein fragments, longer repeats and higher 
expression levels. It was also shown that cells expressing longer protein fragments or lower 
expression levels displayed fewer N il but had a higher frequency of neuritic aggregates, suggesting 
a switch in the site of pathology. Injection of mutant constructs directly into the striatum has 
allowed quick analysis o f the effects that many different mutations have on cells within the
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striatum and has also demonstrated the variations produced by differing expression levels and 
huntingtin protein fragment sizes.
Modelling aspects o f HD pathogenesis has been achieved in many different organisms ranging 
from bacteria to primates. The ability to replicate aspects o f HD pathogenesis in a single cellular 
environment provides the opportunity to investigate the behaviour of CAG repeats and the possible 
modes o f polyglutamine toxicity in simple and easily manipulated organisms. Many observations 
made in cellular models have been replicated in higher organisms, illustrating how these model 
systems can be relevant to HD research. Investigations using Drosophila  and C.elegans transgenic 
models have allowed the consequences o f the HD mutation to be determined in a more complex 
environment. However, it has been suggested that the late-onset, slowly progressive nature o f HD 
pathogenesis may not be fully modelled in organisms with such short life spans. Whilst, the rodent 
and primate brain may provide a more appropriate environment to model HD pathogenesis, there 
are limitations associated with the use o f these organisms due to the com plexity o f this 
environment. It is clear that all HD model systems have the potential to provide useful information 
concerning the mechanism of HD pathogenesis each with its own advantages and disadvantages.
1.5.2 HD m ouse m odels
To date, it is the mouse genome that has been the most successfully manipulated to generate 
models o f HD. Several gene-targeted and transgenic models have been produced to help elucidate 
the phenotypic, cellular and molecular consequences of the HD expansion mutation. In addition, 
mouse models can also be cross-bred with other genetically altered mice to further dissect the 
molecular mechanisms involved in HD (Manley et al., 1999) and specific alterations within the 
cells o f HD mouse models can be investigated using cell cultures derived from these animals 
(Manley et al., 1998; Petersen et al., 2001; Trettel et al., 2000; Zeron et al., 2002).
1.5.2.1 HD ‘knock-out’ mice
The HD mutation is widely considered to generate the pathogenesis o f HD through a gain-of- 
function mechanism. However, the initial genetic manipulation of the mouse genome involved 
generating a null allele for the H D  locus. These studies were primarily designed to help determine 
the wild-type function of the huntingtin protein associated with HD. In addition, these HD knock­
out mice have also been used to establish if  any aspects o f HD pathogenesis can be attributed to a 
loss of protein function (section 1.2.4).
It was observed that homozygous HD knockout animals died during embryogenesis at day E8.5 
(Duyao et al., 1995; Nasir et al., 1995; Zeitlin et al., 1995). This embryonic lethality can be rescued 
by mutant huntingtin, suggesting that the expansion mutation does not result in a significant loss of
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protein function and therefore may work through a gain-of-function mechanism (White et al.,
1997). However, in-depth analysis of mice that are heterozygous for the Hdh knock-out allele did 
reveal neuronal degeneration within the basal ganglia during adulthood (Nasir et al., 1995; Okusky 
et al., 1999). In addition, a conditional knock-out HD mouse, in which huntingtin is selectively 
depleted in the brain and testis during adult life, showed phenotypic alterations reminiscent of HD, 
suggesting that loss o f huntingtin function could contribute, in part, to the disease process 
(Dragatsis et al., 2000). Studies into the function o f normal huntingtin have demonstrated that 
normal huntingtin but not mutant huntingtin possesses functions that if  lost might contribute to the 
disease process. One such example is the involvement of huntingtin in the expression o f BDNF, a 
trophic factor for striatal neurons (Zuccato et al., 2001). Although the knock-out models have 
revealed an essential role for huntingtin in embryonic development and neuronal maintenance in 
adult life, they are not generally considered good models of the HD disease process.
Two further kinds of mouse models have been generated to model the gain-of-function mechanism 
suggested for the HD mutation. Firstly, transgenic mice in which the mutant gene, or part o f it, is 
inserted randomly into the mouse genome, leading to the expression o f a mutant protein in addition 
to normal levels o f endogenous huntingtin. Secondly, knock-in mice, in which the mutation is 
inserted into the endogenous mouse Hdh gene. Typically, knock-in mice express the mutant gene 
under the control o f its natural promoter within the appropriate genomic and protein context.
Many of the HD transgenic and knock-in mouse models display some form o f cellular alteration 
and/or phenotypic change prior to cell death, substantiating the previous suggestions from human 
studies (section 1.1.2.4) that the HD mutation can produce a lengthy period of cellular dysfunction, 
capable o f inducing phenotypic alterations, prior to cell death. Evidence from HD mouse models 
has also supported the observation that longer CAG repeats cause an earlier age at onset and greater 
severity o f disease phenotype (Hodgson et al., 1999; Levine et al., 1999; Lin et al., 2001; 
Mangiarini et al., 1996; Wheeler et al., 1999).
1.5.2.2 Transgenics mouse models of HD
Comparisons between the transgenic HD mouse models can provide information concerning the 
influence of the protein context o f the mutation on the disease process, as several models have been 
generated expressing the HD mutation within a truncated (Table 1.3) (Mangiarini et al., 1996; 
Schilling et a l ,  1999) or full-length (Table 1.4) (Hodgson et al., 1999; Reddy et al., 1998) version 
of the human HD  gene.
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The R6 mice are a well characterised transgenic HD mouse model (Mangiarini et al., 1996). They 
were generated by random insertion o f a -1  kb fragment encompassing the 5 ’ UTR sequences, 
exon 1 containing an expanded CAG repeat of -1 3 0  units and the first 262 bp of intron 1 of the 
human HD  gene and express an N-terminal fragment o f human mutant huntingtin. Several lines 
were generated carrying transgenes with different length repeat tracts on a hybrid genetic 
background. The most frequently used line is the R6/2 line and carries a construct that originally 
contained -1 4 4  CAG repeat units and expresses the mutant protein at -7 5  % o f the endogenous 
huntingtin level.
Another transgenic model expresses an N-terminal truncated human huntingtin cDNA encoding 82 
glutamine residues and the first 171 amino acids of the huntingtin protein (N171-82Q) (Schilling et 
al., 1999). Transgene expression in these mice is directed by the mouse prion protein promotor, 
which typically drives the expression o f foreign genes in virtually every CNS neuron. Levels of 
mutant HD-N171 polypeptide appear to be lower than endogenous full-length huntingtin protein 
( - 10-20 %).
Transgenic mice expressing full-length mutant huntingtin protein carry 2-22 copies of a construct 
containing the entire human huntingtin cDNA with different repeat lengths (16, 48, 89), under the 
control o f the CMV promoter (Reddy et al., 1998). Further lines o f transgenic mice expressing the 
HD mutation within the context o f the full-length huntingtin protein have been generated using a 
yeast artificial chromosome (YAC) containing human genomic DNA spanning the full-length H D  
gene. This sequence is thought to include all HD regulatory elements, including the endogenous 
human promoter and has been manipulated to contain 18, 42 and 72 CAG repeats (Hodgson et a l ,  
1999). Although, one line o f YAC72 (2498) mice expressed mutant huntingtin at twice the 
endogenous level o f normal huntingtin, the other lines (YAC18, YAC46 and YAC72 (2511)) 
expressed mutant huntingtin at 30-50 % o f endogenous huntingtin levels.
Investigations o f these HD transgenic mice have demonstrated that animals expressing truncated 
forms o f mutant human huntingtin display the earliest and most severe phenotype. Despite this 
severe phenotype none o f these animals display any significant cell death until late in life. 
Conversely, mice expressing full-length human huntingtin express phenotypes that are less severe 
and progress more slowly. In addition, neuropathological observations indicate that the expression 
of a truncated form of mutant huntingtin protein produces early nuclear staining and subsequently 
high numbers of N il and neuropil aggregates, with a distribution pattern that does not correlate well 
with patterns of selective pathology in HD. These findings indicate that cells containing aggregates 
can continue for long periods o f time without experiencing cell death. Conversely, in transgenic 
models expressing full-length mutant huntingtin specific patterns of striatal cell loss are 
accompanied by rare N il formation suggesting that the aggregates may not necessarily induce cell
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death. Indeed, even in animals that over-express full-length mutant huntingtin (Reddy et al 1999, 
line HD48) low levels of N il formation are observed.
If proteolysis of the mutant huntingtin protein and subsequent translocation of the cleaved peptide 
to the nucleus are vital steps in HD pathogenesis (section 1.2.6.1) then the severe phenotype 
exhibited in transgenic mice expressing a truncated form of mutant huntingtin may be due to the 
by-passing of the proteolytic processing step required early in the disease process. The large influx 
of truncated mutant huntingtin may explain the high levels o f aggregate formation in animals 
expressing truncated forms of the protein. The widespread distribution o f aggregates in these 
animals may also indicate that a cell-specific mechanism may be involved in the processing of 
mutant huntingtin and that striatal specific neurodegeneration may only occur in animals 
expressing full-length mutant huntingtin.
Comparison of the HD mouse models has also indicated that levels of transgene expression can 
influence the disease process. The R6/1 line differs from the R6/2 line in that it carries a slightly 
shorter repeat expansion (115 repeats) and its transgene is expressed at 10-20 % o f endogenous 
levels (compared to 75 % in the R6/2 line). The R6/1 animals display a more slowly evolving 
neurological phenotype (Mangiarini et al., 1996) and protein aggregation late in the disease course 
(Davies et a l ,  1997). The other transgenic mouse model expressing a truncated fragment of 
huntingtin at 10-20 % of normal levels, also displays a protracted disease course (Schilling et a l ,  
1999). The YAC72 (2498) mouse line expresses 4 times the amount o f full-length mutant 
huntingtin expressed by line YAC72 (2511) mice. Whilst both lines display phenotypic alterations 
only YAC72 (2498) mice display brain atrophy and widespread nuclear huntingtin immuno- 
staining at 12 months o f age. At the same age YAC72 (2511) mice display nuclear huntingtin 
immuno-staining, but specifically within striatal MSN and cortical neurons.
Recently a conditional transgenic mouse model o f HD has been created, taking advantage o f the 
tetracycline-responsive gene system (Yamamoto et a l ,  2000). In this system, the expression o f a 
transgene is turned off by oral administration o f tetracycline analogues. This is possible because the 
tetracycline-regulated transactivator (tTA) protein induces transcription o f the transgene when it 
specifically binds to the tetO operator (tetO). However, tetracycline can bind to tTA, preventing its 
interaction with tetO and consequently switching off transcription of the transgene. Mice carrying a 
transgene containing a chimeric HD mouse/human exon 1 with a CAG repeat expansion o f 94 
repeats under the control of a minimal CMV promoter and a tetO response promoter, were 
produced (BiTetO mice). Mice that carry a transgene encoding the tTA transactivator under the 
control of a calcium/calmodulin kinase Ila  promoter, were also generated (CamKiia-tTA mice). 
When these mouse lines were crossed, progeny expressing both transgenes were under-represented 
because o f perinatal lethality. It was postulated that this was due to the expression of the
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polyglutamine and to ensure that the expression o f polyglutamine did not interfere with 
development, transcription o f the transgene was switched off by administrating doxycycline (an 
analogue o f tetracycline) to the pregnant mothers. Administration o f the doxycycline was 
withdrawn after birth and transgene expression switched on. Mutant huntingtin expression was 
seen in the striatum, septum, cortex, and hippocampus and to a lesser extent the amygdala and 
hypothalamus but no expression was detected within the cerebellum. The animals displayed a 
clasping phenotype, which began at 4 weeks and progressed throughout life until death after a 
normal life span. Immunoreactivity for the polyglutamine stretch was observed in the nuclei o f the 
majority o f striatal cells. Both N il and neuropil aggregates were found within the striatum and 
cortex. At 4.5 months general brain atrophy was displayed with a further decrease in striatal size 
along with reactive gliosis and reduction in dopamine Di receptor levels. There was no TUNEL  
staining and no reduction in cell number observed, suggesting brain atrophy may result from 
shrinkage of the cells or extracellular matrix.
Once the phenotypic and cellular alterations produced by the expression of the mutant huntingtin 
fragment had been established transcription of the transgene was switched off in order to determine 
if the phenotypic and pathological alterations in the HD mice were irreversible or required the 
continued expression of the transgene.
Doxycycline treatment was commenced at 18 weeks to completely abolish the expression o f the 
mutant polyglutamine-containing huntingtin peptide for a 16 week period. Limb clasping and the 
N il and neuropil aggregates were all apparent at this time. At 18 weeks, 40 % of striatal neurons 
had nuclear huntingtin immuno-staining. In the ‘gene-off’ animals only 1 % o f striatal neurons had 
nuclear staining at 34 weeks in contrast to the 60 % observed in gene-on animals of this age. Both 
N il and neuropil aggregates disappeared from the striatum in gene-off animals at 34 weeks of age. 
The reduction in striatal size, astrogliosis and reduction in dopamine Di receptor levels all 
continued in gene-on mice but halted in gene-off animals. Gene-off animals also demonstrated a 
recovery of the clasping phenotype to levels approaching controls.
These studies indicate that neurons can disperse N il and cytoplasmic aggregates, suggesting that 
the proteasome is capable of accessing the N il and the proteolytic pathways needed to clear 
aggregated material are not irreversibly compromised, even in animals displaying cellular 
dysfunction and phenotypic alterations. They also demonstrate that the continuous expression of 
mutant huntingtin is required for the progression of pathology.
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1.5.2.3 HD‘knock-in’ mice
Knock-in mouse models allow the study of the behavioural and functional consequences o f the HD 
expansion mutation in its appropriate genomic and protein context. Although, knock-in HD mice 
tend to display a subtler phenotype than some of the transgenic HD models, studies have revealed 
subtle changes that are reminiscent o f clinical HD (Lin et al., 2001; Shelboume et al., 1999; 
Wheeler et al., 1999). Knock-in mice have been generated by two different strategies. One results 
in wild-type and mutant Hdh alleles that differ only in the length of the repeat sequence (Lin et al., 
2001; Shelboume et al., 1999). The second generates a chimeric mouse/human sequence within 
exon 1 o f the mutant iM * allele (Ishiguro et al., 2001; Levine et al., 1999; Wheeler et al., 1999).
A  consistent feature o f most HD knock-in mice is the presence o f nuclear staining and micro­
aggregates of huntingtin in the brain. These appear between 2-6 months o f age, relatively early in 
the course of the disease (Ishiguro et al., 2001; Levine et al., 1999; Li et al., 2000; Wheeler et a l ,
1999). In contrast, N il are only observed when the mice are older (>10 months) (Ishiguro et a l ,  
2001; Levine et al., 1999; Li et al., 2000; Wheeler et al., 1999). No significant cell death is 
observed in knock-in HD mouse models however, most display reactive gliosis within the striatum 
late in life (Ishiguro et al., 2001; Lin et al., 2001; Wheeler et a l ,  1999; Wheeler et al., 2002). 
Knock-in mice, including those with no dramatic phenotypic alterations, exhibit altered gene 
expression, changes in membrane properties and increased sensitivity to glutamate receptor 
agonists, all suggesting that these animals may be modelling early time points in HD pathogenesis 
(Levine et al., 1999; Shelboume et al., 1999). It is possible that HD mutations expressed at the 
appropriate level, within the correct genomic and protein context are only capable of modelling the 
early stages o f the disease process within the ~2 year life span of this organism. However, this 
situation has benefits in studies designed to determine the initial events responsible for triggering 
HD pathogenesis.
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1.5.3 Knock-in HD m ouse model Hdh6/Q72 and Hdh4/Q80
The work presented in this thesis was carried out on an HD knock-in mouse model designated 
H dh6/Q12  and Hdh4/Q80  (Shelboume et al., 1999). A  brief summary of their generation and 
preliminary characterisation follows.
1.5.3.1 Generation of Hdh6/Q72 and Hdh4/Q80
This mouse model was generated using a gene targeting strategy to modify the H dh  allele by 
homologous recombination in mouse embryonic stem (ES) cells. A  targeting vector was produced 
that contained part o f the Hdh  gene but with the normal polyglutamine-encoding sequence within 
exon 1 replaced with a 72 or 80 CAG repeat tract. A  neomycin resistance expression cassette 
{loxPneo) flanked by 34 bp loxP sites was also inserted ~200 bp downstream of the CAG mutation 
and 60 bp into intron 1. Although correctly targeted ES cell lines carrying the CAG mutation were 
identified, they did not express full-length mutant huntingtin protein until Cre-mediated deletion of 
the loxPneo  sequences within the modified Hdh  locus had occurred. Recombinant ES cell lines 
were used to generate mouse lines carrying the modified Hdh  allele with the CAG expansion and 
the loxPneo sequences. Heterozygous mutant males were then crossed with Cre-expressing females 
to facilitate in vivo deletion of the loxPneo sequences in developing embryos. The resultant founder 
animals of two successful lines were designated Hdh4/Q80 and Hdh6/Q72 and bred to establish the 
HD knock-in mouse lines used in this study.
Western blotting confirmed the expression of full-length mutant huntingtin protein in several 
tissues and that the mutant form of the protein contained an elongated polyglutamine stretch. 
Optical densitometry of the immunoblots indicated that the mutant protein in heterozygous animals 
was expressed at ~ 45 % (Hdh6/Q72) and ~ 55 % (H dh4/Q80) o f wild-type levels. Reduced levels 
of mutant huntingtin expression have been suggested by studies on human HD tissue (Persichetti et 
al., 1996; Trottier et al., 1995). However, the modified mutant Hdh allele does contain a single 34 
bp loxP sequence within intron 1 and it remains a formal possibility that this could exert a residual 
influence on the expression of the mutant Hdh gene.
1.5.3.2 Neuropathological studies of the HD mice
Brain atrophy (10-15 % smaller than wild-type) from 4 months of age was present although no 
other obvious gross abnormalities were observed. Brains from 4-6 and 16-17 month old mice 
exhibited no gliosis, ventricular enlargement or neuronal loss in any brain area. The neuronal- 
specific degeneration in HD was investigated by examining the immunoreactivity o f leucine- 
enkephalin and substance P (markers o f the striatal projection neurons), calbindin (marker of the 
matrix compartment), NADPH-diaphorase (NOS expressing intemeuron marker) and cytochrome
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oxidase activity, reflecting neuronal activity. No differences were detected in HD knock-in mice 
and wild-type littermates.
1.5.3.3 Nuclear and cytoplasmic aggregates in the HD mice
The formation of nuclear aggregates (N il) has been detected in the striatum of 27 month old HD 
mice (Li et al., 2000). Double labelling experiments using calbindin-D and the EM48 antibody, 
which detects long polyglutamine stretches suggested that almost all neurons containing N il were 
MSN. Labelling studies detecting NOS and parvalbumin within the intemeurons showed no co­
localisation with NIL Nuclear immuno-staining of mutant huntingtin occurs in the striatum as early 
as 4 months of age, increasing in intensity until 11 months, when small puncta can be seen. By 21- 
27 months many neuronal nuclei contain a single, large aggregate. The striatum also contains 
neuropil aggregates which appear later than N il, from ~11 months o f age. Using antibodies raised 
against different epitopes o f mutant huntingtin, it was established that the N il and neuropil 
aggregates were made up o f huntingtin fragments smaller than the first N-terminal 549 amino 
acids. The neuropil aggregates reside in the processes and axonal terminals o f the MSN within the 
lateral globus pallidus and the substantia nigra pars reticulata. These neuropil aggregates have been 
associated with degenerating MSN axons containing dark, swollen organelles that resemble 
degenerated mitochondria (Li et ah, 2001).
1.5.3.4 Phenotypic features of the HD mice
General observations suggest that the HD mice displayed heightened aggressive behaviour from 
about 3 months of age. This was confirmed using the resident-intruder test, which demonstrated an 
increased incidence o f isolation-induced aggression in a HD mouse cohort o f 9 months of age 
(Shelboume et a l ,  1999). This abnormal social behaviour appears to occur in the absence of overt 
neurodegeneration and prior to aggregate formation. These findings have led to the conclusion that 
this model, as w ell as other knock-in HD mice, may be m odelling features o f early HD 
pathogenesis and that neuronal dysfunction, rather than cell death may be responsible for some of 
the clinical features of HD.
1.5.3.5 Synaptic dysfunction in the HD mice
Synaptic function has been examined by the input-output relationship o f Schaffer collateral-CAl 
synapses, in response to single electrical stimuli (Usdin et al., 1999). Differences in synaptic 
density or altered strength of individual synapses within the population would cause input-output 
variation. No difference between 8-14 month old HD and wild-type mice was observed, indicating 
the correct density of functioning synapses within the hippocampus o f HD mice.
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LTP, a synaptic mechanism that is thought to be involved in some forms of learning and memory, 
is an increase in synaptic strength induced by a high-frequency stimulus. HD mice showed 
significantly less potentiation than their wild-type littermates. The threshold stimulation needed to 
induce LTP seemed to be raised in HD mice. Post-tetanic potentiation (PTP) immediately 
following stimulation was impaired in mutant mice after both standard and enhanced stimulation. 
PTP arises from changes within the presynaptic terminal, indicating the possibility o f altered 
presynaptic function in HD mice. Paired pulse facilitation (PPF) occurs if two stimuli are delivered 
to synapses in rapid succession and the synaptic response to the second stimulus is facilitated by 
the cumulative calcium influx into the presynaptic terminal. A  depression o f PPF is observed in the 
HD mice, particularly after longer inter-pulse intervals. The observed decrease could be due to a 
reduced capacity for facilitation itself or an increase in synaptic inhibition. However, as HD and 
wild-type mice need the same stimulation to generate a postsynaptic action potential, an increase in 
synaptic inhibition appears less likely. The impairment o f both PPF and PTP suggest that 
presynaptic terminals in HD mice can respond to normal single stimuli but are unable to sustain 
neurotransmitter release with repetitive stimulation. These studies indicate that the HD mutation 
results in an impaired ability o f excitatory synapses to response fully to activation rates as low as 1 
Htz, which is well within the range of normal physiological synaptic activation. As huntingtin 
protein is normally present within synapses and surrounding vesicles, a dysfunction in presynaptic 
activity may be due to deficits in vesicle release or recycling mediated by mutant huntingtin. If this 
was the case then diminished neurotransmitter release and therefore weaker LTP induction, PPF 
and PTP may result. This notion is supported by studies that have shown a reduction in the amount 
of glutamate released from hippocampal synapses during high frequency activation in these HD 
mice (Usdin et al., 1999).
1.5.3.6 Intergenerational mutation length variability in the HD mice
Intercrossing o f heterozygous HD mice produced progeny genotypes that showed no obvious 
deviation from the expected Mendelian ratio (Shelboume et al., 1999). Further backcrossing o f  
heterozygous HD mice was carried out and the intergenerational stability o f the CAG repeat 
mutation was investigated. The germline mutation rate in both males and females was ~25 %, 
lower than that (70-85 %) described in human HD (Duyao et al., 1993; Kremer et al., 1995; 
Leeflang et al., 1995). However, there was a strong sex-of-origin effect observed, mirroring that 
described in human HD (Myers et a l ,  1993; Telenius et al., 1994; Zuhlke et al., 1993). 
Transmission o f the mutation through the female germline tended to be associated with small 
contractions o f up to four repeats in length. In contrast, only increases in the repeat length were 
observed during transmission of the mutation through the male germline. Most of the repeat 
expansions were 1-4 repeats in length with the largest observed exhibiting an increase of 8 repeats.
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1.6 Mechanisms underlying trinucleotide repeat instability
Repeat instability within the germline is responsible for clinical anticipation o f the disease 
phenotype in HD families and within somatic tissues can further contribute to the onset and 
progression of disease pathogenesis. By determining the mechanisms, which underlie repeat 
instability, it may be possible to manipulate these processes and therefore alter pathogenesis. 
Studies into triplet repeat sequences (TRS) suggest that they are more prone to forming secondary 
structures than random DNA sequence and that these formations may play a central role in repeat 
instability. These structures may disrupt DNA processes, such as replication or transcription and 
may even be generated due to the unwinding of the DNA helix associated with these events. It has 
also been established that these structures can act as activating substrates for DNA repair 
mechanisms. It has been suggested that repair can either prevent repeat size changes or increase the 
likelihood that they will occur, depending on the length o f the TRS (Sinden and W ells, 1992). 
Several DNA repair pathways have been implicated in generating triplet repeat instability. These 
include nucleotide excision repair (NER), mismatch repair (MMR) and recombinational 
mechanisms. Many studies have been carried out to investigate the occurrence o f secondary 
structures in TRS and the mechanisms by which DNA repeat instability can occur.
1.6.1 Alternative DNA struc tu res within TRS
Several in vitro  studies have illustrated that repetitive sequences within DNA can form many 
different thermodynamically stable secondary structures such as hairpins, slipped DNA structures, 
triplexes, and quadruplexes (Gacy et al., 1995; Kang et al., 1995; Pearson and Sinden, 1996; 
Sinden and Wells, 1992; Wells, 1996) (Figure 1.3). The type and stability of the structures appear 
to vary depending on the base composition o f the repeat units (Gacy et al., 1995; Sinden, 1999), 
perhaps influencing the differential patterns o f repeat instability displayed by various TRS. 
Biochemical and genetic analyses have also indicated the formation o f hairpin structures within 
(CTG.CAG) repeats in bacteria (Sarkar et al., 1998) and yeast (Moore et al., 1999).
The instability of a triplet repeat stretch is proportional to its length, with longer repeat stretches 
more prone to alterations (Leeflang et al., 1999). The length of the TRS is also proportional to the 
likelihood o f alternative structure formation, suggesting these structures may play a role in 
generating repeat instability (Pearson and Sinden, 1998; W ells, 1996). In addition, it has been 
shown that interruptions within TRS decrease their propensity to form alternative DNA structures 
(Pearson and Sinden, 1998; Sinden, 1999) and to expand (section 1.2.1).
It has been shown that TRS can form alternative structures and that this characteristic may mediate 
their propensity for instability. However, the mechanisms by which these structures may contribute 
to repeat lengths changes remain uncertain.
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F ig u r e  1 .3  A lte r n a tiv e  D N A  stru ctu res that form  in (C T G .C A G )n 
repeat sequences
A. Hairpin structures can form within (CTG)n, (CAG)n, (CGG)n and (CCG)n repeat sequences. 
In the hairpin two stable CG base pair bonds are followed by a T.T, A.A, C.C or G.G mispair. 
These hairpins have varying degrees of thermal stability. Figure modified from Sinden, 1999.
B. Due to the repetitive nature of triplet repeat sequences a variety of slipped strand structures 
could form with varying positions and sizes. Figure modified from Pearson and Sinden, 1996.
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1.6.2 Replication through TRS
Studies have confirmed that alternative structures within triplet repeat sequences can influence the 
fidelity o f DNA polymerases in vitro  (Kang et a l ,  1995; Ohshima e t al., 1996) and in vivo  
(Samadashwily et al., 1997) suggesting increased disruption o f replication through TRS. It has 
been proposed that during replication o f long TRS it is easier for the newly synthesised and 
template DNA strands to become misaligned when DNA enzymes pause and separate from the 
template. Enzyme pausing may be mediated by the replication fork meeting an alternative DNA  
structure within the TRS. This misalignment (replication slippage) can itself cause hairpin loop 
formation and would cause deletions or expansions in the sequence once the replication machinery 
has reformed (Pearson and Sinden, 1998; Wells, 1996) (Figure 1.4).
Several studies have reported findings supportive o f the replication slippage mechanism. Studies 
with (CTG.CAG) repeats have demonstrated that stalling o f the DNA polymerase promotes hairpin 
formation and primer realignment within the repeat sequence (Ohshima and Wells, 1997). In vitro 
analysis of DNA synthesis using a single-stranded template of CAG repeats, also demonstrated that 
human DNA polymerase P and T7 DNA polymerase both introduce frequent deletions into the 
TRS (Kroutil and Kunkel, 1999). Indeed, in vitro  studies have indicated that slippage-generated 
expansions occur during DNA synthesis in (CTG.CAG) and (GGC.CCG) TRS with several 
different DNA polymerases (Ji et al., 1996; Petruska et a l ,  1998). Deletions in (CTG.CAG) repeat 
sequences were dramatically reduced when bacteria were grown at slower rates (Bowater et al., 
1996), perhaps due to the slowing of replication fork progression.
Furthermore, mutations in proteins involved in DNA replication such as the DNA polymerase 
proofreading proteins within E.coli, also affect repeat instability (Iyer et al., 2000). Mutant strains 
that result in destabilising o f the replication fork have also been shown to produce substantial 
deletions in the (CTG.CAG) tract, perhaps due to the increased opportunity to generate slipped 
structures (Iyer et al., 2000).
Many studies have now established that the process of replication through a TRS can mediate 
changes in repeat length. However, further studies have demonstrated several factors, which play a 
role in determining the bias toward expansions or deletions.
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5’ 3>
3’---------- — — — ----------5’
Replication
Lagging strand
Okazaki fragment 1
5’
Leading strand
Hairpin formation
Lagging strand Lagging strand
5’
Leading strand Leading strand
heteroduplex products in first round of replication
5’ ---------------------------- — — 3’ 5’ -----------------------------— — 3’
3’ ^ ---------5’ 3’ — ^ --------- 5’
Second round of replication to produce unchanged alleles, deleted alleles and expanded alleles
Figure 1.4 Replication slippage model o f repeat instability 
A representation of replication through triplet repeat DNA sequence.
During replication hairpins form when the DNA helix unwinds either on the template 
or nascent strand. If the structures form on the template strand they result in deletions 
and if they occur on the nascent strand a expansion is generated. Hairpin formation can 
occur on either the lagging strand or the leading strand, however, is more likely on the lagging 
strand due to the increased proportion of single stranded DNA. In addition, CTG sequences 
form more stable hairpin structures than those with CAG repeat units.
( ------------ ) template DNA. ( ------------- ) nascent DNA. repeat sequence.
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The orientation of the repeat sequences, with respect to the direction of replication, has been shown 
to affect the stability of TRS. This effect has been observed in plasmids within E.coli (Bowater et 
a l.,  1996; Kang et al., 1995) and in chromosomal locations in Saccharom yces cerev is ia e  
(Balakumaran et al., 2000; Freudenreich et al., 1997; Maurer et al., 1996). For example, studies in 
yeast and bacteria have shown that hairpin formation is favoured on the lagging strand since a 
greater proportion o f it is single-stranded during replication. It has been suggested that repeat 
expansions and deletions occur when an alternative DNA structure, such as a hairpin, occurs within 
the newly synthesised DNA strand or on the template DNA, respectively (Figure 1.4). In addition, 
CTG sequences are thought to form more stable hairpin structures than CAG sequences. If this is 
the case, more hairpins may occur on a lagging strand template comprising of CTG repeats thereby 
leading to deletions (Gacy et al., 1995; Pearson and Sinden, 1996). When the lagging strand 
template is made up o f CAG repeats the probability o f a hairpin is lower and deletions are less 
likely. However, stable CTG hairpins could still form on the leading strand template and cause a 
deletion or alternatively a CTG hairpin could form on the nascent lagging strand and result in an 
expansion.
One mechanism that could enhance the formation o f structures on the lagging strand is the 
processing o f the Okazaki fragments. Rad27 is the yeast homologue o f the mammalian protein 
FEN-1; a flap endonuclease that processes Okazaki fragments during replication (Hosfield et al.,
1998). R ad27  mutant yeast strains display an increased frequency o f TRS changes and although 
length changes in wild-type yeast are predominantly deletions, approximately half o f all changes 
seen in R ad27  mutant were expansions in (CTG.CAG) (Freudenreich et al., 1998; Schweitzer and 
Livingston, 1998) and (CGG.CCG) sequences (White et al., 1999) (Figure 1.5A). However, a 
trans-acting factor role for altered or insufficient levels of FEN-1 protein in HD repeat instability is 
unlikely as no mutations in the FEN-1 gene were observed in HD families (Otto et al., 2001). 
Moreover, defective FEN-1 functioning would cause mutations throughout the genome and triplet 
repeat instability is associated with specific loci. It was suggested that secondary structure within 
the displaced flap might prevent normal FEN-1 processing (Gordenin et al., 1997). This hypothesis 
was tested in yeast and secondary structure formation was found to inhibit FEN-1 binding (by 
reducing exposure o f the 5 ’ end of the flap) at TRS leading to expansion (Spiro et al., 1999) 
(Figure 1.5B). These findings demonstrate that normal FEN-1 functioning may be involved in 
repeat instability due to TRS specific secondary structure formation.
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F igure 1.5 Expansion due to disrupted FEN-1 processing in repeat sequences
A. During replication the newly synthesised lagging strand is composed of Okazaki fragments 
which generate flaps of DNA which must be cleaved before the gap can be processed and 
the new strand completed. FEN-1 binds to the 5’ ends of the Okazaki fragment flaps and 
its endonuclease activity removes the excess DNA allowing completion of replication.
B. Okazaki fragments composed of repeat sequence may form secondary structures 
disguising the 5’ end of the flap and inhibiting cleavage. The additional DNA will be 
incorporated into the genome by gap filling DNA synthesis and subsequent replication. 
(■“ ■ ■ ) repeated sequence, (----------) random sequence.
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Studies manipulating the conditions under which replication takes place have produced largely 
consistent patterns o f deletions and expansions, which have substantiated the replication slippage 
model. However, replication is not the only time that secondary structures form and DNA synthesis 
occurs. Many proteins involved in replication also mediate DNA synthesis during such 
mechanisms as DNA repair. Therefore, many studies have investigated the potential role o f DNA  
repair mechanisms in generating repeat instability.
1.6.3 DNA repair of TRS
DNA repair could contribute in many ways to generating repeat length changes. The excision of 
DNA lesions produces a single-stranded region of TRS, which would presumably be highly prone 
to secondary structure formation and result in the wrong number of repeat units being synthesised 
during gap repair. Excision might also generate DNA flaps, which, as in replication, must be 
processed by exonuclease proteins to ensure faithful repair. It has been demonstrated that small 
hairpin structures can activate repair mechanisms such as mismatch repair. DNA repair proteins 
could also bind to and stabilise these structures, thereby promoting their incorporation during 
replication and causing changes in the repeat length. In addition, replication and polymerase 
stalling have been shown to cause strand breaks within TRS and the repair of these lesions might 
involve recombinational repair mechanisms.
1.6.3.1 N ucleotide exc ision  repair (NER) and triplet repeat instability
The NER system recognises DNA damage that distorts the DNA helix and removes a wide range of 
lesions by excising the stretch of DNA surrounding the lesion and promoting resynthesis o f the 
DNA molecule. In humans, a multisubunit ATP-dependent nuclease makes dual incisions, one on 
either side o f the lesion, and excises a ~24-29 base oligonucleotide carrying the damage. 
Approximately 16 polypeptides are required to carry out this excision (including the XPA-E and 
ERCC proteins) and proteins such as DNA polymerases and ligases then carry out gap repair 
(Wood, 1996).
Inactivation of the NER system causes instability of dinucleotide repeats (Modrich and Lahue, 
1996; Petes et al., 1997). Pamiewski et al. (1999) demonstrated that deficiency o f some NER 
functions dramatically affected the stability of a long (CTG.CAG)i75 plasmid insert within E.coli. 
The UvrA protein plays an integral role in the NER process within bacteria (Braun and Grossman, 
1974) and the absence o f the uvrA  gene product greatly enhances the instability o f the TRS 
(increased number of deletions). These findings suggest that UvrA normally destabilises hairpins 
within the TRS and initiates repair. In its absence the hairpin will not be removed from the DNA  
template and DNA synthesis w ill bypass the structure, creating a deletion. Deletions were only 
observed when the lagging strand comprised o f the CTG repeat sequence (Pamiewski et al., 1999).
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These findings support those seen in replication studies and again suggest that the formation of 
stable secondary structures on the CTG strand is a primary event involved in repeat instability and 
that the NER system is able to recognise these structures.
The effects o f deficient NER were shown to be repeat sequence-specific as no effect was 
demonstrated with (CGG.CCG) or (GAA.TTC) tracts (Pamiewski et al., 1999). The repeat tract 
specificity many indicate that different protein isoforms are involved in lesion recognition (due to 
different properties o f the secondary structures formed by different repeats, (Ohshima et al., 1996; 
Wang et a l ,  1994)) or excision in NER. Differential tissue expression patterns o f these proteins 
might help explain the tissue-specific pattern of repeat instability observed with disease-associated 
TRS.
1.6.3.2 M ismatch repair (MMR) in TRS
The mismatch repair (MMR) system not only corrects mismatched base pairs but also alternative 
DNA structures such a small loops and unpaired regions (up to 4 bp in E.coli and 16 bp in humans) 
(Modrich and Lahue, 1996). The bacterial protein MutS recognises and binds to the lesions and 
together with MutL, in the presence o f ATP, activates a third MMR protein, MutH, an 
endonuclease, that cleaves the strand containing the error (Yang, 2000). In humans the MutS 
function is carried out by two heterodimers, MSH2/MSH3 and MSH2/MSH6 (Kolodner and 
Marsischky, 1999). These heterodimers appear to target distinct mismatches. MSH2/MSH6 
complexes preferentially target pair mismatches and slipped structures that are 1-2 nucleotides long 
whereas MSH2/MSH3 complexes preferentially target slipped structures that are larger than 2 
nucleotides (Kolodner and Marsischky, 1999). MutL human homologues have been identified and 
designated MLH1, MLH2, MLH3 and PMS2 (Lipkin et a l ,  2000; Prolla et a l ,  1994). MLH1 
associates with each of the other three MutL homologues, producing three different heterodimers 
with distinct functions in MMR. The heterodimer with the most prominent role in MMR is 
MLH1/PMS2 (Tomer et al., 2002). Although a MutH homologue is yet to be discovered in 
eukaryotes, a polymerase with proofreading activity would be a good candidate. As MMR 
recognises slipped-strand structures and has DNA nicking activity that would produce single­
stranded regions within TRS during repair, it is implicated in repeat instability.
Most studies into the effect o f MMR on the stability o f TRS have been carried out with MMR 
mutant bacterial and yeast strains. These studies had illustrated the contrasting effects o f MMR on 
different lengths o f TRS. MMR defective bacteria and yeast displayed a reduced occurrence of 
large deletions (>8 repeats) with (CTG.CAG)i6o-i75 tracts (Iyer et al., 2000; Jaworski et a l ,  1995). 
However, mutations in MMR proteins also generated an increased frequency of small changes (<8 
repeats) in short (CTG.CAG)<>4-92 repeat tracts in E .co li (Schumacher et al., 1998; W ells et al.,
1998) and yeast (Schweitzer and Livingston, 1997). Further studies have attempted to clarify these
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conflicting results using a variety o f (CTG.CAG)45_i75 tracts to determine the effects o f MMR on 
repeat tract stability in E.coli. These have confirmed that functional MMR appears to promote large 
deletions (>8 repeats) in long (CTG.CAG) tracts, but prevents length changes (expansions and 
deletions) of less than eight repeats (Pamiewski et al., 1999; Schmidt et al., 2000).
The suggested mechanism responsible for these results proposes that slipped structures are 
produced during replication o f TRS and in MMR-deficient cells, these unrepaired structures cause 
small expansions and contractions. On the other hand if repair of these slipped structures is carried 
out there is the opportunity for hairpins to form in the single-stranded DNA, and this creates a 
deletion (Figure 1.6). This is only observed in long TRS as the single-stranded regions within 
smaller TRS are less able to form stable hairpin structures. As in replication and NER-based 
hypotheses, repeat instability appears to occur in a replication origin orientation-dependent manner 
when the CTG is on the lagging strand. This suggests that the more stable CTG slipped structures 
are involved in repeat instability and that the structures are recognised by the MMR system  
(Schmidt et al., 2000).
Several in vivo studies have also demonstrated a role for MMR proteins in the production o f repeat 
expansions. Direct evidence that MSH2 has a role in somatic repeat instability in HD was produced 
by a study that crossed HD transgenic mice (R6/2) onto a MSH2-deficient background. The 
resulting HD mice displayed a significant reduction in the age-dependent, tissue-specific somatic 
repeat instability previously observed (Manley et al., 1999). It has been suggested that MSH2 
would generate repeat instability (expansions) by binding to a slipped structure, stabilising or 
protecting it from repair, and subsequently incorporating the structure during replication and 
producing an expansion (Pearson et al., 1997). Somatic repeat instability in DM1 knock-in mice 
display differing patterns when crossed onto either MSH3- or MSH6-deficient backgrounds (van 
den Broek et al., 2002). Somatic repeat instability was completely abolished in DM1 animals on a 
MSH3-deficient background, but on a MSH6-deficient background greater repeat instability was 
observed that varied in a tissue-specific manner. MSH3 and MSH6 both form functional complexes 
with MSH2 but the MSH2/MSH3 complex recognises slipped structures whereas MSH2/MSH6 is 
involved in mismatch repair (Acharya et al., 1996) (Figure 1.7). The loss o f MSH6 would still 
allow MSH2/MSH3 to recognise and stabilise the looped structures thought to be responsible for 
expansions. In addition, absence of MSH6 might increase the amount of MSH2 protein able to bind 
to MSH3 to carry out this role, thereby increasing the frequency o f expansions. Although the lack 
o f repeat instability observed in DM1 mice on a MSH3-deficient background would suggest that 
the looped structures are resolved it is unknown how this occurs.
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F igu re 1.6 The effect o f  D N A  repair on different length triplet repeat sequences
Small slippage events are recognised by the mismatch repair machinery. Recognition of the lesion 
and excision of the loop generates single-stranded DNA and presents an opportunity for hairpin 
structure formation. Hairpin structures would only be formed if the single-stranded repeat sequence 
is long enough to generate stable secondary structures. Subsequent DNA synthesis would therefore 
either leave alleles unchanged in length or create large deletions.
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Figure 1.7 A  model for mismatch repair induced expansions
MSH2 forms recognition complexes with either MSH6 and MSH3. These complexes have 
preferential recognition for mismatch base pairs (MSH6) and looped structures (MSH3).
A. MSH6 will successfully repair the mismatched base pairs. B. It is postulated that MSH3 binds 
and stabilises the looped structures which results in their incorporation into the genome after 
replication, generating an expansion. In M SH 6-deficient mice the expansions 
will still be generated and may even occur more frequently as there will be an excess of 
MSH2 available to complex with MSH3 and stabilise looped structures. Deficiency in MSH3 
will result in a loss of expansions and this role will not be taken on by MSH6 due to its 
selective recognition of mismatched base pairs. The loops which are not stabilised may 
resolve at the next round of helix unwinding (e.g transcription etc).
£  = mismatched base pair. p| = looped structure, (m m ) repeat sequence.
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Stabilisation o f looped structures within an elongated CAG repeat by MSH2 has also been 
implicated in repairing strand breaks in haploid germ cells, which do not perform replication or 
recombination, from HD transgenic mice (R6/1). MSH2 is proposed to bind to and stabilise looped 
structures which form at DNA breaks and initiate MMR-mediated DNA synthesis and ligation (gap 
repair), incorporating the looped structures into the genome (Kovtun and McMurray, 2001).
In an attempt to investigate whether the MMR machinery could play a role in human repeat 
instability, investigations have been carried out to determine if  the main component o f the human 
MMR system, MSH2, can bind to human (CTG.CAG) tracts in vitro  (Pearson et al., 1997). It 
appears that MSH2 can bind to both slipped-strand stmctures (S-DNA) and slipped-intermediate 
structures (SI-DNA). Slipped-strand structures have an equal number o f repeats and slipped- 
intermediate structures have an excess o f either CTG or CAG repeats. MSH2 was also shown to 
have a greater affinity for CAG hairpin loops. The undefined structural difference between CAG 
and CTG hairpin loops that make CAG structures less stable may render them more prone to 
recognition by MSH2.
These studies have shown that to generate the expansion-biased small repeat size changes, 
commonly observed in human HD, a proficient MMR system is required. This is in contrast to 
earlier findings from bacteria and yeast studies, which suggested that a deficient MMR system was 
needed to generate small fluctuations in repeat length (Pamiewski et al., 1999; Schmidt et al., 
2000). These results demonstrate that the model systems o f bacteria and yeast, although easily 
manipulatible, may not be the best systems to investigate the mechanisms underlying repeat 
instability in humans.
1.6.4 Transcription and Transcription-coupled repair
Another DNA process that has been implicated in triplet repeat instability is transcription. In vitro 
transcription of a wide variety of (CTG.CAG)n and (CGG.CCG)n tracts has been performed using 
human RNA polymerase II (Pearson and Sinden, 1998) and in general, transcription rates through 
TRS are slower than through random DNA sequence. The RNA polymerase also appears to adopt a 
transient elongation-incompetent configuration at the start o f the repeat stretches (Pearson and 
Sinden, 1998). In primate cell culture the (GAA.TTG) repeat sequence also suppresses 
transcription rates in a length and orientation-dependent fashion (Ohshima et al., 1998). These 
studies have shown that TRS can affect transcription and several factors involved in this dismption 
have also been shown to influence repeat instability.
It is possible that transcription could destabilise repeat tracts by promoting the formation of 
alternative DNA stmctures as the RNA polymerase complex opens the DNA helix and generates 
single-stranded DNA (Pearson and Sinden, 1996). Transcription could also produce repeat
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instability by interfering with the replication process. DNA replication and transcription can occur 
simultaneously on the same DNA molecule. As the rate o f replication is much faster than 
transcription, collisions o f the RNA polymerases with the replication fork will eventually occur, 
perhaps resulting in a brief stalling o f the replication fork and replication slippage. In addition, 
transcription is a vital component o f some DNA repair pathways such as transcription coupled 
NER and MMR, as many proteins involved in transcription are also involved in recognition of 
DNA damage and repair (Hanawalt, 1994; Lindahl et al., 1997; Sancar, 1999). Transcription 
through the TRS has been found to be important for mediating the effect on repeat instability by 
NER (Pamiewski et al., 1999) and MMR (Bowater and Wells, 2001).
Transcription o f long (CTG.CAG) TRS in E .coli displaying extended growth times, appears to 
increase the frequency of deletions within the repeat stretch (Bowater et al., 1997; Pamiewski et 
al., 1999). This is also found to occur in an orientation-dependent manner with the (CTG.CAG)i75 
tract more stable when the CTG strand is transcribed than when the CAG strand is transcribed 
(Pamiewski et al., 1999). It is postulated that the transcription o f the CAG strand may allow the 
remaining single-stranded CTG sequence to form secondary stmctures. These findings have also 
been replicated when examining the behaviour of dinucleotide sequences in yeast (Wierdl et al., 
1996).
1.6.5 Recom bination
Repetitive sequences have been shown to be substrates for recombinational mechanisms such as 
homologous recombination, gene conversion, and sister chromatid exchange (Bi and Liu, 1996; 
Lupski, 1998). During these processes strand slippage or unequal crossing over have the potential 
to generate repeat instability. Blocked or stalled replication could promote classical RecA- 
dependent recombinational repair o f chromosomes and result in the loss or gain o f repeat units. 
RecA-independent recombinational mechanisms, which require less homology and have been 
shown to induce rearrangements in direct repeats, include sister-strand or chromosome exchange 
(Bi and Liu, 1994; Morag et al., 1999). It is postulated that such mechanisms could play a role 
when very large expansions (>100s repeats) o f TRS occur in FRAXA or DM1. Human genetic 
studies have illustrated through haplotype analyses that types o f recombination could be involved 
in some repeat length changes in DM1 and FRAXA (Brown et al., 1996; O’Hoy et al., 1993). 
However, as the flanking DNA sequences are generally unaltered after the majority o f TRS 
mutations (Sinden and Wells, 1992) it is thought unlikely that these recombinational events occur 
frequently. Several studies investigating repeat instability in E.coli have demonstrated that the 
frequency of deletions in TRS is independent o f RecA proficiency, suggesting that recombinational 
mechanisms may not play a role in the repeat instability observed in E.coli (Bowater et al., 1996; 
Jaworski et al., 1995).
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However, demonstrations of recombination-based changes in TRS have been achieved when using 
(CTG.CAG) sequences in a two-plasmid system in recombination-proficient E. coli cells (Jakupciak 
and Wells, 1999). Recombination is indicated by the presence o f both antibiotic resistance genes 
(originally on different plasmids) in the recombinant products, the formation o f long cointegrant 
DNAs, the expansion of (CTG.CAG) tracts and the transfer o f a G-to-A polymorphism from the 
TRS in one plasmid to that on the other. Previous studies o f repeat instability have been carried out 
in recombination-deficient E.coli and yeast and have shown deletions and expansions at a ratio of 
100:1 (Freudenreich et al., 1997; Kang et al., 1995; Kang et al., 1996; Maurer et al., 1996; 
Ohshima et al., 1996). In the study using recombination-proficient cells, the ratio o f expansions to 
deletions was as high as 100:1 (Jakupciak and Wells, 1999). These findings are o f interest since 
expansion-biased repeat instability predominates in human HD. The extent o f the expansions 
observed in the bacterial system were several fold the original length o f ~80 repeats.
In summary, it is though that replication slippage and repair may be responsible for smaller repeat 
changes, perhaps responsible for repeats expanding from the intermediate range in the germline, 
but recombination may contribute to the larger changes observed in already expanded repeat 
sequences.
The point of recombination initiation appears to lie within the (CTG.CAG) repeat sequence since 
recombination did not occur in other regions o f the plasmids (Jakupciak and W ells, 1999). As 
previous studies have not reported this level o f expansion in cells proficient in replication and 
repair, it is thought that these additional expansions must occur due to the recombination 
proficiency. They suggest that most realistic way for these large expansions to occur with no 
crossing over o f flanking regions would be by double-stranded break repair (DSBR) within the 
TRS.
1.6.5.1 D ouble-strand break repair
Studies have shown that the DNA replication fork stalls when it encounters (CTG.CAG) sequences 
(Ohshima and Wells, 1997; Samadashwily et al., 1997) and this may result in double-stranded 
breaks (Freudenreich et al., 1998; Tishkoff et al., 1997).
The expansion o f (CTG.CAG) tracts by recombination without the exchange o f flanking sequence 
can be explained by the double-strand break repair (DSBR) model based on gene conversion 
(Figure 1.8A) (Jakupciak and W ells, 1999). Similar mechanisms have been used to explain 
polymorphisms at minisatellites (Jeffreys et al., 1994). The DNA break may cause the broken 
strands to be paired with a homologous template, followed by strand invasion and DNA synthesis. 
Resolution of the two Holliday-like junctions will be carried out in a way that leaves the flanking 
sequences unaltered. Due to the repetitive nature of the sequence, slippage during DNA synthesis
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or misalignment during strand invasion could occur and generate repeat length changes (Jakupciak 
and Wells, 1999) (Figure 1.8B).
Others studies have suggested variations on this model o f DSBR. In addition to the gene 
conversion model already described, a model called synthesis-dependent strand annealing (SDSA) 
has also been proposed (Richard et al., 1999).
SDSA does not require resolution of Holliday junctions, just strand invasion and DNA synthesis, as 
the new strands could unwind from the template before ligation and the two free 3 ’ ends 
surrounding the double-stranded break could then anneal (Figure 1.8C) (Paques et al., 1998). The 
distinctive feature o f this model is that the recipient strand receives two newly synthesised strands 
and the donor template remains unchanged. This model is supported by experiments in yeast in 
which 375 bp repeats shared frequent expansions and contractions in a system in which the donor 
strand and template strand could be recovered and identified after repair o f a double-stranded 
break. Approximately half of all recombinants contained expansions or deletions and the template 
was never modified (Richard et al., 1999). The magnitude o f expansions could exceed more than 4 
kb. For the replication slippage model to generate changes o f this magnitude, it would need to 
extensively unwind the DNA helix and perhaps generate very large unstable alternative structures. 
In the SDSA gene conversion model the creation o f hairpin structures would be likely during DNA  
synthesis and may cause polymerase pausing. This would favour dissociation o f the elongated 
strand from its template and repair would require strand reinvasion. This could take place many 
times during a single repair event and therefore would be capable o f generating very large 
amplifications during repair of one double-stranded break (Paques et a l ,  1998).
A  further mechanism has been suggested for DSBR, based on the finding that MSH2-dependent 
repair o f double or single-stranded breaks during maturation o f sperm cells caused expansion in 
haploid cells displaying no replication or recombination (Kovtun and McMurray, 2001). It is 
postulated that MSH2 binds to the alternative structures formed at the strand breaks, stabilising 
them and initiates DNA synthesis and ligation to perform gap repair. This locks the looped 
structures into the genome and produces germ cells containing DNA with heteroduplex structures 
within the TRS.
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Two alternative models for double-strand break repair have been proposed.
A. The 3’ ends produced by exonucleolytic processing of the strand break invade a homologous template 
and initiate DNA synthesis.
B. The basic gene conversion model proposes that after synthesis and ligation resolution of the 
two Holliday junctions within the repeat sequence produces rearrangements of the donor and 
recipient molecules. Repeat instability could be due to slippage events during DNA synthesis 
(e.g. an expansion as shown) or misalignment at invasion (A.).
C. The synthesis-dependent strand annealing (SDSA) model proposes that the 3 ’ ends do not 
ligate and form Holliday junctions but disassociate from the template and reanneal. This 
mechanism allows for the donor strand to remain unchanged. Repeat instability could be due to 
slippage during DNA synthesis (e.g. an expansion as shown) or misalignment at invasion (A.). 
Disassociation due to slippage may initiate cycles of strand reinvasion incorporating more repeats each time, 
resulting in large changes in repeat length.
D. Repeat instability (e.g. deletion as shown) could also occur due to the unequal annealing of the two 
nascent strands.
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1.6.6 Factors contributing to locus-specific repeat instability
Many studies have generated information concerning mechanisms underlying repeat instability. 
However, all o f the mechanisms proposed are capable of generating repeat instability at all TRS 
within the genome. The MMR system is one such mechanism as mutations within the MMR genes 
are responsible for the high frequency o f genome wide microsatellite instability associated with 
hereditary nonpolyposis colon cancer (HNPCC) (Modrich and Lahue, 1996; Prolla et al., 1996). 
Unlike HNPCC, the trinucleotide repeat disorders are associated with the genetic instability of 
specific loci. Repeat instability of a different locus is responsible for each repeat disorder and each 
repeat sequence displays variations in the relative levels o f instability and the size and direction of 
repeat length changes. These observations suggest that there must be cw-acting factors unique to 
each locus, dictating its propensity to expand.
A  simple illustration of the importance of cLs-acting factors on the repeat sequence within the HD 
locus was provided by a study comparing single sperm containing intermediate alleles (29-35 
repeats), which expanded into new mutations (LAnm) and those that continued in the general 
population without change (LAgp) (Chong et al., 1997). It was demonstrated that while LAgp and 
IAnm may have the same repeat length tract, IAnm are significantly more unstable than IAgp, 
suggesting that ds-acting factors may be involved in the propensity for repeat expansion.
Several different lines o f transgenic mice generated using the 3 ’-untranslated region o f the 
myotonic dystrophy protein kinase (DM PK) gene carrying a (CTG.CAG)i62 tract from a DM1 
patient have been investigated to determine the factors involved in repeat instability (Monckton et 
al., 1997). The Dmt-D and Dmt-E mouse lines carry one copy of this transgene on the same genetic 
background with different integration sites. Differential frequencies o f somatic and germline repeat 
instability have been observed in these animals, with Dmt-D mice displaying higher mutation rates 
and magnitude of repeat size changes compared to the relatively stable Dmt-E mice (Fortune et a l ,  
2000; Zhang et al., 2002). These findings suggest that the sites o f transgene integration and 
therefore the surrounding genome may contribute to the mutation frequency.
The most obvious cis-acting factor influencing repeat instability is the length o f the repeat sequence 
itself. It has been shown that longer repeats have a greater propensity for instability. For example, 
repeat size spectra obtained from sperm cells in HD patients show the mutation frequency and 
mean changes in allele size increase with higher somatic repeat number (Leeflang et al., 1999). The 
integrity o f the repeat sequence is also likely to be a crucial influence on instability as pure repeat 
sequences are much more prone to expansion than those possessing interruptions (Fujigasaki et al., 
2001; Goldberg et al., 1995; McNeil et al., 1997). The GC content o f the DNA flanking TRS has 
been implicated in influencing their tendency to expand. It has been established that the extent of
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expansion associated with a TRS was correlated to their location within CpG islands (Brock et al., 
1999).
Cleary et al. (2002) have recently established a primate cell model o f repeat instability in which 
they observed a repeat-length dependent, expansion-biased pattern o f repeat instability in one line. 
In this system the repeat length, direction of replication and the site o f replication initiation all 
demonstrated an influence on repeat instability. The direction o f replication influenced repeat 
instability in the expected way; the CTG tract on the lagging strand induced a bias towards 
deletions. However, unlike bacteria and yeast, reversing the direction o f replication does not 
influence the frequency o f deletions but alters the type of mutation as there is a biased towards 
expansions if CAG is on the lagging strand. Identical transgenes at different distances from the 
replication origin demonstrated differences in mutation frequency and mutation type. One 
transgene demonstrated a propensity towards expansion, three predominantly displayed deletions, 
one generated both expansions and deletions and two did not display repeat instability (Cleary et 
al., 2002). These findings suggest that the location of replication origin may be important in 
dictating the extent and direction of repeat instability.
These studies have illustrated that cis-acting factors do influence locus-specific repeat instability 
and have presented various candidates for this role. Further studies will be required to determine if 
the same cis-acting factors influence each specific triplet repeat disease locus and to establish if 
manipulating these factors affects repeat instability.
1.7 Aims
Investigations into the molecular and cellular basis of HD were undertaken by utilising a knock-in 
HD mouse model. These mice have displayed a variety of behavioural and cellular alterations in 
the absence of significant cell death, indicating that they are modelling early stages o f the disease 
process. This model system therefore presents the opportunity to investigate the initial events 
involved in HD pathogenesis and possible targets for early therapeutic intervention.
Firstly, this project aimed to contribute to the phenotypic characterisation of the HD knock-in mice. 
Detailed observations of the phenotypic consequences of the HD mutation are required to assess 
the appropriateness o f this system as a model o f HD and to identify suitable disease markers for 
assessing potential therapies. Characterisation of phenotypic alterations may also provide clues to 
the possible molecular and cellular abnormalities underlying the HD phenotype.
Phenotypic characterisation of HD knock-in mice was undertaken by:
• Investigating motor function in HD knock-in mice by examining mouse gait.
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• Examining the cognitive abilities o f HD knock-in mice by assessing spatial 
learning and memory.
Secondly, this study aimed to investigate early cellular mechanisms involved in HD pathogenesis 
by determining the nature and progression of molecular events underlying dysfunction in HD 
knock-in mice
This issue was addressed by:
• Examining the density o f specific neurotransmitter receptors within the striatum 
and cortex o f HD knock-in m ice using quantitative ligand binding  
autoradiography.
• Investigating somatic mutation instability in HD knock-in mice by small pool PCR 
analysis.
These studies aimed to integrate the molecular and cellular changes involved in HD pathogenesis to 
the phenotypic manifestations observed in HD knock-in mice. By incorporating additional studies 
on somatic mutation instability on human juvenile HD tissue it was aimed to decipher the 
molecular changes involved in human HD pathogenesis and to assess the validity o f the findings in 
HD knock-in mice.
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2 Materials and Methods
All chemicals and reagents used were analytical or molecular biology grade. Materials were 
generally purchased from Sigma Chemical Company Ltd or Merck Ltd and other sources are 
mentioned where appropriate.
2.1 Solutions
Benzodiazepine receptor binding 
buffer
10 mM Tris-HCl, 1 mM EDTA, pH 7.4
Chloroform:Octanol 24:1 (v/v) Chloroform (Fisher Chemicals) and 
Octan-l-ol
Denaturing Solution  
Depurinating Solution  
Dilution Buffer
0.4 M NaOH, 0.5 M NaCl
0.25 M HC1
0.1 pM MHD-16 oligonucleotide, 1 x TE
DNA marker (1 kb plus) 40 ng/pl 1 kb plus DNA marker (GibcoBRL)
Dopamine receptor binding 
buffer
25 mM Tris-HCl, pH 7 .5 ,100  mM NaCl, 1 
mM MgCl2, 10 mg/1 Ascorbic acid, and 1 pM 
Pargyline
0.5 M EDTA 0.5 M EDTA with NaOH to pH 8
70 % Ethanol 70:30 (v/v) 100 % Ethanol (Banford Laboratories) 
and dH20
Ethidium Bromide 25 mM Ethidium Bromide
Hybridisation Solution 7 % SDS, 1 mM EDTA, 0.5 M N aP04pH 7.2
Loading Dye (x 5) 15 % Ficoll, 0.05 % Orange G, 5 mM EDTA
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Lysis Buffer 100 mM Tris-HCl, pH 8.5, 200 mM NaCl, 0.2 % 
SDS, 5 mM EDTA, pH 8, 0.1 mg/pl Proteinase K
Neutralising Solution 0.5 M Tris-HCl, 3 M NaCl, pH 7.5
OLB 2:5:3 (v/v) solutions A, B and C 
Solution A: 1.2 M Tris pH 8,121  mM MgCl2, 
0.48 mM dATP, dGTP and dTTP, 18 pi of 2- 
mercaptoethanol in a final volume of 1033 pi. 
Solution B: 2 M Hepes, pH 6.6 
Solution C: Ultrapure dNTP set (Pharmacia 
Biotech) suspended in 0.2 mM EDTA, pH 7 to an 
optical density o f 90 OD units ml'1
Opioid receptor binding 
buffer
0.17 M Tris-HCl, pH 7.4
Phenol: Chloroform 50:50 (v/v) Phenol and Chloroform (Fisher 
Chemicals)
10 % SDS 100 g of SDS in 1 litre of dH2Q
20 x SSC 6 M NaCl, 0.6 M Na3C6H50 7 .2 H20
Subbed slide coating 6 g Gelatin in 600 mis of 3 mM K2S 0 4
10 x TBE 1 M Tris-Base, 1 M Boric Acid, 20 mM EDTA, 
pH 8
l x T E 10 mM Tris-HCl, 1 mM EDTA, pH 7.5
W ash Solution 0.2 % SSC, 0.2 % SDS
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2.2 Mouse lines
Table 2.1 Summary of the different HD mouse lines utilised in the following studies
Name Construct
(Shelbourne et al 1999)
CAG
repeat
number
Genetic
background
Mice used in each 
experiment (Chapter 
or section)
6C9Aneo Hdh6IQ72 72 C57BL/6 3.3, 5, 6.2 & 6.3
4A11Aneo Hdh4/QQ0 80 C57BL/6 4
4A11 Aneo Hdh4/QQ0 80 FVB/N 3.2 ,4
4A11Aneo Hdh4/QQ0 80 DBA/2 4
6C9neo Hdh6/neo 72 C57BLV6 6.4
The generation of the HD mice used is described in (Shelboume et a l, 1999). All mice used were congenic 
to a statistical minimum of 97 % of the stated genetic background.
Animals that were heterozygous for the HD mutation are referred to as HD+/' mice in the text. HD" ' 
mice denote animals homozygous for the HD mutation. Mice that were heterozygous for the HD 
mutation from the 6C9neo line are denoted as HDtruuc mice. Full details of the mutations carried by 
the different mouse lines are provided in section 1.5.3.1.
2.3 General methods
2.3.1 T issue collection
2.3.1.1 Post-mortem human tissue
Post-mortem tissue samples from a known HD case (time from death to autopsy = 10 hours) were 
provided by Dr ER Nairn at Crosshouse Hospital, Kilmarnock, in 1996 after appropriate 
permissions were obtained. All samples were stored at — 7(?C until use.
2.3.1.2 Fresh-frozen mouse tissue
Mice were culled by dislocation o f the neck followed by prompt dissection of several somatic 
tissues and regions of the central nervous system. Tissue samples were frozen immediately on dry 
ice and stored at -70 °C until use.
2.3.1.3 Mouse sperm
Mice were culled by dislocation o f the neck and subsequent dissection of the testes, epididymides 
and vas deferens’ was swiftly carried out. The vas deferens’ were detached from the epididymides 
and immersed in 1 ml of 1 x SSC. Each vas deferens was held at one end with fine-nosed tweezers 
while simultaneously squeezed along the length of its structure, extruding sperm into the solution. 
The solution was transferred to an eppendorf tube and frozen until DNA extraction. The testes and
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epididymides were separated and each immersed in 1 ml of 1 x SSC. The structures were cut into 
small pieces and transferred, along with the 1 x SSC, into eppendorf tubes and frozen awaiting 
DNA extraction.
2.3.2 DNA extraction
2.3.2.1 Mouse DNA extraction
Tissue digestion was performed at 50 °C overnight by agitation o f a 1.5 ml eppendorf tube 
containing the tissue sample and 700 pi of lysis buffer. The digested tissue was further dissociated 
by vigorous vortexing and then centrifuged at 16,000 x g  for 10 minutes.
The tissue digestion supernatant was transferred to a clean eppendorf tube and a phenol:chloroform 
extraction performed to eliminate any protein and fat. An equal volume of phenol:chloroform  
solution was added and the solution emulsified by vortexing. The aqueous and organic phases were 
then separated by centrifugation at 16,000 x g. The aqueous layer was transferred to another clean 
eppendorf tube for repetition of the above phenolichloroform extraction.
The same technique was then used to ensure the full removal o f all phenol by extraction with 
chloroform:octanol solution.
DNA precipitation was achieved by adding 0.1 volume of cold 3 M CH3.COONa, pH 4.8 followed 
by 2 volumes of cold absolute ethanol to the aqueous layer. The mixture was inverted several times 
and stored at -20 °C overnight. The DNA pellet was recovered by centrifugation for 10 minutes at
16,000 x g. To wash excess salt from the pellet the precipitation liquid was removed and replaced 
with 300 p i o f 70 % ethanol. Following vortexing the DNA pellet was again recovered by 
centrifugation and the wash repeated. The pellet was finally allowed to air dry for 30 minutes at 
room temperature.
Once all ethanol had evaporated the pellet was resuspended for 4 hours at 37 °C in an appropriate 
volume of 1 x TE (typically, 30-50 pi).
2.3.2.2 Sperm DNA extraction
To obtain the sperm cells from within the dissected testes and epididymides (section 2.3.1.3), the 
samples were vortexed and the pieces of tissue allowed to settle for 5 minutes. After repeating this 
agitation the cell suspension was removed avoiding any large pieces of tissue. These samples, 
along with the tubes containing the extruded sperm from the vas deferens’ (section 2.3.1.3), were 
then centrifuged at 1,000 x g  for 5 minutes to pellet the cells.
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The supernatant was decanted and the cell pellet resuspended in 100 pi o f 1 x SSC. To lyse non- 
sperm cells, the volume was made up to 900 pi with 1 x SSC followed by 100 pi 10 % SDS. The 
mixture was vortexed and the unlysed sperm cells pelleted as before.
Resuspension of the sperm cells and SDS lysis of non-sperm cells was repeated with the final pellet 
of sperm cells resuspended in 80 pi of 1 x SSC.
To lyse sperm cells 10 pi of 2-mercaptoethanol was added and the solution incubated at room 
temperature for 5 minutes. 10 pi of 10 % SDS was then added and the solution vortexed vigorously 
and incubated for a further 15 minutes. To precipitate any proteins 450 pi of 1 x SSC and 220 pi of 
5 M NaCl were added. The mixture was vortexed and the cellular debris and proteins pelleted at
16,000 x g  for 15 minutes.
DNA precipitation was achieved when the supernatant was transferred to a clean eppendorf tube 
containing 750 pi of cold isopropanol and mixed well. The recovery, washing and resuspension of 
the DNA were carried out as described in section 2.3.1.2 for all mouse DNA samples.
2.3.2.3 Human DNA extraction
DNA was extracted and purified following the protocol outlined in the NucleonST™ Soft Tissue 
Kit (Nucleon Biosciences).
2.3.3 DNA quantification
The concentration of a DNA solution was determined by diluting 5 pi of the solution in 695 pi 1 x 
TE. A  clear quartz glass 1 ml cuvette containing the solution was placed in a spectrophotometer 
(Shimadzu UV-1201) and readings obtained at X260 nm. An OD of 1 corresponds to approximately 
50 pg/ml of double-stranded DNA.
OD 260 nm X  dilution factor X 50 =? ng/pl
2.3.4 Polym erase Chain Reaction (PCR)
Sequences for all primer oligonucleotides used in mouse and human PCR can be found in Table 
2.2. The PCR programs referred to in the text have been outlined in Table 2.3.
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Table 2.2 The sequence, melting temperature (Tm) and orientation of all oligonucleotides used to 
amplify the CAG repeat sequence.
Name Target sequence Direction Tm Sequences
MHD-16 Mouse HD gene Forward 80.3 5'-CCCATTCATTGCCTTGCTGCTAA
G-3'
MHD-18 Mouse HD gene Reverse 71.0 5'-GACTCACGGTCGGTGCAGCGG
TTCC-3'
LK-1 Human HD gene Forward 77.7 5'-CCCATTCATTGCCCCGGTGC
TG-3'
LKH-5 Human HD gene Reverse 70.8 5'-TGGGTTGCTGGGTCACTCTG
C-3'
MHD-5 Mouse HD gene Forward 82.7 5'-GAAAAGCTGATGAAGGCTTTC
GAGTCGCTCAAGTGGTT-3'
MHD-4 Mouse HD gene Reverse 95.1 5'-GCGTGGCGGCGCCTGCGGC
GGTGGCTG-3'
Table 2.3 PCR programs
Name Cycles Temperature (°C) Duration
Touchdown 1 94 5 min
20 94 30 sec
71-61 30 sec (ramping
- 0.5 °C per cycle)
72 30 sec
10 94 30 sec
60 30 sec
72 30 sec
1 72 7 min
4 00
DGM 30 94 45 sec
68 45 sec
70 3 min
1 68 1 min
1 70 10 min
4 00
PCR was performed in a Perkin Elmer Applied Biosystems GeneAmp PCR system 9700.
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2.3.4.1 PCR amplification of the CAG repeat region of the mouse Hdh locus
Amplification was carried out in a volume of 10 pi using the Touchdown PCR program.
Table 2.4 Reaction mixture for amplification of the CAG repeat within the mouse Hdh locus
Reagent Final concentration
10 x PCR buffer 
DMSO
dNTPs (2 mM) (Amersham) 
MHD-16 (24 pM)
MHD-18 (24 pM)
Taq polymerase (5 U/pl) 
MgCI2 (25 mM) 
dH20  
DNA
1 x PCR buffer (10 mM Tris-HCI, pH 8.3, 50 mM KCI) 
1 0 %
200 pM
1.2 pM
1.2 pM 
1 U
1 mM
as required 
as required
2.3.4.2 PCR amplification of the CAG repeat region of the human HD locus
Amplification was carried out in a volume of 10 pi using the DGM PCR program.
Table 2.5 Reaction mixture for amplification of the CAG repeat within the human HD  locus
Reagent Final concentration
10 x custom PCR buffer (ABgene) 1 x custom PCR master mix (6.4 mM Tris-HCI, 
pH 8.8, 1.6 mM (NH4)2S 0 4, 0.6 mM MgCI2, 
0.016 mg/ml BSA, 0.6 pM EDTA, 143 pM each 
of dATP, dCTP, dGTP and dTTP, 6.7 mM 
2-mercaptoethanol)
DMSO 10%
LK-1 (24 pM) 1 pM
LKH-5 (24 pM) 1 pM
Taq polymerase (5 U/pl) 0.5 U
dH20 as required
DNA as required
2.3.5 Gel electrophoresis
Visualisation of PCR products was achieved by running the PCR reaction through an agarose gel 
providing separation of the DNA fragments by size. Typically a 1 % agarose gel in 1 x TBE was 
used. The 1 % agarose gel was made by adding 1 g o f agarose MP (Roche) to 100 mis o f the 
appropriate buffer. This mixture was then heated until the agarose completely dissolved. Once 
cooled, EtBr was added to a final concentration o f 0.25 pM. The mixture was then poured into a 
gel cast containing the appropriate comb and left to set on an even surface. Once set the comb was
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removed and the gel was placed in a tank (Biorad) completely immersed in the same buffer used to 
dissolve the agarose. The PCR reactions were mixed with loading dye (to prevent dispersal into the 
buffer) and loaded into the wells. One lane on each gel was loaded with DNA marker to help size 
and identify the PCR products. The gel was then electrophoresised at between 40 and 120 V at 
room temperature for the time required to achieve appropriate separation of the PCR products.
To visualize the PCR products the gel was removed from the tank and placed on the 
transilluminator (UVP) at X 260 nM. The UV-light illuminates the EtBr intercalated within the 
DNA. A  gel documentation system (UVP 7500) was then used to photograph the gel and produce 
an image on thermal paper K65HM-CE (Mitsubishi).
2.3.6 G enescan analysis of the  m ouse Hdh locus
Amplification of the CAG repeat region o f the mouse Hdh  gene was carried out as previously 
described in section 2.3.4.1 with the exception that the reverse primer, MHD-16, was replaced by 
an identical primer modified to carry a 3' fluorescent tag (Oswell). 1 pi o f the resultant fluorescent 
PCR product was mixed with 1 pi o f the Genescan standard mix and the samples denatured for 2 
minutes. The Genescan standard mix contains 40 pi of Formamide (Kodak), 10 pi of Genescan dye 
(Perkin Elmer) and 13 pi of Rox 1000 internal standard (Perkin Elmer). The samples were then 
electrophoresed through a 4.75 % urea polyacrylamide gel in a 373XL automated sequencing 
machine for 12 hours. A  laser accurately detects the fluorescent PCR products, and by utilising the 
internal standards in each sample lane, provides precise sizing of the DNA fragments. The resultant 
gel file was analysed with the Genescan software version 3.1.
2.4 Small pool PCR (SP-PCR)
2.4.1 DNA digestion
2 pg o f DNA was digested with the restriction enzyme H indlll (GibcoBRL) in a 200 pi volume 
(Table 2.6). The mixture was incubated at 37 °C for 2 hours followed by enzyme inactivation at 
65 °C for 10 minutes and storage at -20 °C.
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Table 2.6 SP-PCR DNA sample digestion
Final concentration
2 pg DNA
40 pg BSA
50 mM Tris-HCI, pH 8.0 1
10 mM MgCI2 r  1 x restriction enzyme React 2 buffer (GibcoBRL)
50 mM NaCI J
20 U Hin6\\\
2.4.2 DNA dilution
SP-PCR reveals the CAG trinucleotide repeat lengths present on individual alleles by amplification 
of a small number of DNA templates followed by sensitive visualisation techniques. This technique 
requires DNA stability in very dilute solutions and dilutions o f uniform DNA quantities. To 
facilitate these requirements, DNA dilutions were made on the day o f the experiment to reduce the 
chance o f DNA degradation. Dilutions were made using dilution buffer (1 x TE containing 1 pM 
MHD-16 oligonucleotide). Dilution buffer increased the DNA concentration o f the dilution thus 
assisting in DNA dispersal by reducing the electrostatic forces between the DNA molecules and the 
eppendorf tubes and also helping to prevent DNA degradation.
The final concentration o f DNA in the digest (section 2.4.1) was 10 ng/pl. To achieve the highest 
dilution (1.2 ng/ul) used for SP-PCR, 20 pi o f digest was added to 147 pi of dilution buffer. Serial 
dilutions were generally performed to obtain the following concentrations: 600 pg/pl, 300 pg/pl, 60 
pg/pl, 30 pg/pl, 12 pg/pl and 6 pg/pl. It is assumed that approximately 6 pg o f DNA is the 
equivalent of 1 cells worth of DNA, i.e. one genome is ~ 3 pg of DNA.
2.4.3 Polym erase Chain Reaction
Due to the sensitivity o f SP-PCR a common technical problem was contamination. The sensitive 
visualisation techniques used could detect extremely small amounts o f contaminating DNA and this 
was of particular significance when analysing the products of a small number of DNA templates. 
To combat this problem all SP-PCR reactions were carried out in designated laminar flow hoods 
using pipettes and filter tips specified for SP-PCR use only.
2.4.3.1 SP-PCR of the CAG repeat within the mouse Hdh locus
SP-PCR amplification o f the mouse Hdh  locus was carried out exactly as described in section
2.3.4.I.
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2.4.3.2 SP-PCR of the CAG repeat within the human HD locus
SP-PCR amplification of the human HD  locus was carried out in a volume of 7 pi (Table 2.7) using 
the DGM PCR program (Table 2.3).
Table 2.7 Reaction mixture for SP-PCR of the CAG repeat region within the human HD  locus
Reagents Final concentration
10 x custom PCR buffer (ABgene) 1 x custom PCR master mix (6.4 mM Tris-HCI, 
pH 8.8, 1.6 mM (NH4)2S 0 4, 0.6 mM MgCI2, 0.016 
mg/ml BSA, 0.6 pM EDTA, 143 pM each of dATP, 
dCTP, dGTP and dTTP, 6.7 mM 
2-mercaptoethanol)
DMSO 10%
LK-1 (24 pM) 200 nM
LKH-5 (24 pM) 200 nM
Taq polymerase (5 U/pl) 0.35 U
dH20 as required
DNA as required
2.4.4 Gel electrophoresis
SP-PCR agarose gels were cast in gel trays measuring 20 cm x 40 cm with a 35 well comb. 400 ml 
o f 1.5 % agarose in 0.5 x TBE was used to prepare each gel. EtBr was added to give a final 
concentration of 0.25 pM to visualise the DNA markers when exposed to UV light. Set gels were 
equilibrated by immersion in 0.5 x TBE buffer for 15 - 30 minutes at 4 °C.
Gels were removed from the buffer and loaded at the bench. 120 ng o f 1 kb plus DNA marker 
(GibcoBRL) was added to the middle and end lanes of each SP-PCR agarose gel. An entire PCR 
reaction, mixed with 5 x loading dye, was added to each of the other lanes. The loaded gel was run 
initially at 300 V for 15-30 minutes and then at 180 V for a further 16-18 hours at 4 °C.
2.4.5 Southern blotting
Once the gel had run sufficient distance the markers were visualised under UV light and the excess 
gel cut off and discarded. The gel was flipped so the underside was face-up and rinsed in dK^O. 
Depurinating solution was added to cover the surface o f each gel and they were shaken on a 
platform (100 rpm) for 10 minutes. The depurinating solution was poured off and the gels again 
rinsed in dt^O. Denaturing solution was added after removal of the dPUO and the gels were left 
shaking for 30 minutes. The gels were rinsed with dlUO once more and neutralising solution was 
added for a minimum of 30 minutes o f shaking. Hybond-N nylon membrane (Amersham) and 4
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pieces o f 3 MM chromatography paper (Whatman) were cut to the appropriate size o f the gel 
(typically, 20 cm x 20 cm). 2 pieces o f 3 MM paper were soaked in neutralising solution and placed 
on the bench protected by Saran wrap film (Dow). The gel was placed on top of the 3 MM paper 
followed by the Hybond-N nylon membrane. The Hybond-N nylon membrane was first soaked in 
dH20  and then in neutralising solution before being placed carefully on the gel. Air bubbles were 
removed by applying slight pressure over the membrane. This technique was repeated a further two 
times with the addition of neutralising solution-soaked pieces of 3 MM paper. A  thick pile o f paper 
towels was added to the top o f the assembly, followed by a glass plate and a weight o f  
approximately 1.5 Kg. This construction was then left for 2 hours 30 minutes. After dismantling 
the ‘Squash blot’ the membrane was placed on a dry piece o f 3 MM paper, DNA side face up, and 
transferred to the 80 °C oven for > 20 minutes. To ensure the DNA was fixed to the membrane it 
was placed in a Stratalinker instrument (Stratagene) and exposed to 120 mJ of UV light.
2.4.6 Visualisation of PCR products by radioactive hybridisation
2.4.6.1 Prehybridisation
Prehybridisation o f the Hybond-N nylon membranes was carried out in rotating hybridisation tubes 
(Biometra) at 65 °C. 10 ml of hybridisation solution was added to each tube containing a maximum 
of 3 rolled membranes and incubated for 30 minutes. This solution was then discarded and 
replaced with fresh hybridisation solution and the prehybridisation repeated.
2.4.6.2 Probe production
The probe template was the PCR product obtained under the conditions described in section
2.3.4.1. The PCR template was a cloned human CAG trinucleotide repeat stretch and requires the 
primer pair MHD-4 and MHD-5 as replacements for MHD-16 and MHD-18. The 300 bp sized  
PCR product was detected by gel electrophoresis through a low melting point agarose (NuSieve 
GTG agarose) gel and the PCR product obtained by cutting out the resultant band. The DNA in the 
gel fragments was then purified using a QIAquick™ gel extraction kit (Qiagen).
To allow simultaneous detection of the DNA marker and the PCR products on the autoradiograms,
2.5 ng of the DNA marker run through the agarose gels was also added to each labelling reaction.
Several methods were used to produce the radio-labelled probe used for hybridisation.
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Table 2.8 Probe production
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Labelling reaction
15.8 \l\ dH20
-25  - 50 ng DNA template
2.5 ng of marker template
mix, spin and denature for 3 minutes at 100 °C. Transfer onto ice and add
6 pi OLB
24 pg BSA
5 pCi 32P-“dCTP
-2.5  - 5 U Klenow (Boehringer)
incubate at 37 °C for at least one hour.
The probe volume was then made up to 150 pi with dH20  and unincorporated radio-nucleotides 
removed by passing through a Sephadex G50 (Amersham Pharmacia) column. Readings from the 
scintillation counter (Bioscan/QC 2000) were obtained before and after probe clean up to check for 
adequate radiolabel incorporation.
M ethod 2
Probe production was achieved by following the protocol outlined in ReadyTo*Go™ DNA  
Labelling Beads (-dCTP) (Amersham Pharmacia Biotech)
Method 3
Probe production was achieved by following the protocol outlined in the Ready-To-Go™ DNA  
Labelling Kit (-dCTP) (Amersham Pharmacia Biotech)
A  final denaturing step was undertaken in all three methods by placing the probe at 100 °C for 5 
minutes before adding the probe to the hybridisation tubes.
2.4.6.3 Hybridisation
Hybridisation of the Hybond-N nylon membranes was carried out in rotating hybridisation tubes at 
65 °C overnight. 4 mis of hybridisation solution was used to dilute the denatured probe and provide 
sufficient coverage of the membranes.
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2.4.6.4 W ashing
The probe and hybridisation solution were removed and the membranes rinsed in wash solution. 10 
mis o f wash solution was then added and the tubes returned to the ovens (65 °C) and left rotating 
for 30 minutes. The wash solution was then removed and the rinse and wash repeated. Membranes 
were then removed from the hybridisation tubes and flat washed at room temperature for 15-20 
minutes. This wash was carried out in a tray shaking at 100 rpm with wash solution preheated to 
65 °C. Washed membranes were either dried in the 80 °C oven for 15 minutes or left to air-dry for 
15 minutes and then covered in cling-film.
2.4.6.5 Film Exposure, D evelopm ent and A n alysis
Membranes were exposed to X-ray film (Konica) and developed using a X-Ograph Compact X2 
(X-Ograph Ltd).
Initially images were obtained by overnight exposure at room temperature. An enhanced image 
could be produced by exposure with intensifier sheets at -70 °C overnight. Intensifier sheets, made 
of calcium tungstate, produce an enhanced image due to the reaction between the radioactive 
particles and the silver halide crystals in the X-ray film emulsion being enhanced five fold by the 
emission of photons from the sheets when they are hit by P particles from the radioactive 
membrane. Exposure with intensifier sheets is carried out at low temperatures because the silver 
atoms and ions formed on the X-ray film are stabilised at this temperature.
Accurate sizing o f bands on SP-PCR autoradiograms was carried out using Kodak digital science 
ID volume 3.5 computer software.
2.5 Quantitative ligand binding autoradiography
2.5.1 T issue collection
Following dislocation o f the neck, dissection o f whole mouse brains was carried out swiftly and 
brains quick-frozen by lowering into dry ice-cooled iso-pentane. Brains were then wrapped in 
Parafilm (American National) and stored at -70 °C until use.
2.5.2 Preparation and sto rage  of brain tissu e  sec tions
Frozen brains were mounted onto chucks using frozen specimen embedding medium (Shandon 
cryomatrix) and the surface o f the brains covered in embedding matrix (Lipshaw) for frozen 
sectioning. Cryostat coronal sections of 20 pM thickness were cut at -15 °C and thaw mounted 
onto subbed microscope slides. Slides were then stored at -70 °C until use.
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2.5.3 Quantitative ligand binding autoradiography
Localisation o f radioactive molecules bound to receptor binding sites by autoradiography produces 
an image in which optical density varies in accordance with the amount o f bound radiolabelled 
ligand. Quantitative ligand binding autoradiography, therefore, allows the measurement of receptor 
density throughout the brain with a high level o f spatial resolution.
Brain sections were incubated with ‘total binding solution’, comprising binding buffer containing a 
previously optimised amount o f a radiolabelled reversible antagonist to the chosen receptor. 
Receptor ligands can however, interact with numerous sites on biological membranes and to 
account for this possibility non-specific binding was determined in a concurrent experiment 
utilising the ‘total binding solution’ containing a non-labelled displacer which preferentially binds 
to the chosen receptor (Table 2.9).
Table 2.9 Radiolabeiled ligands and non-labelled displacers
Receptor Ligand
(cone)
(reference)
Specific activity Displacer
(cone)
Opioid fHJ-Diprenorphine 
(2 nM)
(Biscoe etal., 1972)
50 Cimmol'1 Naloxone Hydrochloride 
(10 pM)
Benzodiazepine ^HJ-RolS-iySS 
(1.5 nM)
(Hunkeleref a/., 1981)
70.8 Cimmol'1 Flunitrazepam 
(10 pM)
Dopamine Di [3H]-SCH23390 
(0.5 nM)
(Hyttel, 1983)
75.5 Cimmol'1 Cis-flupenthixol 
(1 pM)
Dopamine D2 |®H]-YM09151-2 
(240 pM)
(Grew eetal., 1982)
85.5 Cimmol'1 Dopamine 
(50 pM)
cone = concentration used in main study (section 4.2)
Five brain sections were used from each animal examined. Three alternate sections were used to 
analyse total binding and the intervening two sections were used to assess non-specific binding. 
The coronal brain sections used for the studies were cut at the level with the approximate 
stereotaxic co-ordinates o f interaural 4.48 mm and bregna 0.98 mm (Franklin and Paxinos, 1997). 
These sections contained the striatum and motor and somatosensory cortical brain regions.
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The precise binding conditions used for each ligand were based on those found in previously 
published work (Cha et al., 1998; Sur et al., 1999; Young and Kuhar, 1979) and further 
optimisation of the protocols is described in section 4.2.
A ll brain sections were thawed to room temperature before initiation o f receptor binding assays. 
Investigations into opioid and benzodiazepine neurotransmitter receptor densities required an initial 
pre-incubation step with the appropriate binding buffer to wash away any endogenous ligand still 
bound to the neurotransmitter receptors (Table 2.10). Following pre-incubation the binding buffer 
was discarded and all brain sections allowed to dry. Incubation with the appropriate total or non­
specific binding solution was carried out, at the correct temperature, for the predetermined time 
(Table 2.10). After incubation the total or non-specific binding solution was poured off and excess 
ligand and displacer washed off by racking the microscope slides and washing in binding buffer 
(Table 2.10). All protocols were completed with a rinse in ice-cold dH20 .
Table 2.10 Ligand binding assays - Conditions for incubations and washes
Receptor Preincubation 
with binding buffer
Incubation 
with total or 
non-specific 
binding solution
Washes* 
with binding 
buffer
Opioid 15 min/RT 1 h/RT 2 x 5  min/RT
Benzodiazepine 3 x 1 0  min/4 °C 2 h/4°C 2 x 1 min/4 °C
Dopamine D, N/A 150 min/RT 2 x 1 0  min/RT
Dopamine D2 N/A 3 h/RT 2 x 1 0  min/RT
N/A = not applicable, RT = room temperature. *A11 washes were followed by a rinse in ice-cold dH2Q.
Washed slides were dried rapidly in front of a fan for approximately 1 hour and then left overnight 
at room temperature. The microscope slides, with the appropriate animals I.D. numbers clearly 
displayed, were attached firmly to card along with a set of autoradiographic [3H]-microscale tritium 
standards (High 1.4 - 33.3 nCi/mg TE) (Amersham). The cards were then exposed to tritium 
sensitive film, Hyperfilm™-3H (Amersham) or BioMax MR-1 film (Kodak Scientific Imaging) for 
a predetermined period to provide images of the appropriate intensity (Table 2.11).
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Table 2.11 Ligand binding assays - X-ray films and exposure times
Receptor Film Exposure (Duration and temperature)
Opioid Hyperfilm 3 wks RT
Biomax MR-1 4 wks RT
Benzodiazepine Hyperfilm 3 wks RT
Biomax MR-1 4 wks RT
Dopamine Di Hyperfilm 2 wks RT
Biomax MR-1 3 wks RT
Dopamine D2 Hyperfilm 2 wks RT
Biomax MR-1 3 wks RT
wks = weeks, RT = room temperature
2.5.4 Development of autoradiographic films
Exposed films were developed with intermittent shaking for 5 minutes using X19 liquid developer 
(Kodak) followed by incubation in liquid fix (Kodak) for 10 minutes. Films were then rinsed in 
continuously flowing water for 30 minutes and dried.
2.5.5 Data analysis
2.5.5.1 Image capture and analysis
Autoradiogram images were captured by the MCID M4 image analyser and analysed using the 
MCID volume 4.3 imaging software (Imaging research Inc).
Image analysis compares the optical density on the film provided by the tritium standards, 
representing eight different values of the tissue equivalent (TE) tritium concentration (Figure 2.1 A  
and B), to the optical density produced by the brain sections processed through the receptor binding 
assays (Figure 2.1C).
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Figure 2.1 C o m p a r in g  th e  op tica l  d e n s i ty  o f  th e  t r i t iu m  s ta n d a rd s  and  the  b ind ing  
b r a in  s e c t i o n s  to  e s t a b l i s h  a m e a s u r e  o f  b o u n d  r a d i a t i o n  p e r  m g  o f  t i s s u e
A. The standard curve produced by the eight values obtained from the autoradiographic 
microscale tritium standards. The optical density o f  the standards (B.) was converted to a 
measure o f  radiation per mg o f  tissue (nCi/mg) using the manufacturer’s values o f  tissue 
equivalent radiation. Using this standard curve the optical density produced by the brain 
sections (C.) was converted into a value o f  radiation per mg o f  tissue. D. A diagram o f  a 
c o ro n a l  b ra in  s e c t io n  at the  s te re o ta x ic  c o - o r d in a t e s  o f  in te ra u ra l  4 .48  mm 
and bregna 0.98 mm illustrating the two brain regions (striatum and cortex) investigated in 
these studies. The left hemisphere o f  the brain illustrates the areas used and the number 
o f  optical density readings taken in the image capture and analysis (section 2.5.5.1).
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Twelve readings for the cortex and striatum (Figure 2.1D) were taken for each total binding brain 
section, resulting in 36 data points per animal per brain region. Optical density o f the standards was 
converted to a measure of radiation per mg of tissue (nCi/mg) using the manufacturer’s values o f  
tissue equivalent radiation, calibrated for the auto-absorptive features of intact brain grey matter. 
Using these standard values, the optical density data points were converted to ‘specific binding’, a 
measure representative of the total radiation associated with a particular mass of tissue. Specific 
binding, (that is non-specific binding subtracted from total binding) was automatically calculated 
by taking one reading for a specific area of each brain region. This was possible because the image 
of the non-specific brain section was superimposed onto the captured image o f the total binding 
brain section. The mean of the 36 specific binding values was then calculated resulting in 1 data 
point for each animal per brain region. Since each ligand has a specific activity value (a measure of 
the amount of radioactivity in a molar solution of the ligand (Cimmor1)) the data point was finally 
converted to a measure of ligand concentration per weight o f tissue (typically, fmol/mg tissue). 
This value is thought to be representative o f the number o f receptor binding sites in that weight of 
tissue and is referred to in the text by ‘neurotransmitter receptor density’.
2.5.5.2 Statistical analyses of data
All data (neurotransmitter receptor density) was analysed primarily by comparing wild-type and 
HD+/' mice with the unpaired, two-tailed, Student’s l-test. Further analysis o f data obtained was 
carried out by two-way ANOVA. A ll neurotransmitter receptor densities in this text are expressed 
in fmol/mg tissue equivalent as a mean + one S.D.
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2.6 Behavioural Paradigms
2.6.1 Gait analysis
2.6.1.1 Measurement of velocity and vertical reaction forces in mice
To obtain quantitative gait parameters from mice during spontaneous locomotion the apparatus 
shown in Figure 2.2A was used. This general set-up can be used to gather two different kinds of 
locomotor data; spatiotemporal data, including velocity and vertical reaction forces, i.e. the force 
transmitted by a paw (load).
All experiments were carried out in a soundproofed laboratory to which all mice had been 
habituated for 24 hours in a 12:12 lightidark cycle. All observations were made between 1000 and 
1300 hours to minimise possible effects o f diumal variability. Each mouse was weighed before the 
beginning of the procedure as body weight is taken into account when analysing vertical reaction 
forces.
Velocity was assessed in an inverted U-shaped Plexiglas tunnel 98 cm (L) x 4 cm (W) x 6.5 cm (H) 
located over a glass floor. Light was shone into the long edge of the 30 cm central section of the 
floor using an 8-W fluorescent tube. The tube was shielded to prevent light escaping anywhere 
except into the glass causing it to be internally reflected between the top and bottom surfaces. This 
internal light means when a paw touches the surface of the glass floor the contact points show up as 
brightly illuminated areas (Figure 2.2B and C). Images o f the moving mice were recorded from 
below using Panasonic wv-BP310 cameras. For high quality image resolution the camera must be 
close to the glass floor and therefore two cameras were needed to film the entire central area. The 
cameras were deployed with a JVC TK-C50E video effector to provide a split-screen image with 
information from both cameras (Figure 2.2B). The images from the cameras were recorded onto 
tape (Fuji 180) using a Panasonic AG 7350 video cassette recorder.
The apparatus to measure vertical reaction forces was a variant on that described in the previous 
paragraph. Another glass-floored Plexiglas chamber 120 cm (L) x 12 cm (W) x 12 cm (H) was used 
with the 30 cm central floor section divided into 6, 10 x 8 cm pieces o f high quality 5 mm thick 
glass plates (Avimo Ltd). Four of the plates were internally illuminated as described above to allow 
the visualisation of the paw contact points. Another 4 plates, 2 common with the internally 
illuminated 4, form pressure sensitive load cell platforms (Uniweigh FSO cell, Maywood 
Instruments).
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Figure 2.2 Gait analysis apparatus
A. A  diagrammatic cross section of  the general testing chamber to assess velocity and 
vertical reaction forces in mice. B. and C. Representative images o f  mouse paw prints. 
Contact points are illuminated due to internally reflected light within the glass floor. 
Illuminated paw contact points help visualisation of  paw placement by the mouse.
D. A d ia g ra m m a tic  unders ide  im age  o f  a m ouse  in locom otion  c ro ss ing  the 
four load cells. E. A representative trace detected from the load cells, illustrating the 
vertical reaction forces transmitted by each paw (see figure 2.3).
(Diagram modified from Clarke and Still, 1999)
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The output from these load cells was captured by a data acquisition system sampling at 200 Hz 
(Powerlab 400 series) and analysed in an Acer PC running Chart on Windows software shown in 
Figure 2.2E (AD Instruments Ltd). Data collection was restricted to when the mouse was moving 
across the load cells by the incorporation of a trigger threshold switch that began recording only 
when a load cell was triggered by a weight > 5 g. This trigger also activated a 500 ms pre-trigger 
recording period to ensure full data collection. The cameras positioned below the central part o f the 
chamber recorded the underview of the mouse walking (Figure 2.2D). This meant that detailed 
analysis could be performed on the data stored in the Chart files by assigning particular load 
profiles to the limbs transmitting them (Figure 2.3).
2.6.1.2 Data analysis
Typically, normal mouse gait is symmetrical in the left/right axis with limbs on both sides of the 
body transmitting the same force. The distribution of weight however is not symmetrical when 
examining the fore/hind axis. A  normal mouse gait shows that the fore limbs exert greater load than 
the hind limbs by approximately 4 % of the animal’s body weight (Clarke and Still, 1999)
A  mean load for each limb was calculated by assigning each peak on the trace (Figure 2.3) to each 
paw print captured on video. By measuring the force exerted onto the load cell by the paw and 
taking into account the body weight o f the animal a measure o f load for that limb, expressed as a 
percentage of body weight, was produced. This was carried out for 8-15 peaks for each limb from 
each animal and a mean load for each limb was then calculated.
At the 4 and 12 month old time points each animal was put through the apparatus 3 times, once a 
week for three consecutive weeks. Each experiment was terminated after 5 minutes and the mean 
load for each limb calculated from 8-15 runs over the load cell apparatus. A  final mean value for 
each limb, for each mouse was calculated from the three means from the experiments. The 9 month 
old animals were, due to time constraints, put through the apparatus once and the mean from 8-15 
runs used as the overall mean for each limb.
All figures show the mean vertical reaction forces (load) as a percentage of body weight + one S.E. 
These data were obtained for fore, hind, left or right limbs by calculating the mean load between 
both limbs of each category.
When assessing if cohorts exert significantly more load through a particular group of limbs (fore or 
hind or right or left) compared to the load exerted through the same group of limbs in the other 
cohort, the mean loads of a particular group of limbs were compared between cohorts using the 
Mann-Whitney U statistical test.
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A. A representative example of the trace obtained when a mouse has 
traversed the four load cells. Each peak on the trace indicates vertical 
reaction force against time (seconds). B. The image captured from below 
the load cells enables limb assignment to the corresponding loads on 
the trace. FR = Fore right limb, HR = Hind right limb, FL = Fore left limb, 
HL = Hind left limb.
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To examine the distribution of weight during locomotion the mean hind limb load was subtracted 
from the mean fore limb load and the mean left limb load from the mean right limb load. Gait was 
therefore assessed in two planes, side to side and front to back. The resulting difference between 
the mean loads was analysed using a Mann-Whitney U statistical test to determine if weight 
distribution of HD+/' and wild-type mice was significantly different.
The velocity at which the mouse was travelling at each peak was calculated so that measures of gait 
were only obtained when animals were travelling between 10-45 cms'1. This ensured that gait was 
analysed during walking.
Velocity of the mice was measured in cms'1 by calculating the number of video frames needed for 
the mouse to walk over 4 load cells, 10 cm in length. A  mean velocity for each mouse was 
determined and the wild-type and HD+/' mice cohorts then compared using the unpaired, one-tailed, 
Student’s Ftest.
2.6.1.3 Cohorts
The initial study to assess gait of HD+/' mice was performed on a cohort o f HD+/' mice and their 
wild-type littermates at 12 months o f age (group 1). Further studies to investigate the temporal 
nature and onset o f gait abnormalities utilised a cohort o f mice assessed twice, once at age 4 
months and again at 9 months (group 2). Group 1 consisted o f 6 HD+/' mice (3 males and 3 
females) and 6 wild-type littermates (3 males and 3 females). Group 2 contained 10 HD+/' mice (5 
female, 5 male) and 10 wild-type littermates (5 female and 5 male). All mice used in these studies 
are described in Table 2.1. One male wild-type mouse from group 2 died in the intervening time 
between test points and is therefore missing from the 9 month cohort. Group 2 allowed  
comparisons to be made between male and female mice, however, the numbers in group 1 were too 
few to allow comparison of the sexes.
2.6.1.4 Acknowledgements
Data collection for mouse groups at the 4 and 12 month time points was carried out by Jackie Still 
and Linda Grant in Dr Ken. A. Clarke’s laboratory at the University o f Sheffield where the gait 
analysis instrumentation is housed. All experiments with the intermediate, 9 month old, mouse 
group were carried out and analysed by Laura Kennedy. The data obtained from all time points was 
prepared and statistically analysed by Laura Kennedy.
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2.6.2 Spatial learning and memory
2.6.2.1 Rotating Holeboard Paradigm
To investigate possible cognitive deficits in HD mice, spatial learning and memory was assessed 
using the cognitive behavioural paradigm, the rotating holeboard (Brosnan-Watters and Wozniak, 
1997).
Mice used in this paradigm had been handled by the experimenter three times weekly from 
weaning and all animals went through a process o f apparatus habituation for 4 weeks prior to 
testing, in an attempt to minimise the stress response. Habituation involved handling by the 
experimenter and placement into the start box and release into the rotating holeboard apparatus. As 
the design o f the start box was altered all animals were re-habituated to the release procedure. Mice 
were placed in the new start box 3 times weekly and released into the apparatus a minimum of 5 
times in each habituation session. The apparatus was assembled in the same configuration as in the 
future tests, but each hole contained inaccessible and accessible food baits. Animals were housed in 
the testing room from weaning and all experiments were carried out between 0930 and 1130 hours 
to reduce the influence o f any diurnal effects.
The rotating holeboard was made up from several components (Figure 2.4A): 1. a square Perspex 
board with 16 holes cut into the floor in a 4 x 4 matrix (Figure 2.4A(a)), 2. clear Perspex sides to 
enclose the board and allow uninterrupted views around the room (Figure 2.4A(b)), 3. an opaque 
plastic insert placed on the board covering all but four comer holes (Figure 2.4A(c)), 4. punctuated 
screens that cover the holes but allow odour to be released (Figure 2.4A(d)), 5. a turntable for the 
entire apparatus, making rotation easy (Figure 2.4A(e)).
Once assembled (Figure 2.4B) the apparatus was placed in the centre o f a testing room and the 
visual cues set up. The visual cues were conspicuous and constant: 1. green cloth covering home 
cages (Figure 2.4C(i)), 2. black video camera and recorder (Figure 2.4C(ii)), 3. red Perspex sheet in 
front of home cages (Figure 2.4C(iii)) and 4. experimenter wearing blue laboratory coat (Figure 
2.4C(iv)).
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C. Testing room
Figure 2.4  R o ta t ing  ho leb o ard  ap p a ra tu s
A. Diagrammatic representations o f  the individual pieces which make up the rotating holeboard apparatus.
B. T he  r o ta t in g  h o le b o a r d  a p p a r a tu s  w h e n  a s se m b le d  and  p la c e d  on the  r o ta t in g  s ta n d .
C. An overhead  view o f  the te s t ing  room  with the ro ta t ing  ho leboard  appa ra tu s  in the cen tre  
and the constant visual cues around the room.
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In order to test spatial learning and memory the aim of the paradigm was to locate the bait, a small 
piece o f cereal, whose relative position was maintained with respect to the visual cues. To ensure 
that spatial learning and memory were investigated olfactory and tactile cues were eliminated. To 
negate olfactory cues a constant and general food odour was achieved by placing a large piece of 
cereal under the punctuated screens covering the four comer holes. In addition to this constant 
inaccessible bait, the small accessible bait was placed on top o f the screen in one o f the holes. 
Following each trial the apparatus was dismantled and cleaned with detergent (TriGene II, 
MediChem International). To protect against possible tactile cues provided by the apparatus the 
entire construction was rotated after every trial in a pseudo-random manner. The mouse was 
released into the apparatus from a start box, this ensured that the animal was always placed in the 
centre o f the apparatus and did not receive any information about the apparatus set-up prior to the 
initiation o f the experiment.
To encourage the animals to find the bait, food was withdrawn overnight prior to testing. A  trial 
was terminated when the mouse had found the bait or when 3 minutes had elapsed. During the trial 
data collection involved scoring the number o f times the animal poked its nose into an incorrect 
hole. A  successful trial was deemed as one where the mouse found the bait prior to any incorrect 
nose pokes. The entire experiment was terminated when 8 out o f 9 consecutive trials were 
successful. The experimenter carried out data collection during the trial as well as simultaneous 
recording o f the experiment on videotape. This allowed the scores to be double checked and 
verified by a second experimenter. Food was withdrawn from the mice overnight again and the 
experiment repeated using the same criteria the next day to assess if learning had been retained.
2.6.2.2 Cohorts
All mice used in the experiments are described in Table 2.1. HD+/' and wild-type mice o f both 
sexes were investigated and all mice were 6 months o f age.
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3 Investigating phenotypic alterations in a knock-in 
mouse model of Huntington’s disease
3.1 Aims of the study
The following studies were designed to further investigate possible phenotypic alterations in this 
HD mouse model. It is necessary to determine the nature, onset and progression o f phenotypic 
changes to establish if  the phenotypic consequences o f the HD mutation are reminiscent of 
symptoms seen in human HD patients. Investigations into different aspects o f phenotypic alteration 
such as movement disorder and cognitive decline would provide further understanding into the 
relationship between several different aspects o f phenotypic change. Understanding phenotypic 
alterations may offer insights into the possible molecular and cellular consequences o f the HD 
mutation and their downstream effects. In depth investigations may establish whether the same 
underlying mechanisms are responsible for all phenotypic alterations. In addition, quantification of 
any phenotypic consequences of the HD mutation will provide markers o f the disease process, 
allowing the effectiveness o f future HD therapies to be assessed.
3.2 Gait analysis in wild-type and HD+/~ mice
3.2.1 Aims of the study
The aim of the following study was to ascertain if HD mice display alterations in gait, during 
spontaneous locomotion. Gait abnormalities such as lack of movement control and co-ordination 
are prominent symptoms associated with human HD (see section 1.1.1.1). Using gait analysis 
apparatus and associated data acquisition equipment described in section 2.6.1.1, load exerted 
through limbs, weight distribution and velocity were assessed to establish if  HD+/' mice possess an 
altered gait compared to their wild-type littermates. Wild-type and HD+/' mice o f various ages were 
investigated to determine the progressive nature o f any alterations in gait. Previous studies 
investigating co-ordination and balance within these HD+/' mice have illustrated significant 
differences between males and females (C-M Chen, unpublished data). Although there is no 
evidence in the literature that the course or severity o f HD is significantly different in male and 
female HD patients, phenotype can be highly variable between human patients and no detailed 
studies on sex differences in human HD have been carried out. To investigate differences in the 
phenotype o f male and female HD+/' mice animals o f both sexes were used in the studies. These 
investigations will also illustrate whether mixed cohorts could be used in subsequent behavioural 
studies.
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3.2.2 Gait analysis in 4 month old wild-type and HD+/' mice
Gait analysis was performed as described in section 2.6.1. The mean load transmitted through the 
limbs, the difference between the loads for different groups o f limbs and body weight have been 
investigated for 4 month old wild-type and HD+/' mice. The mean body weights for wild-type and 
HD+/‘ mice are presented in Table 3.1. The data representing the load transmitted through each 
group of limbs (fore, hind, left and right) is expressed as a percentage o f body weight and is 
presented in Table 3.2.
The body weights of wild-type (26.6 + 0.9 g) and HD+/' (25.3 + 1.3 g) mice were not significantly 
different at 4 months of age (Table 3.1, p=0.2).
Table 3.1 Summary of mean body weight for 4 month old mice assessed for gait parameters
Genotype Number Mean body weight *p value
/Sex of mice (grams + S.E.)
WT 10 26.6 + 0.9 0.2
HD+/" 10 25.3 ± 1 .3
Male WT 5 28.1 + 1.4 0.5
Male HD+/' 5 28.3 ±1 .5
Female WT 5 25.1 +0.86 0.03
Female HD+/' 5 22.2 ± 0.9
* comparing mean body weight between wild-type and HD+/' mice using the unpaired, one-tailed, Student’s t- 
test.
The mean load transmitted through the fore limbs o f wild-type mice was 71.9 + 2.04 percent of 
their body weight (%) and the mean load transmitted through the hind limbs was 67.5 + 1.20 %. 
Wild-type mice appeared to be transmitting a greater force through their fore limbs than their hind 
limbs (Figure 3.1A and Table 3.2). This is in accordance with previously published data stating that 
normal mouse gait is asymmetrical across the fore/hind axis, with approximately 4 % greater load 
exerted through the fore limbs (Clarke and Still, 1999). The HD+/' mice displayed the same 
asymmetrical distribution of weight across the fore/hind axis. The mean load transmitted through 
the fore limbs was 76.3 + 2.29 % and 69.5 ±  1.1 % through the hind limbs (Figure 3.1A and Table 
3.2).
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Figure 3.1 The mean load exerted through the limbs o f 4 month old wild-type 
and HD+/“ mice
The bar graphs show the mean load, expressed as a percentage o f body 
weight (BW ) ±  one standard error, transmitted through all four groups 
of limbs (fore, hind, left and right) in 4 month old wild-type and HD+/ ‘ mice. 
A. A normal mouse gait displays asymmetry across the fore/hind axis with the fore limb 
transmitting greater load than the hind limb. The median difference between the fore and 
hind limb loads in wild-type (n=10) and HD+/" mice (n=10) were compared using the 
Mann-Whitney U statistical test and no significant difference in weight distribution was 
detected (p=0.2). B. A normal mouse gait displays symmetry across the left/right axis. 
The median difference between the left and right limb loads in wild-type (n=10) and HD+/" 
mice (n=10) were compared using the Mann-Whitney U statistical test and no significant 
difference in weight distribution was detected (p=0.1).
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Table 3.2 Summary of the mean loads, as a percentage of body weight, exerted through all groups 
of limbs in 4 month old mice
Genotype/ Number of Mean load (% BW ± S.E.)
Sex mice Fore Hind Left Right
WT 10 71.9 + 2.04 67.5 ±1.2 70.03 ±1.82 69.4 ± 1.43
HD+/" 10 76.3 ±2.29 69.5 ±1.1 72.3 ±1.92 73.8 ±1.80
Male WT 5 69.6 ±3.73 65.16 ± 1.81 68.1 ±3.31 66.71 ±2.26
Male HD+/’ 5 81.2 ±3.05 71.2 ±1.61 75.4 ± 2.78 77.6 ±2.4
Female WT 5 74.2 ± 1.42 69.8 ±0.78 71.9 ±1.48 72.05 ± 0.75
Female HD+/' 5 71.3 + 1.46 67.9+1.21 69.3 + 2.06 69.92+ 1.21
To assess whether the difference between the loads exerted by the fore and hind limbs differs in 
wild-type and HD+/' mice the mean loads across the hind limbs were subtracted from that o f the 
fore limbs and the resultant measure o f weight distribution analysed by the Mann-Whitney U 
statistical test. The median difference between the fore and hind limb loads in wild-type mice was 
4.9 + 1 % and in HD+/' mice 6.3 + 1.4 %. There was no significant difference (p=0.2) between the 
median difference of the loads transmitted through the fore and hind limbs in wild-type mice and 
HD+/" mice (Table 3.3).
Table 3.3 The median distribution of weight between the fore and hind limbs and the left and right 
limbs in all cohorts and the p values resulting from the Mann-Whitney U statistical test when 
comparing the median difference between loadings in wild-type and HD+/' mice
Genotype
/Sex
Number 
of mice F-H
(%BW ± S.E.)
Weight Distribution 
p value* L-R
(%BW ± S.E.)
*p value
WT 10 4.9 + 1 0.2 0.93 + 0.8 0.1
HD+/‘ 10 6.3 ±1.4 -1.5 ±1.5
Male WT 5 6.1 + 1.9 0.09 1.32 + 1.2 0.1
Male HD+/" 5 11.9 ± 1.5 -1.4 ±2.1
Female WT 5 4.8 + 0.85 0.7 0.54 + 0.95 0.3
Female HD+/' 5 3.9 ±1.33 -1.6 ±2.4
F-H = the median of the values obtained for the difference between the mean loads of the fore and hind 
limbs. L-R = the median of the values obtained for the difference between the mean loads of the left and right 
limbs. * comparing F-H and L-R in wild-type and HD+/' mice using the Mann-Whitney U test.
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Previous investigations into normal mouse gait have illustrated that the loads transmitted through 
the left and right limbs are similar, resulting in a symmetrical gait (Clarke and Still, 1999). In 
agreement with these findings, the mean loads for left and right limbs in 4 month old wild-type 
mice were 70.03 + 1.82 % and 69.4 + 1.43 %, respectively (Figure 3.1B and Table 3.2). The left 
and right limbs o f HD+/' mice were also very similar, 72.3 _+ 1.92 % and 73.8 + 1.80 %, 
respectively (Figure 3 .IB and Table 3.2). No significant difference (p=0.1) was found when the 
median difference between the left and right limb loads in wild-type mice (0.93 + 0.8 %) and HD+/' 
mice (-1.5 + 1.5 %) were compared suggesting a symmetrical gait for mice with and without the 
HD mutation (Table 3.3).
The limb loadings o f 4 month old wild-type and HD+/' mice all showed the pattern of weight 
distribution expected of a normal mouse gait. When comparing the differences between the limb 
loadings across the fore/hind and left/right axis no significant differences were observed between 
wild-type and HD+/' mice. These studies have illustrated that the gait o f 4 month old HD+/' mice 
does not differ from the wild-type controls.
3.2.2.1 Investigating s e x  d ifferen ces in gait o f 4 m onth old m ice
The cohorts o f 4 month old mice used in section 3.2.2 consisted o f equal numbers of male and 
female animals. In order to establish if mean loads transmitted, difference between limb loadings 
and body weight differ in male and female mice, the data were separated according to sex, and re- 
analysed.
3.2.2.1.1 M ale mice
The mean load transmitted by the fore limbs of wild-type male mice was measured at 69.6 + 3.73 
% and the mean load transmitted through the hind limbs was 65.16 + 1.81 % (Table 3.2). Again 
this corresponds to the typical mouse gait as the fore limbs exert more force than the hind limbs 
(Figure 3.2A). This pattern is also repeated in the male HD+/' mice with the load from the fore 
limbs measured at 81.2 + 3.05 % and the hind limbs at 71.2 + 1.61 % (Table 3.2, Figure 3.2A). The 
maintenance of a typical asymmetrical gait in male mice carrying the HD mutation was confirmed 
when the median difference between the fore and hind limb loads was statistically compared to 
wild-type controls and no difference was found (Table 3.3, p=0.09).
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Figure 3.2 The mean load exerted through the limbs o f male 4 month old wild-type 
and HD+/“ mice
The bar graphs show the mean load, expressed as a percentage of body weight (BW) 
±  one standard error, transmitted through all four groups of limbs (fore, hind, left and right) 
in male 4 month old wild-type and HD+/L mice. A. A normal mouse gait displays asymmetry 
across the fore/hind axis with the fore limb transmitting greater load than the hind limb. 
The median difference between the fore and hind limb loads in wild-type (n=5) and HD+/" 
mice (n=5) were compared using the Mann-Whitney U statistical test and no significant 
difference in weight distribution was detected (p=0.09). B. A  normal mouse gait displays 
symmetry across the left/right axis. The median difference between the left and right limb 
loads in wild-type (n=5) and HD+/" mice (n=5) were compared using the Mann-Whitney U 
statistical test and no significant difference in weight distribution was detected (p=0.1). 
Male HD+/' mice seemed to transmit greater loads through all limb groups compared to 
their wild-type controls. Statistical analysis of each limb group between wild-type and HD+/' 
mice showed a significantly greater load transmitted through the hind (p=0.04) and right 
(p=0.04) limbs of HD+//" mice compared to wild-type controls 
(Mann-Whitney, Fore, p=0.06, Left, p=0.3).
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Male mice also demonstrate retention of the symmetrical gait when investigating left and right limb 
loadings. The wild-type mice showed a mean load of 68.1 + 3.31 % for the left limbs and a mean 
load of 66.71 + 2.26 % for the right limbs (Table 3.2, Figure 3.2B). In HD+/' mice the left limbs 
transmitted a mean load of 75.4 + 2.78 % and the right limbs a mean load o f 77.6 + 2.4 % (Table 
3.2, Figure 3.2B). When the median differences between left and right limb loading in wild-type 
and HD+/‘ mice were compared there was no significant difference between the cohorts (Table 3.3,
p=0.1).
Male HD+/' mice do, however, transmit greater peak loads from all limbs compared to their wild- 
type counterparts. When the mean loads for each limb were compared using the Mann-Whitney U 
statistical test, the hind (p=0.04) and right (p=0.04) limbs were found to exert significantly more 
force in HD+/‘ mice compared to their wild-type littermates (Figure 3.2). As no significant 
difference between body weight in wild-type (28.1 + 1.4 g) and HD+/' (28.3 + 1.5 g) male mice 
(Table 3.1) was detected and the velocity between wild-type and HD+/' mice, at a later time point 
(section 3.2.5), showed no significant difference, the reason male mice exert greater peak loads 
through their hind and right limbs is unknown but suggests some variation in limb placement 
perhaps due to poorer co-ordination between limb placements or different posture during 
movement.
The limb loadings o f male 4 month old mice all displayed the pattern o f weight distribution 
expected of a normal mouse gait. When the median differences between the mean loads across the 
fore/hind and left/right axis were compared between wild-type and HD+/' mice, no significant 
differences were detected. Male 4 month old HD+/' mice displayed a gait that was not significantly 
difference from their wild-type controls. This result was consistent with the results obtained from 
the cohorts containing both male and female mice in section 3.2.2.
3.2.2.1.2 Female mice
In female wild-type mice the fore and hind limb mean loads were 74.2 + 1.42 % and 69.8 + 0.78 %, 
respectively and HD+/'m ice exerted mean loads of 71.3 + 1.46 % through the fore limbs and 67.9 + 
1.21 % through the hind limbs (Table 3.2, Figure 3.3A). The asymmetrical gait across the fore/hind 
axis previously observed in both male wild-type and HD+/' mice is also apparent in their female 
counterparts. The weight distribution for the two cohorts was not significantly different when the 
median difference between the fore and hind limb loads in wild-type animals (4.8 %) and HD+/’ 
mice (3.9 %) were compared (Table 3.3, p=0.7).
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Figure 3.3 The mean load exerted through the limbs o f female 4 month old wild-type 
and HD+/“ mice
The bar graphs show the mean load, expressed as a percentage of body weight (BW) 
± one standard error, transmitted through all four groups of limbs (fore, hind, left and right) 
in female 4 month old wild-type (n=5) and HD+/‘ mice (n=5). A. A normal mouse gait displays 
asymmetry across the fore/hind axis with the fore limb transmitting greater load than the 
hind limb. The median difference between the fore and hind limb loads in wild-type (n=5) 
and HD+/- mice (n=5) were compared using the Mann-Whitney U statistical test and no 
significant difference in weight distribution was detected (p=0.7). B. A normal mouse gait 
displays symmetry across the left/right axis. The median difference between the left and right 
limb loads in wild-type and HD+y/" mice were compared using the Mann-Whitney U statistical 
test and no significant difference in weight distribution was detected (p=0.3).
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A  symmetrical gait was observed in wild-type mice as the left limb mean load was 71.9 + 1.48 % 
and the right limb mean load was 72.05 + 0.75 (Table 3.2, Figure 3.3B). The HD+/' mice followed  
this pattern and displayed mean loads for the left limbs of 69.3 + 2.06 % and 69.92 + 1.21 % for the 
right limbs (Table 3.2, Figure 3.3B). As previously shown for the combined wild-type and HD+/' 
mice cohorts and male cohorts, the median difference between left and right limb loadings was not 
significantly different in the female HD+/‘ mice compared to the wild-type controls (Table 3.3, 
p=0.3).
Unlike the male HD+/' mice (section 3.2.2.1.1), female HD+/‘ mice did not seem to exert 
significantly more load through their limbs when the same limb groups were compared in wild-type 
and HD+/' mice (Figure 3.3).
In analysing the mean load data and assessing weight distributions in female 4 month old wild-type 
and HD+/' mice a typical mouse gait was observed, consistent with the previous findings in male 
mice (section 3.2.2.1.1) and the combined cohort (section 3.2.2) of the same age.
The female HD+/‘ mice displayed a mean body weight o f 22.2 + 0.9 g, a significant reduction in 
body weight compared to their wild-type controls (25.1 + 0.86 g, p=0.03)(Table 3.1). This 
difference in body weight was not observed in male mice at this age. At this time point male wild- 
type mice do weigh significantly more than their female counterparts (p=0.05), however in HD+/' 
mice the difference between male and female animals was greater (p=0.004). It may be that the HD 
mutation prevents normal weight gain at this age in female mice although previous publications 
have shown no difference in weight between wild-type and HD+/' mice (Shelboume et al., 1999). 
This discrepancy may be due to the previous investigations analysing larger cohorts.
3.2.3 Gait analysis in 9 month old wild-type and HD+/‘ mice
Gait analysis was again carried out on the wild-type and HD+/‘ mice used in section 3.2.2 at 9 
months o f age to investigate any alterations in gait at a later time point.
Consistent with results from 4 month old female mice a significantly lower body weight (p=0.03) 
was observed when all HD+/' (27.7 + 0.83 g) mice were compared to wild-type mice (30.7 + 1.27 g) 
at 9 months of age (Table 3.4).
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Table 3.4 Summary of mean body weight for 9 month old mice assessed for gait parameters
Genotype
/Sex
Number 
of mice
Mean body weight 
(grams ± S.E.)
*p value
WT 9 30.7+1.27 0.03
HD+/‘ 10 27.7 ± 0.83
Male WT 4 33.4+1.67 0.03
Male HD+/‘ 5 29.36 ±0.91
Female WT 5 28.54+ 1.23 0.08
Female HD+A 5 26.12 ±0.97
* comparing mean body weight between wild-type and HD+/" mice using the unpaired, one-tailed, Student’s t- 
test.
When investigating the fore and hind limb mean loads the wild-type mice displayed mean loads of 
62.5 ±  1.39 % for the fore limbs and 63.3 ±  0.69 % for the hind limbs (Table 3.5). The difference in 
limb loadings between the fore and hind limbs was uncharacteristically symmetrical for wild-type 
animals (0.3 ±  1.76 %) (Table 3.6, Figure 3.4A). The mean loads in HD+/' mice were observed as 
64.4 + 1.07 % for the fore limbs and 67.5 + 1.57 % for the hind limbs (Table 3.5). This median 
difference between the limb loadings for the fore and hind limbs in HD+/‘ mice (-4.8 + 1.48 %) 
illustrated an even larger change from the previously normal gait observed in HD+/‘ mice at 4 
months o f age. HD+/' mice at 9 months o f age exert greater force through their hind limbs than their 
fore limbs (Figure 3.4A). However, when the median difference between the fore and hind limb 
loadings were compared, weight distribution in the wild-type and HD+/' mice was not significantly 
different (Table 3.6, p=0.4).
Table 3.5 Summary of the mean loads, as a percentage of body weight, exerted through all groups 
of limbs in 9 month old mice
Genotype/
Sex
Number of 
mice Fore
Mean load (% BW + S.E.) 
Hind Left Right
WT 9 62.5 ±1.39 63.3 ±0.69 62.88 ±0.78 62.93 ± 0.75
HD+/‘ 10 64.4 ± 1.07 67.5 ± 1.57 66.6 ±1.66 65.29 ± 1.58
Male WT 4 63.6 ±0.32 62.96 ± 0.43 63.3 ±0.52 63.2 ± 0.08
Male HD+/" 5 64.7 ± 0.93 71.2 ±0.51 67.2 ± 2.63 68.7 ±1.91
Female WT 5 61.62 ±2.55 63.6 ±1.25 62.5 ± 1.40 62.74 ±1.41
Female HD+/ 5 64 ± 2.06 63.9 ±2.02 66 ± 2.32 61.9 ±1.40
Laura Kennedy, 2002
Chapters, 129
A.
90
*5 80
Figure 3.4 The mean load exerted through the limbs o f 9 month old wild-type and HD+/“ mice
The bar graphs show the mean load, expressed as a percentage of body weight (BW) + 
one standard error, transmitted through all four groups of limbs (fore, hind, left and right) in 
9 month old wild-type and HD+/" mice. A. A normal mouse gait displays asymmetry across 
the fore/hind axis with the fore limb transmitting greater load than the hind limb. The median 
difference between the fore and hind limb loads in wild-type (n=9) and HD+/' mice (n=10) 
were compared using the Mann-Whitney U statistical test and no significant difference in weight 
distribution was detected (p=0.4). B. A normal mouse gait displays symmetry across the 
left/right axis. The median difference between the left and right limb loads in wild-type (n=9) 
and HD+/_ mice (n=10) were compared using the Mann-Whitney U statistical test and no 
significant difference in weight distribution was detected (p=0.1).
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Table 3.6 The median distribution of weight between the fore and hind limbs and the left and right 
limbs in all cohorts and the p values resulting from the Mann-Whitney U statistical test when 
comparing the median difference between loadings in wild-type and HD+/' mice.___________________
Genotype
/Sex
Number 
of mice F-H
(%BW + S.E.)
Weight Distribution 
*p value L-R
(%BW + S.E.)
*p value
WT 9 0.3 + 1.76 0.4 0.3 + 0.78 0.1
HD+/' 10 -4.8 + 1.48 3.5 ±  2.35
Male WT 4 0.65 + 0.6 0.02 0.1 + 0.54 0.9
Male HD+/‘ 5 -6.4+ 0.9 0.9 ± 4 .4
Female WT 5 -2.8 + 3.19 0.8 0.6 + 1.86 0.1
Female HD+/' 5 0.6 ± 1 .4 4.9 ± 1 .2
F-H = the median of the values obtained for the difference between the mean loads of the fore and hind
limbs. L-R = the median of the values obtained for the difference between the mean loads of the left and right 
limbs. * comparing F-H and L-R in wild-type and HD+/' mice using the Mann-Whitney U test.
When analysing the mean loads and weight distributions for the left and right limbs the normal 
symmetrical gait was observed (Figure 3.4B). Wild-type mice displayed mean loads o f 62.88 ±  
0.78 % for the left limbs and 62.93 ±  0.75 % for the right limbs (Table 3.5). The HD+/‘ mice 
transmitted 66.6 ±  1.66 % mean load through their left limbs and 65.29 + 1.58 % through their 
right limbs (Table 3.5). The median difference between left and right limb loads was not 
significantly different (p=0.1) in wild-type (0.3 + 0.78 %) compared to HD+/' mice (3.5 + 2.35 
%)(Table 3.6).
In summary, the left/right limb axis symmetry o f a normal mouse gait was maintained in 9 month 
old wild-type and HD+/' mice. Wild-type mice showed an uncharacteristic symmetrical gait when 
analysing the distribution o f weight across the fore/hind axis. The abnormal gait was also 
demonstrated in HD+/' mice, however, the distribution o f weight was not significantly different 
when compared to wild-type mice.
3.2.3.1 Investigating sex differences in gait of 9 month old mice
The cohorts used in this study were the same animals investigated in section 3.2.2 and so the cohort 
was again separated according to sex and re-analysed.
3.2.3.1.1 Male mice
Male wild-type mice transmitted 63.6 + 0.32 % mean load through their fore limbs and 62.96 + 
0.43 % through their hind limbs (Table 3.5). These loads illustrated an uncharacteristic symmetrical 
gait. The HD+/' mice showed mean loads o f 64.7 + 0.93 % and 71.2 ±  0.51 % for their fore and hind 
limbs, respectively (Table 3.5). Taking into account the symmetry of the wild-type mouse gait
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HD+/' mice displayed an abnormal gait with the hind limbs transmitting a greater load than the fore 
limbs (Figure 3.5A). When the median difference between the fore and hind limb loadings were 
compared, weight distribution in the HD+/' and wild-type mice was significantly different 
(p=0.02)(Table 3.6).
The alteration in gait of male HD+/' mice appeared only for the distribution of weight through the 
fore and hind limbs as the left and right limbs continued to transmit symmetrical loads (Figure 
3.5B). The wild-type mice transmitted 63.3 + 0.52 % load through their left limbs and 63.2 + 0.08 
% through their right limbs (Table 3.5). HD+/' mice exerted mean loads o f 67.2 + 2.63 % on their 
left limbs and 68.7 + 1.91 % on their right limbs (Table 3.5). When the median differences between 
left and right limb loadings were compared between wild-type mice (0.1 + 0.54 %), and HD+/' mice 
(0.9 + 4.4 %), a symmetrical gait was demonstrated with no significant difference (p=0.9) between 
the cohorts detected (Table 3.6).
When the mean body weight o f male wild-type mice (33.4 + 1.67 g) was compared to that o f male 
HD+/" mice (29.36 + 0.91 g), the HD+/' mice displayed a significantly lower mean body weight than 
the wild-type controls (p=0.03) (Table 3.4). This difference is consistent with female mice at 4 
months of age and the combined cohort at 9 months of age.
As male mice at 4 months of age exerted significantly more load through their hind and right limbs 
compared to their wild-type controls the load exerted through all limbs were compared between 
HD+/' and wild-type male mice at 9 months o f age. Significantly greater load was transmitted 
through the hind (p=0.02) and right limbs (p=0.02) of HD+/' mice compared to wild-type controls at 
this time point. This significant difference was not observed for the fore (p=0.6) and left limbs 
(p=0.2). These findings are consistent with those found at 4 months of age in these animals. It is 
unknown whether this difference in the amount o f load transmitted through some limbs is 
connected to the abnormal weight distribution observed in male HD+/’ mice. If a significant 
increase in load transmitted through certain limbs plays a role in generating gait abnormality then 
an early subtle alteration in male gait may be detected at 4 months of age.
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Figure 3.5 The mean load exerted through the limbs o f male 9 month old wild-type and 
HD+/' mice
The bar graphs show the mean load, expressed as a percentage of body weight (BW) 
+ one standard error, transmitted through all four groups of limbs (fore, hind, left and right) 
in male 9 month old wild-type and HD+/" mice. A. A normal mouse gait displays asymmetry 
across the fore/hind axis with the fore limb transmitting greater load than the hind limb. 
The median difference between the fore and hind limb loads in wild-type (n=4) and 
HD+/- mice (n=5) were compared using the Mann-Whitney U statistical test and a significant 
difference in weight distribution was detected (p=0.02). B. A normal mouse gait displays 
symmetry across the left/right axis. The median difference between the left and right limb 
loads in wild-type (n=4) and HD+/‘ mice (n=5) were compared using the Mann-Whitney U 
statistical test and no significant difference in weight distribution was detected (p=0.9). 
Male HD+/" mice seemed to transmit greater loads through all limb groups compared to their 
wild-type controls. Statistical analysis of each limb group between wild-type and HD+/‘ mice 
showed a significantly greater load transmitted through the hind (p=0.02) and right (p=0.02) 
limbs of HD+/" mice compared to wild-type controls (Mann-Whitney, Fore, p=0.6, Left, p=0.2).
Laura. Kennedy, 2002 Chapters, 133
The male wild-type mice at 9 months o f age display a symmetrical gait across the fore/hind axis. 
This differs from the normal gait observed in all animals at 4 months of age. The HD+/' mice 
display an abnormal gait when investigating the fore/hind axis as a greater load is transmitted 
through the hind limbs. The difference between the fore and hind limb loads is significantly 
different in HD+/' mice compared to wild-type controls. No alteration from the typical mouse gait is 
observed in wild-type and HD+/’ mice when investigating the loads transmitted across the left/right 
axis. Consistent with male HD+/' mice at 4 months of age, male HD+/' mice transmit significantly 
more load through their hind and right limbs compared to the wild-type controls.
In summary, these data suggest that male HD+/" mice at 9 months o f age display a gait that is 
significantly different when compared to their wild-type controls.
3.2.3.1.2 Female mice
The 9 month old female wild-type mice transmitted 61.62 + 2.55 % load through their fore limbs 
and 63.6 + 1.25 % through their hind limbs (Table 3.5). The female wild-type mice showed an 
uncharacteristic distribution of weight across the fore and hind limbs with the fore limb failing to 
transmit a greater load than the hind limb, also seen in the male wild-type 9 month old mice. The 
HD+/' mice exerted mean loads o f 64 + 2.06 % through their fore limbs and 63.9 + 2.02 % through 
their hind limbs (Table 3.5). Female HD+/‘ mice also displayed a relatively symmetrical gait across 
the fore/hind axis (Figure 3.6A). The median differences in loads for the fore and hind limbs in the 
wild-type and HD+/' female mice were not significantly different (Table 3.6, p=0.8).
The left to right symmetry normally observed was apparent in wild-type female mice at 9 months 
(Figure 3.6B). Wild-type mice transmitted 62.5 + 1.40 % load through their left limbs and 62.74 + 
1.41 % through their right limbs (Table 3.5). The HD+/’ mice displayed mean loads o f 66 + 2.32 % 
and 61.9 + 1.40 % for their left and right limbs, respectively (Table 3.5). This HD+/' mouse gait 
shows slight asymmetry, however, the median differences between the left and right limbs for wild- 
type and HD+/' mice are not significantly different (Table 3.6, p=0.1).
Female HD+/' mice do have a lower mean body weight when compared to their wild-type controls 
however, this difference does not reach significance (p=0.08)(Table 3.4). This finding is not 
consistent with the significant reduction in weight o f HD+/' male mice when compared to their 
wild-type controls at 9 months o f age.
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Figure 3.6 The mean load exerted through the limbs of female 9 month old wild-type 
and HD+/- mice
The bar graphs show the mean load, expressed as a percentage of body weight (BW) 
±  one standard error, transmitted through all four groups of limbs (fore, hind, left and right) 
in female 9 month old wild-type and HD+//" mice. A. A normal mouse gait displays asymmetry 
across the fore/hind axis with the fore limb transmitting greater load than the hind limb. 
The median difference between the fore and hind limb loads in wild-type (n=5) and 
HD+/- mice (n=5) were compared using the Mann-Whitney U statistical test and no significant 
difference in weight distribution was detected (p=0.8). B. A normal mouse gait displays 
symmetry across the left/right axis. The median difference between the left and right limb 
loads in wild-type (n=5) and HD+/' mice (n=5) were compared using the Mann-Whitney U 
statistical test and no significant difference in weight distribution was detected (p=0.1).
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Female HD+/' mice at 9 months of age do not display any alteration in gait when compared to their 
wild-type controls. Male HD+/' mice did display a significant difference in gait compared to wild- 
type controls at this age suggesting that there may be sex-specific factors influencing the 
phenotypic consequences o f the HD mutation. Studies at later time points would be needed to 
assess whether this change in gait of male HD+/" mice does eventually occur in female HD+/' mice.
3.2.4 Gait analysis in 12 m onth old wild-type and HD+/' mice
Investigations o f gait in wild-type and HD+/‘ mice at 12 months o f age were carried out. Each 
cohort contained 3 male and 3 female mice.
At 12 months o f age there was no significant difference in mean body weight detected between 
wild-type (34.98 + 1.85 g) and HD+/" (37.3 + 3.32 g) mice (Table 3.7, p=0.3).
Table 3.7 Summary of mean body weight for 12 month old mice assessed for gait parameters______
Genotype Number Mean body weight 
of mice (grams + S.E.)
*p value
WT 6 34.98 ±1.85 0.3
HD+/" 6 37.3 ± 3.32
* comparing mean body weight between wild-type and HD+/' mice using the unpaired, one-tailed, Student’s t- 
test.
The mean load for the fore limbs in wild-type mice was 66.7 + 1.52 % and for the hind limbs was 
61.96 + 2.37 % (Table 3.8). The weight distribution illustrated that the fore limbs transmitted a 
greater load than the hind limbs, as expected in a normal mouse gait. HD+/' mice showed a mean 
load of 62.5 + 1.62 % for the fore limbs and 62.2 + 1.26 % for the hind limbs (Table 3.8). This 
symmetrical gait differs from the normal gait across the fore/hind limb axis. The median 
differences between the loads for the fore and hind limbs in wild-type and HD+/‘ mice were nearly 
significantly different (Table 3.9, p=0.065).
The left and right limb mean loads were 64.5 + 1.27 % for the left limb and 64.2 ±  2.52 % for the 
right, showing a symmetrical and normal gait in wild-type mice at 12 months o f age (Table 3.8, 
Figure 3.7B). The mean loads in HD+/' mice were 61.7 + 1.64 % for the left limbs and 63 + 0.63 % 
for the right limbs (Table 3.8). The median difference between the left and right limb loads in wild- 
type and HD+/' mice were not significantly different (Table 3.9, p=0.6).
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Figure 3.7 The mean load exerted through the limbs o f 12 month old wild-type and HD+/“ mice
The bar graphs show the mean load, expressed as a percentage o f body weight (BW) 
+ one standard error, transmitted through all four groups of limbs (fore, hind, left and right) in 
12 month old wild-type and HD+/' mice. A. A normal mouse gait displays asymmetry across 
the fore/hind axis with the fore limb transmitting greater load than the hind limb. The median 
difference between the fore and hind limb loads in wild-type (n=6) and HD+/L mice (n=6) 
were compared using the Mann-Whitney U statistical test and a nearly significant difference in 
weight distribution was detected (p=0.065). B. A normal mouse gait displays symmetry across 
the left/right axis. The median difference between the left and right limb loads in wild-type 
(n=6) and HD+/" mice (n=6) were compared using the Mann-Whitney U statistical test and 
no significant difference in weight distribution was detected (p=0.6).
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Table 3.8 Summary of the mean loads, as a percentage of body weight, exerted through all groups 
of limbs in 12 month old mice
Genotype/
Sex
Number of 
mice
Mean load (% BW ± S.E.) 
Fore Hind Left Right
WT 6 66.7 ±1.52 61.96 ±2.37 64.5 ±  1.27 64.2 ± 2.52
HD+/’ 6 62.5 ±1.62 62.2 ± 1.26 61.7 ±1.64 63 ±0.63
Table 3.9 The median distribution of weight between the fore and hind limbs and the left and right 
limbs in all cohorts and the p values resulting from the Mann-Whitney U statistical test when 
comparing the median difference between the loadings in wild-type and HD+/' mice
Genotype
F-H (%BW)
Weight Distribution 
*p value L-R (%BW) *p value
WT
HD+/"
5.3 + 1.4 
0.9 ± 1 .4
0.065 0.9 ±1.96  
-1.8 ±1.24
0.6
F-H = the median of the values obtained for the difference between the mean loads of the fore and hind
limbs. L-R = the median of the values obtained for the difference between the mean loads of the left and right 
limbs. * comparing F-H and L-R in wild-type and HD+/' mice using the Mann-Whitney U test.
At 12 months of age HD+/' mice displayed gait that was not significantly different from wild-type 
controls. However, a trend towards an abnormality in the fore/hind axis load distributions within 
the HD+/' mice was observed. The HD+/' mice fail to exert a greater load through their fore limbs 
than their hind limbs, as expected for normal mouse gait. This trend towards an abnormal gait in 
HD+/' mice may represent the alteration in gait of male mice observed at 9 months worsening and 
affecting the results in the combined cohort or an alteration in female gait that may now be 
contributing. It is not possible to determine if  gait varies between sexes at this time point as data 
separation is not recommended with so few animals in each test cohort.
3.2.5 Velocity of 9 and 12 m onth old wild-type and HD+/' mice
As the velocity o f each animal was calculated for each run used in the analysis o f limb loadings, a 
mean velocity for each mouse was obtained. As the runs were captured on video, velocity was 
measured by the number of video frames, taken at known time intervals that were required for the 
animal to cross the load cell o f known length. The mean velocity o f wild-type and HD+/' mice was 
therefore assessed during spontaneous locomotion.
The mean velocity o f wild-type mice at 9 months of age was calculated as described in section
2.6.1.2 and found to be 23.01 cms'1. The velocity o f HD+/" mice at the same age was established as 
24.78 cms'1. These velocities were not significantly different when compared using the unpaired,
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one-tailed, Student’s f-test (p=0.2) (Table 3.10). At 12 months of age wild-type mice displayed a 
mean velocity o f 23.38 cms'1. 12 month old HD+/' mice showed a reduction in mean velocity (19.6 
cm s'1) when compared to their wild-type littermates, however, this reduction just failed to reach 
statistical significance (p=0.06) (Table 3.10).
When investigating the progressive nature of velocity in animals of the same genotype, wild-type 
mice showed no sign o f change in velocity from 9 to 12 months o f age (Table 3.11, p=0.4). The 
trend towards a reduction in velocity of HD+/' mice compared to wild-type mice at 12 months of 
age is supported by a significant progressive change in velocity o f HD+/' mice from 9 months to 12 
months of age (Table 3.11, p=0.007).
Velocity data were not available for 4 months old animals, however, the lack o f any significant 
difference between HD+/' and wild-type mice at 9 months o f age suggests no long term alteration in 
velocity occurred prior to this age.
Table 3.10 Summary of cohorts used and the mean velocities during locomotion in 9 and 12 month 
old wild-type and HD+/~ mice
Age Genotype Number Mean velocity *p value
(months) of mice (cms'1 ± S.E.)
9 WT 9 23.01 + 1.17 0.2
HD+/' 10 24.78 ± 1 .14
12 WT 6 23.38 + 1.73 0.06
HD+/' 6 19.6 ±1 .46
* comparing mean body velocity between wild-type and HD+/' mice using the unpaired, one-tailed, Student’s
f-test.
Table 3.11 Summary of cohorts used and the mean velocities during locomotion in mice of the
same genotype at different ages
Genotype Age Number Mean velocity *p value
(months) of mice (cms'1 ± S.E.)
WT 9 9 23.01 + 1.17 0.4
12 6 23.38 ±1 .73
HD+/' 9 10 24.78 + 1.14 0.007
12 6 19.6 ± 1 .46
* comparing mean velocity between 9 month and 12 month old mice of the same genotype using the
unpaired, one-tailed, Student’s f-test.
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3.2.6 Sum m ary of Results
Both wild-type and HD+/' mice displayed a typical mouse gait during spontaneous locomotion at 4 
months o f age. When the cohorts were separated into males and females both sexes of each 
genotype showed a typical mouse gait. The retention o f the normal left/right axis symmetry in limb 
loadings was observed throughout life for both wild-type and HD+/' mice. The distribution of 
weight across the fore/hind axis, typically asymmetrical with greater load transmitted through the 
fore limb, was observed in wild-type mice at 4 months and 12 months, however, became more 
symmetrical in 9 month old mice. This change in wild-type mouse gait may reflect the smaller 
number o f measurements taken at the intermediate time point (see section 2.6.1.2) or a natural 
variation in gait within this cohort.
At 9 and 12 months o f age alterations of gait were detected in HD+/' mice compared to their wild- 
type littermates. The male HD+/' mice at 9 months o f age did not exhibit the normal mouse gait or 
the more symmetrical gait observed in 9 month old wild-type mice, they displayed an asymmetrical 
gait across the fore/hind axis with the hind limb exerting the greatest load. At 9 months the slight 
alteration in gait o f the combined HD+/' mice cohort was apparently the result o f a significant 
alteration in the gait of male HD+/' mice and no change in the gait o f the female HD+/' mice. Results 
from the 12 month old cohort nearly reached significance and again illustrated a change across the 
fore/hind axis suggesting that the alteration in gait within HD+/‘ mice may be progressive. It is not 
possible to establish from this study if this alteration is due to a further change in male HD+/" mouse 
gait or the initiation of an abnormality in female HD+/' mouse gait. Further evidence supporting a 
change in gait in HD+/‘ mice at 12 months o f age was obtained with a trend towards a reduction in 
velocity of HD+/' mice compared to wild-type mice (p=0.06). This difference between HD+/' and 
wild-type mice was not observed at 9 months o f age. Further analysis did demonstrate that HD+/' 
mice at 12 months o f age did display a significant reduction in velocity compared to their 9 month 
old HD+/' counterparts (p=0.007).
In summary, these studies have provided evidence to support a late onset alteration in gait and 
velocity within HD+/' mice compared to their wild-type littermates.
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3.3 Investigating spatial learning and memory in wild-type and 
HD+/_ mice
3.3.1 Aims of the study
The aim of this study was to investigate spatial learning and memory in wild-type and HD+/" mice. 
Cognitive deficits, in the form o f memory dysfunction, are one o f the principal symptoms 
associated with human HD. Other prominent features o f the human HD phenotype such as 
movement disorder and behavioural abnormalities have previously been observed in this HD 
mouse model (Shelboume et al., 1999) and section 3.2). In order to determine if  this HD mouse 
model exhibits other behavioural aspects o f  the HD phenotype, cognitive functioning was 
investigated. Spatial learning and memory was investigated using the behavioural paradigm called 
the rotating holeboard (Brosnan-Watters and Wozniak, 1997) described in section 2.6.2. Mice were 
first assessed at 6 months of age, allowing time for repeated testing throughout life to establish the 
onset and progression o f possible deficits.
3.3.2 R esults
Practice experiments were carried out in the rotating holeboard apparatus to assess the 
effectiveness of the apparatus design and protocol. Three mice, of unknown genotype, were chosen 
to run through the full protocol. Previous reports o f investigations using the rotating holeboard to 
assess cognitive functioning in mice had suggested that learning would be achieved in 
approximately 25 trials (Brosnan-Watters and Wozniak, 1997). As each trial was estimated to take 
up to 4 minutes (3 minutes per trial plus apparatus cleaning and rotation) the expected duration of 
the experiment was approximately 1 h 40 min. As responses to behavioural paradigms can fluctuate 
depending on sex and mouse strain slight variation was expected. The results from the practice 
experiments using the rotating holeboard are presented in Table 3.12.
Table 3.12 Summary of the animals used and the results and conclusions from the practice 
sessions in the rotating holeboard paradigm
Sex/
Genotype
Acquisition Retention Problems Modifications
F HD+/" Yes 
34 trials
No
42 trials
Scraping 
and moving 
punctuated hole
Redesign hole screens
M WT No
64 trials
screens
Removal of the start
Redesign start box
M WT Yes
46 trials
No
54 trials
box disruptive
F = Female, M = Male, WT = Wild-type, HD+/' = Heterozygote HD mice
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During the first attempt using the rotating holeboard the mouse showed acquisition o f the task after 
34 trials. This was in spite o f the mouse regularly attempting to remove the punctuated screens 
covering the inaccessible bait and taking a prolonged time to emerge from the start box. However, 
the following day retention o f learning in this animal failed to occur after 42 trials. The second 
mouse experienced the same disruption due to the apparatus and became so preoccupied with 
removing the punctuated screens to access the large bait that acquisition was not achieved after 64 
trials. Acquisition o f learning with the third mouse was again successful after 46 trials however, the 
punctuated screens and start box caused disruption and retention of the task failed after 54 trials.
It has previously been observed that mice are easily distracted and sensitive to environmental stress 
during behavioural assessment. However, the failure o f these animals to complete the task was 
primarily attributed to apparatus design problems.
The initial experiments suggested that placing mice in a darkened start box and allowing voluntary 
emergence was unfavourable as the mice, preferring the dark, failed to explore the apparatus. The 
start box also had to be removed from the apparatus after emergence, which again disrupted the 
animals. The start box was redesigned to contain a sliding trap door. After placement o f the box 
into the apparatus the floor was removed and the box lifted leaving the mouse in the centre o f the 
apparatus with no cover and no further need for contact with the experimenter.
An important feature of the rotating holeboard design was the punctuated hole screens. These grids 
prevented access to the large bait in the holes but allowed a food odour around the apparatus, 
eliminating any olfactory cues. It was established in the initial trials that mouse claws could grip 
the screens and remove them, so tempting the mice to retrieve the large bait and ignore the small 
accessible bait. The grids were therefore redesigned and attached to the holes, eliminating the 
possibility of movement or removal.
Once the appropriate design modifications were carried out all remaining animals were fully re­
habituated to the new apparatus. This habituation consisted of thrice weekly handling and exposure 
to the new apparatus for 2 weeks. Animals were handled for 1 minute and then transferred into the 
apparatus by placement into the new start box and removing the sliding floor. This procedure was 
carried out approximately 5 times per habituation session.
Four fully habituated male mice were assessed in the new rotating holeboard apparatus and the 
results are presented in Table 3.13.
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Table 3.13 Summary of rotating holeboard experiments using the modified apparatus
Sex/
Genotype
Acquisition Retention Problems Modifications
M WT No
14 trials
Ignoring bait
M WT No
4 trials 
No
10 trials
Retry acquisition 
after second nights 
starvation
M HD+/" No
10 trials
Retry acquisition after 
second nights starvation
Yes
40 trials
Yes
26 trials
Correct trial criteria 
changed
M WT No
50 trials
Varying bait size
F = Female, M = Male, WT = Wild-type, HD+/' = Heterozygote HD mice
The first two attempts o f the rotating holeboard paradigm were terminated following a small 
number o f trials as the animals were ignoring the accessible bait. Animals would carry out a nose 
poke on the hole containing the accessible bait but fail to present the correct response and eat the 
bait. These incorrect nose pokes into the correct hole continued throughout the trial and no bait was 
eaten. Food deprivation overnight prior to testing was carried out to induce an incentive to learn 
through hunger. Ignoring the accessible bait was suggestive o f insufficient hunger induced by 
overnight food deprivation.
To test this the second animal was deprived of food over a second night and acquisition re-tested. 
The animal continued to ignore the bait from the first trial o f the second acquisition experiment.
The third animal was also subjected to two nights food deprivation as it ignored the bait on the first 
attempt at acquisition. As the animals were failing to eat the bait but frequently picked it up the 
criteria for a correct response was changed. The bait no longer needed to be eaten but only removed 
from the correct hole. These criteria resulted in the successful acquisition and retention o f the task. 
However, as the animal would either ignore the bait or pick it up, the response was not fuelled by 
hunger and appeared to occur randomly. The new criterion was used on a second mouse, which, 
failed to demonstrate acquisition after 50 trials, suggesting that without the hunger incentive, 
learning was not induced.
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To assess the animals response to food under normal conditions crude testing o f olfactory 
functioning was carried out by placing each animal in a fresh home cage with a hidden piece of 
bait. The behaviour o f the animals was assessed for 5 minutes and all subjects spent a high 
proportion of time (~3 min) investigating around the hidden bait. Three male and three female mice 
were tested and all females and two males mice found the bait within 1.5 minutes illustrating a 
positive response to the hidden food. The animals would either pick up the bait or walk away, 
behaviour reminiscent o f that observed in the rotating holeboard paradigm. The bait could elicit a 
response but there was not enough incentive to consistently do so. Three animals tested for 
responsiveness to food were subjected to the rotating holeboard and none successfully achieved 
acquisition of the task (Table 3.14).
The size of both the inaccessible and accessible bait was varied to ensure that the small pieces of 
bait when eaten were not too large to dampen hunger within the first few trials. Varying the type of 
bait used to establish if  the mice responded in the same way failed to elicit an alteration in 
behaviour.
Table 3.14 Summary of the rotating holeboard carried out with animals known to respond to food
Sex/
Genotype
Acquisition Retention Problems Modifications
F WT No Ignoring bait New kind of bait
38 trials
F WT No Retry acquisition after
43 trials second nights starvation
No
45 trials
F WT No
32 trials
F = Female, M = Male, WT = Wild-type, HD+/" = Heterozygote HD mice
3.3.3 Sum m ary of findings
The rotating holeboard experiments were discontinued after testing 10 mice and achieving 
successful acquisition and retention for the task in 1 animal. This success rate was deemed too low  
to acquire the animal numbers required for statistical analysis. Following initial design 
modifications the incentive to find and eat the bait seemed to be absent. Bait type and size was 
varied and mice elicited a positive response to hidden bait. Many mice still showed no sign o f  
learning after more than 4 hours of testing despite previous reports suggesting that approximately
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1 h 40 min should be sufficient for learning under these conditions (Brosnan-Watters and Wozniak, 
1997). In reports o f successful rotating holeboard studies, mice were systematically deprived of 
food until they achieved 80 % of their original body weight and were held at this weight throughout 
testing. According to Home Office advice, food was only withheld overnight prior to testing, and as 
a result no animal used in this study lost any weight. Under these circumstances it may be that mice 
will not learn as the hunger incentive to find the bait is missing. Due to these problems the aim of 
demonstrating cognitive deficits in the HD+/' mice was not achieved and the onset and progressive 
nature of any spatial learning and memory could not be established.
3.3.4 Future stud ies on HD knock-in m ouse cognition
Although this cognitive paradigm did not work well under the above conditions other paradigms 
may be suitable for this task. There are many other possible paradigms designed to assess learning 
and memory in rodents. Basic T or radial mazes could be utilised, however, these paradigms also 
rely on hunger-induced incentive. The most common alternative is adverse conditioning designed 
to force animals into learning an escape or prevention strategy. The Morris water maze is 
frequently used to assess spatial learning and memory by mice utilising spatial cues to find a 
hidden platform under the surface o f a water tank (Morris, 1984). This test however, due to the 
involvement o f water, can elicit a large stress response (Francis et al., 1995). An alternative 
paradigm may be the Barnes circular maze utilising the more subtle adverse stimuli o f light and 
noise (Barnes, 1979) to encourage the mouse to learn which hole around the outside of a domed 
circle leads to a darkened escape tunnel. This paradigm or ones like it may overcome the problem 
of incentive and minimise the stress response and therefore, may be suitable for the assessment of 
cognitive ability in HD+/' mice and their wild-type littermates in the future.
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4 Neurotransmitter receptor profiles in a knock-in 
mouse model of Huntington’s disease
4.1 Aims of the study
To further elucidate the underlying mechanisms of neuronal dysfunction observed in the early 
stages o f human HD (Andrews et a l ,  1999; Antonini et a l , 1996; Lawrence et a l ,  1998b) an 
investigation into the integrity of the neuronal circuitry of mice modelling early HD pathology was 
carried out. Any alterations in the density or distribution of neurotransmitter receptors could affect 
neuronal functioning. Changes in opioid, benzodiazepine, dopamine Di and dopamine D2 receptors 
have all previously been associated with early HD pathogenesis (Ginovart et a l ,  1997; Holthoff et 
a l ,  1993; Weeks et a l ,  1997). The density o f these neurotransmitter receptors within the striatum 
and cortex o f HD mice was investigated by quantitative ligand binding autoradiography (section 
2.5).
The study was designed to address the following questions:
• Are neurotransmitter receptor densities altered in the striatum of HD+/‘ mice compared to 
wild-type controls? The striatum was selected for investigation as this brain region shows 
the earliest pathological changes in HD. The question was investigated by determining the 
density o f opioid, benzodiazepine, dopamine Di and dopamine D2 neurotransmitter 
receptors in the striatum of 18 month old HD+/' and wild-type mice. HD+/' mice of this age 
have previously demonstrated late onset and progressive consequences of the HD mutation 
(Shelboume et a l ,  1999; Usdin et a l ,  1999), L.K., unpublished data, chapter 3).
• Are neurotransmitter receptor densities altered in the cortex o f HD+/' mice compared to 
wild-type controls, and if  so, do the changes parallel with changes in the striatum? 
Neurotransmitter receptor densities were investigated in the cortex because the 
neurodegenerative process associated with HD spreads to this brain region in the later 
stages of the disease. This suggests that the disease process, although less severe than in 
the striatum, does influence cortical cells. Cortical projection neurons innervate the 
striatum and any disruption o f neurotransmission in cortical neurons may contribute to 
dysfunction within the striatum. In order to make comparisons with neurotransmitter 
receptor densities in the striatum, the receptor binding assays mentioned in the previous 
paragraph were performed on brain sections encompassing the striatum and the cerebral 
cortex.
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• Is there any evidence that genetic background influences the effect o f the HD mutation on 
neurotransmitter receptor densities? The cohorts used to investigate neurotransmitter 
receptor densities in the striatum and cortex contained animals with different genetic 
backgrounds. This question w ill be investigated by subdividing the data obtained for 
striatal and cortical receptor densities according to genetic background and carrying out re­
analysis. If a genetic background influence is detected one possible interpretation is that 
genetic modifiers o f the disease process are present. Subsequent identification o f the 
molecular basis o f any genetic modifiers may provide potential targets for future 
therapeutic interventions.
• Do changes in neurotransmitter receptor densities in HD+/' mice occur as a result of a 
progressive process? This question will be addressed by investigating neurotransmitter 
receptor densities within the striatum and cortex o f HD+/' mice at different ages. HD is a 
progressive disorder, characterised by a prolonged symptom-free period during early life. 
Therefore, it is predicted that changes in neurotransmitter receptor densities would have a 
late onset and progress with age. Determining the time point at which neurotransmitter 
receptor density alterations occur would allow a comparison with the phenotypic 
alterations observed in the HD+/' mice. This may uncover a potential involvement o f these 
molecular changes in the symptomatology of HD.
Insights into other questions may also be provided by these studies. These include; Is the molecular 
basis o f pathology the same in different regions o f the brain? Is there a temporal gradient o f brain 
region involvement?
In addition to investigating the possible molecular basis of neuronal dysfunction in HD, studies into 
neurotransmitter receptor densities may provide useful biochemical markers of the disease process 
in HD+/' mice that may be utilised when assessing future HD therapies.
4.2 Optimisation of binding protocols
The concentration of the ligands used and the length of exposure time to autoradiographic film  
were optimised to ensure clear images of the appropriate intensity were produced for all brain 
regions examined.
4.2.1 Ligand concentration
The effect o f ligand concentration on the results obtained from the receptor binding assays was 
investigated. For each ligand a series o f 5-6 different concentrations was selected. For each ligand 
concentration, the total binding solution was added to 3 alternate brain sections from one wild-type
Laura Kennedy, 2002 Chapter 4, 147
animal, and the same animal was used to assess all concentrations of a particular ligand. As 
described in section 2.5.3, non-specific binding associated with each ligand concentration was then 
assessed using the 2 intervening brain sections. Binding assays were performed as described in 
section 2.5.
The effect of increasing ligand concentrations on the resultant neurotransmitter receptor densities 
within the striatum and cortex can be seen in Figures 4.1 and 4.2. The ligand concentration chosen 
for the main study was one where binding saturation had not yet been reached and a clear 
autoradiographic image was produced.
4.2.2 Time of exposure
Tritium standards are composed o f polymer representing eight different values o f the tissue 
equivalent (TE) tritium concentration as calibrated for the auto-absorptive features o f intact brain 
grey matter. Image analysis readings (section 2.5.5) must be taken when the relationship between 
the standard's tritium concentration and the corresponding optical density is linear. Densitometry 
errors may occur below or above this range as small optical density increments may represent large 
increments of tissue radioactivity. In order to produce autoradiographic images o f an optical 
density within the linear range o f the radioactive standards, brain sections bound with the chosen 
ligand concentration used in the assays described in section 4.2.1 were exposed to autoradiographic 
film for varying periods of time.
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Figure 4.1 The effect o f radiolabelled ligand concentration on striatal and cortical 
receptor binding
A. Neurotransmitter receptor density in the striatum and cortex of a wild-type mouse 
after receptor binding with increasing concentrations of [3H]-diprenorphine. 
The boxed value indicates the ligand concentration used in subsequent studies.
B. Neurotransmitter receptor density in the striatum and cortex of a wild-type mouse 
after receptor binding with increasing concentrations o f [3H ]-R ol5-1788. 
The boxed value indicates the ligand concentration used in subsequent studies. 
Values representing neurotransmitter receptor density are expressed as a 
mean + S.D. (fmol/mg tissue).
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A. Dopamine D1 receptors
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Figure 4.2 The effect o f radiolabelled ligand concentration on striatal and cortical 
receptor binding
A. Neurotransmitter receptor density in the striatum and cortex of a wild-type mouse 
after receptor binding with increasing concentrations of [3H]-SCH-23390. 
The boxed value indicates the ligand concentration used in subsequent studies.
B. Neurotransmitter receptor density in the striatum and cortex of a wild-type mouse 
after receptor binding with increasing concentrations of [3H]-YM -90151-2. 
The boxed value indicates the ligand concentration used in subsequent studies. 
Values representing neurotransmitter receptor density expressed as a mean + S.D. 
(fmol/mg tissue).
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The ligand concentrations and exposure times that resulted in the neurotransmitter receptor 
densities shown in Table 4.1 were chosen for the main study.
Table 4.1 The mean specific binding obtained from the brain sections bound with the optimised 
ligand concentration after the chosen exposure times. Values are calculated from comparison with 
the fH\-micro-scales_______________
[3H]-Micro-scales
(nCi/mg estimated 
Tissue Equivalent)
Receptor type and brain region
(Mean specific binding (nCi/mg))
Exposure Time
(Hyperfilm)
33.3
Benzodiazepine cortical binding (28.5) 3 wks
21.8
13.9
Dopamine D! striatal binding (14.6) 
Benzodiazepine striatal binding (10)
2 wks
3 wks
8.4 Dopamine D2 striatal binding (7) 2 wks
5.6
Opioid striatal binding (5) 3 wks
3.4 Opioid cortical binding (3.2) 3 wks
2.2
1.4 Dopamine Dt cortical binding (1) 2 wks
Dopamine D2 cortical binding (0) 2 wks
 values between the dashed lines represent the linear range of the [3H]-Micro-scales
The resultant neurotransmitter receptor density for the striatum and cortex under these conditions 
for opioid receptors were within the linear range of the radioactive standards. The striatal binding 
for both dopamine receptor types was within the linear range, however, cortical binding was 
extremely low. Although dopamine receptor cortical binding could have been established with 
longer exposure times, the length of exposure time needed to produce values within the linear range 
was deemed too long to enable completion o f the study within the designated time. Studies 
examining the densities o f both dopamine receptors in other HD mouse models have also obtained 
insufficient binding within the cortex to include these data within their analyses (Cha et al., 1998). 
As dopamine Di neurotransmitter receptor densities could be detected for cortical regions, binding 
was analysed and the results included in the discussion. Benzodiazepine striatal binding was within 
the linear range o f the radioactive standards, but benzodiazepine cortical binding produced high 
optical density readings out with the linear range. To obtain data for cortical benzodiazepine
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receptors, shorter exposure times were planned. However, when analysing the initial exposures in 
the subsequent studies for striatal binding the values for the cortical region of all animals fell within 
the linear range and a second exposure was not necessary (Table 4.3). Therefore the excessively  
high optical density within the cortex, produced by benzodiazepine receptor binding, appeared to 
be restricted to the one animal used in the optimisation study.
4.2.3 A utoradiographic Film
An investigation into possible differences in the values o f neurotransmitter receptor densities 
acquired from the same brain sections on different types o f autoradiographic films was carried out. 
This was necessary as the Hyperfilm initially used in these studies was discontinued before the 
experiments were completed. The autoradiographic film, Biomax MR-1 (Kodak Scientific  
Imaging) and Hyperfilm™-3H (Amersham) were both used to produce autoradiographic images in 
the main studies. To assess any disparity that may have arisen in the results by using different 
films, brain sections processed to examine benzodiazepine binding were used to produce images on 
both films. Biomax MR-1 film, found to be less susceptible to physical damage, resulted in a duller 
image and required longer exposure times. When the striata and cortices from nine different mice 
were analysed on both kinds of film no significant differences in neurotransmitter receptor density 
were obtained (Figure 4.3).
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4.2.4 Sum m ary of optim ised binding conditions
Table 4.2 The chosen ligand concentrations and exposure times used to detect neurotransmitter 
receptor densities of all four receptor types. The percentage of the data obtained for each receptor 
type on Hyperfilm and Biomax film is indicated.
Conditions for both the striatum and cortex*
Opioid Benzodiazepine Di d2
Ligand concentration
2 nM 1.5 nM 0.5 nM 0.23 nM
Film exposure
Hyperfilm 3 wks 3 wks 2 wks 2 wks
Biomax 4 wks 4 wks 3 wks 3 wks
Film used (% of sections exposed in main study)
Hyperfilm 100% 87.5% 62.5 % 87.5%
Biomax 0% 12.5% 37.5% 12.5%
*values of neurotransmitter receptor density for both cortex and striatum were obtained from the same film. 
Di = dopamine Di and D2 = dopamine D2 receptors.
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4.2.5 Evaluation of optim ised binding protocols
Table 4.3 shows mean specific binding in nCi/mg for the conditions chosen from the optimisation 
experiment and used in the subsequent main study.
Table 4.3 Average specific binding in nCi/mg for all ligands within the striatum and cortex and a 
comparison with the radioactive standard range
[3H]-Micro-scales
(nCi/mg estimated 
Tissue Equivalent)
Mean specific binding (nCi/mg)
Optimisation
Mean specific binding (nCi/mg)
Main study
33.3
Benzodiazepine cortical binding (28.5)
21.8
Benzodiazepine cortical binding 
and Dopamine D1 striata! binding
Dopamine Di striatal binding (14.6) (16)
13.9
Benzodiazepine striatal binding (10) Dopamine D2 striatal binding (10)
8.4
Dopamine D2 striatal binding (7)
Opioid and benzodiazepine 
striatal binding (6)
5.6
Opioid striatal binding (5) Opioid cortical binding (4)
3.4 Opioid cortical binding (3.2)
2.2
1.4 Dopamine Di cortical binding (1) Dopamine D! cortical binding (1)
Dopamine D2 cortical binding (0) Dopamine D2 cortical binding (0)
—  values between the dashed lines represent the linear range of the [3H]-Micro-scales
The results obtained from the chosen ligand concentrations and exposure times in the optimisation 
experiment and the main study suggest that repetition of the chosen protocols produced consistent 
levels o f binding in the striatum and cortex when examining dopamine dopamine D2 and opioid 
receptors. This was also the case when investigating striatal benzodiazepine receptor binding. 
However, cortical benzodiazepine showed significant alteration in values obtained in the 
optimisation and main study. A  significantly higher value o f neurotransmitter receptor densities in 
the cortex for benzodiazepine receptors was observed in the optimisation experiment. This 
variation may be accounted for by the fact that the optimisation study consisted o f one experiment
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using one control brain and the data from the main study represents the neurotransmitter receptor 
density results from a large cohort of wild-type mice. However, no individual animal in the main 
study demonstrated a cortical binding as high as that found in the optimisation study.
In other rodent studies investigating the chosen receptor types receptor binding levels are consistent 
with those found in this investigation (Cha et a l ,  1999; McCabe et a l ,  1988; Savasta et a l , 1986; 
Sur et a l , 1999).
4.2.6 Non-specific binding
Varying levels of non-specific binding were achieved with each optimised binding protocol (Table 
4.4). Non-specific binding was consistent within all brain sections processed through each binding 
protocol. Non-specific binding, expressed as a percentage of total binding, was detected at low  
levels (<20 %) in the striatum and cortex for opioid and benzodiazepine receptor binding (Figure 
4.4A and B). Binding conditions also achieved low non-specific binding within the striatum for 
dopamine Di receptors. The non-specific binding detected in the cortex for dopamine Di binding 
was relatively high, but may reflect the low levels o f total binding achieved (Figure 4.4C). The 
highest non-specific binding was detected for dopamine D2 receptor binding (Figure 4.4D). The 
level within the striatum was considered acceptable (<40 %) and data analysis carried out. Non­
specific binding within the cortex for dopamine D2 receptor binding was too high (90 %) to allow 
interpretation of the specific binding obtained, however, as dopamine D2 receptor binding within 
the cortex was negligible this analysis was not required.
Table 4.4 Non-specific binding levels in the striatum and cortex for all binding protocols as a 
percentage of the total binding obtained
Opioid Benzodiazepine D, d2
Striatum 11 % 2.5 % 5% 25%
Cortex 17% 1 % 35% 90%
Dj = dopamine Di and D2 = dopamine D2 receptors.
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Opioid B. Benzodiazepine
WT
Total
Non- Non­
specific  specific
C. D opam ine Di D. Dopam ine D2
Total
Non- Non­
specific specific
F i g u r e  4 . 4  S p e c i f i c  a n d  n o n - s p e c i f i c  b i n d i n g  fo r  al l  l i g a n d  b i n d i n g  p r o t o c o l s
A.  C o r o n a l  b r a in  s e c t i o n s  in c u b a te d  w i th  [3H ] - d i p r e n o r p h i n e  to a s s e s s  o p i o i d  
neurotransmitter receptor binding. B. Coronal brain sections incubated with [3H]-Ro15-1788 
to assess benzodiazepine neurotransmitter receptor binding. C. Coronal brain sections incubated 
wi th  [ 3 H ] - S C H 2 3 3 9 0  to a s sess  d o p a m i n e  Dj  n e u r o t r a n s m i t t e r  r e c e p to r  b ind ing .  
D. Coronal  brain sect ions  incubated wi th  [ 3 H ] - Y M - 0 9 151 -2 to assess  d o p a m in e  D 2 
neurotransmitter receptor binding. An example o f  a total binding section and the corresponding 
non-specif ic binding section for one wild-type and one H D +/'  mouse.  Scale bar  = 5 mm.
Total
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4.3 Neurotransmitter receptor profiles in the striatum of 18 
month old wild-type and HD+/' mice
Investigations into neurotransmitter receptor densities first concentrated on the striatum, the brain 
region predominantly associated with HD pathology. The initial study compared results from 18 
month old female wild-type and HD+/‘ mice. This time point was selected because phenotypic and 
cellular consequences of the HD mutation have been observed at this age (Shelboume et a l ,  1999; 
Usdin et al., 1999) and L.K., unpublished data, chapter 3). Initial analyses were carried out on 
pooled data from animals on three different genetic backgrounds. All wild-type and HD+/' mice 
used were matched for age and genetic background. This was frequently achieved by using HD+/" 
and wild-type littermates. The exact numbers o f mice on each genetic background in each pooled  
cohort are indicated in Table 4.5.
Table 4.5 The number of mice on three different genetic backgrounds used for striatal analysis of 
each receptor type
Genetic Genotype Striatum
background
Op Ben Di d2
FVB/N WT 6 6 6 5
HD+/' 5 5 5 4
C57BL/6 WT 9 9 7 9
HD+/‘ 9 10 6 6
DBA/2 WT 3 2 4 3
HD+/' 6 2 5 5
Total WT 18 17 17 17
HD+/' 20 17 16 15
Op = Opioid, Ben = Benzodiazepine, Dx= Dopamine Di, D2 = Dopamine D2 neurotransmitter receptors.
The striatum of each mouse in the cohort was assessed for opioid, benzodiazepine, dopamine Di 
and dopamine D2 neurotransmitter receptor densities. The number included in the final analysis 
(Table 4.5) varies between receptor assay due to the number o f brain sections successfully  
processed to produce images o f suitable quality. The neurotransmitter receptor densities for each 
pooled cohort are summarised in Table 4.6.
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Table 4.6 The number of animals utilised and the neurotransmitter receptor density for each study 
investigating the receptor profiles within the striatum of 18 month old HD+/' and wild-type mice
Receptor type Genotype Number 
of mice
Mean *p value 
neurotransmitter 
receptor density 
± S.D. (fmol/mg tissue)
Opioid WT 18 124 + 24 0.07
HD+/‘ 20 141 +33
Benzodiazepine WT 17 8 7 + 1 2 0.005
HD+/‘ 17 99 ± 1 0
Dopamine D1 WT 17 191 +23 0.9
HD+/’ 16 190 ± 2 6
Dopamine D2 WT 17 127 + 18 0.006
HD+/" 15 109 ±  14
* Values in bold represent statistical significance (p<0.05) obtained using two tailed, Student’s Mest.
Opioid receptor binding sites were found at moderate levels within the striatum (Figure 4.4A). The 
neurotransmitter receptor density revealed by this ligand ([3H]-diprenorphine) in wild-type mice 
was 124 ±  24 fmol/mg tissue. No significant difference was detected between this value and that of 
the 141 + 33 fmol/mg tissue detected in HD+/‘ mice using the two tailed, Student’s t-test (p = 0.07) 
(Figure 4.5A).
Benzodiazepine receptors displayed the lowest binding in the striatum within this study with a 
neurotransmitter receptor density in wild-type mice of 87 ±  12 fmol/mg tissue (Figure 4.4B). In 
comparison, the neurotransmitter receptor density in HD+/' mice was 99 ±  10 fmol/mg tissue. 
Statistical analysis o f the results revealed a significant increase in benzodiazepine binding in the 
striatum of HD+/' mice (two tailed, Student’s f-test, p = 0.005) when compared to wild-type mice 
(Figure 4.5B).
Dopamine Di receptors were expressed at high levels in the striatum and the neurotransmitter 
receptor density in wild-type mice was 191 + 23 fmol/mg tissue, (Figure 4.4C) and in HD+/" mice 
was 190 ±  26 fmol/mg tissue. Statistical analysis o f these results illustrated no significant 
difference in dopamine D i receptor density in mice with or without the HD mutation (two-tailed, 
Student’s £test, p = 0.9) (Figure 4.5C).
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Figure 4.5 Striatal neurotransmitter receptor density
A. A bar graph illustrating the neurotransmitter receptor density in wild-type (n=18) and 
HD+/' (n=20) mice. No significant difference was detected when opioid receptor density in the 
striatum of HD+/‘ and wild-type mice were compared using the unpaired, two-tailed, 
Student’s r-test (p =0.07).
B. A bar graph illustrating the neurotransmitter receptor density in wild-type (n=17) and 
HD+/' (n=17) mice. A significant increase in benzodiazepine receptor density in HD+/- mice 
was detected when compared to wild-type mice using the unpaired, two-tailed, 
Student’s r-test (*p =0.005).
C. A bar graph illustrating the neurotransmitter receptor density in wild-type (n=17) 
and HD+//" (n=16) mice. No significant difference in dopamine Dj receptor density was detected 
in HD+/' mice compared to wild-type when compared using the unpaired, two-tailed, Student’s 
r-test (p =0.9).
D. A bar graph illustrating the neurotransmitter receptor density in wild-type (n=17) and 
HD+/‘ mice (n=15). HD+/' mice demonstrated a significant reduction in dopamine D2 
receptors when compared to wild-type mice using the unpaired, two-tailed, Student’s 
r-test (*p =0.006).
Values of neurotransmitter receptor density expressed as a mean ±  S.D. (fmol/mg tissue).
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W ild-type mice displayed a moderate dopamine D 2 binding within the striatum with a 
neurotransmitter receptor density o f 127 ±  18 fmol/mg tissue (Figure 4.4D). In comparison HD+/' 
mice displayed a neurotransmitter receptor density o f 109 + 14 fmol/mg tissue. Statistical analysis 
of the data revealed that HD+/‘ mice exhibit a significantly lower striatal dopamine D2 receptor 
density than their wild-type controls (two-tailed, Student’s Mest, p = 0.006) (Figure 4.5D).
In summary, these studies revealed alterations in the neurotransmitter receptor profile within the 
striatum of mice carrying the HD mutation compared to wild-type controls. These changes are 
restricted to specific receptor types with no alterations observed in the opioid and dopamine Di 
receptor binding densities. In contrast, a significant reduction in the density o f dopamine D2 
receptors and a significant increase o f benzodiazepine receptor number within the striatum were 
observed in HD+/‘ mice, compared to wild-type controls (Table 4.6).
4.4 Neurotransmitter receptor profiles in the cortex of 18 month 
old wild-type and HD+/‘ mice
As in the striatal study (section 4.3), all values for neurotransmitter receptor density in the cortex 
were obtained from image analysis carried out as described in section 2.5.5. All measurements 
were taken from the same brain sections used for the striatal binding studies, since they included 
motor and somatosensory cortical regions (section 2.5.3). The numbers o f animals included in the 
final analysis are indicated in Table 4.7.
Table 4.7 The number of mice on three different genetic backgrounds used for cortical analysis of 
each receptor type
Genetic Genotype Cortex
background
Op Ben Di d2
FVB/N WT 6 6 6 N/A
HD+/ 5 5 5 N/A
C57BL/6 WT 9 9 7 N/A
HD+/‘ 10 10 6 N/A
DBA/2 WT 3 2 4 N/A
HD+/' 6 2 5 N/A
Total WT 18 17 17 N/A
HD+/‘ 21 17 16 N/A
Op = Opioid, Ben = Benzodiazepine, Di = Dopamine Di, D2 = Dopamine D2 neurotransmitter receptors.
N/A= not analysed
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The results indicated that opioid receptor binding was lower in the cortex than the striatum (Figure 
4.4A). Cortical opioid receptor density in wild-type mice was 78 + 16 fmol/mg tissue and in HD+/' 
mice was 86 + 17 fmol/mg tissue. No significant difference in opioid receptor density was detected 
between wild-type and HD+/' mice, consistent with the findings in the striatum (two-tailed, 
Student’s f-test, p = 0.1, Table 4.8) (Figure 4.6A).
Benzodiazepine binding sites were observed at high levels within the cortex (Figure 4.4B) and a 
mean neurotransmitter receptor density value o f 225 + 44 fmol/mg tissue was found in wild-type 
mice. HD+/' mice displayed even higher neurotransmitter receptor density o f 266 + 30 fmol/mg 
tissue. Statistical analysis o f the data revealed significantly more benzodiazepine binding sites 
within the cortex o f HD+/' mice, compared to wild-type controls (two-tailed, Student’s f-test, p =
0.003) (Figure 4.6B). These results are consistent with the increased levels o f benzodiazepine 
binding within the striatum of HD+/' mice, when compared to wild-type controls.
Dopamine Di receptor density was detected at low levels within the cortex (Figure 4.4C). The 
neurotransmitter receptor density in wild-type mice was 12.4 + 3.5 fmol/mg tissue and in HD+/" 
mice was 14 + 4 fmol/mg tissue. No statistically significant difference in dopamine D x receptor 
density in the cortex o f wild type and HD+/" mice was detected, consistent with the observations in 
the striatum (two-tailed, Student’s Mest, p=0.2) (Figure 4.6C).
Receptor binding demonstrated very low levels o f dopamine D 2 binding sites within the cortex 
(Figure 4.4D). In addition, the level of non-specific binding obtained with [3H]-YM09151-2 was 90 
%, the highest non-specific binding obtained in this study. These factors contributed to a negligible 
detection o f cortical dopamine D2 receptor binding and therefore no data analysis was carried out. 
Although both dopamine Di and D2 receptors are expressed on cortical neurons, the low levels of 
binding were not unexpected as previous reports have suggested that dopamine receptors have a 
lower expression in the cortex, especially in the motor and parietal cortex (Gaspar et al., 1995), 
which represent the regions examined in this study. The slightly higher level o f dopamine Di 
receptor density compared to dopamine D2 receptors obtained in this study is also consistent with 
previously published data (Camps et al., 1990).
These studies have demonstrated alterations in the neurotransmitter receptor profiles within the 
cortex of HD+/' mice compared to their wild-type controls. Whilst dopamine Di and opioid receptor 
binding were unaffected, benzodiazepine receptor binding within the cortex o f HD+/* mice was 
significantly increased, when compared to wild-type controls (Table 4.8).
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Figure 4.6 Cortical neurotransmitter receptor densities
Bar graphs comparing cortical neurotransmitter receptor densities in wild-type and HD+/- mice.
A. Opioid neurotransmitter receptor densities expressed as a mean + S.D. (fmol/mg tissue). 
No significant difference between cortical opioid receptor densities were detected  
when comparing wild-type and HD+/" mice using the unpaired, two-tailed, Student’s t-test, 
(P=0.1).
B. Benzodiazepine neurotransmitter receptor densities expressed as a mean + S.D. (fmol/mg tissue). 
A significant increase in cortical benzodiazepine receptor density in HD+/' mice was detected 
when compared to wild-type mice using the unpaired, two-tailed, Student’s r-test, (*p= 0.003).
C. Dopamine Dj neurotransmitter receptor densities expressed as a mean + S.D. (fmol/mg tissue). 
No significant difference between cortical dopamine D i receptor densities were detected 
when comparing wild-type and HD+/" mice using the unpaired, two-tailed, Student’s /-test, (p= 0.2).
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Table 4.8 The number of animals utilised and the neurotransmitter receptor density for each study 
investigating the receptor profiles within the cortex of 18 month old HD+/' and wild-type mice
Receptor type Genotype Number 
of mice
Mean
neurotransmitter 
receptor density 
+ S.D. (fmol/mg tissue)
*p value
Opioid WT 18 78 + 16 0.1
HD+/‘ 21 86 ± 1 7
Benzodiazepine WT 17 225 + 44 0.003
HD+/' 17 266 + 30
Dopamine Di WT 17 12.4 + 3.5 0.2
HD+/" 16 14 + 4
* Values in bold represent statistical significance (p<0.05) obtained using the two tailed, Student’s /-test.
4.5 Investigating the influence of genetic background on 
neurotransmitter receptor profiles in mouse striatum and 
cortex
To explore the possible presence of genetic modifiers of the HD disease process the effect o f three 
different genetic backgrounds on neurotransmitter receptor profiles was investigated. The previous 
experiments investigating neurotransmitter receptor density (sections 4.3 and 4.4) were carried out 
using cohorts of wild-type and HD+/’ mice containing animals on the FVB/N, C57BL/6 and DBA/2 
inbred genetic backgrounds (Table 4.5 and 4.7). To determine whether genetic background has any 
influence on the neurotransmitter receptor densities obtained, the striatal and cortical 
neurotransmitter receptor densities were re-analysed following the subdivision of cohorts according 
to genetic background. As fewer animals were present in these cohorts statistical analysis using 
Student’s /-test was not possible. A  two-way ANOVA was subsequently carried out to detect 
possible trends in the data suggesting an influence of genetic background or the HD mutation on 
neurotransmitter receptor densities in these cohorts. The mean neurotransmitter receptor densities 
detected in HD+/' and wild-type animals on the three different genetic backgrounds are presented in 
Tables 4.9- 4.12.
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Table 4.9 Opioid neurotransmitter receptor densities in 18 month old wild-type and HD+/' mice on 
different genetic backgrounds______________________________________________________________
Genetic
Background
Genotype Number of mice Striatum 
Mean receptor 
density ±  S.D. 
(fmol/mg tissue)
Cortex 
Mean receptor 
density + S.D. 
(fmol/mg tissue)
FVB/N WT 6 140 + 16 87 + 11
HD+/' 5 167 + 34 95 ± 8
C57BL/6 WT 9 113 + 25 70 + 15
HD+/' 9 124 + 29 80 ±21
DBA/2 WT 3 125 + 18 85 + 19
HD+/’ 6 149 ± 2 2 88 ±  8
Table 4.10 Benzodiazepine neurotransmitter receptor densities in 18 month old wild-type and HD+/' 
mice on different genetic backgrounds______________________________________________________
Genetic
Background
Genotype Number of mice Striatum 
Mean receptor 
density ±  S.D. 
(fmol/mg tissue)
Cortex 
Mean receptor 
density ±  S.D. 
(fmol/mg tissue)
FVB/N WT 6 85 + 15 225 + 26
HD+/' 5 98 ± 9 258 ±  31
C57BL76 WT 9 88 + 11 218 + 54
HD+/" 10 98 ±11 262 ± 1 8
DBA/2 WT 2 89 + 13 258 + 37
HD+/’ 2 107 + 12 254 + 29
Table 4.11 Dopamine Dt neurotransmitter receptor densities in 18 month old wild-type and HD+/‘ 
mice on different genetic backgrounds
Genetic
Background
Genotype Number of mice Striatum 
Mean receptor 
density ±  S.D. 
(fmol/mg tissue)
Cortex 
Mean receptor 
density ±  S.D. 
(fmol/mg tissue)
FVB/N WT 6 196 + 24 12 + 3
HD+/' 5 171 ± 2 2 11 ± 5
C57BL/6 WT 7 181 +25 1 1 + 3
HD+/" 6 212 ±  7 17 ±  3
DBA/2 WT 4 200 + 14 16+1
HD+/’ 5 184 + 27 14 + 2
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Table 4.12 Dopamine D2 neurotransmitter receptor densities in 18 month old wild-type and HD+/ 
mice on different genetic backgrounds
Genetic
Background
Genotype Number of mice Striatum 
Mean receptor 
density + S.D. 
(fmol/mg tissue)
Cortex 
Mean receptor 
density + S.D. 
(fmol/mg tissue)
FVB/N WT 5 139 + 16 N/A
HD+/" 4 117 + 15 N/A
C57BLV6 WT 9 125 + 16 N/A
HD+/' 6 113 ±  15 N/A
DBA/2 WT 3 112 + 18 N/A
HD+/" 5 100 ± 9 N/A
This study was designed to ask three important questions:
1. In a cohort o f HD+/' and WT mice on the same genetic background, does the presence of 
the HD mutation influence neurotransmitter receptor densities?
2 . Does genetic background influence the neurotransmitter receptor densities o f cohorts 
containing either HD+/' or WT mice?
3. Does genetic background influence the effect that the HD mutation has on neurotransmitter 
receptor densities, i.e. is there an interaction between genetic background and the 
consequences of the mutation?
4.5.1 Investigating the  influence of the  HD m utation on neuro transm itter 
receptor densities in anim als with the sam e genetic background
To investigate whether the influence of the HD mutation on neurotransmitter receptor densities can 
still be detected following subdivision of the previously used cohorts (sections 4.3 and 4.4) 
according to genetic background, a comparison of neurotransmitter receptor densities in WT and 
HD+/' mice on the same genetic background was carried out (Table 4.13).
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Table 4.13 Comparing neurotransmitter receptor densities in wild-type and HD+/' mice divided into 
cohorts of the same genetic background. Values represent the p values obtained after the two-way 
ANOVA was used to compare the wild-type and HD+/' neurotransmitter receptor density data_______
Striatum Cortex
Op Ben Di d2 Op Ben Di d 2
Two-way ANOVA
(effect of mutation)
0.03 0.01 0.7 0.01 0.2 0.02 0.4 N/A
Values in bold represent statistical significance (p<0.05) obtained using the two-way ANOVA. Op = Opioid, 
Ben = Benzodiazepine, Di = Dopamine Di, D2 = Dopamine D2 neurotransmitter receptors.
When opioid neurotransmitter receptor density in HD+/' and wild-type mice were analysed 
previously (section 4.3 and 4.4), pooling data from animals on different genetic backgrounds, no 
significant differences in opioid receptor densities between HD+/' and wild-type mice were detected 
(Tables 4.6 and 4.8). This was mirrored by the two-way ANOVA suggesting no significant 
influence o f the HD mutation on cortical opioid receptor density. The previous comparison did, 
however, produce a near significant result (p = 0.07) supporting a trend towards an increase in 
striatal opioid receptor density in HD+/" mice compared to wild-type. The two-way ANOVA  
analysis supported this by suggesting an effect of the HD mutation on opioid receptor densities 
within the striatum (Table 4.13).
In previous studies (sections 4.3 and 4.4), a significant increase in benzodiazepine receptor 
densities was detected in the striatum and cortex of HD+/" mice compared to wild-type (Tables 4.6 
and 4.8). The two-way ANOVA, analysing the effect o f the HD mutation when the cohort is 
divided according to genetic background, suggested that the HD mutation does have an influence 
on benzodiazepine neurotransmitter receptor densities in the striatum and cortex (Table 4.13).
The two-way ANOVA suggests that the HD mutation does not significantly influence the densities 
of dopamine Di neurotransmitter receptors in the striatum or cortex. In agreement, dopamine Di 
neurotransmitter receptors displayed no significant differences when analysed previously (sections 
4.3 and 4.4) where data from mice with different genetic backgrounds was pooled (Tables 4.6 and 
4.8).
Previous studies (section 4.3 and 4.4) had detected a significant reduction of dopamine D2 receptors 
in the striatum of HD+/' mice compare to wild-type (Table 4.6). The two-way ANOVA analysis 
suggested a significant influence o f the HD mutation on the densities of striatal dopamine D2 
neurotransmitter receptors (Table 4.13).
Dividing the cohorts according to genetic background and statistical analysis by the two-way 
ANOVA determined whether the influence o f the HD mutation on neurotransmitter receptor
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densities, shown in previous experiments, could still be illustrated when comparing cohorts of 
wild-type and HD+/" mice when distinguishing between different genetic backgrounds.
4.5.2 In v e s tig a tin g  th e  in f lu e n c e  of g e n e t ic  b a c k g ro u n d  on  
neurotransm itter receptor densities in 18 m onth old HD+/' or wild-type 
mice
To investigate whether genetic background influences neurotransmitter receptor densities in 
animals o f the same genotype comparisons o f neurotransmitter receptor densities in wild-type or 
HD+/' mice on different genetic backgrounds were carried out by the two-way ANOVA (Table
4.14).
Table 4.14 The results of the two-way ANOVA comparing wild-type or HD+/' mice on different 
genetic backgrounds
Striatum Cortex
Op Ben o, D2 Op Ben Di d2
Two-way ANOVA
(effect of genetic background)
0.004 0.7 0.3 0.02 0.2 0.2 0.04 N/A
Values in bold represent statistical significance (p<0.05) obtained using the two-way ANOVA. Op = Opioid, 
Ben = Benzodiazepine, Di = Dopamine Di, D2 = Dopamine D2 neurotransmitter receptors.
Data for all mice included in the study o f opioid neurotransmitter receptor density is shown in 
Figure 4.7. This illustration of the data, as well as supporting the suggestion that there is a subtle 
increase in opioid receptors in HD+/' mice compared to wild-type (section 4.5.1), demonstrates that 
this subtle increase may not occur to the same extent in animals on all genetic backgrounds. HD+/' 
mice on the FVB/N genetic background appear to exhibit a marked increase in striatal receptor 
density compared to all other cohorts (Figure 4.7A). The two-way ANOVA also suggests that 
genetic background does significantly influence opioid receptor density in the striatum. This 
suggestion is not repeated for the opioid receptor densities in the cortex and is supported by the raw 
data presented in Figure 4.7B.
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Figure 4.7 Opioid receptor density in the striatum and cortex
Scattergraphs illustrating the neurotransmitter receptor densities in individual mice grouped 
according to genotype and genetic background.
A. A scattergraph where each point represents the mean opioid receptor density in the 
striatum of an individual mouse.
B. A scattergraph where each point represents the mean opioid receptor density in the 
cortex of an individual mouse.
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The two-way ANOVA suggests that genetic background did not influence the striatal or cortical 
density o f benzodiazepine receptors (Table 4.14). These findings are supported as no obvious 
variation between mice of the same genotype on different genetic backgrounds can be seen when 
the data are presented in scattergraphs (Figure 4.8A and B). As the HD mutation has been 
previously shown to significantly effect benzodiazepine receptor binding in the striatum and cortex 
(sections 4.3, 4.4 and 4.5.1), the data are consistent with the notion that it is the HD mutation, not 
genetic background, that is responsible for the increase in benzodiazepine neurotransmitter receptor 
densities in HD+/' mice compared to wild-type controls.
The two-way ANOVA suggested that genetic background was influencing dopamine Di receptor 
densities within the cortex but not in the striatum. The scattergraph does show fluctuations between 
animals o f different genetic backgrounds in the striatum, however, this may be due to variance 
within the cohorts (Figure 4.9A). In addition, as the receptor densities observed for dopamine Di 
receptors within the cortex were extremely low and below the linear range o f the radioactive 
standards, the significance o f the results must be interpreted with caution. These findings suggest 
some influence o f genetic background on the consequences o f the HD mutation, however, this 
influence would need further investigation to establish its exact nature.
The two-way ANOVA suggested an influence o f genetic background on dopamine D2 receptor 
densities and Figure 4.9B illustrates variations between animals o f the same genotype on different 
genetic backgrounds. However, the same general variations are seen between wild-type and HD+/' 
mice on each genetic background. The previous studies (sections 4.3, 4.4 and 4.5.1) detected a 
significant decrease in dopamine D2 receptors in HD+/' mice compared to wild-type controls. 
However, the data discussed in this paragraph could mean that the extent o f this HD mutation 
influence may be modified by genetic background.
In summary, these analyses have illustrated that genetic background alone can influence 
neurotransmitter receptor densities in wild-type and HD+/" mice. It was also demonstrated that the 
effect of genetic background could vary depending on the particular combination o f genetic  
background and receptor type under investigation.
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F ig u re  4 .8  B enzod iazep ine receptor density in the striatum and cortex
Scattergraphs illustrating the neurotransmitter receptor densities in individual mice grouped 
according to genotype and genetic background.
A. A scattergraph where each point represents the mean benzodiazepine receptor density in 
the striatum of an individual mouse.
B. A scattergraph where each point represents the mean benzodiazepine receptor density in 
the cortex of an individual mouse.
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Scattergraphs illustrating the neurotransmitter receptor densities in individual mice grouped 
according to genotype and genetic background.
A. A scattergraph where each point represents the mean dopamine Dj receptor density in the 
striatum of an individual mouse.
B. A scattergraph where each point represents the mean dopamine D2 receptor density in the 
striatum of an individual mouse.
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4.5.3 In v e s tig a tin g  w h e th e r  g e n e tic  b a c k g ro u n d  in f lu e n c e s  th e  
consequences of the HD m utation
To investigate whether genetic background influences the effect that the HD mutation has on 
neurotransmitter receptor densities, two-way ANOVA was carried out (Table 4.15). This analysis 
determines whether there is any interaction between the genetic background o f the animal and the 
consequences of the HD mutation.
Table 4.15 The presence of any interaction between genetic background and the consequences of 
the HD mutation for the previously investigated neurotransmitter receptors
Striatum Cortex
Op Ben Di D2 Op Ben Di d2
Two-way ANOVA
(interaction?)
No No Yes No No No Yes N/A
Op = Opioid, Ben = Benzodiazepine, Di = Dopamine D1? D2 = Dopamine D2 neurotransmitter receptors.
The analysis suggests there is no interaction between genetic background and the consequences of 
the HD mutation when considering opioid, benzodiazepine and dopamine D2 neurotransmitter 
receptor densities in cortex and striatum. This enables the two influencing factors on 
neurotransmitter receptor densities, genetic background and HD mutation, to be analysed 
separately. However, an interaction was suggested when investigating the influence of genetic 
background and the HD mutation on the neurotransmitter receptor densities o f dopamine Di 
receptors. This means that analysing these factors individually may lead to misleading conclusions 
about the influence of each factor on receptor densities.
In summary, it has been demonstrated that genetic background can influence neurotransmitter 
receptor profiles in wild-type and HD+/‘ mice. This effect varies depending on the receptor type 
analysed. For example, it appears that benzodiazepine receptor binding is not affected by the 
genetic backgrounds included in this study and the alterations between wild-type and HD+/' mice 
are due to the HD mutation. However, it has also been established that mice bred onto different 
genetic backgrounds can exhibit differences in receptor densities between mice o f the same 
genotype (e.g. opioid receptors).
These findings have implications when interpreting data obtained from mice on mixed genetic 
backgrounds and comparing mice on different genetic backgrounds. Future experimental design 
should incorporate these findings by utilising cohorts o f animals with the same genetic 
backgrounds. These studies also demonstrate the possible presence of genetic modifiers o f the HD
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disease process. Identification o f the molecular nature o f these modifiers may provide potential 
candidates for new targets in therapeutic intervention.
4.6 Investigating the influence of mouse age on neurotransmitter 
receptor profiles
As alterations in neurotransmitter receptor densities were demonstrated in old (18 month) HD+/' 
mice, when compared to wild-type a pilot study was instigated to investigate the progressive nature 
and onset of the receptor changes. In order to determine the effect o f age on neurotransmitter 
receptor density, cohorts o f wild-type and HD+/‘ mice o f three different ages were examined. The 
time points investigated were 4 months, 10 months and 18 months o f age. All cohorts were made up 
of male mice on the C57BL/6 genetic background. Neurotransmitter receptor density was obtained 
by measurements collected as previously described in section 2.5.3 and the results analysed by the 
two-way ANOVA. The mean receptor densities detected for each neurotransmitter receptor in 
animals o f three different ages are presented in Tables 4 .1 6 -4 .1 9 .
Table 4.16 Opioid neurotransmitter receptor densities in wild-type and HD+/~ mice of different ages
Age Genotype Number of mice Striatum 
Mean receptor 
density ±  S.D. 
(fmol/mg tissue)
Cortex (months) 
Mean receptor 
density + S.D. 
(fmol/mg tissue)
4 WT 5 131 +26 8 7 + 1 7
HD+/‘ 5 143 + 10 91 ± 1 0
10 WT 5 142 + 16 89 + 8
HD+/' 5 150 ± 3 0 96 ± 1 4
18 WT 4 117 + 8 74 + 3
HD+/‘ 4 138 + 36 84 ± 1 7
Table 4.17 Benzodiazepine neurotransmitter receptor densities in wild-type and HD+/' mice of 
different ages
Age
(months)
Genotype Number of mice Striatum 
Mean receptor 
density ±  S.D. 
(fmol/mg tissue)
Cortex 
Mean receptor 
density ± S.D. 
(fmol/mg tissue)
4 WT 5 9 0 + 1 9 251 + 52
HD+/' 5 90 ±  9 244 ±  16
10 WT 5 9 3 + 1 3 253 + 28
HD+/" 4 95 ± 9 232 ±  20
18 WT 4 98 + 5 249+  15
HD+/" 4 95 ± 6 222 ±  35
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Table 4.18 Dopamine Di neurotransmitter receptor densities in wild-type and HD+/‘ mice of different 
ages
Age
(months)
Genotype Number of mice Striatum 
Mean receptor 
density ±  S.D. 
(fmol/mg tissue)
Cortex 
Mean receptor 
density ±  S.D. 
(fmol/mg tissue)
4 WT 5 203 + 22 9 + 4
HD+/’ 4 240 + 16 17 ±  1
10 WT 5 224 + 21 18 + 3
HD+/' 5 222 + 17 15 ±  2
18 WT 4 222 + 6 16 + 2
HD+/‘ 4 231 ±11 1 7 ± 3
Table 4.19 Dopamine D2 neurotransmitter receptor densities in wild-type and HD>+/' mice of different
ages
Age Genotype Number of mice Striatum Cortex
(months) Mean receptor Mean receptor
density + S.D. density ± S.D.
(fmol/mg tissue) (fmol/mg tissue)
4 WT 5 129 + 11 N/A
HD+/‘ 3 128 ± 2 0 N/A
10 WT 4 117 + 5 N/A
HD+/" 5 136 ±21 N/A
18 WT 4 107 + 18 N/A
HD+/" 4 113 ±  11 N/A
The initial comparisons in this pilot study of neurotransmitter receptor densities in the striatum and
cortex o f animals at different ages were carried out by Student’s /-tests comparing HD+/' and wild-
type animals in the same age groups (Table 4.20). The absence of any receptor alterations at 18
months of age disagreed with the previously reported receptor changes (sections 4.3, 4.4 and 4.5)
and illustrated that smaller cohorts fail to demonstrate the subtle receptor density alterations
previously detected in these HD mice.
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Table 4.20 The results of the Student’s f-tests comparing wild-type or HD+/'mice of the same age
Striatum Cortex
Op Ben Di d2 Op Ben Di d2
WT4 vs HD+/- 4 0.30 0.85 0.03 0.69 0.65 0.81 0.02 N/A
WT10vs HD+/- 10 0.61 0.70 0.92 0.12 0.69 0.31 0.6 N/A
WT18v sHD+/- 18 0.66 0.66 0.20 0.52 0.28 0.20 0.49 N/A
Values in bold represent statistical significance (p<0.05) obtained using the two tailed, Student’s t-test. Op = Opioid, Ben 
= Benzodiazepine, Dj = Dopamine Di, D2 = Dopamine D2 neurotransmitter receptors. 4,10,18 = age in months.
The only significant differences detected were increases in dopamine Di receptor density in the 
striatum (p = 0.03) and cortex (p = 0.02) o f HD+/‘ mice compared to their wild-type controls at 4 
months o f age. These were the only significant differences observed at any o f the time points 
examined (Table 4.20).
In an attempt to investigate any trends in this data a two-way ANOVA was carried out (Table 
4.21). The results of the two-way ANOVA tests are consistent with those in Table 4.20, in as much 
as the striatal dopamine Di neurotransmitter receptor density is the only effect of the HD mutation. 
An effect o f age was suggested to produce the significant changes in dopamine Di receptors within 
the cortex. The interpretation o f this data is complicated by the previously detected interaction 
between the consequences of the HD mutation and genetic background when analysing dopamine 
Di receptor density.
Table 4.21 The significance of the effect of the HD mutation and age on neurotransmitter receptor 
densities. Whether there is an interaction between the two factors influencing neurotransmitter 
receptor densities.
Striatum Cortex
Op Ben Di d2 Op Ben Di d2
Two-way ANOVA
(effect of mutation)
0.15 0.97 0.04 0.3 0.15 0.15 0.09 N/A
Two-way ANOVA
(effect of age)
0.29 0.58 0.84 0.08 0.08 0.72 0.02 N/A
Two-way ANOVA
(interaction?)
No No No No No No Yes N/A
Values in bold represent statistical significance (p<0.05) obtained using the two-way ANOVA. Op = Opioid, 
Ben = Benzodiazepine, Di = Dopamine Di, D2 = Dopamine D2 neurotransmitter receptors.
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These results suggest no alterations in neurotransmitter receptor densities in 18 month old HD+/' 
mice compared to wild-type controls. This does not support the findings in sections 4.3, 4.4 and 
4.5, using larger cohorts o f animals. This pilot study suggests that the changes in neurotransmitter 
receptor densities in these HD+/' mice at 18 months of age are subtle and larger cohorts are needed 
to detect significant changes. The findings also suggest that any progressive changes in HD+/' or 
wild-type mice may be masked or confounded by small numbers o f animals in each cohort. The 
subtlety o f changes observed in this study are emphasised by reports that similar sized cohorts 
(n=6-12) o f other HD mouse models provided highly significant results when used in 
autoradiographic binding studies (Cha et al., 1998).
4.7 Summary of Results
This study has demonstrated that there are alterations in the neurotransmitter receptor profiles 
within the brains of 18 month old mice carrying the HD mutation. Within the striatum a significant 
increase in the density o f benzodiazepine neurotransmitter receptors has been shown in HD+/' mice. 
This alteration was also observed in the cerebral cortex demonstrating that the effects of the HD 
mutation are not restricted to the striatum. Further investigation would be required to determine if 
these alterations occur at the same time point in the animals life and occur in the same progressive 
manner. In keeping with previous studies in human HD subjects and HD mice (Andrews et al., 
1999; Cha et a l ,  1998; Kunig et al., 2000; Lawrence et al., 1998b; Tuijanski et al., 1995; Weeks et 
al., 1996) a significant reduction in dopamine D2 receptor density within the striatum was also 
detected in the mutant mice. The lack of neurodegeneration observed within the brains o f the HD+/" 
mice (section 1.5.3.2) suggests that the neurotransmitter receptor changes may not be the result of 
depleted neuronal populations but may represent cellular alterations involved in early HD 
pathogenesis. By investigating the effect of mutation and genetic background on these results it 
was demonstrated that genetic background could, to varying extents, influence the receptor 
densities reported. This effect was most obvious when investigating opioid and dopamine Di 
receptor types. In contrast genetic background was found to have no effect on the result when 
examining benzodiazepine receptor binding and the alterations observed were due to the HD 
mutation. These findings illustrate the care needed when designing experiments and interpreting 
data obtained from mice on mixed or different genetic backgrounds. An attempt was also made to 
establish the temporal nature o f receptor density alterations. By examining mice of different ages it 
was anticipated that the onset and association with phenotypic changes could be assessed. 
However, the pilot study demonstrated that the subtle changes in receptor densities occurring in 
this HD mouse model cannot be assessed using cohorts that contain a small number o f animals. 
Therefore, in order to further explore the temporal nature o f any receptor density alterations, it is 
likely that cohorts consisting o f > 15 mice on the same genetic background would probably be 
required.
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5 Characterisation of somatic repeat instability in a 
knock-in mouse model of Huntington’s disease
5.1 Aims of the study
The mutation responsible for Huntington’s disease is the expansion o f the trinucleotide (CAG) 
repeat within exon 1 of the HD  gene ((HDCRG), 1993). The number of repeats present is inversely 
correlated to age at onset and the degree of neuropathology at death (Andrew et a l ,  1993; Duyao et 
a l., 1993; Ranen et a l ,  1995; Telenius et al., 1993; Trottier et al., 1994). Cell-selective  
vulnerability has been observed in HD with the medium spiny neurons within the striatum initially 
affected by the disease process (Vonsattel et al., 1985). The ubiquitous expression pattern o f the 
HD  gene does not correlate with the tissue-selective pattern o f HD neuropathology. We 
hypothesise that somatic repeat instability could play a role in the selective vulnerability observed 
in HD. Specific cell-types may be more prone to changes in repeat length producing a population 
of cells, expressing longer CAG repeats, that would be more vulnerable to the disease process. The 
aim of this study was to explore the existence o f somatic repeat instability in the HD mouse model 
and, if found, to characterise the pattern and extent o f repeat instability present. This study utilised 
the sensitive technique o f small pool PCR, which allows the determination of the CAG repeat copy 
number on individual mutant alleles and therefore reveals the distribution o f repeat sizes within a 
tissue.
The study was designed to address the following questions:
• Is somatic repeat instability present in HD+/" mice? This question was investigated by small 
pool PCR analysis to determine the length o f the CAG repeat present in the mouse H dh  
gene in DNA obtained from 16 different tissues. 24 month old HD+/* mice were used as 
previous investigations have indicated late-onset and progressive consequences of the HD 
mutation in these animals (Shelboume et a l ,  1999; Usdin et al., 1999), L.K., unpublished 
data, chapters 3 and 4).
• Does the striatum display significantly greater repeat instability compared to other tissues 
and brain regions? Quantification o f repeat size distributions within selected tissues by 
single molecule small pool PCR analysis was used to determine if the striatum, the brain 
region predominantly affected by HD pathology, exhibits the greatest repeat instability. 
This investigation was carried out on several 24 month old animals to determine the 
reproducibility of the results.
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• Is somatic repeat instability apparent from birth or does it display a late onset? Does 
somatic repeat instability occur in a progressive manner and what is the nature of the 
progression? Does somatic repeat instability maintain the same pattern o f tissue-specificity 
at all ages where repeat instability is observed? HD is a late onset and progressive disorder, 
and molecular events such as repeat instability, if involved in or acting as a surrogate 
marker o f the disease process, would be expected to occur in a similar manner. 
Investigating the nature and timing o f the molecular consequences of the HD mutation and 
its association with phenotypic alterations in HD+/' mice will provide insights into the 
possible molecular mechanisms underlying these phenotypic changes. If repeat instability 
is a molecular marker of the disease process, the knowledge o f its onset and progression 
may have implications for the timing and duration of any HD treatment strategies. These 
questions were addressed by investigating repeat instability within several brain regions of 
HD+/' mice at 5 different time points throughout life.
• Does somatic repeat instability occur in human HD patients? It is essential to establish if 
molecular changes observed in HD+/' mice are present in human HD patients to assess the 
relevance of the findings. Investigating somatic repeat instability in human tissue may 
uncover an early molecular mechanism underlying pathogenesis in human HD. To answer 
this question small pool PCR analysis was carried out on several brain regions from a 
human juvenile HD patient.
• Does experimental technique influence the extent o f somatic repeat instability detected? 
This study aims to evaluate the relative sensitivity of techniques used to detect somatic 
repeat instability. To address this issue, identical samples were analysed using both small 
pool PCR and Genescan technology.
By investigating somatic repeat instability, early molecular events contributing to HD pathogenesis 
may be uncovered and present possible targets for future therapeutic intervention. Somatic repeat 
instability may also be a molecular marker o f the disease process and, as such, may provide one 
approach to assess the efficacy of future therapies.
5.2 Investigating somatic repeat instability in 24 month old HD+/' 
mice
Small pool PCR (section 2.4) was utilised to investigate the presence of somatic repeat instability 
in HD+/' mice. This technique amplifies relatively small amounts of template DNA (1.2 ng - 3 pg) 
and visualises the PCR products by Southern blotting. Reduced competition during amplification 
and the sensitive visualisation technique enables PCR products from individual alleles to be
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detected. Small pool PCR can therefore establish if alleles within the same tissue carry different 
sized repeats.
Initially, multiple (5-6) PCR amplifications with serial dilutions (1.2 ng - 3 pg o f template DNA  
per reaction) of template DNA were carried out (Figure 5.1). The PCR products obtained from 
amplifications using the highest DNA concentrations (e.g. >300 pg) allowed the general spectrum 
o f repeat sizes within a tissue to be demonstrated. Lower DNA concentrations (e.g. <12 pg) 
revealed PCR products representing the CAG repeat lengths within the Hdh gene from individual 
cells. Several different dilutions o f template DNA were used as analysis o f small numbers of 
genomes alone can produce misleading patterns of repeat instability due to random sampling 
variation.
Small pool PCR amplifications using 5 different dilutions (1.2 ng - 12 pg) o f template DNA  
allowed semi-quantitative analysis to be carried out on between 1000-3000 mutant alleles from 16 
different tissues (Table 5.1) obtained from 24 month old HD+/' mice (Table 2.1). The HD+/‘ mice 
originated from a line carrying a mutant Hdh allele with 72 CAG repeats (Shelboume et al., 1999). 
The 16 tissues analysed included major somatic organs, sperm and several regions o f the central 
nervous system, as HD is a neurological disorder. Analysis was carried out for all 16 tissues in two 
24 month old HD+/' mice and selected tissues from a further four 24 month old HD+A mice.
It was apparent from the small pool PCR autoradiograms that somatic repeat instability occurred in 
the tissues of old HD+/' mice (Figure 5.2).
The maximum repeat length observed for each tissue and the percentage o f alleles that appeared to 
exhibit a repeat size change distinguishable from the prominent band representing the mutant 
progenitor allele repeat length were determined. The maximum repeat length observed, although 
dependent on the number of mutant alleles examined, does give a general indication o f the potential 
for repeat length changes in each tissue.
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F ig u r e  5 .1  Serial dilutions of striatal D N A  from a 2 4  month old H D +/L mouse analysed 
by small pool PCR (SP-PCR)
A rep re se n ta t iv e  au to ra d io g ra m  o f  f ive  S P -P C R  a m p l i f ic a t io n  r e p l ic a te s  fo r  each  D N A  
concentra tion  plus five lanes represen ting  the negative  control reactions contain ing  no D N A  
template. M denotes the lane contain ing  the 1 kb plus size m arker used to establish the size 
of  the PCR products. The numbers listed on the right of the panel correspond to the values present 
in the 1 kb plus size marker and the numbers on the left indicate the estimated number of  CA G 
repeats.  The  D N A  concen tra t ion  ind ica ted  under the panel rep resen ts  the am ount added  as 
template to each PCR am plif ication . The band in each lane found at ~300 bp rep resen ts  the 
wild-type allele carrying 7 CAG repeats. The PCR products found at -5 0 0  bp and above represent the 
Hdh  m u tan t  a l le le .  T he  v a ry in g  s ized  P C R  p ro d u c ts  rep re se n t  in d iv id u a l  m u tan t  a l le le s  
demonstrating somatic repeat instability.
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Figure 5.2 Somatic repeat instability of the CAG repeat mutation in 24 month old HD+/' mice
A  com parison o f  the CAG repeat m utation instability in 16 different tissues from 24 m onth  old 
H D+/- m ice.  Each pane l  show s  4 lanes  o f  S P -P C R  p ro d u c ts  de r ived  f rom  a p p ro x im a te ly  
10 ce l ls  w orth  ( - 6 0  pg) o f  D N A  o b ta in ed  from  the  t is su es  sp e c if ie d  ab o v e  each  pane l .  
T h e  t issues  are o rdered  ac ross  the page  from  the top left to the bo ttom  right to rep resen t 
the order of variability and magnitude of  repeat instability observed in these reactions and confirmed 
in o thers  (data not show n). The num bers  on the far left o f  the panels  ind icate  the es t im ated  
number of CAG repeats carried by the PCR products.
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Table 5.1 Semi-quantitative analysis of 1000-3000 mutant alleles for 16 different tissues in 24 
month old HD+/' mice
% of alleles 
unstable
largest alleles 
detected
Striatum >80% 398
Cortex, Hippocampus, Cerebellum, Hindbrain 
Spinal cord, Eye, Olfactory bulbs, Kidney
30-80% 124-192
Liver, Colon, Spleen, Heart, Skeletal muscle 
Sperm, Lung
2-30% 85-112
of alleles unstable’ is the percentage of total alleles analysed, which produced bands, not contained within 
the prominent mutant allele band. In semi-quantitative analysis, to discriminate unstable alleles from the 
progenitor allele band, it is estimated that the repeat size change must be > ± 2 repeats from the progenitor 
allele repeat length.
‘Largest alleles detected’ is the range of alleles that encompasses the individual maximum repeat lengths for 
every tissue within the category.
When ordered with respect to the variability and magnitude of repeat instability, the highest ranked 
tissues were predominantly regions o f the central nervous system. The region that consistently 
displayed the highest repeat instability was the striatum, the region selectively involved in HD 
pathology (Figure 5.2). The striatum contained a high percentage (>80 %) of cells that no longer 
contained the progenitor allele repeat size (Table 5.1). This brain region also displayed cells 
containing the longest repeat lengths when compared to other tissues. It was estimated that ~5 % of 
striatal cells in 24 month old HD+/_ mice contained a repeat length double that o f the progenitor 
allele length and ~0.5 % of cells contained a repeat of >250 CAG repeats.
Two male and four female mice were included in these investigations and no significant difference 
in the pattern and extent o f somatic repeat instability was observed between the sexes.
Repeat instability of the mutant allele appeared to occur in an expansion-biased manner. Bands in a 
size range between the wild-type allele (7 CAG) and the prominent mutant band (~72 CAG) were 
rarely observed (Figure 5.1 and 5.2) suggesting that although contractions o f the mutant CAG 
repeat may occur, they do not occur as frequently as expansions.
An investigation into the stability o f the repeat on the wild-type allele was necessary to allow full 
evaluation o f the mutation repeat instability. The wild-type allele in heterozygous HD+/' mice 
consistently produced a discrete band and failed to display any obvious fluctuation in repeat size. 
The absence o f bands representing intermediate allele sizes between the wild-type and mutant
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allele suggested that if significant repeat instability o f the wild-type allele were occurring, the 
resulting PCR products would fall within the mutant allele repeat range (i.e. >500 bp). To 
investigate whether the wild-type allele was contributing to the mutation repeat instability profile, 
the occurrence o f bands within the mutant range in DNA from wild-type animals was investigated. 
Striatal DNA from two wild-type animals, matched for age and genetic background to the HD+/' 
mice investigated, was analysed and -1000  wild-type alleles amplified in serial dilutions. No bands 
other than those representing the wild-type (7 CAG) allele were detected, suggesting that no 
significant repeat instability occurs on the Hdh allele within wild-type mice (Figure 5.3). However, 
this investigation does not account for the possibility that the wild-type allele may display greater 
repeat instability in the presence of an HD mutant allele. However, it seems unlikely that repeat 
length changes, o f the magnitude required for the wild-type allele to contribute to the mutation 
profile, are generated from the short, interrupted repeat sequence found on the wild-type allele 
within these HD+/' mice.
In summary, repeat length variability of the mutant allele was observed in HD+/' mice and occurred 
in a tissue-specific, expansion-biased manner. The striatum, the brain region selectively vulnerable 
in early HD pathology, was the brain region in all HD+/' mice examined that displayed the greatest 
repeat instability.
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F igu re 5.3 The CAG  repeat length variability  in 24 m onth  old w ild-type mice
A r e p r e s e n t a t i v e  a u t o r a d i o g r a m  o f  6 l a n e s  o f  P C R  p r o d u c t s  o b t a i n e d  f ro m  
approxim ate ly  150 pg of  tem pla te  D N A  derived from the s tr ia tum o f  a w ild-type mouse. 
M denotes the lane containing the 1 kb plus size marker used to establish the number of CAG repeats 
carried by the PCR products. SP-PCR analysis of striatal DNA for two 24 month old wild-type mice 
demonstrated the absence of any significant repeat size variation when -1000  wild-type alleles were 
examined.
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5.3 Quantification of somatic repeat instability in 24 month old 
HD+/- mice
5.3.1 Quantitative small pool PCR
Analysis of single genomes by small pool PCR allows the quantification of the mutation spectrum 
present within different tissues (Jeffreys et al., 1994; Monckton et al., 1995). Obtaining the 
mutation spectrum for different tissues permits more detailed characterisation o f repeat instability 
and allows statistical comparison in order to further investigate tissue-specificity and inter-animal 
differences.
To quantify repeat instability the number o f amplifiable molecules present within a sample must be 
accurately determined. This calculation must be carried out empirically for each DNA sample 
investigated. Calculating the dilution needed to obtain one amplifiable molecule in each PCR 
allows the CAG repeat length within the mutant Hdh gene in individual cells to be determined.
To determine the concentration of amplifiable molecules within a sample, 8-10 small pool PCR 
amplifications of several low (estimated at <12 pg of template DNA per reaction) dilutions were 
carried out to obtain a dilution that provided several lanes that displayed a radioactive signal 
(positive lanes), and in addition, several which failed to produce a signal (blank lanes). The 
resultant autoradiograms were then used to accurately determine the exact number o f amplifiable 
templates in the known DNA dilution.
As the concentration of DNA template for each PCR amplification was obtained by dilution it is 
possible that amplifications producing one band could contain more than one template DNA  
molecule, as both may have the same repeat length giving rise to bands of equal size. Thus using 
lanes that display a radioactive signal (positive lanes) to calculate the number o f template 
molecules in each PCR may under-estimate the DNA concentration o f the dilution. However, there 
is no ambiguity concerning the concentration of amplifiable DNA molecules within reactions that 
produce blank lanes (lanes with no radioactive signal) as no products are observed.
p(0), the proportion of blank lanes was calculated for a known dilution,
p(0) = (total number of lanes - number of positive lanes) / total number of lanes
The Poisson distribution is then exploited to calculate the exact number of DNA templates in that 
dilution,
Number of amplifiable molecules per reaction = -In p(0)
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5.3.2 Quantification of se lected  tis su e s  from a 24 month old HD+/' m ouse
Small pool PCR analysis was carried out to determine the repeat copy number carried by individual 
mutant Hdh  alleles in striatal and cortical brain regions, as these regions are implicated in HD 
neuropathology. In addition, hippocampal and cerebellar brain regions, thought to be less involved 
in HD pathology, were investigated for comparison. The kidney, the non-CNS somatic tissue 
displaying the highest variability of repeat lengths, was also investigated for comparison with the 
brain regions.
Multiple amplifications were carried out using single molecule dilutions (section 5.3.1) and each 
resultant PCR product sized as described in section 2.4.6.5. To illustrate the distribution o f CAG 
repeat lengths on the mutant Hdh allele in individual tissues, histograms were produced showing 
the percentage of alleles investigated containing a specific repeat length. The mutant allele repeat 
size distributions for these selected tissues from a HD+/' mouse (animal 1) are shown in Figure 5.4.
Small pool PCR analysis utilising DNA derived from a tail-tip sample obtained at weaning 
established this animal’s progenitor mutant allele repeat size as 77 CAG repeats. To investigate the 
mutation spectra observed in different tissues, several characteristics o f the repeat size distributions 
were examined and are presented in Tables 5.2 and 5.3.
Table 5.2 presents the ‘median repeat length’ to assess whether an overall change in repeat size 
within a tissue has occurred and the ‘median repeat change’ to establish the magnitude of the repeat 
changes, which typically occur. The range o f repeat lengths present within each tissue were 
determined by the maximum and minimum repeat lengths (Table 5.2, Max and Min repeat length).
To further assess the mutation spectra, Table 5.3 presents the ‘percentage o f total alleles undergone 
repeat size change’ illustrating the number o f mutant alleles that have undergone a change in 
mutation load. The ‘percentage o f total alleles double the progenitor repeat’ was calculated to 
assess the occurrence of large repeat lengths within a tissue. To assess the direction and magnitude 
of the repeat length changes that have occurred, the relationship between expansions and 
contractions was investigated by examining the ‘percentage of altered alleles that have expanded’. 
To assess the typical magnitude of changes the proportion o f alleles that have undergone expansion 
or contraction, which remained within 3 repeats of the progenitor allele ‘% o f expansions < 3 
repeats’ and ‘% of contractions < 3 repeats’ were calculated.
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Figure 5.4 The distribution of CAG repeat lengths carried by individual alleles within 
tissues o f a 24 month old HD+/‘ mouse
Histograms illustrating the distribution of repeat sizes within each tissue by demonstrating 
the proportion of alleles analysed containing the designated repeat length. The tissue type 
is denoted in the top right of each panel, n = the number of mutant alleles analysed for each 
tissue. The median repeat length and statistical comparisons of these distributions are shown 
in Tables 5.2, 5.3. and 5.4.
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Table 5.2 Mutation length profiles of 5 different tissues from a 24 month old HD+/' mouse with a 
progenitor allele of 77 CAG repeats (animal 1)
Tissue Number 
of alleles 
examined
Median
repeat
length
Median
repeat
change
Max
repeat
length
Min
repeat
length
Striatum (St) 380 89 + 12 201 68
Cortex (Ctx) 157 82 + 5 135 65
Cerebellum (Cb) 121 82 + 5 135 66
Hippocampus (Hip) 196 81 + 4 140 67
Kidney (K) 251 79 + 2 136 68
max = maximum, min = minimum.
Table 5.3 Mutation length profiles of 5 different tissues from a 24 month old HD+/' mouse with a 
progenitor allele of 77 CAG repeats (animal 1)
Tissue % of total 
alleles 
undergone 
repeat size 
change
% of total
alleles
double
progenitor
repeat
% of altered 
alleles 
that have 
expanded
%of
expansions 
< 3 repeats
%of
contractions 
< 3 repeats
Striatum (St) 95% 4.5 % 89% 11 % 68%
Cortex (Ctx) 95% 0% 96% 28% 33%
Cerebellum
(Cb)
94% 0% 88% 24% 79%
Hippocampus
(Hip)
95% 0% 79% 27% 67%
Kidney (K) 92% 0% 63% 24% 52%
‘% of total alleles undergone repeat size change’ is the percentage of mutant alleles investigated that no 
longer carried 77 CAG repeats.
of total alleles double progenitor repeat’ is the percentage of mutant alleles investigated that carried > 154 
CAG repeats.
of altered alleles that have expanded’ is the percentage of all the mutant alleles which no longer carried 
77 CAG repeats which carried > 77 CAG repeats.
‘% of expansions < 3 repeats’ is the percentage of alleles with > 77 CAG repeats which carried 78 - 80 CAG 
repeats.
‘% of contractions < 3 repeats’ is the percentage of alleles displaying < 77 CAG repeats which carried 74 -76 
CAG repeats.
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As expected from previous small pool PCR experiments investigating serial dilutions o f DNA  
samples (section 5.2), the distribution o f mutant allele repeat lengths in the kidney was relatively 
limited (Figure 5.4). The kidney had a median repeat length o f 79 CAG repeats and displayed a 
small median repeat length change o f + 2 repeats (Table 5.2). The maximum and minimum repeat 
lengths observed from 251 mutant alleles were 136 repeats and 68 repeats, respectively (Table 5.2). 
Very large changes in repeat length within kidney cells appeared to be relatively rare as no alleles 
carrying a repeat size that had doubled in length, compared to the mutant progenitor allele, were 
obtained (Table 5.3). Repeat instability occurred in an expansion-biased manner, accounting for 63 
% of all changes in repeat length (Table 5.3). The magnitude of expansions was commonly greater 
than 3 repeats as only 24 % of expansions remained within 3 repeats o f the progenitor allele. 
Contractions displayed a reduced propensity to produce alleles with large repeat length changes, as 
52 % of all contractions remained within 3 repeats of the progenitor allele (Table 5.3).
A  high percentage (95 %) of hippocampal cells displayed a change in repeat length and 79 % of 
these changes were expansions (Table 5.3). A  preponderance o f large expansions and small 
contractions (as seen in the kidney) was also observed (Table 5.3). The median repeat length was 
81 repeats and the median repeat length change + 4 repeats (Table 5.2). The maximum repeat 
length detected from 196 mutant alleles was 140 repeats and the minimum was 67 repeats (Table
5.2). No alleles with a repeat size that was over double the mutant progenitor allele size were 
detected (Table 5.3).
The patterns o f repeat instability in the cerebellum and hippocampus were similar. Within the 
cerebellum approximately 88 % o f all changes in repeat length on the mutant allele were 
expansions and only 24 % of these remained within 3 repeats of the progenitor mutation size (Table
5.3). Of the few contractions observed, 79 % remained within 3 repeats o f the progenitor mutation 
repeat length (Table 5.3). The cerebellum displayed a median repeat length o f 82 repeats with a 
median repeat length change of + 5 repeats (Table 5.2). A  maximum of 135 repeats and a minimum 
of 66 repeats were detected in the 121 mutant alleles sampled (Table 5.2). No alleles were detected 
carrying a repeat size that had doubled in length compared to the mutant progenitor allele size 
(Table 5.3).
The cortex displayed a median repeat length of 82 repeats and a median repeat change o f + 5 
repeats (Table 5.2). Amongst the 157 mutant alleles sampled, the maximum repeat size detected 
was 135 repeats and the minimum was 65 repeats (Table 5.2). No cortical cells carrying a repeat 
size that had doubled in length, compared to the mutant progenitor allele size, were detected (Table
5.3). The same expansion-biased pattern of repeat instability was observed and the propensity for 
large expansions but small contractions was seen (Table 5.3).
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In contrast, the profile o f repeat sizes in the striatum encompassed a significantly wider range of 
repeat lengths, compared to other tissues (Figure 5.4). The maximum repeat length detected from 
380 mutant alleles sampled was 201 repeats and the minimum was 68 repeats (Table 5.2). A  higher 
median repeat length (89 repeats) was observed and the median repeat change was + 12 repeats 
(Table 5.2). To illustrate the magnitude of repeat size changes, approximately 4.5 % of all striatal 
cells analysed contained a repeat size over double the mutant progenitor length (Table 5.3). 
Expansion-biased repeat instability was observed in the striatum with 89 % o f altered alleles 
displaying an expansion and 89 % of the expansions over three repeats longer than the progenitor 
allele repeat length (Table 5.3). The mutation profiles observed within the striatum of this HD+/* 
mouse were consistent with the semi-quantitative analysis in section 5.3.
In summary, the mutation profile data showed that the kidney displayed the narrowest range of 
repeat sizes and the highest number o f mutant alleles that retained the progenitor allele repeat 
length. The cortex, cerebellum and hippocampus all showed similar patterns of repeat instability. 
However, the striatum displayed a significantly wider repeat length distribution than the other 
tissues, with the highest values for median repeat length and median repeat length change. The 
results suggest that the cells within the striatum contain the largest mutation sizes and greatest 
variability.
Statistical comparison of the mutation profiles obtained for each tissue was carried out to further 
examine the tissue-specific pattern o f repeat instability. Statistical comparisons of the repeat length 
distributions from different tissues were made using the Mann-Whitney U statistical test (Table
5.4). The Mann-Whitney U test is used to compare the elements o f two populations to assess 
whether the bulk of elements in one population are larger than those in the other, by asking whether 
the median repeat length o f one population is significantly different from the other.
Statistical comparison o f the repeat length distributions revealed that the median repeat length in 
the kidney was significantly smaller than that in all other tissues examined (Table 5.4). The repeat 
size distributions o f the cortex, hippocampus and cerebellum were not significantly different (Table
5.4) suggesting several regions o f the brain display similar patterns of repeat instability. The 
median repeat length of the striatum was significantly higher than the median repeat lengths 
observed in all other tissues examined. This suggests that the striatum displays significantly greater 
somatic repeat instability than all other tissues examined in old HD+/' mice (Table 5.4).
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Table 5.4 Statistical comparison of the mutation length distributions of five different tissues from 
one 24 month old HD+/' mouse (animal 1)
Tissue Comparison *p value
Striatum (St) St vs Ctx <0.0001
St vs Hip <0.0001
St vs Cb <0.0001
St vs K <0.0001
Cortex (Ctx) Ctx vs Hip 0.9
Ctx vs Cb 0.6
Ctx vs K 0.004
Hippocampus (Hip) Hip vs Cb 0.6
Hip vs K 0.0004
Cerebellum (Cb) Cb vs K 0.0002
K = Kidney , * Values in bold represent statistical significance (p<0.05) of data analysed using the Mann- 
Whitney U statistical test. All comparisons are based on the median repeat lengths found in Table 5.2. 
obtained from the size distributions shown in Figure 5.4.
5.3.3 R eproducibility of repeat instability  profiles in 24 m onth old HD+/' 
mice
The studies carried out in section 5.3.2 were replicated to establish the reproducibility o f the pattern 
and distribution of repeat instability observed in a single 24 month old HD+/' mouse (animal 1). The 
variability and magnitude of somatic repeat instability was investigated in a second HD+/' mouse 
(animal 2) matched for genetic background and age to animal 1. The progenitor allele repeat length 
for animal 2 was established at 79 CAG repeats by small pool PCR analysis of DNA obtained from 
a tail-tip sample taken at weaning. The characteristics o f the mutation profiles obtained from 
animal 2 are presented in Tables 5.5 and 5.6. The repeat distributions for the 5 selected tissues are 
shown in Figure 5.5.
Statistical analysis was carried out to assess the relationship between the mutation profiles of 
different tissues within animal 2 (Table 5.7) followed by statistical comparison o f the mutation 
profiles obtained from animals 1 and 2 (Table 5.8 and 5.9).
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Figure 5.5 Comparison o f the mutation profiles in old HD+y/' mice
Histograms illustrating the distribution of repeat sizes within each tissue by demonstrating the 
proportion of cells analysed containing a particular repeat length. The tissue type is denoted 
in the top right of each panel. A. Repeat size distributions for the HD+y/~ mouse previously shown 
in Figure 5.4. B. Repeat size distributions for a second HD+//" mouse, n = the number of mutant Hdh 
alleles analysed for each tissue. The median repeat lengths and statistical comparisons between the 
tissues of animal 2 can be seen in Table 5.5, 5.6 and 5.7 and for the same tissues between 
the two HD+/- mice in Table 5.8 and 5.9.
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Table 5.5 Mutation length profiles of 5 different tissues from a 24 month old HD+/' mouse with a 
progenitor allele of 79 repeats (animal 2)
Tissue Number 
of alleles 
examined
Median
repeat
length
Median
repeat
change
Max
repeat
Min
repeat
Striatum (St) 331 87 + 8 398 68
Cortex (Ctx) 218 84.5 + 5.5 258 68
Cerebellum (Cb) 287 83 + 4 210 66
Hippocampus (Hip) 161 82 + 3 161 66
Kidney (K) 256 82 + 3 124 69
max = maximum, min = minimum
Table 5.6 Mutation length profiles of 5 different tissues from a 24 month old HD+/' mouse with a 
progenitor allele of 79 repeats (animal 2)____________________________________________________
Tissue % of total 
alleles 
undergone 
repeat size 
change
% of total
alleles
double
progenitor
repeat
% of altered 
alleles 
that have 
expanded
%of
expansions 
< 3 repeats
% of
contractions 
< 3 repeats
Striatum (St) 95% 6% 80% 13% 61 %
Cortex (Ctx) 94% 1.4 % 77% 19% 74%
Cerebellum
(Cb)
94% 1.4 % 75% 25% 47%
Hippocampus
(Hip)
94% 1 % 65% 25% 51 %
Kidney (K) 91 % 0% 76% 37% 64%
‘% of total alleles undergone repeat size change’ is the percentage of mutant alleles investigated that no 
longer carried 79 CAG repeats.
‘% of total alleles double progenitor repeat’ is the percentage of mutant alleles investigated that carried > 158 
CAG repeats.
‘% of altered alleles that have expanded’ is the percentage of all the alleles which no longer carried 79 CAG 
repeats which carried > 79 CAG repeats.
‘% of expansions < 3 repeats’ is the percentage of alleles displaying > 79 CAG repeats which carried 80 - 82 
CAG repeats.
of contractions < 3 repeats’ is the percentage of alleles displaying < 79 CAG repeats which carried 76 - 
78 CAG repeats.
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The data obtained from animal 2 illustrates that the repeat instability in this HD+/' mouse appears 
similar to that found in animal 1. The somatic repeat instability in animal 2 also occurred in an 
expansion-biased manner with a small percentage o f cells retaining the progenitor allele repeat 
length. Variation in the magnitude o f expansions and contractions was again observed, with 
contractions tending to be small (1-3 repeats) and expansions tending to be > 3 repeats greater than 
the progenitor allele. However, the magnitude o f mutation size appeared to be greater in animal 2 
(when compared to animal 1) as all brain regions contained repeats twice the size o f the progenitor 
allele.
Despite this difference, features o f the overall pattern of tissue-specificity were maintained, as the 
striatum still displayed a significantly higher median repeat length compared to all other tissues 
examined (Table 5.7) and the kidney still displayed the most limited variation in repeat size (Figure
5.5). The cortex displayed a significantly higher median repeat length than all other tissues except 
the striatum (Table 5.7) and the hippocampus, cerebellum and kidney did not differ statistically 
from each other but all showed significantly smaller median repeat lengths than the cortex and 
striatum (Table 5.7).
Table 5.7 Statistical comparison of the repeat size distributions of five different tissues from one 24 
month old HD+/' mouse (animal 2)
Tissue Comparison *p value
Striatum (St) St vs Ctx 0.02
St vs Hip <0.0001
St vs Cb <0.0001
St vs K <0.0001
Cortex (Ctx) Ctx vs Hip 0.003
Ctx vs Cb 0.005
Ctx vs K <0.0001
Hippocampus (Hip) Hip vs Cb 0.5
Hip vs K 0.8
Cerebellum (Cb) Cb vs K 0.1
K = Kidney, * Values in bold represent statistical significance (p<0.05) of data analysed using the Mann- 
Whitney U statistical test. All comparisons are based on the median repeat lengths found in Table 5.5. 
obtained from the repeat distributions shown in Figure 5.5.
Statistical comparison o f the repeat size distributions from the same tissues in animal 1 and 2 
revealed similar repeat size distributions in both animals (Table 5.8). However, there were 
significant differences in the mutation profiles displayed by the cortex and kidney (Table 5.8). 
These differences may be a consequence of random sampling variation or inter-animal variation.
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Table 5.8 Statistical comparison of the repeat size distributions of the same tissues in different 24 
month old HD+/' mice
Tissue Median repeat lengths 
Animal 1 Animal 2 
(# alleles) (# alleles)
Comparison p value*
repeat
length
Striatum (St) 89 (380) 87 (331) St vs St 0.4
Cortex (Ctx) 82 (157) 84.5 (218) Ctx vs Ctx 0.0002
Cerebellum (Cb) 82 (121) 83 (287) Cb vs Cb 0.2
Hippocampus (Hip) 81 (196) 82 (161) Hip vs Hip 0.4
Kidney (K) 79 (251) 82 (256) K vs K <0.0001
* Values in bold represent statistical significance (p<0.05) of data analysed using the Mann-Whitney U 
statistical test. All comparisons are based on the median repeat lengths found in Tables 5.2 and 5.5.
As longer repeats display a greater tendency to expand, it is possible that the slight variation in the 
mutation profiles of the two HD+/' mice is due to the two repeats difference in the progenitor allele 
repeat length. To take the progenitor allele repeat length into account, re-analysis o f the 
distributions was carried out using the change in repeat length (median repeat length change) rather 
than the absolute repeat length for each comparison (Table 5.9). When comparing the median 
repeat length change in the striatum of animal 1 and 2, a significant difference was obtained. The 
median repeat length change distributions for all other tissues did not display statistically 
significant variation between animals. It is still unknown whether the comparisons between the 
animals yielded significant differences due to sampling variation or natural variation between 
individual mice.
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Table 5.9 Statistical comparison of the repeat change distributions of the same tissues in different 
24 month old HD+/' mice
Tissue Median repeat change 
Animal 1 Animal 2 
(# alleles) (# alleles)
Comparison p value*
repeat
change
Striatum (St) + 12 (380) + 8(331) St vs St 0.007
Cortex (Ctx) + 5 (157) + 5.5 (218) Ctx vs Ctx 0.06
Cerebellum (Cb) + 5(121) + 4 (287) Cb vs Cb 0.1
Hippocampus (Hip) + 4(196) + 3(161) Hip vs Hip 0.1
Kidney (K) + 2(251) + 3 (256) K vs K 0.1
* Values in bold represent statistical significance (p<0.05) of data analysed using the Mann-Whitney U 
statistical test. All comparisons are based on the median repeat changes found in Table 5.2. and 5.5.
In summary, although some differences in the extent of repeat instability were detected when 
absolute repeat length or repeat length change distributions were compared, the general pattern of 
tissue-specificity in both HD+/‘ mice analysed, in terms of the variability and magnitude of repeat 
instability, was maintained. The striatum consistently displayed a significantly greater variability 
and magnitude of repeat instability compared to all other tissues examined in both animals.
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5.4 Investigating the progressive nature of somatic repeat 
instability within HD+/“ mice
In order to ascertain the time course o f mutation instability in HD+/' mice, DNA samples from the 
striatum, cortex, hippocampus and cerebellum were analysed from animals o f 3, 9, 15, 19 and 24 
months o f age (Figure 5.6). Approximately 1000 mutant alleles were examined from the chosen 
brain regions o f several HD+/' mice (2-6 animals) o f each time point, matched for genetic 
background and mutation line (Table 2.1).
Negligible repeat instability was observed at 3 months o f age in all brain regions (Figure 5.6) 
suggesting somatic repeat instability has an onset in adult life.
Consistent with this speculation, small changes o f 3-5 repeats were seen infrequently but to a 
similar extent in all brain regions o f 9 month old mice (Figure 5.6). This suggests that the 
mechanism responsible for repeat size change may initiate at the same time and have a similar 
effect in all brain regions sampled.
At 15 months o f age larger changes in repeat length were observed and these seemed to occur in a 
tissue-specific manner. The repeat instability had increased in all brain regions compared to that 
observed at 9 months. However, analysis of ~ 1000 mutant alleles from each brain region showed 
that the striatum displayed the greatest variability and magnitude o f repeat size changes, when 
compared to the other brain regions examined (Figure 5.6).
The progressive increase in repeat instability in all brain regions continued at 19 and 24 months of 
age (Figure 5.6). At all time points after the initial appearance of repeat instability, the striatum 
demonstrated the greatest variability and magnitude o f repeat instability. These observations 
suggest that the underlying mechanism responsible for repeat instability occurs in all brain regions 
and initiates at a similar time point during adult life. However, the tissue-specific mutation profiles 
within older mice suggest that a brain region-specific factor may be responsible for the greater 
repeat length variability and mutation size observed in the striatum.
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5.5 Investigating somatic repeat instability in human HD
To investigate the occurrence o f somatic repeat instability in human HD patients, small pool PCR 
was carried out on human HD tissue obtained from a juvenile HD patient. Post-mortem  
examination of the brain established extensive neurodegeneration within the caudate nucleus and 
confirmed the diagnosis of HD.
The predominant mutant allele repeat size obtained from the post-mortem tissue was estimated at 
87 CAG repeats. As earlier DNA samples were not available for this individual, it is unknown if 
this repeat length was carried on the mutant HD  allele at birth.
Tissue samples from the cortex, hippocampus, substantia nigra and caudate nucleus brain regions 
were obtained. Two different regions o f the cortex, the temporal lobe and the parietal lobe were 
available for comparison. The small sample denoted the caudate nucleus was collected from a 
region that had suffered extensive degenerative changes, as noted in the post-mortem report. The 
results obtained from this sample must therefore be interpreted with caution, as the cell populations 
retained will not necessarily reflect that of an intact caudate nucleus.
Small pool PCR analysis was carried out on DNA from all available brain regions by multiple 
amplifications of serial DNA concentrations as described in sections 5.3 and 2.4.
Based on data obtained from wild-type mouse tissue (section 5.3), it is assumed that wild-type 
alleles within human tissue would not exhibit a significant degree o f repeat instability. The human 
wild-type allele in this patient contained approximately 24 CAG repeats (Figure 5.7) and 
demonstrated no obvious fluctuations in repeat length in all brain regions. As in mouse tissue, no 
intermediate bands between the products from the wild-type and prominent mutant allele were 
observed. This suggests that repeat instability on the wild-type allele would have to produce PCR 
products within the mutant allele range. It is deemed unlikely that the wild-type allele is capable of 
expanding to an extent in which it contributes to the mutant allele mutation spectrum.
Expansion-biased somatic repeat instability o f the mutant allele repeat was detected in brain 
regions from this human HD patient (Figure 5.7). Extensive repeat instability was observed in both 
cortical regions analysed (Figure 5.7). High variability and magnitude of repeat size changes were 
observed and a maximum repeat length of >700 repeats from ~500 mutant alleles was detected. No 
expanded CAG repeat o f this length, associated with HD, has previously been reported in the 
literature.
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Figure 5.7 Somatic repeat instability of the CAG repeat m utation in human juvenile HD 
brain tissue
Each panel illustrates 4 lanes o f  SP-PCR products from 10-30 cells worth of  template DNA. 
The numbers on the right side of  the panels represent the estimated CAG repeat number carried 
by the PCR products o f  the wild-type, progenitor mutant allele and the further expanded alleles. 
The brain regions exam ined are denoted as CN = caudate nucleus, SN = substantia  nigra, 
Hip = hippocampus, TC = temporal cortex and PC = parietal cortex.
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The hippocampus also displayed repeat length variation and a maximum repeat length o f 246  
repeats was detected from ~500 mutant alleles (Figure 5.7). The variability and magnitude 
however, appeared substantially lower than that observed in the cortex.
The substantia nigra displayed repeat instability and a maximum repeat size of 146 repeats was 
detected from -5 0 0  mutant alleles (Figure 5.7). The variability and magnitude of repeat instability 
appeared lower than that observed in the hippocampus and considerably lower than that in the 
cortex.
The caudate nucleus, the brain region most affected by the HD disease process showed the lowest 
level of repeat instability (Figure 5.7). As this region had undergone extensive neurodegeneration it 
is possible that the surviving cell populations were the least affected by the disease process. Our 
hypothesis predicts that cells containing the largest repeats will be more vulnerable to the disease 
process and will therefore be absent from the post-mortem sample. The lack o f mutation length 
variability is consistent with the cells containing the largest repeats having succumbed to the 
disease process first.
In summary, this study has illustrated that extensive somatic repeat instability does occur in human 
HD tissue. Whilst this somatic repeat instability occurs in a tissue-specific manner, the significance 
of this variability must be investigated in tissue that has not undergone neurodegeneration.
The dramatic tissue-specific pattern of repeat instability in human tissue is similar to that observed 
in HD+/' mice and suggests that the findings in this mouse model may be relevant to human HD. As 
subtle phenotypic changes and no neurodegeneration are observed in the HD mouse model, 
variations in repeat length may be an early molecular change in the HD disease process. Further 
studies are needed to assess the occurrence of repeat instability in human tissue obtained from 
earlier time points in the disease process. More in-depth characterisation o f the somatic repeat 
instability in the HD mouse model w ill present an opportunity to further investigate the molecular 
mechanisms underlying repeat instability and the resulting phenotypic consequences. Deciphering 
these mechanisms may therefore, present possible targets for therapeutic intervention that would be 
relevant to human HD.
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5.6 Investigating experimental techniques utilised to detect 
somatic repeat instability
5.6.1 M ethods used to investigate som atic repeat instability
5.6.1.1 Radioactive PCR
Investigations into CAG repeat length variation in somatic tissues have previously been carried out 
by radioactive PCR amplification, typically using 100 ng o f template DNA (De Rooij et al., 1995; 
M acDonald et al., 1993; Telenius et al., 1994; Zuhlke et al., 1993). The PCR products were 
separated through polyacrylam ide gels, visualised by autoradiography and the image 
densitometrically analysed. PCR amplification o f this number o f DNA  templates (-3 3 0 0 0  
genomes) usually generates a smear of fragments on an autoradiogram. There have been several 
suggested origins o f the various sizes o f PCR products responsible for the smear, including 
slippage of the Taq polymerase through the repeat sequence during the amplification process 
and/or CAG repeat length variation in the template DNA. These varying interpretations o f the 
results have led to confusion regarding the presence o f somatic CAG repeat length variation (De 
Rooij et al., 1995; MacDonald et al., 1993; Telenius et al., 1994; Zuhlke et al., 1993) in HD 
tissues.
5.6.1.2 Genescan Analysis
Analysis o f PCR products from 100 ng of template DNA electrophoresed through polyacrylamide 
gels is commonly carried out by Genescan technology. PCR amplification is carried out using a 
fluorescently tagged primer and the subsequent fluorescent signal from the PCR products is 
visualised by a laser. Highly accurate sizing of the PCR products is carried out by comparison to 
internal standards within every lane by the Genescan software. As the PCR amplification is carried 
out using -1 0 0  ng o f template DNA, the resultant smear does prevent the detection o f individual 
alleles. However, the technique has been successfully used in assessing the occurrence of somatic 
repeat instability in a number o f HD mouse models (Ishiguro et al., 2001; Mangiarini et a l ,  1996; 
Manley et al., 1999).
5.6.1.3 Small pool PCR
Small pool PCR (section 2.4) investigates the presence of somatic repeat instability by quantifying 
the CAG repeat length on individual alleles within a tissue. Techniques described in sections 
5.6.1.1 and 5.6.1.2 use relatively large amounts o f template DN A so that the repeat length o f  
thousands of alleles is analysed simultaneously. The expanded alleles are therefore observed as a 
smear made up o f multiple unresolved bands. The technique o f small pool PCR allows the
Laura Kennedy, 2002 Chapter 5, 203
resolution of this smear into discrete bands by analysing small amounts of template DNA (1.2 ng - 
3 pg) and visualising the products by Southern blotting.
5.6.2 C om parison of som atic  repeat instability analysed  by SP-PCR and 
G enescan technology
Previous investigations into somatic repeat instability in other HD mouse models (Ishiguro et al., 
2001; Mangiarini et al., 1997; Manley et al., 1999) have failed to detect the levels o f somatic repeat 
instability observed in this model. One possible reason for this disparity is the difference in 
experimental techniques utilised. To determine if Genescan technology and small pool PCR differ 
in their representation o f mutation length within the same sample o f DNA, half o f a PCR 
amplification was investigated with Genescan technology (section 2.3.6) and the other half was 
subjected to the small pool PCR visualisation and image analysis protocol (sections 2.4.5 and 
2.4.6). Three different concentrations o f striatal DNA from a 24 month old HD+/' mouse were used 
as PCR template.
When small pool PCR was carried out using 100 ng (-33000  genomes) o f striatal template DNA, 
the vast number o f PCR products resulted in a large smear on the autoradiogram (Figure 5.8A). The 
smear prevented the different sized products from individual cells, seen previously (Figure 5.1), 
being elucidated. This large amount of template DNA, commonly used for Genescan technology, 
reduces the chance of observing rarer large changes in repeat size as they may not be amplified due 
to preferential amplification o f smaller DNA fragments and increased competition for reaction 
components. When 100 ng o f DNA was used as PCR template and Genescan technology used to 
detect the products, a obvious range of repeat sizes representing 70 to 80 repeats on the mutant 
allele was apparent. The resolution of this technique allowed the possible detection of a maximum 
repeat size of approximately 86 repeats.
300 pg (-100  genomes) o f striatal template DNA is a common concentration used to assess the 
overall pattern o f repeat instability within a tissue during small pool PCR analysis. The products 
from this number of individual alleles can be distinguished on a small pool PCR autoradiogram if 
repeat length variability is significantly high (Figure 5.8A). A  range o f 77 to >150 CAG repeats 
was observed in this sample. This repeat size range is greater than the range previously observed 
using Genescan technology with 100 ng o f DNA template from the same tissue. Genescan 
technology using 300 pg of striatal template DNA detects less repeat instability than at the higher 
dilution and is again unsuccessful in detecting the range o f repeat lengths observed in the small 
pool PCR analysis. The result suggests that Genescan technology, at this DNA concentration, fails 
to detect the entire spectrum o f repeat sizes, as the smaller amount of PCR product does not 
produce an adequate fluorescent signal.
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F ig u r e  5 .8  Comparison of CAG repeat length variation detected in striatal tissue from a 
24 m onth old H D +//" m ouse using SP-PCR analyses and G enescan-based technology
A. SP-PCR analyses dem onstrating  the level o f  CAG repeat length variation detectable in 
PCR amplifications generated from differing amounts of input genomic DNA. The amount of 
tem pla te  D N A  can be seen under each panel.  M ind ica tes  the 1 kb p lus  size m arker.  
The numbers on the far right side of  the panels indicate the estimated number of  CAG repeats 
carried  by the PCR products.  B. R epresen ta tive  G enescan  traces generated  by the same 
P C R  p ro d u c ts  in the  S P -P C R  a u to ra d io g ra m s .  T h e  v e r t ic a l  sca le  on the  t r a c e s  is 
arbitrary units of fluorescence intensity.
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Genescan technology failed to detect a fluorescent signal from the products generated by PCR 
amplification o f 20 pg (~7 genomes) o f striatal template DNA. In small pool PCR analyses, the 
sensitivity o f the Southern blotting visualisation technique allowed the amplified products from 
individual molecules to be detected, thus more fully revealing the extent o f the somatic repeat 
instability within the tissue.
Comparisons o f repeat size distributions obtained by SP-PCR and Genescan technologies must take 
into account the use of denaturing polyacrylamide gels in association with Genescan in contrast to 
the non-denaturing agarose gels used in SP-PCR. As both techniques separate DNA fragments 
according to size, it is proposed that this technical difference will not account for the significant 
differences in repeat size distributions observed. The range o f repeat sizes detected using 
autoradiography of radioactive PCR separated on polyacrylamide gels, has also failed to 
demonstrate significant repeat instability in human HD tissue (De Rooij et al., 1995; Telenius et 
a l ,  1994; Zuhlke et a l ,  1993). These studies, like those using Genescan technology, presumably 
suffer from the use of bulk quantities o f DNA template (~100 ng) impeding the resolution and 
visualisation of products from individual mutant alleles.
In summary, this study has illustrated one reason why significant levels o f somatic repeat 
instability in HD has not been detected previously. The sensitivity offered by small pool PCR 
permits the detection and quantification of the full range of repeat sizes. Other techniques including 
Genescan technology have been shown to lack the sensitivity capable of detecting all PCR products 
and therefore, the true spectrum of repeat sizes present.
5.7 Summary of results
In summary, these studies have uncovered extensive somatic repeat instability in HD+/' mice. In 24 
month old HD+/' mice the 16 different tissues investigated presented mutation profiles that vary in a 
tissue-specific manner. The brain regions examined displayed higher variability and magnitude of 
repeat instability than non-CNS somatic tissues and sperm. The striatum, the region of the brain 
selectively involved in HD neuropathology, was found to display the greatest degree o f repeat 
instability. It was observed that repeat instability on the mutant allele occurred in an expansion- 
biased manner. The mutation lengths carried by individual alleles in selected tissues were compiled 
and distributions o f the mutant allele repeat sizes were produced. It was shown independently in 
two animals that the striatum has a distribution of repeat sizes that differs significantly from all 
other tissues examined. In general, the rank order o f repeat instability in other tissues was also 
consistent.
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After identifying somatic repeat instability in the HD mouse model and discovering the dramatic 
and significant difference in repeat instability of the striatum, further studies were carried out to 
assess the temporal nature of this somatic repeat instability. Small pool PCR analysis of brain 
regions at different ages, demonstrated that this tissue-specific somatic repeat instability is not 
present in early life and occurs in a progressive manner. The repeat instability becomes obvious at 
15 months o f age and occurs in a tissue-specific manner. The striatum, at all time points when 
significant repeat instability was detected, displayed the greatest variability and magnitude of 
repeat lengths.
A  dramatic pattern o f somatic repeat instability was also detected in human HD tissue. Brain 
regions from a juvenile HD patient were analysed by small pool PCR and extensive somatic repeat 
instability was observed. Within the cortical regions mutations over 700 CAG repeats were 
detected, over 8 times longer than the original expansion mutation. However, it was not possible to 
determine if the striatum displayed significantly higher levels o f repeat instability in human HD as 
profound neurodegenerative changes in this region were reported.
The fact that previous studies had failed to report significant levels of somatic HD mutation 
instability, led to an examination o f HD+/' mouse striatal samples using the commonly utilised 
Genescan technology. It was demonstrated that rare large expansions in repeat length were not 
detected using this approach and a highly truncated distribution o f the more common allele sizes 
was obtained. These findings suggest that the variability and magnitude o f repeat instability in HD 
human and mouse tissue may have been under-estimated in previous studies. The increased 
sensitivity offered by reduced competition during amplification and the visualisation technique 
utilised in small pool PCR technology provides a more detailed mutation profile o f a tissue.
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6 Investigating the underlying mechanisms of somatic 
repeat instability in HD mouse models
6.1 Aims of the study
The aim o f this study was to investigate the possible underlying mechanisms o f somatic repeat 
instability observed in human and mouse HD tissues. The studies were designed to address the 
following questions:
• Is the underlying mechanism of brain repeat instability in HD+/' mice replication based? A  
number o f mechanisms proposed to explain repeat size changes are based on DNA strand 
slippage during replication (section 1.6.2). As the most striking somatic repeat instability 
observed in this HD mouse model was detected in the brain, a predominantly post-mitotic 
tissue, further investigations were carried out to determine if cell division may play a role 
in brain repeat instability.
In order to ascertain whether replication is involved in mutation length variability in the brains of 
HD mice, the following issues were addressed.
■ Is the dramatic pattern of striatal repeat instability produced by replication-competent 
cells within this brain region? The striatal samples used in previous studies (Chapter 5) 
may have contained the brain region called the subventricular zone (SVZ). The SVZ is 
known to include replication-competent progenitor cells and to generate neurons 
destined for the olfactory bulbs (Barres, 1999; Doetsch et al., 1999). Small pool PCR 
analysis of striatal samples from a 24 month old HD+/‘ mouse that either contained or 
omitted the SVZ, was performed to determine whether the extensive pattern o f repeat 
instability observed in the striatum was altered due to the inclusion of these replication- 
competent cells.
■ Does repeat instability occur in the brain during periods o f significant cell 
proliferation? During neurogenesis neural stem cells go through extensive proliferation 
to provide adequate numbers of cells to ensure the correct connections are made in the 
developing brain. Once the appropriate connections are made the surplus cells are 
culled by apoptosis (Gordon, 1995). If the replication process is the underlying 
mechanism responsible for repeat instability it is postulated that mutation length 
variability would be observed during this period of increased cell division. Negligible 
levels o f repeat instability within the brain were previously demonstrated at 3 months 
of age in HD+/_ mice (section 5.4). If repeat instability does occur during neurogenesis,
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the absence o f repeat instability in the early post-natal period may be due to the 
selective advantage of cells with smaller mutations. This selection may occur because 
the detrimental effects o f large repeats may prevent the cells from making the 
appropriate connections and therefore promote their elimination by apoptosis. To 
investigate whether there is repeat instability during neurogenesis, brain samples from 
different embryonic time points were analysed by small pool PCR.
■ Is the pattern o f somatic repeat instability reflected in the germline? By comparing the 
pattern of repeat instability in sperm and striatal samples the repeat size changes 
produced in a post-mitotic environment can be compared to that in mature sperm, cells 
that are the products of many cell divisions (Drost and Lee, 1995).
• Does carrying two copies o f the HD mutation affect the pattern and extent o f somatic 
repeat instability? One possible mechanism involved in producing repeat instability is 
DNA repair. The repair process may utilise the w ild-type H dh  allele through 
recombinational mechanisms such as homologous recombination/unequal crossing over or 
gene conversion/break repair (section 1.6.5). Greater scope for large repeat size changes 
would be provided during recombinational DNA repair if both Hdh alleles carried an 
expanded CAG repeat. Therefore, the mutation profiles o f several different tissues were 
determined to establish if the pattern and extent o f somatic repeat instability differed in 
homozygous (HD'A) and heterozygous (HD+/ ) mice.
• Is the pattern and extent o f somatic repeat instability previously observed in HD+/' mice 
maintained in mice expressing a truncated form of the mutant huntingtin protein? By 
comparing the somatic repeat instability in heterozygous mice expressing full-length 
mutant huntingtin (HD+/ ) and mice expressing a mutant N-terminal region o f the protein 
(HDtrunc), the involvement of the sequence downstream of the expanded CAG repeat in 
repeat instability can be investigated. Small pool PCR analysis was carried out on selected 
tissues from 24 month old HD+/' and HDtrunc mice.
6.2 Investigating the possible involvement of replication in brain 
repeat instability in HD+/'mice
Replication has been suggested as one possible underlying mechanism responsible for generating 
repeat instability. The detection o f extensive repeat instability in the brain, a predominantly post­
mitotic tissue merits further investigation to determine any possible connection between replication 
and brain repeat instability in the HD+/' mice.
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Replication-competent progenitor cells have been found within the adult brain. A  known 
population of these stem cells, which give rise to olfactory bulb neurons, are found within the 
subventricular zone (SVZ) (Barres, 1999; Doetsch et al., 1999). This brain region is located  
between the striatum and the lateral ventricle and was probably included in the striatal samples 
previously analysed (Chapter 5). To establish whether the inclusion o f a small population o f these 
replication-competent cells is responsible for the extensive repeat instability observed in the 
striatum compared to other brain regions, striatal samples containing or omitting the SVZ were 
analysed by small pool PCR. To obtain striatal samples without the SVZ, 1 mm thick coronal brain 
sections, at the level o f the head of the caudate putamen (striatum), were visualised under a 
dissection microscope (Nikon SMZ-U). Hole punches of several regions o f the striatum distant 
from the lateral ventricle were obtained.
Small pool PCR using several dilutions o f template DNA (1.2 ng - 60 pg) allowed the analysis of 
-1000  mutant alleles from each striatal sample and demonstrated no significant difference, in terms 
of variability and magnitude o f repeat instability, between striatal samples with or without the SVZ 
(Figure 6.1 A).
During neurogenesis, embryonic stem cells participate in a period o f vast cell division. If the 
process o f DNA replication contributes to somatic repeat instability, it is postulated that the 
resultant neuronal population would display mutant repeat length variation.
Small pool PCR analysis was carried out on whole brain samples collected from HD+/' embryos at 
embryonic day 14 and 18. Investigations were restricted to whole brain samples as distinguishing 
and dissecting the defined brain regions analysed previously (Chapter 5) was difficult due to the 
early developmental stage and technical restrains.
Small pool PCR of -2 0 0 0  mutant alleles by amplifying 1.2 pg - 60 ng o f template DN A per 
reaction failed to detect repeat instability at either embryonic time point (Figure 6. IB).
Comparison of the repeat instability within striatal and sperm cells from the same HD+/' mice was 
carried out. The extensive repeat instability seen in the striatum contrasted to the low-level repeat 
instability seen in sperm (Figure 6.1C). The extent o f repeat instability in sperm is supported by the 
modest amount of intergenerational changes in repeat length observed in this HD mouse model (see 
section 1.5.3.6). The results suggest that the extent of repeat instability detected does not correlate 
with increased cell division, as adult brain is a predominantly post-mitotic tissue and mouse mature 
sperm cells are the products of -165  cell divisions (24 month old mouse) (Drost and Lee, 1995).
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Figure 6.1 I n v e s t i g a t i n g  th e  p o s s ib le  ro le  o f  r e p l i c a t io n  in s o m a t i c  r e p e a t  in s t a b i l i ty
A . R epea t  in s tab il i ty  in s tr ia ta l  sam ples  w ith  or w ithou t the su b v e n tr icu la r  zone  (SVZ). 
A  representative SP-PCR autoradiogram in which each lane contains the products o f  -2 0  cells worth 
o f  template DNA. Both samples, obta ined from the same 24 month old H D +/‘ m ouse,  either 
contained or omitted the replication com petent cells derived from the SVZ. The SP-PCR data 
o b ta ined  from  several  co n cen tra t ions  o f  tem pla te  D N A  (12 pg - 60 pg) d em o n s tra ted  no 
apparent difference between the striatal samples. B. Repeat instability in em bryonic brain from 
HD+/- mice. R ep resen ta tive  S P -PC R  au to rad iogram  show ing  m ult ip le  reac tions  using  - 2 0  
cells worth o f  D N A  from brain sample collected from H D +/L em bryos at day 14 (E14) and 18 
(E18) o f  gestation, the period of  m axim al neuronal precursor cell division. N eglig ib le repeat 
instability was observed in embryonic brain at both time points examined. C. Somatic and germline 
repeat instability in 24 month old H D +//" mice. A  comparison o f  somatic (striatum) and germline 
(sperm) repeat instability o f  the mutation in a 24 month old H D +,/" mouse. Each lane o f  SP-PCR 
analysis contains the products o f  - 1 0  cells worth of template DNA. M indicates the 1 kb plus 
DNA  marker. The numbers on the right side of each panel indicate the estimated number of  triplet 
repeats carried by the amplified alleles.
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Microglia are present within the normal adult brain in a resting state (Barron 1995). However, they 
are capable of vast cell division in response to neuronal injury or toxicity, such as that associated 
with neurodegenerative disorders (Meda et al 2000, Brown 2001, Rozemuller and Muiswinkel 
2000). Increased gliosis has been reported in post-mortem human HD tissue (Sapp et al., 2001) and 
several HD mouse models (Lin et al., 2001; Reddy et al., 1998; Yamamoto et al., 2000). If this 
gliotic reaction occurs within the brain o f the HD mouse model, the increased rate o f  cell 
proliferation may account for the increased occurrence o f repeat instability. However, no 
neurodegeneration or gliosis have been observed in this HD mouse model (Shelboume et al., 1999) 
and although microglia are capable o f proliferating in normal brain, the rate is thought to be 
extremely low. It is therefore postulated that the extensive brain repeat instability detected in this 
HD mouse model is not the consequence of a gliotic reaction.
In addition, microglia are unlikely to be entirely responsible for the extensive repeat instability 
previously observed within the striatum of HD+/' mice (section 5.2) as a high percentage (90 %) of 
the neuronal population within the striatum is made up of medium spiny neurons (Gerfen, 1988), 
the cell-type selectively affected in early HD. The extent o f repeat instability observed and the cell 
proportions within the striatum suggest that repeat size changes are unlikely to be solely restricted 
to the glial cell-type.
In summary, these studies illustrate that repeat instability in brain is not directly correlated to the 
levels of cell division. The contrast in repeat instability in germline and somatic tissues suggests 
that different underlying mechanisms maybe responsible for the respective repeat size changes. The 
observation of extensive repeat instability in post-mitotic cells and negligible repeat instability in 
highly replicating neuronal progenitor cells suggests that the underlying mechanism of brain repeat 
instability may not be replication based.
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6.3 Investigating somatic repeat instability in 24 month old 
homozygous HD mice
Repeat instability was quantified using small pool PCR by determining the mutation length on 
individual alleles (section 5.3.1) in tissues from two 24 month old homozygous HD (HD'7') mice. 
The repeat size distributions o f striatal, cortical and kidney DNA samples were obtained and 
compared within each animal to determine the tissue specificity o f somatic repeat instability. The 
consistency of the variability and magnitude o f the repeat size changes detected in HD'7' mice were 
investigated by comparing the distributions obtained for the same tissues in different mice. To 
establish if somatic repeat instability differs in animals carrying two copies o f the HD mutation 
from those with one, the repeat size distributions from HD'7' mice were compared to those 
previously obtained from HD+7' mice (section 5.3.2 and 5.3.3). The HD'7' mice used in this study 
were matched with respect to age, mutation and genetic background to each other and the 
previously studied HD+7' animals (Table 2.1). It was determined (section 5.3.2) that the mutant 
progenitor allele lengths were similar in both HD'7' mice investigated, 78 repeats for animal 3 and 
76 repeats for animal 4.
6.3.1 Quantification of som atic  repeat instability in a 24 m onth old HD'1’ 
m ouse
The characteristics o f the somatic repeat instability pattern within the striatum, cortex and kidney 
of a HD'7' mouse (animal 3) were examined in the same manner as the HD+7' mice (animal 1 and 2, 
see section 5.3.2 and 5.3.3) and the data presented in Tables 6.1 and 6.2.
Table 6.1 Mutation length profiles of 3 different tissues from a 24 month old HD'7' mouse with a 
progenitor allele size of 78 repeats (animal 3)
Tissue Number 
of alleles 
examined
Median
repeat
length
Median
repeat
change
Max
repeat
length
Min
repeat
length
Striatum (St) 499 90 + 12 252 63
Cortex (Ctx) 332 84 + 6 172 61
Kidney (K) 218 80 + 2 104 63
max = maximum, m i n  =  m i n i m u m .
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Table 6.2 Mutation length profiles of 3 different tissues from a 24 month old HD'7' mouse with a 
progenitor allele of 78 CAG repeats (animal 3)
Tissue % of total 
alleles 
undergone 
repeat size 
change
% of total
alleles
double
progenitor
repeat
% of altered 
alleles 
that have 
expanded
%of
expansions 
< 3 repeats
%of
contractions 
< 3 repeats
Striatum (St) 95% 6% 85% 11 % 47%
Cortex (Ctx) 95% 1 % 80% 20% 94%
Kidney (K) 95% 0 % 61 % 37% 52%
‘% of total alleles undergone repeat size change’ is the percentage of mutant alleles investigated that no 
longer carried 78 CAG repeats.
of total alleles double progenitor repeat’ is the percentage of mutant alleles investigated that carried > 156 
CAG repeats.
‘% of altered alleles that have expanded’ is the percentage of all the alleles which no longer carried 78 CAG 
repeats which carried > 78 CAG repeats.
‘% of expansions < 3 repeats’ is the percentage of alleles displaying > 78 CAG repeats which carried 79 - 81 
CAG repeats.
‘% of contractions < 3 repeats’ is the percentage of alleles displaying < 78 CAG repeats which carried 75 - 
77 CAG repeats.
The repeat size distribution within the kidney spanned a narrow range o f repeat lengths (Figure
6.2). The median repeat size detected was 80 CAG repeats and the median repeat length change 
was + 2 repeats (Table 6.1). The maximum repeat length observed when 218 individual alleles 
were investigated was 104 repeats and the minimum 63 repeats (Table 6.1). The low level o f large 
repeat size changes within kidney cells was illustrated by the absence o f kidney cells containing a 
repeat size double the mutant progenitor allele repeat length (Table 6.3). Somatic repeat instability 
occurred in an expansion-biased manner as 61 % of all alleles, which displayed an altered, repeat 
length exhibited an expansion (Table 6.3).
The cortex displayed a wider range o f repeat sizes than the kidney (Figure 6.2) with a minimum 
repeat size o f 61 and a maximum of 172 repeats from 332 mutant alleles investigated (Table 6.1). 
The cortex displayed a median repeat length of 84 repeats and a median repeat length change o f + 6 
repeats (Table 6.1). The cortical repeat size distribution showed that 1 % o f cortical cells contained 
a repeat that had doubled in length compared to the mutant progenitor allele (Table 6.2). The 
expansion-biased nature o f the somatic repeat instability was illustrated by 80 % of all alleles 
having undergone a change in repeat size resulting in an expansion (Table 6.2). Approximately 20 
% of the expansions remained within 3 repeats of the progenitor allele repeat size, in contrast to the 
94 % o f all contractions that remained within 3 repeats o f the progenitor allele (Table 6.2).
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F ig u re  6 .2  M utation p rofiles in tissu es from  a 24  m onth old  H D -/" m ouse
Histograms illustrating the distribution of repeat sizes within each tissue by demonstrating the 
percentage of alleles analysed containing the appropriate repeat length. The tissue type is denoted 
in the top right of each panel, n = the number of mutant alleles analysed for each tissue. 
The median repeat length and statistical comparisons of these distributions are shown in 
Tables 6.1, 6.2, 6.3, 6.7 and 6.8.
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The striatal repeat size distribution comprised o f a wider range of repeat lengths than the cortex or 
kidney (Figure 6.2). A  median repeat length o f 90 repeats was observed and the median repeat 
length change was + 12 repeats (Table 6.1). The largest allele detected from 499 mutant alleles 
investigated carried 252 repeats and the minimum 63 repeats. In this brain region, 6 % of cells 
contained a repeat that had doubled in length compared to the mutant progenitor allele size (Table
6.2). The expansion-biased pattern o f repeat instability was once again observed with only 11 % of 
the high number o f expansions (85 %) remaining within 3 repeats o f the mutant progenitor allele 
repeat length (Table 6.2).
When the repeat size distributions for all three tissues were compared using the Mann-Whitney U 
statistical test, the results suggested that the kidney displayed a significantly smaller median repeat 
length than the cortex and striatum (Table 6.3). The mutation distribution in the cortex and striatum 
were also significantly different, with the striatal cells carrying the largest median repeat length 
(Table 6.3).
Table 6.3 Statistical comparison of the repeat size distributions of three different tissues from one 
24 month old HD'7' mouse (animal 3)
Tissue Comparison *p value
Striatum (St) St vs Ctx <0.0001
St vs K <0.0001
Cortex (Ctx) Ctx vs K <0.0001
K=Kidney, * Values in bold represent statistical significance (p<0.05) when comparing the median repeat 
lengths quoted in Table 6.1 using the Mann-Whitney U statistical test.
In summary, the results suggest that mutation profiles in HD'7' mice are similar to those previously 
detected in HD+7' mice (section 5.3.2 and 5.3.3). Both the median repeat lengths and the median 
repeat length changes within the tissues are comparable and the expansion-biased repeat instability 
apparent. The percentage o f cells containing repeat sizes double the mutant progenitor allele is also 
consistent with the findings in HD+7' mice (Table 5.2 and 5.4). The pattern o f tissue-specificity was 
maintained for the tissues examined, and in all mice investigated the striatum shows the greatest 
variability and magnitude of repeat instability.
6.3.2 Reproducibility of som atic  repeat instability  in 24 m onth old HD'7' 
mice
The studies carried out in section 6.3.1 were replicated to establish the reproducibility o f the pattern 
of repeat instability observed in a single 24 month old HD'7' mouse (animal 3, Figure 6.2). A  
second HD'7' mouse (animal 4), matched for genetic background and age to animals 1, 2 and 3 was
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investigated by small pool PCR to determine the variability and magnitude of the somatic repeat 
instability in selected tissues. Statistical analysis o f the repeat size distributions obtained for the 
striatum, cortex and kidney o f animal 4 were compared to determine the tissue-specificity of 
somatic repeat instability present (Table 6.6). The mutation profiles for these tissues were also 
compared to those obtained from animal 3 in order to assess the consistency of somatic repeat 
instability between HD7' mice (Table 6.7 and 6.8). The general characteristics o f the somatic repeat 
instability observed in animal 4 is shown in Tables 6.4 and 6.5.
Table 6.4 Mutation length profiles of 3 different tissues from a 24 month old HD7" mouse with a 
progenitor allele size of 76 repeats (animal 4)
Tissue Number Median 
of alleles repeat 
examined length
i Median 
repeat 
change
Max
repeat
length
Min
repeat
length
Striatum (St) 92 93 + 17 252 72
Cortex (Ctx) 196 87.5 + 11.5 172 72
Kidney (K) 274 82 + 6 104 72
max = maximum, min = minimum.
Table 6.5 Mutation length profiles of 3 different tissues from a 24 month old HD7' mouse with a 
Droaenitor allele of 76 CAG repeats (animal 4)
Tissue % of total 
alleles 
undergone 
repeat size  
change
% of total
alleles
double
progenitor
repeat
% of altered 
alleles 
that have 
expanded
% of
expansions 
< 3 repeats
%of
contractions 
< 3 repeats
Striatum (St) 92% 7% 97% 7% 67%
Cortex (Ctx) 94% 2% 96% 8% 57%
Kidney (K) 93% 0% 97% 19% 86%
‘% of total alleles undergone repeat size change’ is the percentage of mutant alleles investigated that no 
longer carried 76 CAG repeats.
of total alleles double progenitor repeat’ is the percentage of mutant alleles investigated that carried > 152 
CAG repeats.
‘% of altered alleles that have expanded’ is the percentage of all the alleles which no longer carried 76 CAG 
repeats which carried > 76 CAG repeats.
of expansions < 3 repeats’ is the percentage of alleles displaying > 76 CAG repeats which carried 77 - 79 
CAG repeats.
of contractions < 3 repeats’ is the percentage of alleles displaying < 76  CAG repeats which carried 73 - 
75 CAG repeats.
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Somatic repeat instability was observed in the second HD7" mouse in an expansion-biased manner, 
with similar numbers o f large changes in repeat sizes demonstrated (% of alleles double the 
progenitor) compared to the previously investigated HD7" mouse (animal 3). The percentage o f 
repeat changes which resulted in expansions was high in all tissues (>95%) and the median repeat 
length changes were larger than previously detected. These factors resulted in a slight increase in 
the median repeat lengths in the tissues of animal 4 compared to those in animal 3 (Figure 6.3 and 
Table 6.7).
Despite these variations in repeat instability, features o f the overall pattern o f tissue-specificity 
were maintained (Table 6.6). The kidney displayed a significantly smaller median repeat length 
compared to the cortex and striatum. The striatum displayed a significantly larger median repeat 
length compared to all other tissues. The striatum demonstrated the greatest variability and 
magnitude of repeat size changes (Figure 6.3).
Table 6.6 Statistical comparison of the repeat size distributions of three different tissues from a 
second 24 month old HD7' mouse (animal 4)
Tissue Comparison *p value
Striatum (St) St vs Ctx 0.0342
St vs K <0.0001
Cortex (Ctx) Ctx vs K <0.0001
K=Kidney, * Values in bold represent statistical significance (p<0.05) when comparing the median repeat 
lengths quoted in Table 6.4 using the Mann-Whitney U statistical test.
The repeat size distributions from the same tissue from animals 3 and 4 were compared to assess if 
mutation profiles were reproducible in HD7' mice (Table 6.7). The overall variability and 
magnitude of repeat instability in both HD7" mice appeared to be similar (Figure 6.3). The mutation 
profiles obtained from the striatum of both HD7" mice were not significantly different (Table 6.7). 
However, there were significant differences in the mutation profiles displayed by the cortex and 
kidney. Variations in repeat size distributions were previously detected in the tissues with lower 
levels of repeat instability relative to the striatum (section 5.3.3). Sampling error introduced to 
these mutation profiles by the number o f mutant alleles investigated may be responsible for these 
small statistical variations in repeat length distributions.
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Figure 6.3 Mutation profiles in 24 month old HD"/" mice
Histograms illustrating the distribution of repeat sizes within each tissue. The proportion of alleles 
carrying a particular mutation length are indicated. The tissue type is denoted in the top right of 
each panel, n = the number of mutant alleles analysed for each tissue.
A. The repeat size distributions of a HD‘/‘ mouse previously shown in Figure 6.2 (animal 3).
B. Repeat size distributions for a second HD-/- mouse (animal 4). Statistical comparison between 
the striatum, cortex and kidney animal 4 displayed a tissue-specific pattern in repeat instability 
consistent with the first HD"/" mouse analysed (animal 3). The median repeat length and statistical 
comparisons of the distributions in the second animal are shown in Tables 6.4, 6.5 and 6.6. 
Statistical comparison between the animals can be seen in Tables 6.7 and 6.8.
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Table 6.7 Statistical comparison of the repeat size distributions from the same tissues in different 
24 month old HD7' mice
Tissue Median repeat lengths Comparison *p value
Animal 3 Animal 4 repeat
(# alleles) (# alleles) length
Striatum (St) 90 (499) 93 (92) St vs St 0.2
Cortex (Ctx) 84 (332) 87.5 (196) Ctx vs Ctx 0.0001
Kidney (K) 80 (218) 82 (274) K vs K <0.0001
* Values in bold represent statistical significance at p<0.05 using the Mann-Whitney U statistical 
test. All comparisons are based on the median repeat lengths found in Tables 6.1 and 6.3.
The slight variations in the mutation profiles of the two HD7' mice may be due to the two repeats 
difference in the progenitor allele repeat length. To take the progenitor allele repeat length into 
account, re-analysis o f the distributions was carried out using the change in repeat length (median 
repeat length change) rather than the absolute repeat length for each comparison (Table 6.8). As 
animal 4 had displayed a relative propensity for expansions in repeat size the repeat length change 
distributions proved to be statistically different for each tissue when comparing animals 3 and 4 
(Table 6.8). It is still unknown whether the comparisons between the animals yielded statistical 
differences due to random sampling variation or natural variation between individual mice.
Table 6.8 Statistical comparison of the repeat change distributions of the same tissues in different 
24 month old HD+/' mice
Tissue Median repeat change Comparison p value*
Animal 3 Animal 4 repeat
(# alleles) (# alleles) change
Striatum (St) + 12 (499) + 17 (92) St vs St 0.03
Cortex (Ctx) + 6 (332) + 11.5 (196) Ctx vs Ctx <0.0001
Kidney (K) + 2 (218) + 6 (274) K vs K <0.0001
* Values in bold represent statistical significance (p<0.05) of data analysed by using the Mann-Whitney U 
statistical test. All comparisons are based on the median repeat changes found in Table 6.1 and 6.4.
In both HD7' mice (animals 3 and 4), a consistent pattern o f somatic repeat instability was 
observed. In general, the variability and magnitude of repeat instability was preserved with the 
kidney demonstrating the least amount of repeat instability and the striatum displaying the greatest
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magnitude and variability of repeat length changes. The mutation profiles within the striatum, when 
statistically compared between animals, were not significantly different. Some variation was 
detected when comparing the mutation profiles of other tissues.
In summary, repeat instability has been detected in mice that are homozygous for the HD mutation. 
The repeat instability occurs in a tissue-specific and expansion-biased manner and quantitative 
analysis has revealed repeat size distributions indicating that the striatum displays the greatest 
variability and magnitude of somatic repeat instability.
6.3.3 Comparing m utation profiles in HD'7' and HD+/' mice
Qualitative analysis suggested that there was little difference between the somatic repeat instability 
observed in the three tissues investigated in homozygous and heterozygous HD mice (Figure 6.4). 
A  consistent pattern of extensive repeat instability was observed in the striatum of HD7' and HD+/' 
animals. When the striatal repeat size distributions for each HD7' and HD+/' mouse were compared 
there were no significant differences (Table 6.9) and only one significant result when using the 
median repeat length change distributions (Table 6.10). Previous comparisons had demonstrated 
that all striatal repeat size distributions were significantly different, carrying a larger median repeat 
length, compared to all other tissues examined (Figure 6.5 and Tables 5.4, 5.7, 6.3 and 6.6). The 
kidney was the tissue examined, in animals o f both genotypes, which consistently displayed the 
least amount of repeat instability (Figure 6.5). The repeat size distributions for the kidney and 
cortex did yield some statistical differences between HD7' and HD+/' mice (Tables 6.9 and 6.10). 
As repeat size distributions derived from these tissues in different HD+/' animals had previously 
displayed statistical variation (Tables 5.8, 6.7 and 6.8), this is unsurprising and unlikely to signify 
any overall difference between HD+/' and HD7' mice.
In summary, when comparing the repeat instability in HD+/' and HD7' mice qualitative analysis 
suggested no obvious difference in the pattern o f repeat instability. Statistical analysis o f the repeat 
size distributions obtained revealed only minor variations between the striatal repeat instability but 
slightly greater differences in the tissues that displayed less extensive repeat instability in HD7' and 
HD+/' mice.
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Figure 6.4 C o m p a r iso n  o f  repea t  in s tab il i ty  in s e lec ted  t is sues  f ro m  HD'7' an d  HD+7~ m ic e
R epresen ta tive  data from SP-PC R  analyses  dem onstra t ing  repeat instabil ity  in the str ia tum, 
cortex and kidney of  24 month old HD*/' and H D +/‘ mice. 5 reactions containing ~ 10-20 cells 
worth o f  D N A  are shown for the stria tum and ~ 5-10 cells worth for the cortex and kidney. 
No apparent differences in the variability and magnitude or tissue-specific pattern of repeat instability 
was observed when comparing H D '7'  and H D +7' mice.
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Figure 6.5 Mutation profiles in tissues from 24 month old HD"/' and H D+/' m ice
Histograms illustrating the distribution of repeat sizes within each tissue examined from HD+/~ 
and HD'/" mice. The proportion of alleles carrying a particular mutation length are indicated. 
The tissue type is denoted in the top right of each panel, n = the number of mutant alleles 
analysed for each tissue. Statistical comparisons of the distributions between all animals 
are shown in Tables 6.9 and 6.10.
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Table 6.9 Statistical comparison of the repeat size distributions of the same tissues in 24 month old 
mice of different genotypes
Tissue Animal Median
repeat
lengths
Comparison *p value
repeat
length
Striatum (St) Animal 1 89 1 vs 3 0.9
Animal 2 87 1 vs 4 0.2
Animal 3 90 2 vs 3 0.4
Animal 4 93 2 vs 4 0.06
Cortex (Ctx) Animal 1 82 1 vs 3 0.001
Animal 2 84.5 1 vs 4 <0.0001
Animal 3 84 2 vs 3 0.3
Animal 4 87.5 2 vs 4 0.01
Kidney (K) Animal 1 79 1 vs 3 0.7
Animal 2 82 1 vs 4 <0.0001
Animal 3 80 2 vs 3 <0.0001
Animal 4 82 2 vs 4 0.3
* Values in bold represent statistical significance (p<0.05) when using the Mann-Whitney U statistical test. 
All comparisons are based on the median repeat lengths found in Tables 6.1 and 6.4.
Table 6.10 Statistical comparison of the repeat change distributions of the same tissues in 24 
month old mice of different genotypes
Tissue Animal Median
repeat
change
Comparison *p value
repeat
change
Striatum (St) Animal 1 + 12 1 vs 3 0.4
Animal 2 + 8 1 vs 4 0.07
Animal 3 + 12 2 vs 3 0.07
Animal 4 + 17 2 vs 4 0.0005
Cortex (Ctx) Animal 1 + 5 1 vs 3 0.03
Animal 2 + 8 1 vs 4 <0.0001
Animal 3 + 6 2 vs 3 0.9
Animal 4 + 11.5 2 vs 4 <0.0001
Kidney (K) Animal 1 + 2 1 vs 3 0.2
Animal 2 + 3 1 vs 4 <0.0001
Animal 3 + 2 2 vs 3 0.004
Animal 4 + 6 2 vs 4 <0.0001
* Values in bold represent statistical significance (p<0.05) when using the Mann-Whitney U statistical test. 
All comparisons are based on the median repeat changes found in Tables 6.2 and 6.5.
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6.4 Investigating somatic repeat instability in 24 month old 
HDtrunc mice
During the production o f the HD mouse model discussed in this thesis (HD+/' and HD'/_ mice), mice 
were generated carrying a mutant copy o f the Hdh gene interrupted, in intron 1, by the neomycin 
resistant (neo) marker gene. This mutant Hdh  allele expresses a truncated form o f the mutant 
huntingtin protein (HDtrunc mice). As HD+/' mice express the full-length mutant huntingtin protein, 
comparison o f these mice with HDtrunc mice presents the opportunity to investigate the 
consequences o f expressing a truncated mutant huntingtin peptide. Any alterations in the 
mechanism o f HD pathogenesis caused by the failure to express the H dh  D N A  sequence 
downstream of the expanded CAG repeat can be determined in mice matched for age, genetic 
background and mutation length. By comparing the pattern of repeat instability in HD+/" and HDtrunc 
mice it may be examined whether the expression o f the full-length Hdh  gene sequence influences 
the variability and magnitude of the molecular changes found in HD mice.
Investigations into somatic repeat instability in mice heterozygous for the allele that produces the 
truncated form of mutant huntingtin protein (HD,runc) were carried out by small pool PCR analysis. 
Multiple PCR amplifications of serial dilutions of DNA template (1.2 ng -1 2  pg template DNA per 
reaction)(section 5.2) were preformed allowing examination of between 1000-2000 mutant alleles 
for each tissue. Somatic repeat instability in the striatum, cortex, hippocampus, cerebellum and 
kidney was investigated in three HDtrunc littermates matched for age and genetic background to the 
HD+/'m ice previously studies (Table 2.1). Small pool PCR analysis of DNA from tail-tip samples 
obtained at weaning indicated that these HDtrunc littermates all possessed a progenitor allele repeat 
length of 69 CAG repeats, 8-10 repeats smaller than the HD+/' mice used for comparison (section 
5.3.2 and 5.3.3). As longer repeats are more prone to repeat size changes, this difference in mutant 
progenitor allele length should be taken into account when interpreting the data.
The kidney from HD+/' mice exhibited minimal variability of repeat sizes on the mutant allele 
(section 5.3). Small pool PCR analysis o f the kidney in HDtrunc mice illustrated a similar low level 
of repeat size changes (Figure 6.6). The maximum repeat sizes observed in the kidney from HDtrunc 
and HD+/‘ mice were 134 and 136 repeats, respectively. The kidney in HDtrunc mice (as previously 
detected in HD+/' mice) displayed the least repeat instability compared to the other tissues 
examined.
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F igure 6.6 C o m p a r i s o n  o f  s o m a t i c  r e p e a t  in s t a b i l i t y  in  H D+/' m ic e  a n d  H Dtrunc m ic e
Representative data from SP-PC R analyses of  the striatum, cortex, h ippocam pus,  cerebellum  and 
kidney  from 24 m onth old H D +/L and H D trunc mice. Each lane represen ts  the PC R  products  of 
~ 10-20 cells worth of  DNA. HD +//'  mice express a full-length mutant copy of  the Hdh gene and HDtrunc 
m ice  e x p re ss  an in te r ru p te d  fo rm  o f  the m u ta n t  Hdh  g en e  g e n e ra t in g  a t ru n c a te d  m u ta n t  
huntingtin peptide.
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In HD+/' mice the pattern o f repeat instability observed within the brain regions demonstrated that 
the striatum displayed a significantly greater variability and magnitude o f repeat instability 
compared to all other brain regions examined (section 5.2 and 5.3). The cortex was shown to be the 
brain region that generally displayed a repeat instability profile that was second only to the 
striatum. The hippocampus and the cerebellum displayed repeat instability at a higher variability 
and magnitude compared to the non-CNS tissues but significantly lower repeat instability than the 
striatum.
When the four brain regions were investigated in HDtrunc mice, analysis revealed an altered brain 
region specific pattern of repeat instability, compared to HD+/‘ mice.
In general, no significant differences between the HDtrunc and HD+/' mice were suggested by the 
analysis of cortical and hippocampal samples (Figure 6.6). The cortex within HDtninc mice 
displayed a maximum repeat o f 126 repeats and the hippocampus was similar with a maximum of 
121 repeats. In comparison the cortex from HD+/' mice displayed a maximum repeat length of 258 
and 161 repeats in the hippocampus. However, the general profile of repeat sizes appeared similar 
between these brain regions in HDlrunc and HD+/' mice, and the larger maximum repeat lengths in 
the HD+/' mice may be due to the smaller number (~60 %) of alleles sampled in the HDtrunc mice.
In contrast, variation between HDtnu,c and HD+/' mice in the pattern o f brain repeat instability was 
detected when analysis of the striatum and cerebellum was carried out. HDtrunc mice displayed 
reduced variability and magnitude of repeat size changes in the striatum compared to HD+/" mice 
(Figure 6.6). Since the HDtrunc mice in this study carried progenitor alleles containing shorter repeat 
stretches than those carried by the HD+/' mice used for comparison, a slight reduction in repeat 
instability might be expected. However, HD+/' mice display significantly greater levels of repeat 
instability within the striatum compared to the cortex and hippocampus and in HDlrunc mice this 
pattern o f tissue-specificity was not as apparent. The maximum repeat length detected in HDtrunc 
striatal samples was 131 repeats compared to the maximum of 398 observed from HD+/' mice. 
Again a smaller number o f alleles (~60 %) have been sampled for HDtrunc mice, however, the 
reduced variability of repeat sizes (Figure 6.6) and the absence o f any alleles containing a repeat 
length double the progenitor allele in HDlrunc mice (something commonly observed within the 
striatum of HD+/' mice), suggested an overall reduction in striatal repeat instability compared to 
HD+/' mice.
The cerebellum in HDtrunc mice demonstrated a repeat instability profile that differed from that 
observed in HD+/' mice (Table 6.11). The mutation lengths in some cerebellar cells within HD+/' 
mice are much greater than those in the HDtrunc mice. However, larger numbers o f cells in the 
HDtrunc cerebellum appeared to contain smaller repeat length changes (20-30 repeat expansions).
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The maximum repeat size observed in HDtrunc mice was 174 repeats and the maximum repeat size 
observed in HD+/' mice was 210 repeats. HDtrunc mice carrying shorter progenitor allele repeats 
would perhaps be expected to display a reduction in repeat instability compared to the HD+/’ mice. 
Therefore, it is possible that these alterations in repeat variability may be even more prominent if 
comparisons were made between HDtrunc and HD+/' mice with the same mutation size.
Table 6.11 Semi-quantitative analysis of 1000-2000 mutant alleles for 5 different tissues in 24 
month old HD+/’ and HDtrunc mice. HD+/' data reproduced from Table 5.1.
% of alleles unstable
HD+/ HDtrunc
largest allele detected
HD+/’ HDtrunc
Cerebellum 30-80 % >60% 210 174
Striatum >80 % 30-80 % 398 131
Cortex 30-80 % 30-80 % 258 126
Hippocampus 30-80 % 30-80 % 161 121
Kidney 30-80 % 20-50 % 136 134
of alleles unstable’ is the percentage of total alleles analysed which produced bands which were not 
contained within the prominent mutant allele band. In semi-quantitative analysis, to discriminate unstable 
alleles from the progenitor allele band, it is estimated that the repeat size change must be > + 2 repeats from 
the progenitor allele repeat length.
In summary, the tissue-specific pattern o f repeat instability within HDtrunc mice was altered in 
comparison to HD+/' mice. In HDtrunc mice it appeared that the cerebellum was the brain region, 
which displayed the greatest variability and magnitude of repeat size changes. Although this brain 
region is not generally thought to be involved in HD pathology HDtrunc mice do display a higher 
level o f cerebellar huntingtin aggregates, a cellular hallmark of the HD disease process, providing 
supportive evidence that the cerebellar cells do express longer repeats. If longer repeats are more 
toxic to cells this would suggest that cells within the cerebellum maybe more vulnerable to HD 
pathogenesis in HDtrunc mice. The pattern o f repeat instability in the brains o f HDtrunc mice 
suggested a loss o f the region specific repeat instability previously observed in the striatum of 
HD+/' mice which reflects the selective pattern of HD pathology.
It is important to determine if the full-length and truncated forms of mutant huntingtin vary in their 
downstream cellular effects, as this may provide insights into the molecular events influencing 
early HD pathogenesis. If repeat instability is involved in HD pathogenesis, variations in the extent
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or pattern of repeat size changes in HD+/* and HDtrunc mice suggest that the expression o f the entire 
sequence downstream of the expanded CAG repeat maybe required to produce the specific  
mechanism of toxicity responsible for HD pathogenesis. A  number of HD mouse models have been 
generated by integration o f truncated forms of the mutant H D  gene into the mouse genome 
(Mangiarini et al., 1996; Schilling et al., 1999; Yamamoto et al., 2000). If expression of a truncated 
form of the mutant HD  gene or peptide initiates an altered time course or nature o f pathogenesis 
this should be taken into account when interpreting findings from these models.
6.5 Summary of results
In summary, investigations into repeat instability within different tissues demonstrate that repeat 
size changes did not correlate with the rate of cell division. These findings are not consistent with 
the suggested mechanism underlying repeat instability based on strand slippage during replication. 
Contrasting repeat instability profiles observed in the brain and sperm cells also suggested that 
different mechanisms maybe responsible for somatic and germline repeat instability. The extensive 
repeat instability observed in the brain, a predominantly post-mitotic tissue, suggested that the 
underlying mechanism of this repeat instability might not be replication-based.
Quantitative small pool PCR analysis demonstrated similar tissue-specific patterns o f repeat 
instability in mice homozygous for the HD mutation. These findings confirmed a similar 
magnitude and pattern of somatic repeat instability in HD'/_ mice and HD+/' animals. The striatum in 
all mice analysed consistently displayed the greatest repeat instability compared to other tissues 
examined. The tissues that showed repeat instability below that observed in the striatum did 
demonstrate variation between animals. It is not clear whether this is due to the random sampling 
variation or inter-animal variation.
The absence o f a significant difference in repeat instability between HD+/' and HD'/_ mice 
suggested, if repeat instability is a molecular marker of the HD disease process, that the severity o f 
this process is not significantly higher in animals carrying two copies o f the HD mutation. This 
hypothesis is supported by the observation that human HD patients carrying two expanded HD 
alleles appear clinically similar to their heterozygous siblings (Wexler et al., 1987).
It is hypothesised that if recombinational forms of DNA repair are involved in the process of repeat 
size change, animals with two expanded repeats possess greater scope for larger changes in repeat 
length. The observation that the variability and magnitude o f repeat instability in HD’7" mice is 
similar in HD+/' mice suggests that the underlying mechanism responsible for repeat size changes 
occurs independently on both mutant alleles.
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Somatic repeat instability was detected in mice heterozygous for a mutant Hdh  allele that produced 
a truncated form of the mutant huntingtin protein (HDlrunc). Repeat instability appeared to occur in a 
similar pattern in the cortex, hippocampus and kidney o f HDtrunc mice when compared to HD+/" 
mice. In all HD mice expressing the full-length mutant huntingtin protein the striatum, the brain 
region selectively involved in HD pathology, displayed the greatest repeat instability. However, 
the striatum of HD*™110 mice exhibited repeat instability that appeared nearer the variability and 
magnitude of mutations in the cortex and hippocampus. These findings suggest a loss o f the tissue- 
specific pattern of repeat instability in the brain that reflects tissue-specific HD pathology.
However, a brain-region specific pattern o f repeat instability was observed in HDlrunc mice. The 
cerebellum in HDtruDC mice displayed a greater variability in repeat sizes than previously observed 
in HD+/' mice. The cerebellum within HDtrunc mice appeared to exhibit greater repeat instability 
compared to the striatum. The tissue-specific pattern o f repeat instability in HDlrunc mice therefore, 
does not reflect the tissue-specific pathology in HD.
This alteration in the pattern of repeat instability in HDtrunc mice compared to HD+/' mice suggests 
that the expression of the sequence downstream of the expanded CAG repeat within the mutant 
H d h  gene might influence the mechanism involved in producing repeat instability.
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7 Discussion
The aim of the work presented within this thesis is to contribute to the understanding of the cellular 
and molecular mechanisms underlying HD pathogenesis. In order to achieve this aim a knock-in 
HD mouse model expressing the HD mutation within the appropriate genomic and protein context 
was utilised to study HD pathogenesis. Previous studies have demonstrated cellular dysfunction 
and subtle phenotypic alterations reminiscent o f HD, in the absence o f obvious neurodegeneration 
(Shelboume et al., 1999; Usdin et al., 1999). These studies have suggested that the HD knock-in 
mice model early stages of the disease process and provide the opportunity to investigate the initial 
cellular and molecular events involved in HD pathogenesis and perhaps elucidate targets for early 
therapeutic intervention.
7.1 Investigating phenotypic alterations in a knock-in mouse 
model of Huntington’s disease
Further characterisation o f the phenotypic changes within HD+/' knock-in mice was carried out to 
assess aspects o f their phenotype and to relate the changes detected to the symptom profile o f  
human HD patients. These studies may also provide clues to the mechanisms o f neuronal 
dysfunction responsible for the phenotypic alterations observed. Gathering detailed knowledge o f 
the phenotypic changes that occur in the HD+/' mice will also aid in assessing the efficiency o f 
future HD therapies.
7.1.1 Investigating gait abnorm alities in HD knock-in mice
Movement disorder is one of the most prominent symptoms associated with human HD (section  
1.1.1.1). Among the earliest signs of motor disturbance in HD patients is an awkward gait due to 
abnormalities in voluntary movement (Kirkwood et al., 2001). However, general observations of 
the HD+/' knock-in mice had previously failed to reveal any obvious motor disturbances. As 
reaction force analyses have been used to reveal consistent and quantifiable features o f mouse gait 
(Clarke and Still, 1999), this sensitive technique was used to examine the gait o f HD+/' and wild- 
type mice.
In the present study wild-type mice displayed a typical mouse gait, consistent with published data 
(Clarke and Still, 1999) at 4 and 12 months o f age. However, wild-type mice analysed at 9 months 
of age displayed an abnormal gait, with respect to weight distribution, across the fore/hind axis. 
Although these data could reflect a natural alteration in gait with age, this seems unlikely as 
published reports depicting a typical mouse gait are based on mice of ~8 months of age (Clarke and 
Still, 1999). In addition, the typical fore/hind weight distribution resumed in HD mice at 12 months
of age. It therefore seems more likely that the slight deviation from the typical weight distribution 
during locomotion in wild-type mice at 9 months o f age is due to the smaller number of 
observations (section 2.6.1.2) in this dataset, dictated by time constraints during experimentation.
HD+/' mice also displayed a typical mouse gait during spontaneous locomotion at 4 months of age. 
The male HD+/' mice at 9 months of age did not exhibit the normal mouse gait or the slightly 
altered gait observed in 9 month old wild-type mice. They displayed an abnormal gait across the 
fore/hind axis. In contrast, there was no difference in gait between female HD+/' and wild-type mice 
at this age. It was not possible to establish from this study if  the slight alteration observed in the 
mixed-sex cohort at 12 months of age was due to a further change in male HD+/' mouse gait or the 
initiation of an abnormality in female HD+/' mouse gait, because the numbers of animals in each 
cohort were so small. These studies suggest that further gait analyses are warranted to determine if 
and when motor abnormalities can be observed in female HD+/" mice.
Studies of wild-type mouse gait have previously indicated that there are no differences between 
males and females (Clarke and Still, 1999). However, the sex-bias in the HD+/' mouse gait 
abnormalities is supported by data generated using the rotarod apparatus that investigates 
coordination and balance. Rotarod deficits in both male and female HD+/' mice have been detected 
as early as 4 months o f age but they appear to be more prominent in males (C-M Chen, 
unpublished data). Behavioural changes in the form of hyperaggression have been reported in the 
HD+/' mice (Shelboume et a l ,  1999). These were also expressed to a greater extent in male mice. 
Although aggression is a typical male trait and this may be sufficient to explain these findings, the 
difference may be due to possible underlying sex-specific influences within these animals. The 
reason why the HD mutation would manifest greater phenotypic alterations in male HD+/' mice 
compared to their female counterparts is unknown but may suggest some sex-specific genetic 
modifiers of the HD disease process. It is also possible that different phenotypic alterations interact 
with each other. For example, the hyperaggression and hyperactivity displayed by male mice may 
make motor alterations more noticeable. To date, no sex-specific differences in the clinical 
manifestation o f HD have been reported in human HD patients. However, gait analysis of this 
sensitivity has not been carried out on humans and the subtlety o f these differential deficits could 
go undetected. In addition, human HD symptoms can be highly variable between individuals and 
this issue is further complicated by the fact that differing repeat sizes cause varying onset ages and 
disease severity. Given these confounding effects, small differences between the sexes in human 
HD may be overlooked.
Previous studies in other HD mouse models have reported motor disturbances. The demonstration 
of limb clasping on suspension by the tail has been used to indicate motor dysfunction. Progressive 
clasping has been observed in all transgenic HD mice expressing a mutant huntingtin fragment
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(Mangiarini et al., 1996; Schilling et al., 1999; Yamamoto et al., 2000). However, this observation 
does not necessarily indicate a striatal-specific abnormality but may represent a cerebellar deficit, 
as in the case o f the weaver and staggerer  mouse mutants that display loss o f cerebellar neurons 
(Lalonde, 1987a; Lalonde, 1987b). Additional reports of resting tremor and involuntary movements 
(Mangiarini et al., 1996; Schilling et al., 1999; Yamamoto et al., 2000) have suggested motor 
abnormalities that are probably more relevant to HD. Obvious lack o f coordination and abnormal 
gait have also been observed in end-stage N171-Q82 HD mice (5-6 months old) with progressive 
rotarod deficits presenting from 3 months of age (Schilling et al., 1999).
Transgenic HD mice expressing full-length mutant human huntingtin also display motor 
abnormalities in the form of late onset involuntary movements (~9 months) (Hodgson et al., 1999), 
followed by gait ataxia (Hodgson et al., 1999; Reddy et a l ,  1998). No obvious movement disorder 
has been reported in any o f the knock-in HD mouse models (Ishiguro et al., 2001; Lin et a l ,  2001; 
Shelboume et a l ,  1999; Wheeler et a l ,  1999). However, in agreement with the findings o f the 
present study, a late-onset, subtle variability in gait has been observed at ~10 months o f age (Lin et 
al.,  2001) in Hdh150 knock-in mice, although no comment about sex-specific differences were 
made. Motor deficits on the rotarod apparatus were also observed in a cohort o f Hdh150 mice aged 
between 4-10 months (Lin et a l ,  2001). At 24 months the H dhQin knock-in mice display gait 
abnormalities with imprecise hind/fore paw placement (Wheeler et a l ,  2002) supporting the 
observed alteration in fore/hind weight distribution of HD+/' mice in the present study.
From published reports of motor abnormalities in HD patients and mouse models it appears that 
movement disorders occur early in the HD disease process (Carter et a l ,  1999; Kirkwood et al., 
1999) and begin with involuntary movement deficits generating abnormalities in gait. The data 
presented in this thesis has also demonstrated a subtle gait abnormality, supporting the notion that 
the HD+/' knock-in mice are modelling early stages o f the HD disease process. The broad 
similarities in movement disorder between mouse models and humans raise the possibility that 
similar underlying cellular dysfunction may be involved.
7.1.2 Investigating spatial learning and memory in HD knock-in mice
Reports that detectible cognitive deficits are present in presymptomatic HD gene carriers (Foroud 
et a l ,  1995; Jason et a l ,  1997; Kirkwood et a l ,  1999; Lawrence et a l ,  1998a) have supported the 
suggestion that cognitive deficits occur early in the HD process (section 1.1.1.2) and indicate that 
cognitive impairment may be caused by neuronal dysfunction rather than cell death. Previous 
studies in the HD+/' mice have demonstrated hippocampal synaptic deficits affecting long-term 
potentiation, implicated in forms of hippocampal-dependent learning and memory (Usdin et al., 
1999). Does this cellular dysfunction manifest as phenotypic changes in HD+/' mice? Although 
behavioural changes and motor disturbances have been detected in the HD knock-in mice,
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cognitive function had not been studied previously. Therefore an investigation o f possible cognitive 
deficits was attempted in the present study.
Common cognitive deficits observed in HD that can be studied in mice, are those involving 
memory and visuospatial functioning. The paradigm chosen to assess spatial learning and memory 
in HD+/' and wild-type mice was the rotating holeboard (sections 2.6.2 and 3.3). The rotating 
holeboard determines spatial learning and memory by assessing the ability to leam the position of a 
hidden food bait using constant spatial clues. The learning process is encouraged by food  
deprivation and the ability to remember the constant location o f the food bait in the test area is 
assessed the following day. Despite, a number of experimental design modifications, the success 
rate of task completion was still very low. Further changes such as varying bait type and size and 
verifying a positive response to hidden food did not improve the situation as many mice still 
showed no signs o f learning after more than 4 hours o f testing. Previous reports o f rotating 
holeboard experiments have suggested that approximately 1 h 40 min should be sufficient for 
learning under these conditions (Brosnan-Watters and Wozniak, 1997). The experiments were 
discontinued after testing 10 mice and achieving successful acquisition and retention o f the task in 
1 animal. Due to these problems the aim of investigating cognitive deficits in the HD+/' mice was 
not achieved.
Successful studies o f spatial learning and memory utilising the rotating holeboard paradigm have 
previously been reported (Brosnan-Watters et al., 1996; Brosnan-Watters et al., 1999; Hartman et 
al., 2001; Wozniak et al., 1996) suggesting that, under the right conditions, this paradigm can be 
used to obtain robust data. Although the mice in this study were fully habituated to the apparatus 
and the experimental conditions kept constant, there was one known deviation from the published 
protocol. In previous studies the mice had been systematically deprived of food until they achieved 
80 % of their original body weight, after which time this weight was maintained throughout testing. 
According to Home Office advice, food was only withheld for the night prior to testing in this 
study and as a result no animal lost weight. Under these circumstances it is possible that mice 
would not leam the task as the hunger incentive to find the bait was missing. This restriction also 
modified the habituation process. In published work, the animals undergo food deprivation during 
this time, encouraging them to retrieve hidden food from the apparatus. Although bait was present 
within the apparatus during habituation of HD+/’ mice, the incentive to eat was missing as food 
deprivation had not occurred. Therefore, it is possible that whilst habituation with respect to the 
apparatus was successful, this did not extent to the task o f retrieving the bait. In support of this 
suggestion, a recent successful rotating holeboard experiment describes a habituation process that 
trained food-deprived animals to carry out the task until 8 out o f 9 trials were correct and then 
proceeded with the learning session by simply changing the position of the bait (Hartman et al.,
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2001). This form of task habituation was only possible because the animals possessed the hunger 
incentive during the habituation period.
Although it is not known whether the HD+/‘ knock-in mice display cognitive deficits previous 
studies in other HD mouse models have successfully reported cognitive deficits. Lione et al. (1999) 
presented a series o f cognitive tasks carried out on the R6/2 mice that demonstrated a differential 
pattern of deficits depending on the paradigm used. No obvious deficits were detected in the two- 
choice swim tank or the Morris water maze. However, the application o f more stringent criteria to 
the Morris water maze data revealed progressive deficits between 3.5-5.5 weeks o f age (Lione et 
al., 1999). A  candidate for the underlying cellular mechanism of these cognitive deficits has been 
suggested by the study that demonstrated impaired synaptic plasticity in the R6/2 mice at a time 
prior to overt phenotypic abnormalities (Murphy et al., 2000). Impairment o f LTP in the CA1 
synapses has also been observed in other HD mice, including the YAC72 knock-in mice (Hodgson 
et a l ,  1999) and those used in this study (Usdin et al., 1999). These findings suggest that synaptic 
alterations may occur early in HD animals, and may be responsible for the presentation o f cognitive 
deficits. They also suggest that both cellular dysfunction and cognitive impairment occur early in 
HD pathogenesis. It is possible that the HD+/' mice express cellular dysfunction but possess a 
functional reserve, which will prevent detectable cognitive deficits. However, as other behavioural 
changes have been observed and other HD mice with similar cellular dysfunction do express 
cognitive deficits, further studies into the possible cognitive impairment in HD+/' mice are 
warranted.
7.2 Investigating the cellular mechanisms underlying 
pathogenesis in HD knock-in mice by examining 
neurotransmitter receptor density
The integrity o f the neuronal circuitry in HD knock-in mice was examined in order to establish 
possible cellular mechanisms underlying the neuronal dysfunction and phenotypic changes 
observed in HD. Changes in the neuronal circuitry could contribute to the clinical features of HD 
by altering normal neurotransmission and/or contribute to HD pathogenesis by producing an 
environment that, over time, could contribute to neuronal degeneration e.g. by promoting glutamate 
or dopamine toxicity. Alterations in synaptic activity have previously been implicated in HD 
pathogenesis as a result o f studies that demonstrate progressive reductions in cerebral blood flow  
and glucose metabolism, processes intimately coupled to synaptic activity (Hasselbalch et al., 
1992; Hayden et al., 1986; Holthoff et al., 1993; Kuwert et al., 1990; Sax et al., 1996; Young et al., 
1986). Further studies have shown that a proportion of relatives at risk of HD already display a 
significant reduction in striatal glucose metabolism (Grafton et al., 1992; Hayden et al., 1986; 
Kuwert et al., 1993), suggesting that altered synaptic activity could contribute to early HD
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pathogenesis. Neurotransmitter receptors are vital for normal neurotransmission and alterations in 
their distribution and/or expression levels could disrupt synaptic functioning. Many studies have 
previously demonstrated alterations in several neurotransmitter receptor types throughout the 
disease process in human HD brains (section 1.2.8). These HD-associated changes in synaptic 
activity and receptor levels have been observed prior to obvious cell loss, suggesting that synaptic 
dysfunction and alterations in receptor density may contribute to neuronal dysfunction early in the 
disease process. To explore the integrity o f the neuronal circuitry in the HD+/' knock-in mice the 
density o f specific neurotransmitter receptors was investigated.
7.2.1 GABAa /Benzodiazepine receptor density
In this study a significant increase in the density o f BNZ neurotransmitter receptor binding sites 
was shown within the striatum and cortex o f 18 month old HD+/' mice compared to wild-type 
littermates. As detectable phenotypic changes and neuronal dysfunction have been observed in 
HD+/" mice without obvious cell loss, neuronal dysfunction may be inducing compensatory up- 
regulation of receptor expression.
Previous studies in human HD post-mortem tissue have revealed reductions in GABAa/BNZ  
binding within the striatum of HD patients (Faull et al., 1993; Penney and Young, 1982; Reisine et 
al., 1979; Walker et a l ,  1984). Several brain imaging studies in early HD patients have also found 
reduced BNZ binding within the caudate nucleus (Holthoff et al., 1993; Kunig et al., 2000; Pinborg 
et al., 2001). However, as significant neurodegenerative changes were observed within these 
subjects, the reductions in receptor density may simply reflect cell loss. Conversely, post-mortem 
studies have also demonstrated a ~30-40 % increase in BNZ binding, despite brain atrophy in the 
mid-frontal cortex, globus pallidus and the substantia nigra pars reticulata (Glass et a l ,  2000; 
Penney and Young, 1982; Reisine et al., 1979; Trifiletti et a l ,  1987). Brain imaging studies have 
also shown substantial increases in GABAa/BNZ receptor density within the putamen despite 
concomitant reductions in glucose metabolism and dopamine D2 receptor density in early HD 
patients (Kunig et al., 2000; Pinborg et al., 2001). These findings have shown that increased BNZ 
receptor density can occur within the striatum, cortex and pallidum despite cell loss, suggesting 
compensatory receptor up-regulation in the remaining cells. Human studies have also shown 
increases in BNZ receptor binding in other basal ganglia regions (e.g. globus pallidus) early in the 
disease process suggesting that cellular dysfunction alone may initiate receptor expression changes 
(Walker et al., 1984).
In human HD the reduction in receptor density within the caudate nucleus probably reflects 1. cell 
loss and 2. a disease stage that follows the phase of receptor up-regulation. The increases within the 
putamen and cortex may reflect brain regions that lag behind the caudate nucleus with respect to 
neuropathological changes and are still able to elicit a compensatory up-regulation response. As the
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caudate nucleus and putamen are an integrated structure in mouse brain, it is difficult to make 
structural distinctions. However, the up-regulation observed in the striatum of the HD+/' mice may 
be due to the fact that the HD mice are modelling an earlier time point in HD pathogenesis than 
that represented by many of the human HD subjects.
7.2.2 Dopamine receptor density
In this study a significant reduction in dopamine D2 receptor density within the striatum was 
detected in the HD+/' mice. However, no alteration in dopamine Di receptor density was observed 
between HD+/' and wild-type mice. Significant reductions in striatal, dopamine D2 receptor density 
in asymptomatic and early HD patients has been observed suggesting a role contributing to 
neuronal dysfunction early in HD pathogenesis (Antonini et al., 1996; Lawrence et al., 1998b). An 
absence of dopamine Di receptor reduction suggests that the mice are modelling a time point in HD 
pathogenesis where no cell loss has occurred, but where D2 expression is declining. However, this 
time point precedes the onset o f dopamine Di receptor reduction, previously observed in clinical 
HD (Ginovart et al., 1997; Lawrence et al., 1998b; Tuijanski et al., 1995).
Based on the observation that the indirect pathway MSN are selectively vulnerable to early HD 
neuropathology (Albin, 1995) and that these MSN preferentially express dopamine D2 receptors 
(Gerfen et al., 1990), a preferential decline in dopamine D2 receptors may be expected. However, 
this may not be the case as studies have reported that the indirect pathway is not preferentially 
targeted in HD (Storey and Beal, 1993) and have questioned the selective expression o f dopamine 
receptors on MSN (Surmeier et al., 1996).
Initial post-mortem studies o f early human HD tissue reported a greater reduction o f striatal 
dopamine Di receptors than dopamine D2 receptors (Joyce et al., 1988; Richfield et al., 1991). 
However, brain-imaging studies have gone on to illustrate a parallel reduction in both dopamine 
receptors in early clinical HD (Ginovart et al., 1997; Lawrence et al., 1998b; Tuijanski et al., 1995) 
and asymptomatic HD gene carriers (Weeks et al., 1996). Conversely autoradiographic studies in 
grade 0 HD brains have reported a significant reduction in dopamine D2 receptors and no decline of 
dopamine Di receptors (Glass et al., 2000). Brain-imaging studies, which have shown decline of 
both dopamine Di and D2 receptor density in early HD have noted an earlier and greater annual loss 
of dopamine D2 receptors compared to that of dopamine Di receptors in presymptomatic HD gene 
carriers (Andrews et al., 1999). The discrepancies between these studies may be due to differences 
in the stage o f HD pathogenesis at which the receptor levels were assessed and warrant further 
studies to clarify the temporal relationship between dopamine receptors and their involvement in 
HD.
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7.2.3 Opioid receptor density
No significant difference in opioid receptor density was observed in the striatum and cortex of 
HD+/" mice when compared to wild-type, although there was a strong trend towards increased 
opioid receptor density in the striatum (section 4.3). The findings presented here may indicate that 
the absence o f opioid receptor reductions reflects the lack of cell loss in the HD+/' mice. The trend 
towards an increase o f opioid receptor density within the striatum may be another example of 
receptor up-regulation, occurring in response to cellular dysfunction in the brains o f HD+/' mice.
Brain imaging studies o f early HD patients have demonstrated significantly reduced opioid receptor 
binding in the striatum, globus pallidus, midbrain and cortex, and increased binding in the thalamus 
and prefrontal areas (Weeks et al., 1997). The reductions in some brain regions could be due to cell 
loss whereas the increases in other brain regions suggest the capacity for compensatory up- 
regulation. Up-regulation may not have been observed in the striatum o f clinically affected HD 
patients as the extent of cell loss and/or cellular dysfunction may be too great or too advanced to 
elicit a change in receptor expression.
7.2.4 Receptor alterations and the effect on brain function
Consideration of the localisation and function o f the neurotransmitter receptors that are altered 
within HD+/' mouse brain tissue may provide information concerning the possible cellular 
mechanisms underlying HD pathogenesis.
Approximately 50 % of all cells within the rat striatum are positive for dopamine Di receptor 
mRNA and -7 5  % of all cells contain dopamine D2 receptor mRNA, with co-localisation of both 
Di and D2 receptors -  30 % of all cells in the striatum (Meador-Woodruff et a l ,  1991). Dopamine 
Di and/or D2 receptor mRNA is found in all MSN within the striatum (Meador-Woodruff et a l ,  
1991). Dopamine Di and D2 receptors are also thought to be present on large cholinergic 
intemeurons and dopamine D2 receptors on NAPDH-diaphorase intemeurons (Dawson et a l ,  1990; 
Joyce and Marshall, 1987).
Stimulation of dopamine D2 receptors leads to inhibition o f adenylylcyclase (Stoof and Kebabian, 
1981), which attenuates neurotransmitter actions (Cepeda et a l ,  1993; Flores-Hemandez et a l ,  
1997; Levine et a l ,  1996). The postsynaptic (Joyce and Marshall, 1987) and presynaptic (Filloux et 
al.,  1988; Garau et a l ,  1978; Schwarcz et al., 1978) distribution o f dopamine D2 receptors on 
neurons means that this inhibitory function could either attenuate the excitability o f postsynaptic 
neurons or prevent the release of neurotransmitters from presynaptic neurons. The loss o f a 
mechanism mediating these processes could contribute to neuronal toxicity since the excessive 
stimulation o f neurotransmitter receptors (e.g. through glutamate excitotoxicity) or excessive
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concentrations o f neurotransmitters (e.g. dopamine toxicity) have both been implicated as 
mechanisms of HD pathogenesis (section 1.3). Loss o f attenuating postsynaptic dopamine D2 
receptors would bring the membrane potential o f striatal neurons closer to activation thereby 
enhancing the responsiveness o f striatal neurons to physiological concentrations o f excitatory 
neurotransmitters. Several studies have already shown that excessive concentrations o f or an 
increased sensitivity to glutamate can cause neurodegeneration (section 1.3.1.1). Loss o f 
presynaptic dopamine D2 receptors would attenuate the control o f glutamate and dopamine release 
onto the MSN, causing excess neurotransmitter release and opposing the negative feedback control 
mechanism. In addition, the highest expression levels o f dopamine D2 receptors can be found in the 
ventral lateral striatum with decreasing levels along the medial and dorsal axes. This gradient 
correlates with neuropathological profiles in HD (section 1.1.2.3), with lower levels o f dopamine 
D2 receptors associated with areas that are most vulnerable to HD pathology (Dubois and Scatton, 
1985).
In support o f this proposed mechanism, increased release o f glutamate occurs in dopamine D2 
receptor-deficient mice (Cepeda et al., 2001b). The resulting structural dendritic alterations in 
striatal neurons, consistent with neurodegeneration, are thought to be caused by long term exposure 
to increased levels o f glutamate. The early reduction in presynaptic dopamine D2 receptors in HD 
may initiate a chronic exposure to excessive concentrations o f glutamate that would result in 
dendritic alterations in the MSN, which have been previously reported in HD+/' mice (Li et al., 
2001) and other HD mouse models (Petersen et al., 2001). In addition, mild movement 
impairments (Kelly et al., 1998) and alterations in synaptic plasticity (Calabresi et al., 1997b) have 
also been observed in dopamine D2-deficient mice, changes that have been previously observed in 
HD+/‘ mice (Usdin et al., 1999), section 3.2).
Conversely, stimulation o f dopamine D2 receptors expressed on NAPDH-diaphorase and 
cholinergic intemeurons appear to activate production of toxic NO (Xia et al., 2001). The loss of 
dopamine D2 receptors could therefore reduce the production of NO, resulting in a neuroprotective 
effect. This neuroprotection may provide a mechanism to slow down the cellular toxicity and 
dysfunction generated by the loss o f dopamine D2 receptors on the MSN. In addition, if the 
dopamine D2 receptor reduction extends to the intemeurons, it provides a possible mechanism that 
explains the selective resistance of intemeurons to HD pathogenesis.
In general, stimulation of dopamine Di receptors results in the activation of adenylylcyclase (Stoof 
and Kebabian, 1981), resulting in postsynaptic (Joyce et al., 1988) signal enhancement (Cepeda et 
al., 1998; Flores-Hemandez et al., 1997). A  decline in dopamine Di receptors could reflect cell loss 
or an active neuroprotective mechanism that reduces the excitatory capabilities o f neurons. In the 
present study no reduction was observed in dopamine Di receptor density was observed in HD+/'
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mice compared to wild-type. These findings suggest that HD+/' mice may be modelling a time point 
of HD pathogenesis before dopamine Di receptor reduction occurs as a result of cell loss or as a 
compensatory response.
Three different subtypes (p , 6, k )  of opioid receptors are expressed in brain (Mansour et a l ,  1993; 
Nishi et a l ,  1993; Wang et a l ,  1993). Evidence that opioid receptors are expressed presynaptically 
and postsynaptically in the striatum has been presented (Rawls et a l ,  1999; Svingos et a l ,  1998). 
The opiates are predominantly inhibitory in their actions and the endogenous opioid receptor 
ligands include ENK and DN (Pleuvry, 1991), both of which are expressed in the striatum.
The suggested up-regulation of opioid receptors in HD+/’ mice may be an attempt to dampen the 
excessive excitation caused by a loss of dopamine D2 receptors. An overlap o f function may occur 
between opioid and dopamine D2 receptors, as they are both found presynaptically on the same 
projection neurons and both mediate the release of glutamate. An increase in opioid receptors may 
be a direct substitution mechanism for the loss o f dopamine D2 receptors. Postsynaptic opioid 
receptors could exert an inhibitory effect on the cells that are being bombarded with increased 
levels of glutamate and dopamine.
Benzodiazepines (BNZ) bind to a modulatory site on the GABAa receptor complex mediating 
GABA-induced chloride flux (Mehta and Ticku, 1999). The GABA/^/BNZ receptor complex is 
highly expressed on virtually all cortical and striatal neurons and axon terminals (Olsen, 1981; 
Olsen and Tobin, 1990). The up-regulation of BNZ receptors would have a non-specific inhibitory 
influence within the brain region. This may occur in an attempt to reduce the excess stimulation of 
the MSN and their firing, which may be responsible for the HD symptoms such as involuntary 
movements.
7.2.5 Future stud ies into neurotransm itter receptor densities in HD
Further studies should be carried out to determine the progression of receptor changes observed in 
the HD+/" mice. Human studies suggest that receptor levels in HD brains are eventually reduced, 
probably because the disease process renders it impossible for the cells to exert an up-regulation in 
expression. Do BNZ, opioid and dopamine Di receptors show reductions at any time point in the 
lifespan of the HD+/' mice? It is most probable that the entire HD disease process cannot be 
modelled in the two-year life span of a mouse and that the HD+/' mice, if  modelling an early stage 
in HD pathogenesis, will never display the general receptor reductions associated with late stage 
human HD. Despite this limitation, the temporal nature of receptor changes in HD+/' mice might 
provide answers to questions such as: When do the receptor changes begin? And what is the 
relationship to the onset o f phenotypic changes? Do dopamine D2 receptors decline prior to the 
compensatory increases in BNZ receptors?
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Deciphering the relationship between the onset and progression o f receptor changes and the 
phenotypic alterations in HD would help to determine if alterations in different receptor types are 
responsible for different HD-associated symptoms. If aspects o f clinical HD have different 
aetiologies, this would have implications for treatment strategies. If future studies demonstrate that 
receptor changes occur prior to phenotypic alterations, one interpretation would be that HD 
pathogenesis has a preclinical period. This would have implications for the timing o f any potential 
treatment regimes in order to maximise efficacy. If a significant preclinical period does exist and 
the HD+/' mice are used to assess the efficacy o f potential treatments in the future, it w ill be 
important to have sensitive biological markers of disease progression. In addition, by defining the 
nature o f the early neuronal dysfunction in HD, potential targets for the new therapies may be 
revealed.
Changes in receptor levels within other regions of the basal ganglia in HD have been demonstrated 
(Enna et al., 1976; Kunig et al., 2000; Penney and Young, 1982; Richfield et al., 1995). The 
temporal nature o f these extra-striatal changes would help determine if  all changes initiate in the 
striatum or whether specific receptor changes occur in different brain regions. The studies may also 
indicate whether other brain regions are responsible for the phenotypic alterations observed in HD.
Whilst this study has demonstrated alterations in the density o f neurotransmitter receptors, it has 
not determined whether the changes are due to alterations in gene transcription or protein 
processing, trafficking or folding. Changes in receptor expression levels in HD could be due to 
transcriptional dysregulation (section 1.2.7.2), abnormal protein trafficking to the synapse (section 
1.2.4), or sequestering o f the receptor protein into aggregates (section 1.2.6). Further studies that 
explore the relationship between the onset of receptor density changes and aggregate formation 
might provide clues to which mechanism is responsible. As demonstrated in other human and HD 
mouse model studies (Augood et al., 1997; Cha et al., 1998), in situ hybridisation techniques could 
be used to determine whether the receptor changes observed are a consequence of reduced mRNA 
levels.
Human HD studies have demonstrated early loss o f adenosine A2a receptors within the striatum 
(Glass et al., 2000; Varani et al., 2001). Adenosine A2A receptors are exclusively expressed 
alongside dopamine D2 receptors on ENK/GABA MSN (Ferre et al., 1993) and a concurrent 
reduction in adenosine A 2A receptors might establish whether the consequences of the HD mutation 
produce general neuronal dysfunction or alterations in specific neurotransmission pathways. 
Interestingly, adenosine A2A receptor knock-out mice display a phenotype that consists o f hyper­
aggression (Ledent et al., 1997). This similarity with the first phenotypic alterations observed in 
HD+/' mice, raise the possibility that adenosine A2A receptor loss may play a role in early HD 
pathogenesis.
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7.2.6 Additional issu es  raised by the receptor density  stud ies
By examining the receptor densities in HD+/' mice o f different ages it was anticipated that the onset 
and association with phenotypic alterations could be assessed. However, a pilot study (section 4.6) 
demonstrated that the subtlety of changes observed in HD+/‘ knock-in mice requires large cohorts in 
order to obtain statistically valid data. From previous experiments it is estimated that in order to 
further explore the temporal nature o f any receptor density alterations, it is likely that cohorts o f > 
15 mice would probably be required. As these numbers are high it may be prudent to find more 
sensitive techniques to assess receptor expression (e.g in situ hybridisation) or explore other 
cellular mechanisms that may be responsible for early neuronal dysfunction in HD.
The congenic HD+/' mice in the present study have been backcrossed onto 3 different genetic 
backgrounds, providing an opportunity to address the influence o f genetic background on receptor 
densities within the striatum and cortex o f HD+/' and wild-type mice. By investigating the effect of 
mutation and genetic background on these results it was demonstrated that genetic background 
could, to varying extents, influence the receptor densities reported (section 4.5). This effect was 
most obvious when investigating opioid and dopamine Di receptor types. In contrast genetic 
background was found to have no effect on the result when examining benzodiazepine receptor 
binding and in this case it was concluded that the alterations observed were due to the HD 
mutation.
The process of generating gene targeted mouse models generally utilises embryonic stem cells 
obtained from the 129 inbred mouse strain and other mouse stains (e.g. C57BL/6) for subsequent 
breeding. The mice generated often have a mixed genetic background and therefore the behaviour 
and cellular phenotypes o f the resulting mouse may not only reflect the functional consequences of 
the targeted gene but also the interactions between different background genes and other unknown 
mutations carried by the parental strains. In addition to these problems, even when progeny mice 
are backcrossed for several generations to a stated inbred strain, a small section of the 129 genome 
will continue to flank the targeted gene. Genes or cis-acting factors within this flanking region may 
have phenotypic or molecular consequences for the mutant mice.
Maintaining mutant mice on hybrid genetic backgrounds has implications for experimental design. 
The variability in the genetic background of the experimental mice has the potential o f generating 
variability in the resulting data set. This increased variability may require larger cohorts in order to 
observe significant differences between wild-type and mutant mice. The variable background of 
each hybrid animal also has implications when choosing experimental control animals. Parental 
strains may differ in the trait under investigation and so the particular trait should be assessed in 
both parental strains as well as hybrid controls to determine if detected alterations are caused solely 
by the mutation.
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Backcrossing progeny mice onto one background strain to produce congenic animals, should  
reduce intra-cohort variability and allow the use o f smaller cohorts to obtain significant results. 
When investigating congenic animals, wild-type littermates can be used as controls since the 
influence o f different background strains should be minimised. In addition, comparisons o f mutant 
mice on different congenic background may result in the detection o f genetic modifiers o f the 
disease process. This may provide clues to cellular processes involved in pathogenesis and offer 
novel ways to manipulate the disease process.
Interesting indications that genetic modifiers influence the extent o f cell death following system ic 
injections o f kainic acid (Schauwecker and Steward, 1997) have been presented in recent studies. 
For example, strains such as FVB/N and DBA/2J appear to be relatively vulnerable to kainic acid 
administration whereas 129SvJ and C57BL/6 relatively invulnerable. As excitotoxicity has been  
implicated in HD pathogenesis these findings demonstrate the importance o f genetic background 
when interpreting results obtained from different HD mouse models. Further studies have also 
shown that the C57BL/6 strain is more susceptible to the neurotoxic effects of l-methyl-4-phenyI- 
1,2,3,6-tetrahydropyridine (MPTP), which causes nigrostratial dopaminergic damage, another 
pathway implicated in HD pathogenesis (Muthane et a l ,  1994; Zimmer and Geneser, 1987).
7.3 Investigating molecular mechanisms underlying HD 
pathogenesis by characterising somatic repeat instability
It has previously been suggested that instability of the mutation in somatic tissues may contribute 
to HD pathogenesis (De Rooij et al., 1995; Telenius et a l ,  1994). Investigations in HD+/' mice have 
demonstrated somatic repeat instability. Repeat size changes occur in a tissue-specific and 
expansion-biased manner, with the greatest variability and magnitude o f somatic repeat size  
changes within the brain. In particular, the striatum displays the most dramatic pattern o f repeat 
instability (section 5.2). Conversely, the cerebellum has a relatively low level o f repeat instability 
compared to other brain regions. In the periphery it is predominantly the kidney and liver cells that 
display low levels of repeat instability in HD+/’ mice. Tissue-specific somatic repeat instability was 
also detected within human juvenile HD brain tissue (section 5.5). Extensive repeat size changes 
(>600 repeats) were observed within the human HD cortex compared to other brain regions. Due to 
the extensive neurodegeneration within the caudate nucleus it was not possible to determine the 
extent o f somatic repeat instability in this brain region. In order to resolve this issue, investigations 
on early human HD brain tissue that has not undergone any neuropathological cell loss would be 
needed.
Prominent expansion-biased somatic repeat instability in the brain, with the largest repeat length 
changes in the striatum and lower levels o f repeat instability in the cerebellum, has been
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demonstrated in other mouse models o f HD (Ishiguro et al., 2001; Mangiarini et al., 1997; Wheeler 
et a l ,  1999). The reduced extent of repeat instability within the cerebellum compared to other brain 
regions observed in HD mouse models may mask cell-type specific repeat instability. For example, 
the Purkinje neurons are the least numerous cell-type in the cerebellum (Naim et a l ,  1989) and 
significantly increased levels o f repeat size changes within these cells might be concealed by the 
inclusion of many other cell-types within the tissue samples used for analysis. In peripheral tissues 
repeat instability is also consistently demonstrated in the kidney and liver (Ishiguro et a l ,  2001; 
Mangiarini et al., 1997; Wheeler et al., 1999). Previously published data on human somatic repeat 
instability initially reported no heterogeneity of repeat size within different HD tissues (MacDonald 
et a l ,  1993; Zuhlke et al., 1993). However, subsequent studies o f juvenile HD patients 
demonstrated minor, but consistent levels o f increased repeat instability associated with the 
striatum compared to other brain regions (De Rooij et al., 1995; Telenius et al., 1995).
Whilst the patterns o f somatic repeat instability are broadly similar between the previously 
published data and the present study significant differences are apparent when comparing the 
magnitude of the repeat size changes observed. The largest expansions detected within the striatum 
of HD mice expressing significantly longer progenitor repeat tracts (111-145 repeats) than the 
HD+/‘ mice in this study, were only -3  repeats in the knock-in mouse (Wheeler et al., 1999) and 
-2 5  repeats in the R6/2 mice (Mangiarini et al., 1997). A  knock-in HD mouse model carrying a 
progenitor repeat size o f 77 repeats, similar to the progenitor allele size o f  H D+/‘ mice, 
demonstrated expansions of -  20 repeats within the striatum (Ishiguro et al., 2001) compared to 
regular increases of over 80 repeats observed in HD+/’ mice in this study. Expansion-biased (<15 
repeats) changes in repeat length within the striatum and cortex of juvenile HD patients have been 
reported (Ishiguro et al., 2001) compared to the repeat size changes of >600 repeats observed in 
juvenile HD tissue in this study.
To determine whether different experimental techniques could contribute to the discrepancies in 
mutation profiles observed, the PCR products from the same PCR amplification were analysed by 
both small pool PCR and Genescan imaging techniques (section 5.6). The increased sensitivity o f  
the visualisation technique and the lower numbers of DNA templates amplified in small pool PCR 
permits the detection of a significantly wider spectrum o f repeat lengths (section 5.6). Therefore, 
the use of a small pool PCR approach may be responsible for the more dramatic mutation profiles 
observed in this study compared to others.
7.3.1 Small pool PCR
Small pool PCR was used to detect the extensive somatic repeat instability in brain regions of HD+/" 
mice and human HD patients. However, it is well established that the amplification o f DNA  
templates by PCR is associated with the production o f PCR artefacts due to slippage o f Taq
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polymerase or preferential amplification of smaller molecules. Several observations suggest that 
the spectrum of PCR products obtained from the small pool PCR analyses in this study are not PCR 
artefacts and do represent the products from individual templates.
• The PCR products observed are not merely a reflection o f the progenitor allele repeat
length as a tissue-specific pattern o f repeat instability is observed in individual animals and 
a consistent pattern o f somatic repeat instability is generated for animals o f a particular 
age. Previous studies have also illustrated that the variability of repeat lengths observed in 
different samples reflects the variation observed on Southern blot analysis o f genomic 
DNA (Monckton et al., 1995).
• In sperm analyses the frequency of individual mutant PCR products is proportional to the 
amount o f input template DNA (over the range o f 60-960 pg of sperm DNA per reaction) 
(Jeffreys et a l ,  1994). This suggests that heteroduplex formation, which would produce 
additional bands leading to a disproportionate increase in PCR products with increasing 
concentrations of template DNA, does not occur.
• The PCR signal from a mutant allele is similar to that seen for progenitor alleles in single
molecule dilutions of sperm DNA. This observation is consistent with the signal being
derived from a single input molecule (Jeffreys et al., 1994).
• Although PCR artefacts could arise at any stage of the PCR amplification process and 
produce bands of different intensities longer autoradiography exposures do not pick up any 
additional faint bands compared to the strong signal from the original PCR products.
7.3.2 Polyglutam ine load and HD pathogenesis
In an attempt to further elucidate the possible role o f somatic repeat instability in HD pathogenesis, 
the pattern and extent o f somatic repeat instability was investigated in homozygous HD'/_ mice 
(section 6.3). The tissue-specific pattern o f somatic repeat instability was similar in homozygous 
and heterozygous HD mice, with comparable size changes observed.
The overall similarities between homozygous and heterozygous HD patients and HD+/' mice 
support the idea that the HD mutation is dominant and therefore 50 % of total huntingtin protein 
carrying an extended poly glutamine stretch is sufficient to initiate the disease process. However, it 
has been shown that the disease process can be influenced by increasing the toxicity o f mutant 
huntingtin protein (Andrew et al., 1993; Duyao et a l ,  1995; (HDCRG), 1993; Penney et al., 1997; 
Snell et al., 1993). Therefore, the length o f the polyglutamine tract rather than the overall 
polyglutamine concentration appears to influence the degree o f cellular dysfunction. A s there are
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no significant differences in the extent and magnitude o f repeat instability in homozygous and 
heterozygous HD mice, the likelihood that an individual cell within the striatum contains a repeat 
length above the threshold number required to precipitate neuronal dysfunction, would be the same 
in both genotypes. This hypothesis may explain the absence o f a earlier disease onset in 
homozygous compared to heterozygous HD mice.
Homozygous HD'7' mice are phenotypically similar to heterozygous HD+/' mice and this is 
consistent with previous reports that homozygous human HD patients appear to be phenotypically 
indistinguishable from their heterozygous counterparts (W exler et al., 1987). However, some 
studies o f HD knock-in mice have reported that disease progression is faster in homozygous 
animals (Lin et al., 2001; Wheeler et al., 2000). These findings suggest that a higher cellular 
polyglutamine load may expedite disease progression, perhaps at a later stage in the disease process 
when both mutations have crossed the threshold length.
7.3.3 Expression of full-length m utant huntingtin and HD pathogenesis
The present study demonstrates that the pattern of tissue-specific repeat instability is altered in 
mice expressing a truncated form of mutant huntingtin protein when compared to mice expressing 
full-length mutant huntingtin protein (section 6.4). Although there were tissue-specific differences 
in somatic repeat instability, the striatum of HDlrunc mice no longer showed significantly greater 
repeat instability than other brain regions. In addition, the cerebellum displayed the greatest extent 
and magnitude of repeat length variation. It is interesting to note that a higher incidence o f protein 
aggregates have been reported within the cerebellum of mice expressing truncated mutant 
huntingtin, suggesting that these cells may have an increased poly glutamine load (Xiao-Jiang Li, 
unpublished data). This study raises the possibility that the expression o f a mutant huntingtin 
protein lacking the protein sequence downstream o f the elongated polyglutamine stretch influences 
patterns of tissue-specific repeat instability.
These findings may have implications for HD transgenic mouse models that have been generated 
using transgenes expressing a truncated form of the human mutant huntingtin protein (Mangiarini 
et al., 1996; Schilling et al., 1999; Yamamoto et al., 2000). The expression of a truncated mutant 
huntingtin protein is associated with a more progressive phenotype and widespread distribution of 
protein aggregates (Davies et al., 1997; Schilling et al., 1999). Aggregates, a cellular hallmark of 
HD pathology, are restricted to brain cells vulnerable to HD pathogenesis in humans (Becher et al., 
1998; DiFiglia et al., 1997), suggesting that the expression o f truncated mutant huntingtin could 
alter the selective pattern of cellular changes in HD. Full-length mutant huntingtin may influence 
cell-selective vulnerability by cell-specific protein-protein interactions (section 1.2.7) and/or tissue- 
specific protein processing prior to nuclear translocation (section 1.2.6.1). The absence o f the full- 
length protein could disrupt or bypass these tissue-specific steps in HD pathogenesis and allow
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other cellular factors to determine the specificity of pathology. However, the pattern of somatic 
repeat instability in HDtrunc mice and other HD mouse models expressing truncated huntingtin 
cannot be accurately compared as the different experimental techniques used in these investigations 
have previously shown significantly different detection sensitivities (section 5.6).
7.3.4 Som atic repeat instability and m echanism s of HD pathogenesis
The progressive somatic repeat instability in the HD+/' mice (section 5.4) suggests a role for repeat 
length expansions in the initiation and/or progression o f HD pathogenesis. Behavioural alterations 
in the HD+/' mice are present from 3 months o f age (Shelboume et al., 1999). However, clear 
tissue-specific repeat instability does not occur until ~ 9 months of age. These findings suggest that 
somatic repeat instability does not contribute to the initiation of HD pathogenesis in the HD+/' mice. 
However, huntingtin-mediated pathogenesis and repeat instability could interact and initiate a 
vicious cycle, as longer repeats are more toxic to cells but are also more prone to expansion. 
Tissue-specific differences in the extent and magnitude o f repeat instability might result in more 
rapid progression o f the disease process in specific regions with the temporal gradient o f  
neuropathology matching the pattern of somatic repeat instability.
It is postulated that somatic repeat instability might play a role in the initiation of HD pathogenesis. 
As all mouse models have been generated using repeat lengths significantly larger than those 
generally seen in human HD, it is possible that subtle forms o f neuronal dysfunction are already 
apparent at birth since the repeat threshold required to initiate HD pathogenesis has already been 
exceeded. Initial HD pathogenesis observed in HD mice would therefore be independent o f repeat 
instability. Conversely, the mutation length that most human patients inherit may be below the 
threshold required to initiate neuronal dysfunction. The late onset o f clinical HD symptoms may 
reflect the time taken to generate a significant proportion o f neurons with repeat lengths above this 
threshold and cause observable dysfunction. The selective vulnerability of the striatum may occur 
as a greater proportion of striatal cells reach the threshold repeat length earlier than other regions of 
the brain. This hypothesis would suggest that the 36 CAG repeat threshold, distinguishing non- 
pathogenic and pathogenic HD mutations in humans, may not encode the polyglutamine length 
required to initiate pathogenesis but the size at which repeat instability becomes more likely.
7.3.5 Future stud ies into som atic repeat instability in HD
In order for somatic repeat instability to contribute to HD pathogenesis in the manner indicated in 
previous sections, repeat length must be correlated with the degree o f cellular dysfunction. To 
directly relate cellular function and repeat length an examination o f the electrophysiological 
properties o f visualised MSN followed by collection o f the nucleus and mutation length
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determination could be carried out. It is postulated that the cells with larger repeats would display 
greater cellular dysfunction.
Based on this assumption it would be expected that the MSN, the cell-type most vulnerable to the 
HD disease process, would carry the longest repeats. As a high (-9 5  %) percentage o f the neurons 
within the striatum are MSN and a high percentage of cells (-9 5  %) investigated exhibit repeat 
length changes, it is almost certain that the MSN will exhibit some level o f somatic repeat 
instability. However, it is possible that other cell-types within the striatum also display repeat 
instability. An investigation to harvest single cells from striatal tissue using laser capture micro­
dissection followed by PCR amplification o f the mutation would allow the assessment of the range 
of repeat lengths within specific cell-types.
An alternative approach of assessing the contribution o f somatic repeat instability to HD 
pathogenesis would be to generate a mouse model that expresses a long polyglutamine stretch 
within the mutant huntingtin molecule encoded by an extended but stable repeat stretch. This could 
be achieved by generating a HD mouse in which the extended CAG repeat within the Hdh gene is 
frequently interrupted by CAA codons. This would still encode a pure glutamine stretch but should 
display reduced instability as studies have demonstrated that interruptions to CAG repeat tracts can 
dramatically reduce levels of repeat instability (Goldberg et a l ,  1995; McNeil et a l ,  1997).
7.3.6 Underlying m echanism s of som atic repeat instability
As mutation length variability in somatic tissue may play a crucial role in the initiation and 
progression o f HD pathogenesis, elucidation of the mechanisms underlying the CAG repeat 
instability may provide targets for future therapeutic intervention strategies. Studies o f the somatic 
repeat instability in HD+/‘ mice have provided clues to the mechanisms that might be responsible 
for repeat size changes.
Although many of the previously reported mechanisms for repeat instability are replication-based 
(section 1.6.2) the progressive somatic repeat instability observed in HD+/' mice is predominantly 
observed in brain regions, tissues that are largely comprised o f post-mitotic cells. These findings 
suggest that brain repeat instability within HD+/' mice may not be caused by a replication-based 
process. Further studies of repeat instability in cells with differing proliferation capacities also 
demonstrated a lack of correlation between cell division rate and repeat instability (section 6.2). 
This observation is also supported by studies o f triplet repeat instability in other mouse models 
(Fortune et a l ,  2000) and cell culture systems (Gomes-Pereira et a l ,  2001).
It has been suggested that recombination-based mechanisms o f DNA repair can generate repeat 
instability (section 1.6.5.1). If recombinational repair is responsible for repeat instability then it
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might be postulated that homozygous HD 7' mice, carrying two elongated CAG repeats, would have 
a greater propensity for expansion because longer repair templates are present. The observation that 
there is no significant difference in the somatic repeat instability profiles of homozygous and 
heterozygous HD mice suggests that repeat instability is generated by a mechanism working 
independently on each chromosome. This suggestion has also been supported by the observations 
that repeat instability occurs in post-mitotic haploid sperm cells (Kovtun and McMurray, 2001).
Studies have shown that a functional mismatch repair (MMR) system is required to generate 
somatic repeat instability within R6/2 HD mouse tissues (Manley et al., 1999) (section 1.6.3.2) and 
mouse models of other triplet repeat diseases (van den Broek et a l ,  2002). The ability o f the MMR 
protein MSH2 to bind looped DNA structures (Pearson et a l ,  1997) that can form in repetitive 
sequences (Sinden and Wells, 1992), has been postulated to stabilise these structures and aid with 
their incorporation into the genome (section 1.6.3.2).
In cycling E.coli  cells, loop formation during replication would activate MMR methylation- 
directed strand-specific repair to excise the looped structure and preventing repeat instability. As 
brain cells are predominantly post-mitotic this loop formation and repair cannot occur. However, 
single-stranded DNA is still generated during processes such as transcription and/or during DNA  
repair. Formation o f secondary structures during DNA  repair could be exacerbated in non­
replicating cells by increased levels of DNA damage associated with enhanced oxidative stress. It 
is predicted that there will be no methylation-based recognition o f the loops formed during repair 
and therefore either DNA strand may be processed. When presented with the choice o f either 
deleting DNA and perhaps potentially important sequence or adding new repeat units to 
incorporate the loop, incorporation might be favoured, generating an expansion-biased pattern of 
repeat instability (M. Gomes-Pereira and D. Monckton, personal communication).
If mutation length variability plays a role in the initiation and progression o f HD pathogenesis 
further investigation of the mechanisms responsible for repeat instability, particularly in non­
replicating cells, are needed to identify cis- and trans-acting factors that could be manipulated to 
prevent repeat instability. If increased oxidative stress associated with HD pathogenesis 
exacerbates the process o f repeat instability, then early administration of antioxidants may be a 
straightforward and effective treatment for HD.
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